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Summary 
Staphylococcus aureus is a highly versatile pathogen that causes a wide range of 
diseases. Appropriate gene expression in various niches within the human body and 
abiotic environments requires the sensing of environmental conditions. An important 
environmental parameter affecting S. aureus is NaC1 concentration. This study 
investigated S. aureus virulence determinant regulation in the presence and absence of 
NaCl stress. 
In the absence of NaCl stress, aB was found to repress hla transcription and protease 
activity, possibly via the repression of agr transcription. The effect of aB on agr 
probably occurs indirectly, although sarA, sarHi and rot are unlikely to function as 
intermediates in this pathway. Tn551 mutagenesis identified numerous genes, including 
lysC, ykuQ, lysA, brnQ and telA, which repress hla transcription and protease activity by 
upregulating aB activity. These genes are clustered in the SVS (S. aureus virulence and 
survival) region of the S. aureus genome, in which transposon insertion affected the 
virulence and survival of mutants isolated in numerous published screens. Other SVS 
region genes, including asd, dapA, hipO, ac1P and norQ were also found to repress hla 
transcription and protease activity by upregulating aB activity. 
In the presence of NaCl stress, virulence determinants (which are normally regulated by 
agr) come under the control of a novel regulatory system involving an-dependent and 
aB-independent pathways. Tn917 mutagenesis identified several genes, including citG, 
opuD, yugT, oppF, ykrP, eprH, yubA, unkl and unk2, which have putative roles in the 
aB-independent pathway. The SVS region genes analysed may function in the aB- 
dependent pathway. The sensor saeS was found to upregulate hla transcription in the 
absence of NaCI stress and may be involved in sensing NaCI stress. The NaCI stress 
signal may act in concert with other parameters to allow stringent virulence determinant 
regulation in response to the prevailing environmental conditions. 
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CHAPTER 1 
INTRODUCTION 
1.1 The staphylococci 
Staphylococci are Gram-positive cocci of -1 gm diameter that characteristically divide 
in more than one plane to form grape-like clusters. In 1883, this clustering prompted 
Ogston to introduce the word Staphylococcus (from staphyle, meaning bunch of grapes) 
to name a group of micrococci causing inflammation and suppuration (Kloos & Lambe, 
1991). The genus Staphylococcus belongs to the low G+C content phylogenetic group 
of Gram-positive bacteria (Woese, 1987), and comprises 32 species and eight 
subspecies (Kloos & Bannerman, 1994). 
The staphylococci are non-sporulating, non-motile bacteria, and are generally non- 
encapsulated. The presence of multiple glycine residues in the interpeptide bridge 
makes the cell wall peptidoglycan unique and renders it susceptible to lysostaphin. 
Members of the genus have complex nutritional needs, and in general require 5- 12 
essential amino acids and 2-3 B-group vitamins (Wilkinson, 1997). Staphylococci are 
catalase-positive and oxidase-negative, and are usually facultative anaerobes, capable of 
generating energy by respiratory or fermentative pathways. 
Staphylococci are ubiquitous in the environment, and can be isolated from soil, dust, air 
and water. They are some of the hardiest non-sporulating bacteria known, 
demonstrating resistance to disinfectants, heat (ie. 50 °C for 30 min), desiccation, and 
salt, with most species capable of growth in the presence of 1.7 M NaC1 or higher 
concentrations (Kloos & Lambe, 1991; Kloos & Bannerman, 1994). 
Typically, the staphylococci are found in association with the skin, skin glands and 
mucous membranes of warm-blooded animals. Pathogenic staphylococci are usually 
identified by their ability to clot plasma by the production of coagulase (Kloos & 
Lambe, 1991). At present, only three species of staphylococci have been shown to be 
coagulase-positive. These include S. intermedius and S. hyicus, which are found in 
animals (Devriese et al., 1978; Hajek, 1976) and S. aureus, which is a human pathogen. 
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The remaining members of the genus Staphylococcus are coagulase-negative and do not 
generally cause disease. However, a few coagulase-negative pathogenic staphylococci 
have been identified, such as S. epidermidis, although these are considered opportunistic 
pathogens as they infect indwelling medical devices, or following trauma or pre- 
disposing disease (Kloos & Lambe, 1991). 
1.2 Staphylococcus aureus 
Staphylococcus aureus is one of the most prevalent species in the genus 
Staphylococcus, second only to S. epidermidis. However, whereas S. epidermidis until 
only recently rarely caused disease, S. aureus is a highly versatile human pathogen and 
has been the focus of extensive research. The species name aureus (meaning `golden') 
is derived from the fact that on agar, colonies of most S. aureus strains display yellow 
pigmentation due to the presence of triterpenoid carotenoids and staphyloxanthin, 
whereas other species form white colonies (Marshall & Wilmoth, 1981). S. aureus 
strains are alkaline phosphatase-positive and show no ß-galactosidase activity. The 
entire genomes of a number of S. aureus strains have been sequenced and shown to be 
2.8 megabase pairs in size (Baba et al., 2002). Assuming that the average gene size is 
1 kb, S. aureus is likely to possess - 3,000 genes (Coulter et al., 1998). 
1.3 Diseases caused by S. aureus 
S. aureus causes a range of diseases, which vary widely in seriousness, from the minor 
to the life-threatening. The diseases can be divided into three groups, including the 
superficial lesions (eg. small skin abscesses and wound infections), the toxinoses (eg. 
toxic shock syndrome, scalded skin syndrome and food-poisoning) and the potentially 
fatal systemic conditions (eg. bacteraemia, septicaemia, endocarditis, osteomyelitis, 
pneumonia and meningitis). 
As the fourth most frequently isolated pathogen in hospital environments (Kloos & 
Bannerman, 1994), S. aureus is a major cause of nosocomial infections, although it also 
causes community-acquired infections. Infection with S. aureus is a common 
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complication following invasive hospital techniques, as skin damage allows entry into 
the body. For example, S. aureus has been identified as the main cause of postoperative 
wound infections, being responsible for 28 % of cases (Giacometti et al., 2000). In 
addition, S. aureus frequently infects indwelling medical devices such as catheters and 
central venous lines, and has been shown to cause 20 % and 29 % of infections 
involving intravascular canulae and pacemakers respectively (Bluhm, 1985). 
Toxic shock syndrome (TSS) is an acute and potentially fatal illness characterized by 
shock, high fever, a diffuse erythematous rash, hypotension, and involvement of 
multiple organ systems (Dinges et al., 2000). High absorbency menstrual tampons have 
been identified as a risk factor for developing TSS (Reingold et al., 1980), although 
only strains possessing the gene encoding toxic shock syndrome toxin 1 (TSST-1) are 
capable of causing the disease. 
S. aureus causes staphylococcal food-poisoning (SFP) by contaminating food with one 
or more of its enterotoxins (Table 1.1). However, SFP does not require the presence of 
viable bacteria, and the heat-stable enterotoxins often survive the cooking process. The 
incidence of SFP is unknown, although it is probably the most common cause of food- 
poisoning in America (Dinges et al., 2000). Symptoms of SFP include nausea, 
vomiting, abdominal pain and diarrhoea. However, SFP is a self-limiting condition that 
typically resolves within 24 to 48 h of onset, and is rarely fatal (Dinges et al., 2000). 
Bacteraemia caused by S. aureus generally results from local infection with 
dissemination into the blood stream, although it may also occur due to direct inoculation 
during intravenous drug abuse. Septicaemia involves the multiplication of bacteria in 
the blood, and often results in a secondary site of infection (eg. endocarditis). 
S. aureus is responsible for 80 - 90 % of cases of pyogenic osteomyelitis (Dirschl & 
Almekinders, 1993), and can also cause septic arthritis and orthopaedic implant failure. 
The ability of S. aureus to cause bone and joint pathology has been reviewed by Nair et 
al. (2000). 
The fact that 19 - 51 % of healthy individuals are carriers of S. aureus (Kluytmans et 
al., 1997) has been an important factor in the spread of S. aureus-associated diseases by 
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food preparation and hospital workers. The anterior nares are the main site of carriage, 
although S. aureus is also found on the skin and in faeces (Novick, 1990; Kloos & 
Bannerman, 1994). The ability of the bacterium to survive in abiotic environments, and 
to resist common disinfection procedures has also played an important role in allowing 
the bacterium to become a major cause of nosocomial infection. 
1.4 Treatment and prevention of S. aureus infections 
Penicillin was introduced for the treatment of severe S. aureus infections in the 1940's. 
However, by the late 1940's the emergence of 13-lactamase allowed approximately 60 % 
of hospital-acquired strains to become penicillin-resistant (Barber and Rozwadowska- 
Dowzenko, 1948). In addition, strains resistant to other commonly used antibiotics such 
as streptomycin, tetracycline and erythromycin were reported shortly after they began to 
be administered clinically (Demerec, 1948; Haight & Finland, 1952). In the 1960's, ß- 
lactamase-resistant antibiotics, such as methicillin, were introduced. However, strains of 
methicillin-resistant S. aureus (MRSA) possessing a novel form of a penicillin binding 
protein (PBP2A (MecA)) with reduced affinity for methicillin rapidly emerged 
(Hartman & Tomasz, 1984; Jevons, 1961). Over the last decade, vancomycin has been 
reserved to treat S. aureus infections that are resistant to the other major antibiotics. 
However, S. aureus strains displaying intermediate resistance to vancomycin were 
identified initially in Japan (Kremery et aL, 1996), and subsequently in the United 
States and France. The first case of vancomycin-resistant S. aureus (VRSA) occurred in 
2002 (Centres for Disease Control, 2002). 
The antibiotic linezolid is effective against S. aureus and a number of other Gram- 
positive pathogens (Biedenbach & Jones, 1997). However, following its recent 
introduction into clinical use, S. aureus strains resistant to linezolid have already begun 
to emerge (Potoski et al., 2002), and resistance to other new antibiotics is inevitable. 
Therefore, it is imperative that future research focuses on finding ways of preventing, in 
addition to curing, S. aureus-associated diseases. At present, mupirocin is administered 
topically to prevent nasal carriage of S. aureus by hospital staff, in order to reduce the 
incidence of nosocomial infection (Hudson, 1994). Numerous attempts to develop 
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vaccines have also been made (Foster, 1991; Schennings et al., 1993; Fattom et al., 
1996; Menzies & Kernodle, 1996; Nilsson et al., 1998). 
1.5 Virulence determinants produced by S. aureus 
Virulence determinants are bacterial products that contribute to the pathogenicity of a 
microorganism. The ability of S. aureus to cause a wide range of diseases (Chapter 1.3) 
can be accounted for by its ability to produce a vast repertoire of virulence 
determinants, which are shown in Table 1.1. The virulence determinants of S. aureus 
can be divided into three categories, including those involved in: 1) attachment (ie. 
factors involved in the attachment of S. aureus to cells or extracellular matrices), 2) host 
defence evasion (ie. factors that reduce or prevent phagocytosis, or that interfere with 
the function of anti-staphylococcal antibodies or other specific host-defence 
mechanisms), and 3) invasion/tissue penetration (ie. factors involved in attacking host 
cells or that degrade components of extracellular matrices) (Projan & Novick, 1997), 
although it is possible that some factors may have a role in more than one of these 
categories. However, the list of virulence determinants (Table 1.1) is not 
comprehensive, and it is possible that additional virulence determinants are yet to be 
discovered. Furthermore, many of the genes involved in the pathogenesis of S. aureus 
also have overlapping housekeeping functions. For example, whilst the peptidoglycan 
of S. aureus has the housekeeping function of conferring structure and stability, it also 
plays an important role in pathogenesis by provoking a harmful immune response 
(Kaplan & Tenenbaum, 1982). It is disputable whether such components should be 
included in the list of virulence determinants. 
With the exception of the toxinoses, no single factor is responsible for the pathogenesis 
caused by S. aureus; disease instead occurs due to the coordinate action of multiple 
factors (Projan & Novick, 1997). In addition, it is important to note that some of the S. 
aureus virulence determinants are only important in particular diseases, and that no 
strain capable of producing all of the known virulence determinants has yet been 
identified. 
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Virulence determinant Gene Growth phase of expression 
Attachment 
Clumping factor cifA Log phase 
Fibrinogen-binding protein fbpA Log phase 
Fibronectin-binding protein A fnbA Log phase 
Fibronectin-binding protein B fnbB Log phase 
Collagen-binding protein cna Log phase 
Coagulase cga / coa Log phase 
Polysaccharide/adhesin (PS/A) - - 
Polysaccharide intracellular adhesin - - 
Host defence evasion 
Enterotoxin A sea Constitutive 
Enterotoxins B, C 1-3, D, E, H seb-h Post-exponential 
Toxic shock syndrome toxin-1 (TSST-1) tst Post-exponential 
Staphylococcal exotoxin-like proteins set 1-5 - 
Exfoliative toxins A, B eta, etb Post-exponential 
Protein A spa Log phase 
Lipase geh Post-exponential 
V8 protease (serine protease) sspA Post-exponential 
Fatty acid modifying enzyme (FAME) fine Post-exponential 
Panton-Valentine leukocidin lukPV, lukS-PV Post-exponential 
Capsular polysaccharide types 1 cap] locus Post-exponential 
Capsular polysaccharide type 5 caps locus Post-exponential 
Capsular polysaccharide type 8 cap8 locus Post-exponential 
Staphylokinase sak Post-exponential 
Catalase katA Post-exponential 
Invasion/tissue penetration 
a-haemolysin (a-toxin) hla Post-exponential 
ß-haemolysin (ß-toxin) hlb Post-exponential 
S-haemolysin (8-toxin) hid Post-exponential 
y-haemolysin (y-toxin) h1gA, B, C Post-exponential 
Metalloprotease (aureolysin) aurA Post-exponential 
Cysteine protease sspB Post-exponential 
Phospholipase C plc Post-exponential 
Hyaluronidase (hyaluronate lyase) hysA Post-exponential 
Table 1.1 
Virulence determinants produced by S. aureus. 
Adapted from Projan & Novick (1997). (- = not determined). 
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Three representative virulence determinants are considered in this thesis; surface protein 
A, a-haemolysin and the proteases. Protein A (Spa) is a 42 kDa cell wall protein, 
although it may also be released extracellularly. In both cases, protein A interacts non- 
specifically with the Fc portion of all subclasses of human immunoglobulin (IgG) 
except IgG3 (Forsgren & Sjoguist, 1966). The function of protein A is to inhibit 
opsonisation and therefore prevent phagocytosis. 
a-haemolysin is one of the most extensively studied S. aureus virulence factors, and is 
encoded by the gene hla (Gray & Kehoe, 1984). Monomers of a-haemolysin bind to 
cell membranes and associate to form a hexamer (or heptamer), resulting in pore 
formation and cell lysis (Bhakdi & Tranum-Jensen, 1991). a-haemolysin lyses a wide 
range of cell types, including leukocytes, platelets and fibroblasts, although erythrocytes 
represent the most sensitive target. Furthermore, a-haemolysin displays a wide variation 
in activity against erythrocytes of different species. It is at least 100-times more active 
against rabbit erythrocytes than those from any other species (Bhakdi et al., 1984), and 
so rabbit blood is used to assay the toxin. 
S. aureus produces three main proteases; serine protease (V8 protease) (sspA), cysteine 
protease (sspB) and metalloprotease (aurA) (reviewed by Dubin, 2002). Serine protease 
is synthesised as an inactive precursor that is activated by the metalloprotease. 
Activated serine protease then activates a cysteine protease precursor. The ability of 
activated serine protease to cleave IgG antibodies in vitro suggests that it may have a 
role in immune response evasion, and it has also been suggested that the proteases may 
provide protection against antimicrobial peptides such as the platelet microbicidal 
proteins (PMPs) (Yeaman et al., 1994) or neutrophil defensins (Selsted et al., 1993). 
Additionally, the proteases of S. aureus may play a role in the destruction of tissue 
proteins and therefore contribute to invasiveness (Goguen et al., 1995). However, it is 
also possible that the proteases act as molecular scavengers to obtain utilisable nutrients 
from the environment, and that they are involved in regulating the stability and activity 
of other S. aureus virulence determinants. 
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1.6 Control of virulence determinant production 
1.6.1 General mechanisms involved in coordinate virulence determinant 
regulation 
The growth and survival of bacteria is competitive, and is dependent on the ability to 
adapt to environmental changes. In all bacteria, only a small proportion of genes, termed 
housekeeping genes, are essential for growth and survival. These are often expressed 
constitutively. However, the remaining genes are non-essential, and are referred to as 
accessory factors. Although the virulence determinants produced by S. aureus (Chapter 
1.5) provide the bacterium with an advantage during infection, none are essential for 
growth and survival, and can therefore be considered accessory factors. The production 
of accessory factors diverts metabolic resources away from housekeeping gene 
expression, and so a strain which produces accessory factors constitutively would be 
less competitive than a strain which restricts their synthesis to the times when they are 
required. Therefore, bacteria have evolved a number of regulatory systems that allow 
gene expression to occur only when appropriate. However, the following list is not 
comprehensive, but instead introduces a number of important mechanisms that will be 
considered further in this thesis. 
1.6.1.1 Signal transduction 
1.6.1.1.1 Two-component sensor-regulator systems 
In order for a bacterium to adapt its gene expression appropriately, it must be able to 
sense environmental changes. The majority of environmental stimuli do not penetrate 
the cell wall. Therefore, bacteria have evolved mechanisms that allow signals to be 
relayed from the outside to the inside of the cell. Two-component signal transduction 
systems detect changes in one or more environmental parameter (eg. temperature, 
osmolarity, pH, and nutrient availability), and mediate appropriate changes in gene 
expression. However, although the bacteria in which two-component systems have been 
identified are extremely diverse, ranging from soil bacteria to pathogens, their signal 
transduction pathways involve a common mechanism and homologous protein domains 
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(Nixon et al., 1986: Miller et al., 1989: Stock et al., 1989). Similar two-component 
signal transduction systems have also been identified in eukaryotes. 
In general, two-component systems comprise two proteins; a transmembrane sensor 
kinase and a transcription factor known as a response regulator. Environmental signals 
are detected by the extracellular or periplasmic N-terminus of the sensor kinase. This 
causes the sensor kinase to become autophosphorylated at a conserved histidine residue 
on its C-terminus. The phosphate is then transferred to a conserved aspartyl residue on 
the N-terminus of the response regulator, causing a conformational change that allows 
the C-terminal domain of the response regulator to activate or repress target gene 
transcription. 
1.6.1.1.2 Quorum sensing 
Quorum sensing systems allow bacteria to regulate gene expression in a cell density- 
dependent manner. A diffusible signal molecule (pheromone) is released and 
accumulates in the surrounding environment at concentrations directly proportional to 
cell density. When the concentration of the signal molecule exceeds a threshold level, 
the signal is transduced to make appropriate changes in gene expression. The signal 
molecules of Gram-positive bacteria are usually peptides (Clewell, 1993: Solomon et 
al., 1996), which are produced by cleavage of a larger precursor molecule and which 
may then be further post-translationally modified. Quorum sensing systems have also 
been identified in Gram-negative bacteria, although their signal molecules are usually 
non-processed N-acyl homoserine lactones (Eberhard et al., 1981). 
Pseudomonas aeruginosa is a Gram-negative pathogen that mainly infects 
immunocompromised patients and suffers of cystic fibrosis. P. aeruginosa uses quorum 
sensing to allow the elastase-specific protease LasB to be expressed only when the 
bacterial population is large enough to produce sufficient amounts of LasB to cause an 
appreciable effect (Pearson et al., 1994). This allows the bacterium to conserve 
metabolic resources at times when LasB production is unnecessary. 
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1.6.1.2 Alternative sigma factors (ß) 
Many bacteria coordinately control the transcription of sets of genes in response to 
environmental changes through the use of sigma factors (a). a factors are proteins that 
bind to core RNA polymerase to form holoenzymes which direct transcription from 
specific promoters with conserved sequence motifs (reviewed by Heimann & Moran, 
2002), and can be subdivided into two groups (Dombroski et al., 1993). The primary a 
factor is required for the transcription of housekeeping genes whose products are 
essential for growth. The second group comprises the alternative a factors, which 
coordinate the transcription of particular sets of genes under specific cellular conditions. 
The general stress response of the low-GC Gram-positive bacterium Bacillus subtilis is 
controlled by the alternative transcription factor aB (reviewed by Price, 2002). It is 
estimated that over 200 genes are directly or indirectly regulated by QB of B. subtilis in 
response to environmental stresses including acid, alkali, ethanol, heat, osmotic, or 
oxidative stress, and by energy depletion caused by starvation or entry into stationary 
phase (Bernhardt et al., 1997; Price, 2000; Price et al., 2001). In addition, d is a major 
transcription regulator in stress resistance in Listeria monocytogenes (Becker et al., 
1998) and contributes to virulence in Bacillus anthraces (Fouet et al., 2000). 
A similar role in the general stress response of the Gram-negative bacteria Escherichia 
coli and Salmonella typhimurium has been suggested for RpoS (Hengge-Aronis, 1993; 
Loewen & Hengge-Aronis, 1994). The finding that mutation of rpoS in Gram-negative 
bacteria leads to reduced virulence in mice indicates the importance of rpoS in 
pathogenesis (Chen et al., 1995; Nickerson & Curtiss, 1997, Wilson & Gulig, 1998). 
1.6.1.3 DNA supercoiling 
Classical models of bacterial gene regulation represent DNA as a passive substrate upon 
which regulatory proteins act. However, in the last four decades it has been recognised 
that topological changes in the DNA itself may play a role in the control of cellular 
processes such as transcription (Dorman, 1994). Eubacterial DNA mainly occurs as a 
right-handed duplex (Drlica & Riley, 1990) that forms closed loops or covalently closed 
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circles. In terms of DNA secondary structure, these are topologically equivalent. The 
DNA duplex in these loops is usually in an underwound state (Worcel & Burgi, 1972). 
This creates torsional tension which causes either strand separation or a distortion of the 
DNA helical axis in which the duplex coils around itself. Coiling of the already coiled 
DNA duplex is termed `supercoiling', and is controlled by topoisomerases (eg. DNA 
gyrase) and histone-like proteins. Supercoiling of DNA in the same sense as the right- 
handed coiling of the duplex is referred to as `positive supercoiling', whilst coiling in 
the opposite sense causes negative supercoiling. 
The physical chemistry of DNA suggests that underwinding of the double helix 
thermodynamically favours DNA reactions that require strand separation (Drlica, 1984). 
These include transcription, replication and recombination. Furthermore, the possible 
importance of DNA supercoiling in the regulation of gene expression has been 
highlighted by the finding that the E. coli chromosome is subdivided into independently 
supercoiled domains (Sinden & Pettijohn, 1981). This suggests that genetic geography 
(ie. the position of a gene on the chromosome) could play a role in gene regulation. 
DNA supercoiling is sensitive to a wide range of environmental conditions, including 
osmolarity (Higgins et al., 1988), anaerobiosis (Dorman et al., 1988) and temperature 
(Goldstein & Drlica, 1984). Consequently, DNA supercoiling has the potential to 
coordinately regulate every gene in the bacterial cell in response to a range of 
environmental variables experienced during infection, and may contribute not only to 
environmental adaptation and survival, but also to pathogenicity. Transcription of invA, 
required for the invasive phenotype of S. typhimurium, is induced eight-fold by osmotic 
stress via DNA supercoiling (Galan & Curtiss, 1990). Additionally, DNA supercoiling 
regulates the expression of the alginate (a1g) genes of P. aeruginosa and a-haemolysin 
of E. coli in response to osmolarity (Berry et al., 1989; Carmona et al., 1993). 
1.6.2 Regulation of virulence determinant production in S. aureus 
1.6.2.1 Expression of virulence determinants in S. aureus 
The pattern of virulence determinant expression in S. aureus follows a coordinated 
program that parallels the development of an infection (Figure 1.1). The expression of 
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Figure 1.1 
Hypothetical role of virulence determinants in S. aureus infection. 
In this model, bacteria in lag phase would initiate the infection and would enter 
exponential phase, where multiplication begins, accompanied by synthesis of surface- 
associated virulence determinants to allow attachment to host cells. Crowding during 
post-exponential phase would activate a density-sensing mechanism that would 
stimulate the production of the extracellular virulence determinants, enabling the 
organisms to escape from the localised infection (abscess) during stationary phase and 
spread to new sites, where the cycle would be repeated. 
Adapted from Projan and Novick (1997). 
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the surface-associated virulence determinants, which are mainly involved in attachment 
to host tissues, is up-regulated in early exponential phase and is sharply down-regulated 
in late exponential phase. In contrast, the expression of the extracellular virulence 
determinants, which are mainly associated with tissue damage (required for dispersal or 
nutrient acquisition) and host defence evasion is not up-regulated until the post- 
exponential phase, and continues until the cells enter stationary phase (Coleman et al., 
1978). This suggests that a genetic "switch" exists which allows S. aureus to change 
from expressing surface-associated virulence determinants during early growth, to 
expressing extracellular virulence determinants during post-exponential growth. 
However, a few exceptions to this model exist; for example, enterotoxin A is expressed 
constitutively, whilst coagulase (an extracellular protein) is expressed during 
logarithmic growth (Tremaine et al., 1993). Table 1.1 shows a list of S. aureus virulence 
determinants, and indicates, where possible, the growth phase during which they are 
expressed. 
1.6.2.2 Regulators of virulence determinant production in S. aureus 
The control of virulence determinant production in S. aureus is mediated by a number 
of global regulators that have mainly been identified by transposon mutagenesis. 
Inactivation of these loci results in pleiotropic effects on the production of exoproteins 
and/or virulence determinants. These regulatory loci act either coordinately or 
independently, and include agr (Recsei et al., 1986), sar (Cheung et al., 1992) (and its 
homologues rot (McNamara et al., 2000) and sarHl-5 (Tegmark et al., 2000)), as well 
as sae (Giraudo et al., 1994), arl (Fournier & Hooper, 2000), IE3 (Cheung et al., 1995) 
and srrAB (Yarwood et al., 2001). A further potential global regulator, xpr (extracellular 
protein regulator), was identified in 1992 by Smeltzer et al., although the xpr mutant 
was subsequently shown to contain an additional agr mutation (McNamara & landolo, 
1998). The alternative sigma factor, aB (Wu et al., 1996) has been shown to regulate 
virulence determinant expression, and further unknown regulators may also play a role 
in this complex process. 
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1.6.2.2.1 agr (accessory gene regulator) 
The agr (accessory gene regulator) locus was identified as the site of a Tn551 insertion 
affecting the expression of several virulence determinants (Recsei et al., 1986, Morfeldt 
et al., 1988; Peng et al., 1988). agr upregulates a number of extracellular virulence 
determinants, including toxic-shock syndrome toxin 1 (TSST-1), several enterotoxins 
(ie. B, C and D), leukocidin, the haemolysins (ie. (x, ß, S and y), serine protease, 
metalloprotease, phospholipase C, hyaluronate lyase and lipase. In addition, agr 
represses the production of a number of cell surface-associated virulence determinants, 
including surface protein A and fibronectin binding protein A. The importance of agr in 
pathogenicity has been confirmed by the fact that agr mutants have greatly attenuated 
virulence in a number of animal models of infection, including arthritis, mastitis and 
osteomyelitis (Projan et al., 1989; Collins & Tarkowski, 2000). 
The chromosomal DNA around the Tn551 insertion was sequenced by Peng et al. 
(1988), and the complete sequence of the agr locus determined (Kornblum et al., 1990). 
The agr locus consists of two divergent transcription units (Figure 1.2) whose 
transcripts, RNAII and RNAIII, are transcribed from the two major promoters, P2 and 
P3, respectively (Komblum et al., 1990: Novick et al., 1995). The 3 kb RNAII 
transcript encodes four proteins, designated AgrB, AgrD, AgrC and AgrA (Novick et 
al., 1995), whilst the 0.5 kb RNAIII transcript encodes S-haemolysin (hid) (Janzon et 
al., 1989) and has two presumably untranslated ORFs at its 3' end. A third transcript, 
RNAI, is produced and is transcribed from the P1 promoter. However, the transcription 
of RNAI is weak and constitutive, and its role remains unclear (Peng et al., 1988). 
1.6.2.2.1.1 RNAIII as a regulatory RNA molecule 
RNAIII is a 512 base transcript, and is the main effector of virulence determinant 
regulation by agr (Novick et al., 1993). S-haemolysin, the only translated product 
encoded by RNAIII, has no general regulatory role (Janzon & Arvidson, 1990; Novick 
et al., 1993). For example, an insertion in the 3' region of RNAIII did not impair S- 
haemolysin production, but resulted in a typical agr mutant phenotype (Arvidson et al., 
1990). However, although a nonsense mutation in codon 3 of S-haemolysin prevented 
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500 bp 
Figure 1.2 
The agr locus of S. aureus. 
The positions of the three agr promoters, P1, P2 and P3, and the length of their 
transcripts are indicated. The genes agrC and agrA encode a sensor kinase and response 
regulator of a two-component signal transduction system, respectively. The product of 
agrD is modified by the product of the agrB gene to give an octapeptide know as AIP 
(auto-inducing peptide). The hid gene encodes S-haemolysin. 
Adapted from Kornblum et al. (1990). 
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transcriptional activation of the gene encoding serine protease (Janzon & Arvidson, 
1990), this probably occurred as a result of changes in RNAIII secondary structure. 
RNAIII acts primarily at the level of transcription, presumably via one or more 
regulatory proteins (Novick et al., 1993), to upregulate extracellular virulence 
determinant expression and repress cell surface-associated virulence determinant 
expression. Experiments involving deletions (Novick et al., 1993) and interspecies 
RNAIII hybrids (Benito et al., 1998, Tegmark et al., 1998) have indicated that RNAIII 
may contain subdomains that may interact with different regulatory proteins. 
However, in addition to affecting a-haemolysin (hla) expression at the level of 
transcription, RNAIII also controls hla translation by acting as an antisense RNA 
molecule. The 5' region of RNAIII contains a nucleotide sequence which is 
complementary to the leader region of hla, and which is essential for a-haemolysin 
translation (Novick et al., 1993). In the absence of RNAIII, a stem-loop structure forms 
within hla mRNA which blocks access to the ribosome-binding site (Morfeldt et al., 
1995). However, the formation of a specific complex between the 5' end of RNAIII 
and the leader sequence of hla mRNA prevents the formation of the stem-loop structure 
(Morfeldt et al., 1995). Consequently, the hla ribosome-binding site remains exposed, 
and hla translation occurs (Morfeldt et al., 1995). It is possible that RNAIII may affect 
the expression of other virulence determinants at the translational level. For example, 
complementarity between the leader sequence of the gene encoding enterotoxin D (sett) 
and RNAIII has been demonstrated (Morfeldt, 1996). 
1.6.2.2.1.2 Activation of agr 
The main role of the P2 operon is to control RNAIII transcription in a cell density- 
dependent manner (Chapter 1.6.1.1.2). AgrC and AgrA are the sensor kinase and 
response regulator of a two-component signal transduction system respectively (Novick 
et al., 1995). The signal molecule detected by AgrC is an octapeptide termed AIP (auto- 
inducing peptide) which is produced by cleavage of the 46 residue pre-peptide AgrD by 
AgrB (Ji et al., 1995). The octapeptide is further post-translationally modified by AgrB 
by the introduction of a cyclic thioester bond between a conserved cysteine residue and 
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the C-terminal carboxyl group (Ji et al., 1997). AIP is then released from the cell 
through AgrB, which is a transmembrane protein (Ji et al., 1997). 
Binding of AIP to AgrC induces autophosphorylation of a conserved C-terminal 
cytoplasmic histidine residue (Lina et al., 1998). The phosphate group presumably then 
transphosphorylates the conserved N-terminal aspartyl residue of AgrA. However, 
although the main function of AgrA is to activate P2 and P3, purified AgrA is unable to 
bind to the intergenic region between the RNAII and RNAIII transcription initiation 
sites (Morfeldt et al., 1996a). Instead, activated AgrA aids the binding of SarA to P2 
and P3, resulting in an upregulation of transcription from both promoters (Cheung & 
Projan, 1994: Heinrichs, et al., 1996) (Chapter 1.6.2.2.2). 
Therefore, the P2 operon demonstrates two levels of autocatalysis; (i) it encodes its own 
activator (AIP), which is the ligand for the sensor kinase (AgrC) encoded by the same 
operon: (ii) the primary function of the signal transduction pathway is the activation of 
its own promoter (as well as of P3), which up-regulates production of AIP as well as the 
signal transduction proteins. Consequently, the net effect of this dual activation is the 
rapid expression of RNAIII at very high levels once the threshold cell density has been 
reached. The mechanism by which agr regulates virulence determinant expression in a 
density-dependent manner, and the interaction of SarA with AgrA to achieve this, is 
represented diagrammatically in Figure 1.3. 
The agr system is conserved among many staphylococci (Ji et al., 1997). However, 
regional variations in the sequences of agrB, agrC and agrD occur, resulting in highly 
variant AIP molecules (Ji et al., 1997). Strains of S. aureus can be divided into four 
groups, based on the type of AIP that they produce. Within each group, mutual cross- 
activation of the agr-signalling pathway is observed. However, the AIP from one group 
inhibits the expression of agr in the other groups (Ji et al., 1997). This phenomenon, 
known as bacterial interference, has possibly evolved to allow one strain to exclude 
others from an infection site, and exploitation of the AIP structure may have therapeutic 
potential (Ji et a1., 1997). 
However, an additional mechanism for the control of agr activity has been suggested by 
Balaban et al. (1995,1998 and 2001). These authors reported that a 38 kDa protein, 
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Figure 1.3 
Model of the interaction between the agr and sar gene products (depicted in bold type) 
which mediate changes in expression from the P2 and P3 promoters of the agr locus. 
AgrC and AgrA are the sensor kinase and response regulator, respectively, of a two- 
component signal transduction system. AIP (auto-inducing peptide) is encoded within 
the agrD gene, and is modified from a 46 amino acid prepeptide to an octapeptide, by 
the product of the agrB gene. AIP is released from the cell, where it accumulates at a 
level proportional to cell density. When the level of AIP exceeds a critical threshold, 
AgrC becomes autophosphorylated and phosporylates AgrA. Activated AgrA aids the 
binding of SarA to P2 and P3, resulting in an upregulation of transcription from both 
promoters. The RNAIII transcript has been shown to upregulate extracellular virulence 
determinant expression and to repress the expression of surface-associated virulence 
determinants. Not to scale. 
Adapted from Wiltshire (2000). 
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termed RAP (RNAIII activating protein), which is produced by both wild-type and agr 
mutant strains of S. aureus, induces RNAIII synthesis via the phosphorylation of a 21 
kDa protein termed TRAP (target of RAP). However, the inability of other researchers 
to demonstrate any activation of RNAIII transcription with fractionated or 
unfractionated culture filtrates from the agr-null mutant RN6911 used by Balaban et al. 
has caused this system to be questioned (Novick et al., 2000). 
1.6.2.2.2 sar (staphylococcal accessory regulator) 
The sar (staphylococcal accessory regulator) locus was identified as a Tn917 insertion 
causing pleiotropic effects on the expression of several virulence determinants (Cheung 
et al., 1992). Subsequent studies have shown that the sar locus activates the expression 
of the haemolysins (a, ß and 8), TSST-1 and fibronectin binding protein A, but 
represses the expression of serine protease, metalloprotease, collagen adhesin and 
protein A (Chan & Foster, 1998a, Chien et al., 1999; Wolz et al., 2000; Cheung & 
Ying, 1994; Chan et al., 1998; Cheung et al., 1997). The importance of sarA in 
virulence has been confirmed using several animal models of infection (Booth et al., 
1997; Cheung et al., 1994; Gillaspy et al., 1995; Nilsson et al., 1997). 
The sar locus (Figure 1.3) is 1.2 kb in length, and has been mapped by Bayer et al. 
(1996). Three promoters (ie. P1, P3 and P2) are present, from which three overlapping 
transcripts (ie. sarA, sarC and sarB) originate respectively (Bayer et al., 1996; 
Heinrichs et al., 1996). All three sar transcripts have common 3' ends and encode a 372 
bp ORF (sarA) that has been shown to be necessary for optimal a-haemolysin 
expression (Cheung & Ying, 1994). Upstream of sarA are two small ORFs (ie. the 39 
bp ORF3 and the 18 bp ORF4). Deletion of these ORFs affects the regulatory ability of 
the sar locus, although reporter gene fusion experiments have shown that these effects 
are due to altered production of SarA rather than the disruption of the ORFs (Manna et 
al., 1998). The P1 and P2 promoters are recognised by the housekeeping sigma factor 
aA (Chapter 1.6.1.2), and are mainly expressed during the early exponential phase of 
growth, whilst P3 is recognised by the alternative sigma factor aB (Chapter 1.6.2.2.8), 
and is induced as the cells enter the late exponential growth phase (Bayer et al., 1996; 
Deora et al., 1997; Manna et al., 1998; Miyazaki et al., 1999; Bischoff et al., 2001). 
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However, transcription from PI is stronger than that from P2 or P3 (Cheung et al., 
1998). 
SarA is dimeric, consists mostly of a-helices (Rechtin et al., 1999), and has been shown 
to be a DNA-binding protein capable of binding to elements upstream of both the P2 
and P3 promoters of the agr locus (Chein & Cheung, 1998) (Figure 1.3). Three binding 
sites (each consisting of two 18 bp half sites), which have a high-affinity for stable SarA 
dimers, have been identified upstream of the agr promoters (Rechtin et al., 1999). By 
binding to these sites, SarA activates RNAII and RNAIII transcription (Chien & 
Cheung, 1998; Chien et al., 1998; Heinrichs et al., 1996), with concomitant effects on 
virulence determinant expression. 
However, the finding that an agr, sarA double mutant displays a greater reduction in 
virulence determinant expression than either agr or sarA single mutant indicates that 
sarA is also able to regulate the expression of virulence determinants via an agr- 
independent mechanism (Cheung et al., 1994; Booth et al., 1997). This has been 
supported by studies which showed that the transcription of h1a, tst and fnbA is activated 
by sarA in an agr-independent manner (Chan & Foster, 1998a, Chien et al., 1999; Wolz 
et al., 2000). However, there is no significant similarity between the sequence elements 
proposed as SarA-binding sites, indicating that SarA can bind multiple DNA targets, 
although they are preferably A/T-rich sequences (Arvidson & Tegmark, 2001). 
One model for the mechanism by which SarA affects gene expression was originally 
proposed by Morfeldt et al. (1996b). This model is based on the ability of SarA to alter 
the superhelicity of DNA, and is supported by a number of findings. Firstly, Morfeldt et 
al. (1996b) have shown that the spacing between the -10 and -35 regions of the P2 and 
P3 promoters of agr is approximately 3 bp too far; this suggests that SarA may serve to 
overcome this spacing in order to activate agr. Secondly, the gene encoding collagen 
adhesin (cna) is repressed by sarA; the spacing of the -10 and -35 regions of the cna 
promoter is near optimal, and so SarA may act to overwind this promoter (Rechtin et 
al., 1999). Consequently, it is possible that sarA may function as both an activator and a 
repressor. 
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1.6.2.2.3 The sar homologues 
In recent years, a number of homologues of sarA have been identified. These include rot 
(McNamara et al., 2000) and sarHl-5 (Tegmark et al., 2000). Of these, rot and sarHi 
have been the most extensively researched, and are discussed below. 
1.6.2.2.3.1 rot (repressor of toxins) 
Based on the observation that protein synthesis inhibitors suppress the production of 
several virulence factors that are positively regulated by agr, Balaban & Novick (1995) 
suggested that protein factors must be required for RNAIII to exert its regulatory 
function. To identify such factors, McNamara et al. (2000) screened Tn917 mutants in 
an agr background to identify mutations that restored protease and a-haemolysin 
production. A 498 bp ORF was identified, and its predicted 161 amino acid protein 
product, named Rot, was found to demonstrate a high level of similarity to SarA over 
the entire length of the protein. Rot has been shown to represses hla transcription in an 
agr background, but not in the presence of functional agr (McNamara et al., 2000). 
Additionally, in an agr background, rot was shown to repress numerous other genes, 
including hlb and sspA, although an upregulatory effect was observed for spa (Said- 
Salim et al., 2003). This indicates that rot may be an important global regulator which 
has opposing effects to agr on the expression of particular virulence genes (Chapter 
1.6.2.2.1). Said-Salim et al. (2003) have suggested that the effects of rot in relation to 
those of agr may occur as a result of RNAIII inhibiting Rot. 
1.6.2.2.3.2 sarHl (sar homologue 1) 
SarHI was originally isolated as a protein bound to the promoter regions of h1a, spa, ssp 
and RNAIII in extracts from sarA and agr mutants, but not in extracts from wild-type 
cells (Tegmark et al., 2000). SarHI has been shown to have a strong repressive effect on 
hla and an activating effect on spa at the transcriptional level (Tegmark et al., 2000). 
However, no significant effect on the transcription of agr or ssp could be identified, and 
the repression of h1a by sarHi was only observed in a sarA background (Tegmark et al., 
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2000). Northern blot analysis has identified three sarHi-specific transcripts, two of 
which share a common terminator (Tegmark et al., 2000). The P1 promoter is o-- 
dependent, whilst the P2 promoter has a aB-dependent consensus sequence (Tegmark et 
al., 2000). The promoter of the third transcript has not yet been identified. The PI 
transcript is strongly repressed by agr and sarA (Tegmark et al., 2000). This agrees with 
the fact that SarHi was not bound to the h1a, spa, ssp or RNAIII promoter regions in 
extracts derived from agr or sarA mutants. The gene encoding the same protein has 
been identified by Cheung et al. (2001) and designated sarS. 
1.6.2.2.4 sae (S. aureus exoprotein expression) 
The sae locus was discovered by Giraudo et al. (1994), following the isolation of a 
Tn551 mutant displaying reduced ß-haemolysin activity. The mutant has subsequently 
been shown to have diminished or null levels of a-haemolysin, DNase, coagulase and 
protein A (Giraudo et al., 1994; Giraudo et al., 1996; Goerke et al., 2001). Indeed, a 
decrease in total extracellular protein levels was also observed, although proteases, 
lipase, staphylokinase and enterotoxin A were not affected (Giraudo et al., 1994). 
Pathogenicity assays involving intraperitoneal injection into mice have shown that 
inactivation of sae results in a slower mortality rate (Giraudo et al., 1996). 
Cloning and sequencing of the locus has revealed two potentially co-transcribed genes 
(Giraudo et al., 1999). These are saeS and saeR, which encode a histidine kinase and a 
response regulator respectively (Giraudo et al., 1999) (Chapter 1.6.1.1.1). However, the 
actual stimuli that activate sae are unknown. Northern blot analysis has revealed that 
sae affects the expression of hla, hlb, coa and spa at the transcriptional level (Giraudo et 
al., 1997). Importantly, however, sae has been shown to have no effect on the 
transcription of agr or sar (Giraudo et al., 1997). Therefore, it has been hypothesised 
that saeR may exert its effect by direct interaction with target genes which are also 
subject to regulation by agr (Giraudo et al., 1999). Nevertheless, a direct interaction 
between sae and agr cannot currently be ruled out. The production of several virulence 
determinants (including ß-haemolysin, DNase and protease) was found to be lower in 
an sae, agr double mutant than the already diminished levels in either single mutant 
(Giraudo et al., 1996). Additionally, the sae, agr double mutant demonstrated a further 
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decrease in virulence (Giraudo et al., 1996). This suggests that there may be an additive 
or synergistic interaction between the two loci. 
Interestingly, the effect of sae mutation on the agr phenotype is different for two 
virulence determinants that are normally up-regulated in an agr mutant; in the sae, agr 
double mutant coagulase expression dropped close to the null levels of the sae parent 
strain, while protein A displayed the high levels characteristic of the agr single mutant 
(Giraudo et al., 1996). This suggests that the sae and agr loci interact in a complex way, 
and that the production of these two virulence determinants might be controlled by 
different mechanisms (Giraudo et al., 1996). 
1.6.2.2.5 arl 
The arl locus comprises two genes, arlS and ar1R, which encode a histidine kinase and a 
response regulator respectively (Fournier & Hooper, 2000) (Chapter 1.6.1.1.1). 
Inactivation of arl has been shown to reduce the production of a- and ß-haemolysin, 
lipase, coagulase, serine protease and protein A (Fournier & Hooper, 2000; Fournier et 
al., 2001). In addition, disruption of the arl locus alters biofilm formation and increases 
autolysis (Fournier et al., 2001). 
1.6.2.2.6 IE3 
IE3 was defined by a Tn551 insertion into a unique locus of the S. aureus chromosome 
(Cheung et al., 1995). The locus has not been mapped or sequenced, although it has 
been shown to be distinct from agr and sarA (Cheung et al., 1995). The IE3 transposon 
mutant was found to have significantly reduced levels of protein A transcription and 
clumping activity with fibrinogen, although a-haemolysin transcription and the level of 
RNAIII were slightly increased (Cheung et al., 1995). In a rabbit endocarditis model, a 
significant decrease in both the infectivity rate and intravegetation bacterial density was 
observed for the IE3 mutant, compared to the parent strain (Cheung et al., 1995). 
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1.6.2.2.7 srrAB (staphylococcal respiratory response) 
The srrAB locus of S. aureus is a homologue of the resDE two-component regulator 
system involved in the regulation of aerobic and anaerobic respiratory metabolism in B. 
subtilis (Yarwood et al., 2001). The srrAB locus has also been termed srhSR by Throup 
et al. (2001). Disruption of the locus lead to altered expression of proteins involved in 
energy metabolism and other metabolic processes (Throup et al., 2001). These effects 
were generally increased under anaerobic conditions, and were accompanied by a 
reduction in growth rate under anaerobic conditions and attenuated growth in a murine 
pyelonephritis model (Throup et al., 2001). The srrAB locus has also been shown to 
regulate RNAIII, protein A, and TSST-1 in response to oxygen availability (Yarwood et 
al., 2001). This suggests that the srrAB locus may provide a link between respiratory 
metabolism, environmental sensing and virulence determinant regulation in S. aureus. 
1.6.2.2.8 The alternative sigma factor aB 
The role of the alternative a-factor aB in regulating the general stress response of B. 
subtilis and other low-GC Gram-positive bacteria has been introduced in Chapter 
1.6.1.2. The aB operon of B. subtilis (Figure 1.4) contains eight genes in the order PA- 
rsbR-rsbS-rsbT-rsbU-PB-rsbV-rsbW-sigB-rsbX, where rsb stands for regulator of sigma 
B, and PA and PB are aA and aB-dependent promoters respectively (Kalman et al., 1990; 
Wise and Price, 1995). Two additional genes, rsbQ and rsbP reside outside the aB 
operon. In B. subtilis, the Rsb proteins function to regulate aB activity in response to 
signals detected by two separate pathways; the environmental stress pathway (RsbX, 
RsbS, RsbT, RsbR and RsbU) and the energy stress pathway (RsbQ and RsbP) (Figure 
1.5) (reviewed by Price, 2002). A homologue of B. subtilis has been identified in S. 
aureus (Wu et al., 1996; Deora et al., 1997; Kullik & Giachino, 1997). However, the S. 
aureus aB operon only comprises the genes PA-rsbU-PB-rsbV-rsbW-sigB (Wu et al., 
1996) (Figure 1.4). Genes encoding RsbR, RsbS, RsbT, RsbX, RsbQ and RsbP are 
apparently not present. However, RsbW and RsbU have been shown to play a similar 
role in S. aureus as they do in B. subtilis (Miyazaki et al., 1999; Palma & Cheung, 
2001; Giachino et al., 2001), although it remains unclear as to whether the remaining 
Rsb proteins or unknown proteins compensate for the missing components. 
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Figure 1.4 
Comparison of the aB operons of (A) B. subtilis and (B) S. aureus. 
Reproduced from Price (2002). 
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Figure 1.5 
Model of the 6B signal-transduction network of B. subtilis. 
Two signalling pathways converge on RsbV-P, the antagonist form found in unstressed 
cells. The energy-stress pathway terminates with the RsbP, which has a Per-Arnt-Sim 
(PAS) domain for energy-stress sensing and a PP2C phosphatase domain. RsbQ is a 
positive regulator presumed to act in conjunction with RsbP. The environmental-stress 
signalling pathway terminates with the RsbU phosphatase (PP2C), and is activated by 
upstream signalling elements. When activated by their respective stress, either the RsbP 
or the RsbU phosphatase removes the serine phosphate from RsbV-P. 
Dephosphorylated RsbV then binds to the RsbW anti-a factor, forcing it to release aB, 
which can then activate the transcription of its target genes. The upstream regulators 
that activate RsbU include the RsbS antagonist and the RsbT kinase, which are 
homologues of RsbV and RsbW respectively. Unphosphorylated RsbS is thought to be 
the antagonist form found in unstressed cells, and this form binds the RsbT kinase. 
Following environmental stress, RsbS is phosphorylated by RsbT, which is then 
released to bind and activate the RsbU phosphatase by direct protein-protein interaction. 
RsbR acts as a positive regulator of aB activity by potentiating the activity of the RsbT 
kinase. The RsbX phosphatase (PP2C) fulfills a negative feed-back role by indirectly 
communicating aB protein levels. 
Genes encoding only the proteins shown in boxes with solid lines have also been 
identified in S. aureus. 
Adapted from Price (2002). 
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In B. subtilis, the regulation of aB occurs post-translationally and involves a "partner- 
switching" mechanism controlled by protein phosphorylation (Figure 1.5). Under 
normal 'conditions, the anti-a-factor RsbW binds to the aB protein, which prevents the 
interaction of RNA polymerase with aB (Benson & Haldenwang, 1993). However, 
RsbV (the anti-anti-a-factor), when dephosphorylated at a conserved serine residue, 
binds competitively to RsbW, resulting in the release and activation of aB (Dufour & 
Haldenwang, 1994). Control of the phosphorylation state of RsbV is modulated by 
dephosphorylation by RsbU and RsbP (and also by RsbW-mediated phosphorylation) in 
response to the conditions sensed (Wise & Price, 1995; Vijay et al, 2000; Dufour & 
Haldenwang, 1994). It is likely that this mechanism of control of aB activity is 
conserved in S. aureus (Miyazaki et al., 1999; Palma & Cheung, 2001; Giachino et al., 
2001). 
& has been shown to play a role in the response of S. aureus to a number of 
environmental stresses, including hydrogen peroxide-mediated oxidative stress, 
exposure to acid or alkali, heat shock (54 °C), and entry into stationary phase (Kullik et 
al., 1998; Chan et al., 1998; Gertz et al., 1999; Palma & Cheung, 2001; Kullik & 
Giachino, 1997). Indeed, the & regulon of S. aureus has been shown to contain many 
components that are perceived to be important for protecting cells from various 
environmental stresses (Gertz et al., 1999; Gertz et al., 2000; Giachino et al., 2001). For 
example, the operon involved in the biosynthesis of the yellow pigment 
staphyloxanthin, which protects cells from damage by environmental factors such as 
U. V. radiation and desiccation, has a aB-dependent promoter consensus sequence 
(Kullik et al., 1998). A role for & in the development of antibiotic resistance has also 
been demonstrated (Bischoff& Berger-Bachi, 2001; Morikawa et al., 2001). 
aB has also been shown to directly or indirectly regulate a number of S. aureus virulence 
determinants, including lipase, thermonuclease, coagulase, haemolysins, proteases and 
enterotoxin B (Kullik et al., 1998; Nicholas et al., 1999; Cheung et al., 1999; Horsburgh 
et al., 2002; Palma & Cheung, 2001; Ziebandt et al., 2001). The P3 promoter of the 
virulence regulator sar and the P2 promoter of sarHi have been shown to be aB- 
dependent (Deora et al., 1997; Manna et al., 1998; Miyazaki et al., 1999; Bischoff et al., 
2001). Furthermore, aB contributes directly to the ability of S. epidermidis and S. aureus 
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to form adherent biofilms (Rachid et al., 2000; Knobloch et al., 2001), a factor that is 
considered important in their ability to cause nosocomial infections (Costerton et al., 
1999). However, investigations involving mouse and rat pathogenicity models have 
been unable to show a role for o in virulence (Chan et al., 1998, Nicholas et al., 1999), 
although Gertz et al. (2000) have questioned whether the infection models analysed so 
far truly reflect the natural situation in the human host. 
1.6.2.3 Environmental regulation of virulence determinant expression in 
S. aureus 
S. aureus is an extremely adaptable bacterium, which survives in a range of abiotic 
environments (Chapter 1.1) and causes disease in diverse areas of the human body 
(Chapter 1.3). Therefore, as well as being regulated in a growth-phase dependent 
manner (Chapter 1.6.2.1), the virulence determinants of S. aureus are regulated in 
response to a number of environmental parameters. Detection of environmental 
conditions allows S. aureus to determine whether it has entered the human body, to 
identify its location within the host, and to respond appropriately. These signals include 
temperature, pH, the concentration of metal ions (eg. magnesium, calcium and iron), 
and the concentration of oxygen, glucose and NaCI (Mekalanos, 1992). 
Temperature is a key signal indicating entry into the host for many pathogenic bacteria 
(Mekalanos, 1992). Interestingly however, whereas the virulence genes of many 
pathogens are optimally expressed at 37 °C, in S. aureus RNAIII and hla are expressed 
maximally at 42 °C (Fairhead, 1998; Ohlsen et al., 1997). The reason for this is 
unknown. pH also plays a role in virulence determinant regulation. The expression of 
Seb was found to be higher in BHI at pH 6.9 than at pH 5.1 (Genigeorgis & Sadler, 
1966). In addition, Regassa and Betley (1993) have shown that steady-state growth 
under alkaline conditions (pH 8.0) virtually eliminates the expression of RNAIII, 
suggesting that virulence determinant expression occurs over a reasonably narrow pH 
range. Chan and Foster (1998a) have shown that the addition of MgC12 or CaC12 to BHI 
represses tst expression. Similarly, Fairhead (1998) showed that decreased levels of 
available Mg2+ or Ca2+ increase the expression of RNAIII and hla, suggesting that these 
divalent cations have important effects on virulence determinant expression. Iron 
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deprivation has been shown to increase RNAIII and hla expression (P. F. Chan, 
unpublished data), possibly to allow iron-acquisition in the low free iron-concentration 
environment of the human body. Decreased oxygen availability, but not anaerobic 
growth, has also been shown to increase RNAIII and hla expression (Fairhead 1998). 
This may be important in low-oxygen concentration infection sites. 
Glucose downregulates the expression of RNAII, RNAIII, hla, sea, seb, sec and geh 
(Morse et al., 1969; Duncan & Cho, 1972; Jarvis et al., 1975; landolo & Shafer, 1977; 
Miller & Fung, 1976; Regassa et al., 1991; Regassa et al., 1992; Smith et al., 1986). In 
the majority of cases, the effect of glucose was shown to occur independently of the 
reduction in pH caused by the accumulation of acidic end products during glucose 
metabolism. However, the mechanisms by which glucose affects virulence determinant 
expression are poorly understood. Glucose-mediated repression of sec transcription 
occurs in an agr mutant, and is therefore agr-independent (Regassa et al., 1991). 
However, Regassa et al. (1992) have shown that the mechanism by which glucose 
represses sec and hla may also involve an agr-dependent pathway, although this only 
occurs at low pH. The effects of glucose (0.1 M) on sec, hla and RNAIII have been 
shown by Regassa et al. (1992) not to occur as a result of increased osmolarity, as their 
transcription was unaltered in a culture containing an iso-osmotic concentration of NaCl 
(0.05 M). It has been suggested that the repression of Seb by glucose involves catabolite 
repression (Morse et al., 1969). This is interesting, as it implies a link between virulence 
determinant regulation and nutrition. Nevertheless, the ability of the non-metabolisable 
glucose analogues to inhibit hla and seb expression (Duncan & Cho, 1972; Iandolo & 
Shafer, 1977) suggests that the effects of glucose may involve mechanisms in addition 
to, or instead of, catabolite repression. 
However, one of the most extensively studied environmental conditions affecting S. 
aureus is NaCl concentration. S. aureus is one of the most salt tolerant non-halophiles, 
and is capable of growth in up to 3.5 M NaC1(Scott, 1953; Armstrong-Buisseret et al., 
1995). This reflects the fact that high concentrations of NaCl are frequently encountered 
by S. aureus in abiotic environments and also when in association with a host. As 
described in Chapter 1.3,19 - 51 % of healthy individuals are carriers of S. aureus, with 
the skin and anterior nares being the main sites of carriage. These are two particularly 
high-NaCI concentration niches of the human body. The concentration of NaCl has been 
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shown to be a maximum of 225 mM in nasal secretions and up to 170 mM in sweat as 
they are secreted, prior to further drying (Lorin et al., 1972; Magnos, 1973)). 
Additionally, S. aureus is a common cause of food-poisoning (Chapter 1.3), especially 
where foods have been preserved using curing salts (Troller, 1986), as this reduces 
competition from less osmotolerant bacteria. For example, salt-cured ham (600 mM 
NaCI) caused 24 % of the food-poisoning outbreaks reviewed by Holmberg and Blake 
(1984). 
NaCl affects S. aureus at two levels. Firstly, it affects general cell physiology, for 
example by stimulating an osmotic stress response. Secondly, the presence of NaCl 
alters virulence determinant expression. These two effects will be considered separately, 
although they may indeed be linked. 
1.6.2.3.1 Effects of NaC1 on the general cell physiology of S. aureus 
1.6.2.3.1.1 The osmotic stress response 
Water availability is a fundamental environmental parameter affecting the growth and 
survival of microorganisms. Turgor pressure (the hydrostatic pressure difference 
between the inside and the outside of the cell, which pushes the cytoplasmic membrane 
against the murein sacculus) is considered essential for viability and cell wall expansion 
(Holtje, 1998). Changes in external osmolarity cause water to move along the osmotic 
gradient, and potentially result in either swelling and bursting in hypotonic 
environments, or in dehydration and plasmolysis under hypertonic conditions. 
Therefore, it is vital that the cell possesses effective measures to counteract adverse 
changes in external osmolarity, and to allow a suitable level of cytoplasmic water and 
turgor pressure to be maintained (reviewed by Bremer & Kramer, 2000). S. aureus 
possesses a highly versatile osmotic stress response, which allows adaptation to 
environments containing both high and low osmolarity, and involves the accumulation 
of K+ ions and a range of osmoprotective compounds. 
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1.6.2.1.1.1 K+ accumulation 
The initial effect of osmotic upshock in many bacteria, including B. subtilis and E. coli, 
is the accumulation of KK from environmental sources (Whatmore & Reed, 1990; Kunin 
& Rudy, 1991). However, S. aureus naturally contains high a level of cytoplasmic K+, 
which is relatively unaffected by osmotic stress (Kunin & Rudy, 1991; Graham & 
Wilkinson, 1992). For example, the cytoplasmic concentration of K+ in E. coli K10 rose 
from 0.6 mmol /g protein in TSB containing no added NaCl to 1.6 mmol /g protein in 
TSB containing 0.9 M NaCl (Kunin & Rudy, 1991). In contrast, the cytoplasmic 
concentration of K+ in S. aureus was found to be approximately 2.5 mmol /g protein at 
both NaCl concentrations (Kunin & Rudy, 1991). 
However, high intracellular concentrations of inorganic ions such as KK induce 
macromolecule aggregation by enhancing hydrophobic interactions, and restrict the 
availability of water for biochemical processes (Bremer & Kramer, 2000). The 
halophilic bacteria (ie. the Halobacteriales and Haloanaerobiales) rely on the 
accumulation of molar concentrations of K+ and other ions for survival in hyperosmotic 
environments (2 -5M NaCl). Consequently, these bacteria have had to undergo 
evolutionary changes in essentially all of their proteins to adjust the entire cell 
physiology to the high ion content of the cytoplasm (Elcock & McCammon, 1998). This 
has severely limited the habitats of the halophilic bacteria, as they are unable to colonise 
environments with moderate osmolarities. However, instead of accumulating KK to the 
high levels found in the halophilic bacteria, S. aureus is able to grow in the presence of 
NaCl concentrations of up to 3.5 M (Scott, 1953; Armstrong-Buisseret et al., 1995) by 
combining a more moderate level of cytoplasmic KK with the accumulation of 
osmoprotective compounds which can be released from the cell following a reduction in 
external osmolarity. This allows S. aureus to grow in environments of both high and 
low osmolarity. 
1.6.2.3.1.1.2 Osmoprotectant accumulation 
Osmoprotectants are compounds that relieve the growth inhibition caused by high 
osmolarity (Wilkinson, 1997). These include the compatible solutes, which are 
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compounds that can be accumulated to high amounts within the cell without inhibiting 
cellular processes (Wilkinson, 1997). The accumulation of compatible solutes is an 
almost universal response to high osmolarity, and occurs in the cells of many bacteria, 
fungi, plants and animals (Csonka, 1989; Sakamoto & Murata, 2000). 
In general, compatible solutes are polar, highly soluble molecules, and do not usually 
carry a net charge at physiological pH (Bremer & Kramer, 2000). When accumulated in 
up to molar concentrations, they lower the osmolarity of the cytoplasm and therefore aid 
the restoration of a suitable cytoplasmic water volume and turgor pressure (Kempf & 
Bremer, 1998). Compatible solutes also stabilise proteins during periods of osmotic 
stress, and prevent proteins from being denatured by freezing, heating and high ionic 
strength (reviewed by Bremer, 2002). 
The compatible solutes comprise a wide range of compounds, although the main ones 
accumulated by S. aureus in response to osmotic stress include the trimethylammonium 
compound glycine betaine and the amino acid L-proline (Miller et al., 1991; Graham & 
Wilkinson, 1992; Townsend & Wilkinson, 1992; Bae & Miller, 1992; Bae et al., 1993; 
Pourkomailian & Booth, 1992; Pourkomailian & Booth, 1994). Glycine betaine is the 
most potent osmoprotectant. The addition of 1 mM glycine betaine has been shown to 
increase the maximum stationary phase population level (OD580) of S. aureus in defined 
medium containing 1.5 M NaCl from 0.05 to 0.89 (Graham & Wilkinson, 1992). The 
addition of 1 mM L-proline resulted in an increase to 0.48 (Graham & Wilkinson, 
1992). Taurine also acts as an osmoprotectant, although it has a weaker effect; the 
addition of 1 mM taurine to defined medium containing 1.5 M NaCI resulted in a 
maximum stationary phase OD580 of 0.21 (Graham & Wilkinson, 1992). 
Glycine betaine is also the osmoprotectant accumulated to the highest levels by S. 
aureus in response to osmotic stress. The concentration of glycine betaine, L-proline 
and taurine rose from 76 mM, 21 mM and 8 mM to 1,167 mM, 309 mM and 209 mM 
respectively upon addition of 2M NaCl to defined medium (Graham & Wilkinson, 
1992). Glycine betaine can be synthesised within S. aureus cells by the uptake and 
oxidisation of choline in response to osmotic stress (Graham & Wilkinson, 1992; 
Kaenjak et al., 1993). However, although many other bacteria are able to synthesise 
compatible solutes de novo (Galinski & Truper, 1994; Whatmore et al., 1990), no 
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evidence has yet been presented of a biosynthesised compatible solute in osmotically 
stressed S. aureus in the absence of exogenous osmoprotectants (Wilkinson, 1997). 
Instead, the accumulation of compatible solutes in S. aureus involves their transport into 
the cell from environmental sources. 
S. aureus possesses two proline transporters, including a high-affinity and a low-affinity 
system (Townsend & Wilkinson, 1992; Bae & Miller, 1992). The low-affinity 
transporter has a broad substrate specificity, and its activity is stimulated by increased 
external osmolarity (Townsend & Wilkinson, 1992). In contrast, the high-affinity 
system is specific for L-proline and is involved in scavenging low concentrations of 
proline, possibly for nutritional purposes (Townsend & Wilkinson, 1992). S. aureus also 
possesses a high-affinity and a low-affinity glycine betaine transporter (Pourkomailian 
& Booth, 1992; Pourkomailian & Booth, 1994). Similar to the proline transporters, the 
activity of the low-affinity glycine betaine transporter is increased by high external 
osmolarity, whilst the high-affinity system is activated independently of osmolarity 
(Pourkomailian & Booth, 1992). Indeed, Pourkomailian & Booth (1994) have shown 
that the low-affinity glycine betaine and proline transporters may be identical. 
1.6.2.3.1.1.3 Additional effects of osmotic stress on general cell physiology 
Osmotic stress has been shown to induce the expression of four major proteins (with 
molecular masses of 50,40,34 and 25 kDa) in S. aureus (Armstrong-Buisseret et al., 
1995). N-terminal sequencing and database analysis were used to identify the gene 
encoding the 25 kDa protein. Extensive homology with ahpC (alkyl hydroperoxide 
reductase) from E. coli and S. typhimurium was demonstrated (Armstrong-Buisseret et 
al., 1995). AhpC protects against the toxic by-products of oxidative metabolism. 
Significantly, this suggests that osmotic stress may cross-activate the oxidative stress 
response, and possibly other stress responses. Indeed, Qoronfleh et al. (1990) found that 
the majority of the 12 heat shock proteins that they identified in S. aureus using 
L-[35S]methionine and SDS-PAGE were also induced by high NaC1 concentrations. In 
B. subtilis, NaC1-mediated stress induces the production of both NaC1-specific stress 
proteins and general stress proteins via the alternative sigma factor Q'B (Chapters 1.6.1.2 
and 1.6.2.2.8). 
35 
CHAPTER 1: INTRODUCTION 
1.6.2.3.1.2 Ionic effects of NaCl on general cell physiology 
In addition to providing an osmotic stress, it should be appreciated that NaCI may also 
affect the general cell physiology of S. aureus as a result of ionic stress (due to Na+ or 
Cl" ions). Vijaranakul et al. (1995) showed that growth in defined medium containing 
2.5 M NaCl caused cells to grow more slowly, to become significantly larger (as a result 
of defective cell division), and to possess a less cross-linked peptidoglycan containing 
shorter interpeptide bridges. The charged osmolytes potassium chloride and sodium 
nitrite were able to cause a similar increase in cell size, although the uncharged 
osmolytes sucrose and sorbitol were unable to do so (Vijaranakul et al. 1995). This 
suggests that the effects observed were due to an ionic, rather than an osmotic effect, 
but that neither Na+ nor Ct ions were specifically responsible. 
1.6.2.3.2 Virulence determinant regulation in response to NaCI 
NaCl has been shown to repress the transcription of h1a, tst, eta, sec and spa (Chan & 
Foster, 1998a; Chan & Foster, 1998b; Lindsay & Foster; 1999, Ohlsen et al., 1997; 
Sheehan et al., 1992; Regassa & Betley, 1993). The concentration of NaCI used in these 
studies was either 1M or 1.2 M. The expression of Seb has also been shown to be 
repressed in a culture containing 1.7 M NaCI (Genigeorgis & Sadler, 1966). In contrast, 
1M NaCl up-regulates the transcription of sspA (Lindsay & Foster, 1999). It has been 
suggested that the effects of NaCl on virulence determinant expression may aid the 
ability of S. aureus to survive asymptomatically as a commensal in the high-NaC1 
concentration niches of the skin and anterior nares (Lindsay & Foster, 1999) (Chapters 
1.3 and 1.6.2.3). This is because NaCl not only represses virulence determinants which 
cause harm to the host, but also simultaneously upregulates sspA, which may possibly 
function to destroy preformed toxins. 
Importantly, the studies introduced above also show that NaCI represses not only 
extracellular virulence determinants (ie. hla, tst, eta, sec and Seb, which are normally 
up-regulated by agr) but also a cell surface-associated virulence determinant (ie. spa, 
which is normally down-regulated by agr). Furthermore, the effects of NaCI on hla, tst, 
sec, sspA and spa have been shown to occur independently of agr and/or sarA (Chan & 
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Foster, 1998a; Chan & Foster, 1998b; Lindsay & Foster; 1999, Regassa & Betley, 
1993). This is supported by the fact that 1M NaC1 has no appreciable effect on sarA or 
RNAIII expression (Chan & Foster, 1998a; Lindsay & Foster, 1999). Overall, this 
suggests that S. aureus virulence determinants, which are normally regulated by agr and 
sarA, may come under the control of a currently unknown alternative regulatory 
mechanism in the presence of high NaCI concentrations (Chan & Foster, 1998a). 
1.6.2.3.2.1 The mechanism by which NaC1 affects virulence determinant 
expression 
A number of studies have been performed to determine whether the mechanism by 
which NaCI affects virulence determinant expression involves an ionic effect and/or an 
osmotic effect. Sheehan et al. (1992) showed that, when grown in TSB for up to 8 h, 
the uncharged osmolyte sucrose (0.44 M) represses eta transcription to a similar level as 
an iso-osmotic concentration of NaCI (0.3 M). This suggests that NaC1 alters virulence 
determinant expression by an osmotic, rather than an ionic effect. Additionally, Ohlsen 
et al. (1997) showed that potassium chloride and sodium glutamate have similar 
repressive effects on h1a transcription as NaCl, indicating that neither Na+ nor CI' ions 
are specifically required for the effect of NaCI on virulence determinant expression. The 
possibility that the effect of NaCI on virulence determinant expression involves an 
osmotic effect is further supported by the fact that the osmoprotectants glycine betaine, 
L-proline and choline relieved the NaCI-induced repression of sec transcription 
(Regassa & Betley, 1993) (Chapter 1.6.2.3.1.1.2). 
As shown in Chapter 1.6.1.3, the osmoregulation of virulence determinant expression in 
many pathogens involves changes in DNA supercoiling. The presence of high NaC1 
concentrations has been shown to decrease eta transcription and increase the negative 
supercoiling of S. aureus plasmid DNA (Sheehan et al, 1992). Sheehan et al. (1992) 
correlated these observations with the finding that novobiocin (which inhibits DNA 
gyrase, and therefore reduces negative DNA supercoiling) increases eta transcription. 
However, Chan and Foster (1998a) showed that novobiocin had no effect on the 
repression of tst by 1M NaCl. Therefore, the involvement of DNA supercoiling in the 
repression of virulence determinant expression by NaCl remains debatable, although it 
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is possible that the effects of novobiocin, and consequently of DNA supercoiling, may 
be restricted to specific virulence determinant genes. 
1.7 Rationale and objectives for this project 
The ability to sense environmental parameters and respond appropriately is vital to the 
survival of S. aureus in abiotic environments, in infection situations, and whilst existing 
as a commensal. NaCI is an important environmental parameter encountered by S. 
aureus. However, the mechanisms by which S. aureus senses the level of NaCl in the 
surrounding environment and transduces this signal into changes in gene expression 
remain poorly understood. The objective of this project was to characterise the effects of 
NaCI-mediated stress on virulence determinant production and to determine the role of 
known regulators in this process through the use of reporter gene fusions. A further aim 
of this project was to identify novel genes involved in NaCI-mediated virulence 
determinant regulation through the use of transposon mutagenesis. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 Media and antibiotics 
2.1.1 Media 
Unless otherwise stated all media were prepared using distilled water (dH2O) and 
were sterilised by autoclaving for 20 min at 121 °C (15 pounds per square inch). 
2.1.1.1 B2 
Casein acid hydrolysate (Oxoid) 10 g 1", 
Yeast extract (Oxoid) 25 g 1"' 
K2HP04 1g 1' 
NaCl 5g 1"1 
The pH was adjusted to 7.5. Once autoclaved and cooled, sterile glucose was added to 
1 mM (final concentration). 
2.1.1.2 Brain heart infusion (BHI) (Oxoid) 
Brain heart infusion (BHI) 37 g 1-' 
Oxoid agar No. 1 (1 % (w/v)) was used for BHI agar. 
Details of the composition of BHI are shown in Table A. 1.1. 
When NaCl was added to BHI, equal volumes of 2X BHI and 2X the relevant 
concentration of NaCl were prepared separately and mixed after autoclaving. 
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2.1.1.3 Luria-Bertani (LB) (Miller, 1972) 
Tryptone (Oxoid) 10 g 1'' 
Yeast extract (Oxoid) 5g 1"l 
NaCl lOgrl 
The pH was adjusted to 7.2 using NaOH. Oxoid Agar No. 1 (1.0 % (w/v)) was added 
for LB agar. 
2.1.1.4 LK 
Tryptone (Oxoid) 10 g 1"' 
Yeast extract (Oxoid) 5g 1"1 
KCI 7 g1"1 
Oxoid Agar No. 1 (1.0 % (w/v)) was added for LK bottom agar. 
Oxoid Agar No. 1 (0.7 % (w/v)) was added for LK top agar. 
2.1.1.5 Milk agar 
Milk agar was made using equal volumes of 2X BHI agar and 2% (w/v) dried 
skimmed milk powder (Marvel). The components were prepared separately and 
mixed after autoclaving. 
2.1.1.6 Phage agar 
Casamino acids (Oxoid) 3g 1' 
Yeast extract (Oxoid) 3g 1'' 
NaCl 5.9 g 1'i 
Oxoid Agar No. 1 (1.0 % (w/v)) was added for phage bottom agar. 
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Oxoid Agar No. 1 (0.33 % (w/v)) was added for phage top agar. 
2.1.1.7 Rabbit blood agar 
Blood agar base (Oxoid) 39.5 g 1' 
Details of the composition of blood agar base are shown in Table A. 1.2. 
25 ml sterile defibrinated rabbit blood (E &0 laboratories) was added to 225 ml 
blood agar base which had been cooled to 50 °C. This gave a final rabbit blood 
concentration of 10 % (w/v). 6 ml was then used to overlay warm 20 ml blood agar 
base plates. 
For plates containing added NaCl, equal volumes of 2X the relevant concentration of 
NaCI and 2X blood agar base/overlay were prepared separately and mixed after 
autoclaving and cooling. 
2.1.1.8 SOB (Sambrook et a!., 1989) 
Tryptone (Oxoid) 2% (w/v) 
Yeast extract (Oxoid) 0.5 % (w/v) 
NaCl 10 mm 
KCl 2.5 mM 
Once autoclaved and cooled, sterile supplements of MgC12 and MgSO4 were added, 
each to 10 mM (final concentration). 
2.1.1.9 SOC (Sambrook et A, 1989) 
SOC was prepared by the addition of sterile glucose (to 20 mM) to SOB. 
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2.1.2 Antibiotics 
All antibiotics used in this study are listed in Table 2.1. The stock solutions were filter- 
sterilised (0.2 µm pore size) and stored at -20 T. For use in agar plates, the antibiotic 
stock solutions were added to the media once they had cooled to below 55 T. For use 
in liquid media, the antibiotic stock solutions were added just before use. 
Concentrations of antibiotics used for selection were as in Table 2.1, unless otherwise 
stated. 
2.2 Buffers and stock solutions 
All buffers were prepared in dH2O and stored at room temperature. Solutions for use 
in microbiological work and in vitro DNA manipulations were sterilised by 
autoclaving. All of the methods in this chapter are as in Sambrook et al. (1989), 
unless otherwise stated. 
2.2.1 ABT buffer 
NaCl 100 mm 
K2HPO4 60 mM 
KH2PO4 40 mM 
Triton® X-100 0.1 % (v/v) 
2.2.2 ABTN buffer 
ABTN buffer was made by mixing equal volumes of ABT buffer and 0.4 M Na2CO3. 
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Antibiotic Stock 
Concentration 
(mg mr) 
Working 
Concentration 
In S. aureus 
(µ ml-) 
Working 
Concentration 
In E. coli 
(g ml-) 
Ampicillin (Amp) 50a - 50 
Erythromycin (Ery) 5 or 75 5 300 
Lincomycin (Lin) 25' 25 - 
Kanamycin (Kan) 50a 50 50 
Neomycin (Neo) 50a 50 - 
Tetracycline (Tet) 5° 5 12.5 
Spectinomycin (Spec) 150a 150 150 
Chloramphenicol (Cm) 5 5 - 
Cadmium chloride 
(CdC12) 
100a 250 - 
Table 2.1 
Antibiotics used in this study. 
Stock concentrations of antibiotics were dissolved in dH2Oa, 95 % (v/v) ethanolb, or 50 
% (v/v) ethanol °, filter-sterilised and stored at -20 T. The inducing concentration of 
Ery was 0.15 µgml"1. 
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2.2.3 DNA loading buffer (6X) 
Bromophenol blue 0.25 % (w/v) 
Xylene cyanol FF 0.25 % (w/v) 
Glycerol 30 % (v/v) 
2.2.4 Frozen storage buffer (FSB) 
KC1 7.4 g 
MnC12.4H2O 8.9 g 
CaC12.2H2O 1.5 g 
Co(NH3)Cl3 0.8 g 
Potassium acetate (1 M, pH 7.5) 10 ml 
Glycerol 100 ml 
The constituents were made up to 11 with sterile dH2O and the pH adjusted to 6.4 using 
0.1 M HCI. The solution was divided into 100 ml aliquots and stored at -20°C. Aliquots 
were defrosted as required and filter-sterilized (0.45 µM pore size) before use. 
2.2.5 Haemolysin salts solution 
NaC1 0.145M 
CaC12 20 mM 
2.2.6 Phosphate buffered saline (PBS) 
NaCl 8g 1-' 
Na2HPO4 1.4 g 1"1 
KC1 0.2 g 11 
KH2PO4 0.2 g 1"t 
The pH of PBS was adjusted to 7.4 using NaOH. 
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2.2.7 Phage buffer 
MgSO4 1 mm 
CaC12 4 mM 
Tris-HCI pH 7.8 50 mM 
NaC1 0.59 % (w/v) 
Gelatine 0.1 % (w/v) 
2.2.8 QIAGEN buffers 
The composition of QIAGEN buffers is detailed in the manufacturer's instructions 
provided with the kits. 
2.2.9 SDS-PAGE and Western blotting solutions 
2.2.9.1 5X Laemmli SDS-PAGE sample buffer 
1M Tris-HCl (pH 6.8) 2.5 ml 
SDS lg 
Glycerol (100 % (v/v)) 5 ml 
Bromophenol blue 0.05 g 
ß-mercaptoethanol (100 % (v/v)) 2.8 ml 
1X sample buffer was made by diluting the 5X stock 1: 5 with dH2O. 
2.2.9.2 SDS-PAGE gel formulations and construction of gel 
The following components were added together in a 30 ml plastic universal; 
45 
CHAPTER 2; MATERIALS AND MET! TODS 
12 % (w/v) Resolving gel 
dH2O 3.4 ml 
1.5M Tris-HC1(pH 8.8) 2.5 ml 
10%(w/v)SDS 100µ1 
30 % (w/v) Acrylamide/Bis (37.5: 1) (BioRad) 4.0 ml 
10 % (w/v) Ammonium persulphate 50 µ1 
TEMED 5 µl 
The components were mixed by gentle swirling, so as not to introduce air bubbles, and 
loaded into the gel casting apparatus using a plastic 10 ml syringe. A layer of water- 
saturated isobutanol was carefully pipetted on top of the gel to isolate it from the air. 
After the gel had solidified, the stacking gel was made up as follows; 
Stacking gel 
dH2O 6.1 ml 
0.5 M Tris-HC1(pH 6.8) 2.5 ml 
10%(w/v)SDS 100µ1 
30 % (w/v) AcrylamideBis (37.5: 1) (BioRad) 1.3 ml 
10 % (w/v) Ammonium persulphate 50 µ1 
TEMED 10 µl 
The contents were mixed by gentle swirling and pipetted on top of the resolving gel. 
A plastic comb was inserted into the gel to create wells and to separate the gel from the 
air. After the gel had solidified, it was transferred to the gel-running tank and 
submerged in 1X SDS-PAGE buffer. 
2.2.9.3 lOX SDS-PAGE electrophoresis buffer 
Glycine 144 g 1"1 
Tris base 30.3 g1l 
SDS 10 g 1"1 
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1X SDS-PAGE buffer was made by diluting lOX SDS-PAGE buffer 1: 10 with dH2O. 
2.2.9.4 Coomassie Blue staining solution 
Coomassie Blue R-250 0.25% (w/v) 
Acetic acid 10 % (v/v) 
Methanol 50 % (v/v) 
Coomassie stain is light-sensitive and was stored in a foil-wrapped duran. 
2.2.9.5 Destain solution 
Acetic acid 10 % (v/v) 
Methanol 5% (v/v) 
2.2.9.6 Western blotting solutions 
2.2.9.6.1 Blotting buffer 
Glycine 150 mm 
Tris-HCI 20 mM 
Methanol 20 % (v/v) 
2.2.9.6.2 20X Washing solution 
1M Tris-HCl (pH 7.4) 200 ml 
NaCl 180 mg 
Tween® 20 10 ml 
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The components were made up to 11 with dH2O. 1X washing solution was made by 
diluting the 20X stock 1: 20 with dH2O. 
2.2.9.6.3 Blocking solution 
Western blocking solution consisted of 1X Western washing solution containing 5% 
(w/v) dried skimmed milk powder (Marvel). 
2.2.9.6.4 Primary antibody solution 
The primary antibody was diluted 1: 6,000,1: 2,500 and 1: 2,000 in blocking solution 
for anti-Hla, SspA and SarA rabbit antibodies respectively, and stored at -20 T. 
2.2.9.6.5 Secondary antibody solution 
The secondary antibody was diluted 1: 30,000 and 1: 1,000 in blocking solution for 
alkaline phosphatase (Sigma) and horseradish peroxidase-conjugated antibodies 
respectively (Amersham Pharmacia), and made fresh for each experiment. 
2.2.9.6.6 Alkaline phosphatase (AP) buffer 
Tris-HCI (pH 9.5) 100 ml 1"' 
NaCl 5.8 g 1"1 
MgC12.6H20 10.2 g 1'1 
2.2.9.6.7 Colour substrate solution 
10 ml AP buffer containing 200 µl NBTBCIP solution (Roche). 
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2.2.9.7 Southern blotting buffers and solutions 
2.2.9.7.1 Southern depurination solution 
HCl 250 mM 
2.2.9.7.2 Southern denaturing buffer 
NaOH 0.5 M 
NaCl 1.5 M 
2.2.9.7.3 Southern neutralising buffer 
Tris-HC1(pH 7.5) 0.5 M 
NaCl 3M 
2.2.9.7.4 SSC (20X) 
NaCl 
Tri-sodium citrate-2H20 
3M 
300mM 
The pH was adjusted to 7.0 with 1M NaOH. 20X SSC was diluted with water to 
make 10X, 5X, 2X and 0.5X SSC. 
2.2.9.7.5 Pre-hybridisation solution 
SSC 5X 
Blocking reagent (Roche) 1% (w/v) 
N-lauroylsarcosine, Na salt 0.1 % (w/v) 
SDS 0.02 % (w/v) 
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2.2.9.7.6 Hybridisation solution 
Digoxigenin-labelled DNA probes were diluted in prehybridisation buffer to 5- 25 ng 
mr'. 
2.2.9.7.7 %'ash solution (2X 
ssc 
SDS 
2X 
0.1 % (w/v) 
2.2.9.7.8 Wash solution (O. SX) 
ssc 
SDS 
o. sx 
0.1 % (w/v) 
2.2.9.7.9 Afalcic acid buffcr 
Malcic acid 0.1 M 
NaCl 0.15 M 
l7hc pi i was adjustcd to 7.5 with solid NaO11. 
2.2.9.7.10 Washing buffer 
Malcis acid buffer containing 3% (v/v) Twccn® 20. 
2.2.9.7.11 Blocking solution 
Makic acid buffer containing I% (w/v) blocking reagent (Roche). 
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Blocking reagent was dissolved in maleic acid buffer by microwaving and stored at 
-20 °C. 
2.2.9.7.12 Antibody solution 
Blocking solution containing 0.2 µl ml"' Anti-digoxigenin-AP conjugate (Roche). 
2.2.9.7.13 Detection buffer 
Tris-liC1(pH 9.5) loo mm 
NaCI loo mm 
MgCl2-6H2O 50 mM 
The pH was adjusted to 7.5 using 1M NaOH. 
2.2.9.7.14 Colour substrate solution 
Detection buffer containing 2% (v/v) NBT/BCIP (Roche). 
2.2.9.8 TAE (50X) 
Trisma base 242 g 171 
Glacial acetic acid 57.1 m11' 
Na2EDTA (0.5 M pH 8.0) 100 ml 1"1 
Before use the buffer was diluted 1: 50 to produce TAE. 
51 
CHAPTER 2; MATERIALS AND METHODS 
2.2.9.9 TE 
Tris-HCl 
EDTA 
1mM 
0.1mM 
The pH was adjusted to 7.5 using 1M HC1 before autoclaving. 
2.3 Enzymes and chemicals 
All chemicals and enzymes were of analytical grade and purchased from Sigma, Merck 
(BDH) or Fisons unless otherwise stated. All restriction enzymes, RNase A, DNase, 
T4 ligase, polymerases and buffers for the modification of DNA were purchased from 
ABI Perkin-Elmer, Life Technologies (formally Gibco BRL), Northumbria Biologicals 
Limited (NBL), Promega, MBI Fermentas or Roche (formally Boehringer Mannheim). 
Lysostaphin (Sigma) was dissolved in 20 mM sodium acetate to 5 mg m1' and stored 
at -20 T. MUG (4-methylumbelliferyl-ß-D-galactopyranoside) (Sigma) was dissolved 
in DMSO to 4 mg ml'' and stored at -20 °C. MU (4-methylumbelliferone) (Sigma) 
was dissolved in DMSO to 1 mM and stored at -20 T. PMSF was dissolved to 0.25 M 
in 100 % ethanol and stored at -20 T. RNase A (DNase-free) (Sigma) was dissolved 
in dH2O to 10 mg ml-1 and stored at -20 T. X-Gal (Sigma) was dissolved in DMF to 
20 - 100 mg mt' and stored at -20 °C in a foil-wrapped 30 ml universal tube. Purified 
SspA (Sigma) was dissolved to 100 ng µl"1 in 50 mM tris, pH 7.5, and stored at - 20 
°C. 
2.4 Bacterial strains, plasmids and bacteriophage 
2.4.1 Bacterial maintenance, culture and storage conditions 
Bacterial strains used in this study are listed in Table 2.2 - 2.3. 
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2.4.1.1 Staphylococcus aureus strains 
Staphylococcus aureus strains (Table 2.2) were taken from glycerol stocks and grown 
on BHI agar plates containing antibiotics where appropriate to maintain selection of 
resistance markers. Plate cultures were stored for up to two weeks at 4 °C, before 
being re-streaked from glycerol stocks. For long-term storage, a single colony was 
spread onto a BHI agar plate containing relevant antibiotics and grown overnight at 37 
T. A loopful of cells was resuspended in 2X 1 ml BHI containing 15 % (v/v) glycerol 
in a sterile 1.5 ml microfuge tube. These glycerol stocks were then snap-frozen in 
liquid nitrogen and stored at -20 °C and -70 T. 
Liquid cultures were normally prepared by inoculation of culture medium with a single 
isolated colony. Unless otherwise stated, cultures were grown overnight in conical 
flasks (culture: flask volume ratio 1: 2.5), and were aerated on a rotary shaker at 250 
rpm. All S. aureus plates or liquid medium cultures were grown at 37 °C unless 
otherwise stated. These conditions are referred to as standard conditions. For additional 
information on growth conditions for reporter gene fusion analysis and/or growth 
experiments, see Chapter 2.7. 
2.4.1.2 Escherichia coli strains 
Escherichia coli strains (Table 2.3) were cultured, at 37 °C, using LB broth or LB agar 
containing antibiotics where necessary to ensure selection of plasmids. Plate cultures 
were stored at 4 °C for up to two weeks before re-streaking from glycerol stocks. Liquid 
cultures were prepared as for S. aureus (Chapter 2.4.1.1) using LB medium in place of 
BHI. For long-term storage, glycerol stocks of E. coli strains were prepared as for S. 
aureus (Chapter 2.4.1.1), using LB medium rather than BHI. 
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Strain Relevant Genotype / Markers Source / Reference 
8325-4 8325 cured of known ro ha es Novick, 1963 
SH1000 Functional rsb derivative of 8325-4 Horsburgh et al., 2002 
RN4220 Restriction deficient transformation recipient Kreiswirth et al., 1983 
PC400 8325-4 si B:: tet Tet Chan et al., 1998 
SH1002 SH1000 sarA:: kan (Kan Horsbur h et al., 2002 
PM783 RN6390 rot:: tet (Tet) P. McNamara, 
personal 
communication 
SMH1005 8325-4 sarHl:: pAULA (E ) S. Horsburgh, personal 
communication 
PC6911 8325-4 a :: tet Tet Chan& Foster, 1998b 
JL140 8325-4hla:: ery (EryK) O'Reilly et 1986 
MJH502 SH1000 rsb si B:: tet Tet Horsburgh et al., 2002 
PC203 8325-4 s a:: lacZ spa' (EryK) Chan & Foster, 1998a 
PC161 8325-4 sarA:: lacZsarA (Ery) Chan & Foster, 1998a 
JLA311 SH1000 sarA:: lacZ sarA+ (E ) This study 
PC4030 8325-4 sarA:: lacZ sarA si B:: tet E, TetR) Chan et al., 1998 
JLA313 SH 1000 sarA:: IacZ sarA+ si B:: tet (EryR, TetR) This study 
SH101F7 8325-4 agr agr+ E) Fairhead, 1998 
JLA341 SH1000 agr RNAIII :: IacZa (EryR) This study 
PC604 8325-4 agr (RNAIII):: IacZ agr sigB:: tet (Ery' , TetR) 
Horsburgh et al., 2002 
JLA343 SH 1000 agr (RNAIII):: IacZ agr sigB:: tet 
E, TetR) 
This study 
PC600 8325-4 agr (RNAIII):: lacZ agr sarA:: kan 
E, Kann 
Horsburgh et al., 2002 
JLA345 SH 1000 agr (RNAIII):: lacZ agr sarA:: kan 
(Er?, Kann 
This study 
PC602 8325-4 agr (RNAIII):: IacZ agr sigB:: tet 
sarA:: kan E, TetR, Kann 
Horsburgh et al., 2002 
JLA347 SH 1000 agr (RNAIII):: lacZ agr sigB:: tet 
sarA:: kan E, TetR, KanR) 
This study 
JLA511 RN4220 hla:: lacZ hla (TetR) This study 
JLA512 8325-4 hla:: lacZ hla Tet) This study 
JLA513 SH 1000 h! a:: lacZ hla Tet This stud 
PC322 8325-4 hla:: lacZ hla E Chan & Foster, 1998a 
JLA371 SH1000 hla:: lacZ hla (E ) This study 
PC4044 8325-4 hla:: lacZ hla si B:: tet E, Tet Horsburgh et al., 2002 
JLA373 S111000 hla:: lacZ hla sigB:: tet E, Tet) This study 
PC3221 8325-4 hla:: lacZ hla sarA: -k-nn (E e, Ka e) h et al., 2002 
JLA375 SH 1000 h! a:: lacZ hla sarA:: kan (E , Kan) This study 
JLA376 8325-4 hla:: lacZ hla sigB:: tet sarA:: kan (E , TetR, Kann 
This study 
JLA377 SH 1000 hla:: lacZ hla sigB:: tet sarA:: kan 
E, TetR, Kan R 
This study 
JLA378 8325-4 hla:: lacZ hla rot:: tet E, TetR) This study 
JLA379 S111000 hla:: lacZ hla rot:: tet E, Tet This study 
JLA380 8325-4 hla:: lacZ hla sarHl:: pAULA (Tet , E 
This study 
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Strain 
Cont. 
Relevant Genotype / Markers Source / Reference 
JLA381 SH1000 hla:: lacZ hla+sarHl:: pAULA 
(TetR9E 
This study 
hanl 8325-4 hanl:: Tn917 unkl:: Tn91 E This study 
han2 8325-4 han2:: Tn917 citG:: Tn91 E) This study 
han3 8325-4 han3:: Tn917 citG:: Tn91 E) This study 
han4 8325-4 han4:: Tn917 (unk2:: Tn91 E) This study 
han5 8325-4 han5:: Tn917 citG:: Tn91 E This study 
han6 8325-4 han6:: Tn917 citG:: Tn91 (E ) This study 
han7 8325-4 han7:: Tn917 (citG:: Tn91 (E ) This study 
han8 8325-4 han8:: Tn917 citG:: Tn91 (Eryj) This study 
han9 8325-4 han9:: Tn917 (o uD:: Tn917) E) This study 
hanlO 8325-4 hanlO:: Tn917 unkl:: Tn91 (EryR) This study 
hanl1 8325-4 hanll:: Tn917 ugT:: Tn917) (E ) This study 
han12 8325-4 hanl2:: Tn917 (o F:: Tn91 (E This study 
hanl3 8325-4 hanl3:: Tn917 krP:: Tn91 (EryR) This study 
han14 8325-4 han14:: Tn917 (e rH:: Tn917) (E ) This study 
han15 8325-4 hanl5:: Tn917 (yubA:: Tn9l7) (EryR) This study 
han16 8325-4 hanl6:: Tn917 ubA:: Tn91 E) This study 
JLA401 hanl:: Tn917 (unkl:: Tn917) transduced into 
8325-4 (EryR) 
This study 
JLA402 han2:: Tn917 (citG:: Tn917) transduced into 
8325-4 (EryR) 
This study 
JLA403 han3:: Tn917 (citG:: Tn917) transduced into 
8325-4 (EryR) 
This study 
JLA404 han4:: Tn917 (unk2:: Tn917) transduced into 
8325-4 E 
This study 
JLA405 han5:: Tn917 (citG:: Tn917) transduced into 
8325-4 (EryR) 
This study 
JLA406 han6:: Tn917 (citG:: Tn917) transduced into 
8325-4 (EryR) 
This study 
JLA407 han7:: Tn917 (citG:: Tn917) transduced into 
8325-4 (EryR) 
This study 
JLA408 han8:: Tn917 (citG:: Tn917) transduced into 
8325-4 (EryR) 
This study 
JLA409 han9:: Tn917 (opuD:: Tn917) transduced into 
8325-4 E 
This study 
JLA410 han10:: Tn917 (unkl:: Tn917) transduced into 
8325-4 E 
This study 
JLA411 hanl 1:: Tn917 (yugT:: Tn917 transduced into 
8325-4 (EryR) 
This study 
JLA412 hanl2:: Tn917 (oppF:: Tn917) transduced into 
8325-4 E 
This study 
JLA413 hanl3:: Tn917 (ykrP:: Tn917) transduced into 
8325-4 (EryR) 
This study 
JLA414 hanl4:: Tn917 (eprH:: Tn917) transduced into 
8325-4 (EryR) 
This study 
JLA415 hanl5:: Tn917 (yubA:: Tn917) transduced into 
8325-4 (E 
This study 
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Strain Relevant Genotype / Markers Source / Reference 
Cont. 
JLA416 han16:: Tn917 (yubA:: Tn917) transduced into This study 
8325-4 (E ) 
JLA417 8325-4 hanl:: Tn917 agr:: tet (unkl:: Tn917) This study 
E TetR) , 
JLA418 8325-4 han2:: Tn917 agr:: tet (citG:: Tn917) This study 
E, TetR) 
JLA419 8325-4 han4:: Tn917 agr:: tet (unk2:: Tn917) This study 
(E , TetR) 
JLA420 8325-4 han9:: Tn917 agr:: tet (opuD:: Tn917) This study 
Tee (EryR , 
JLA421 8325-4 hanI 1:: Tn917 agr:: tet (yugT:: Tn917) This study 
E TetR) , 
JLA422 8325-4 hanl2:: Tn917 agr:: tet (oppF:: Tn917) This study 
E, TetR) 
JLA423 8325-4 hanl3:: Tn917 agr:: tet (ykrP:: Tn917) This study 
TetR) (EryR 
, 
JLA424 8325-4 hanl4:: Tn917 agr:: tet (eprH:: Tn917) This study 
TetR) (EryR , 
JLA425 8325-4 hanl5:: Tn917 agr:: tet (yubA:: Tn917) This study 
(EryR, TetR) 
JLA501 RN4220 EZ:: TN tet Tet) This study 
JLA502 RN4220 EZ:: TN tet (Tet') This study 
JLA503 RN4220 EZ:: TN(tet) Tet) This study 
JLA504 RN4220 EZ:: TN(tet) Tet) This study 
JLA505 RN4220 EZ:: TN tet Tet This study 
JLA506 RN4220 EZ:: TN(tet) Tet) This study 
JLA507 RN4220 EZ:: TN tet Tet This study 
JLA508 RN4220 EZ:: TN tet (TetK) This study 
JLA509 RN4220 EZ:: TN tet Tet This stud 
JLA5 10 RN4220 EZ: : TN tet (Tet This study 
JLA514 SH 1000 hla:: lacZ hla , pRN3208 (Tet Cd This study E 
ahtl SH 1000 hla:: lacZhla ahtl:: Tn551 This study 
rsbU:: Tn551 TetR, ErYR) 
aht2 SH 1000 hla:: IacZhla aht2:: Tn551 This study 
ku :: Tn551 TetR, EryR) 
aht3 SH 1000 hla:: lacZhla aht3:: Tn551 This study 
ku :: Tn551 TetR, EryR) 
aht4 SH 1000 hla:: lacZhla aht4:: Tn551 This study 
telA:: Tn551 TetR, E 
aht5 SH1000 hla:: lacZ hla aht5:: Tn551 This study 
1 sA:: Tn551 TetR, E 
aht6 SH 1000 hla:: lacZhla aht6:: Tn551 This study 
brn :: Tn551 TetR, EryR) 
ah17 SH 1000 hla:: lacZ hla aht7:: Tn551 This study 
rsbU:: Tn551 TetR, EryR) 
aht8 SH1000 hla:: lacZhla aht8:: Tn551 This study 
rsbU:: Tn551 TetR, EryR) 
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Strain Relevant Genotype / Markers Source / Reference 
Cont. 
aht9 SH1000 hla:: lacZ hla aht9:: Tn551 This study 
rsbU:: Tn551 TetR, EryR) 
ahtl0 SH1000 hla:: lacZ hla ahtl0:: Tn551 This study 
(y'bH:: Tn551 TetR, EryR) 
ahtl l SH1000 hla:: lacZ hla ahtl 1:: Tn551 This study 
(yjbH.: Tn551) TetR, EryR) 
ahtl2 SH1000 hla:: lacZ hla ahtl2:: Tn551 This study 
(yjbH-: Tn551) TetR, EryR) 
ahtl3 SH1000 hla:: IacZ hla aht13:: Tn551 This study 
'bH:: Tn551) (TetR, EryR) 
aht14 SH 1000 hla:: lacZ hla ahtl4:: Tn551 This study 
a B:: Tn551 TetR, EryR) 
aht15 SH1000 hla:: lacZ hla ahtl5:: Tn551 This study 
(agrB:: Tn551) TetR, E 
aht16 SH 1000 hla:: lacZ hla ahtl6:: Tn551 This study 
(a B:: Tn551 TetR, EryR) 
aht17 SH1000 hla:: lacZhla ahtl7:: Tn551 This study 
a B:: Tn551 TetR, EryR) 
aht18 SH 1000 hla:: lacZhla ahtI8:: Tn551 This study 
(saeR:: Tn551) TetR, ErYR) 
JLA515 ahtl:: Tn551 (rsbU:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: IacZ hla+ E, TetR 
JLA516 aht2:: Tn551 (ykuQ:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: lacZ hla+ E, TetR) 
JLA517 aht3:: Tn551 (ykuQ:: Tn551) transduced into This study 
JLA513 SH1000 hla:: lacZhla E, TetR 
JLA518 aht4:: Tn551 (telA:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: IacZhla) (E , TetR) 
JLA519 aht5:: Tn551 (lysA:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: lacZ hla E, TetR) 
JLA520 aht6:: Tn551 (brnQ:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: lacZ hla E, TetR) 
JLA521 aht7:: Tn551 (rsbU:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: lacZ hla E, TetR 
JLA522 aht8:: Tn551 (rsbU:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: lacZ hla (E , TetR) 
JLA523 aht9:: Tn551 (rsb U:: Tn551) transduced into This study 
JLA513 SH1000 hla:: lacZhla (E , TetR) 
JLA524 aht10:: Tn551(yjbH:: Tn551) transduced into This study 
JLA513 (SH1000 hla:: lacZ hla E, TetR) 
JLA525 aht! 1:: Tn551 (yjbH:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: lacZ hla4) (E TetR) , 
JLA526 ahtl2:: Tn551 (yjbH:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: lacZ hla E, TetR) 
JLA527 ahtI3:: Tn551 (yjbH:: Tn551) transduced into This study 
JLA513 SH1000 hla:: lacZ hla E, TetR 
JLA528 ahtl4:: Tn551 (agrB:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: lacZhla+ E TetR , 
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Strain Relevant Genotype / Markers Source / Reference 
Cont. 
JLA529 ahtl5:: Tn551 (agrB:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: IacZ hla E, TetR 
JLA530 ahtl6:: Tn551 (agrB:: Tn551) transduced into This study 
JLA513 (SH1000 hla:: lacZ hla E, TetR 
JLA531 aht17:: Tn551 (agrB:: Tn551) transduced into This study 
JLA513 (SH1000 hla:: lacZ hla+ (E , TetR 
JLA532 ahtl8:: Tn551(saeR:: Tn551) transduced into This study 
JLA513 (SH1000 hia:: lacZ hla E, TetR 
htnl SH1000 hla:: IacZ hla htnl:: Tn551 This study 
rsb U:: Tn551 TetR, EryR) 
htn2 SH1000 hla:: IacZ hla htn2:: Tn551 This study 
rsbU:: Tn551 (TetR) ErYR) 
htn3 SH1000 hla:: lacZ hla htn3:: Tn551 This study 
(rsb U:: Tn551) TetR, ErYR) 
htn4 SH1000 hla:: IacZ h1a htn4:: Tn551 This study 
(rsb U:: Tn551) TetR, EryR) 
htn5 SH1000 hla:: IacZ hla htn5:: Tn551 This study 
rsbU:: Tn551 TetR, ErYR) 
htn6 SH1000 hla:: lacZ hla htn6:: Tn551 This study 
rsbU:: Tn551 TetR, EryR) 
htn7 SH1000 hia:: lacZ hla htn7:: Tn551 This study 
rsb U:: Tn551 TetR, ErYR) 
htn8 SH1000 hla:: IacZ hla htn8:: Tn551 This study 
rsbU:: Tn551 TetR, EryR) 
htn9 SH1000 hla:: IacZ hIa htn9:: Tn551 This study 
rsbU : Tn551 TetR, EryR) 
htn10 SH1000 hla:: lacZ hla htnI0:: Tn551 This study 
1 sC:: Tn551) TetR, EryR) 
htnl 1 SH1000 hla:: lacZ hIa htnI 1:: Tn551 This study 
1 sA:: Tn551 TetR, E 
htnl2 SH1000 hla:: lacZ h1a htnI2:: Tn551 This study 
1 sA:: Tn551) TetR, ErYR 
htnl3 SH1000 hla:: IacZ hla htnI3:: Tn551 This study 
1 sA:: Tn551 TetR, E 
htnl4 SH1000 hla:: lacZ hIa htnI4:: Tn551 This study 
(rsb U:: Tn551 (TetR, EryR 
htn15 SH1000 hla:: lacZ hla htnl5:: Tn551 This study 
(telA:: Tn551 (TetR, E) 
htnl6 SH1000 hla:: lacZ hIa htnI6:: Tn551 This study 
(telA:: Tn551) TetR, E) 
htnl7 SH1000 hla:: lacZ hla htnI7:: Tn551 This study 
hl:: Tn551) TetR, EryR) 
htnl8 SH1000 hla:: lacZhla htnl8:: Tn551 This study 
(saeS:: Tn551) TetR, EryR) 
htnl9 SH1000 hla:: IacZ hla htn19:: Tn551 This study 
(saeS:: Tn551) TetR, E ryR) 
htn20 SH 1000 hla:: IacZ h1a htn20:: Tn551 This study 
1 sA:: Tn551 TetR, EryR) 
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Strain Relevant Genotype / Markers Source / Reference 
Cont. 
htn21 SH1000 hla:: IacZ hla htn21:: Tn551 This study 
(pstC:: Tn551) (TetR, EryR) 
JLA533 htnl:: Tn551 (rsbU:: Tn551) transduced into This study 
JLA513 (SH1000 hla:: IacZ hla+ E, TetR) 
JLA534 htn2:: Tn551 (rsbU:: Tn551) transduced into This study 
JLA513 (SH1000 hia:: lacZ hla+) E, TetR) 
JLA535 htn3:: Tn551 (rsbU:: Tn551) transduced into This study 
JLA513 (SH1000 hla:: IacZ hla (EryR, TetR) 
JLA536 htn4:: Tn551 (rsbU:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: IacZ hla+ E, TetR) 
JLA537 htn5:: Tn551(rsbU:: Tn551) transduced into This study 
JLA513 (SH1000 hla:: IacZ hla+ E, TetR) 
JLA538 htn6:: Tn551 (rsbU:: Tn551) transduced into This study 
JLA513 (SH1000 hla:: lacZ hla+) E, TetR) 
JLA539 htn7:: Tn551(rsbU:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: IacZ hla+) (EryR, TetR 
JLA540 htn8:: Tn551 (rsbU:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: IacZ hla (EryR, TetR) 
JLA541 htn9:: Tn551 (rsb U:: Tn551) transduced into This study 
JLA513 (SH 1000 h1a:: IacZ hla+ (EryR, TetR) 
JLA542 htnl0:: Tn551 (lysC:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: IacZ hla+ (EryR, TetR) 
JLA543 htn 11:: Tn551 (lysA:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: IacZ hla (EryR, TetR) 
JLA544 htnl2:: Tn551 (lysA:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: IacZ hla+ (EryR, TetR) 
JLA545 htnl3:: Tn551 (lysA:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: IacZ hla (EryR, Tee 
JLA546 htn14:: Tn551 (rsbU:: Tn551) transduced into This study 
JLA513 SH1000 hla:: lacZ hla+) (EryR, TetR) 
JLA547 htnl5:: Tn551(teiA:: Tn551) transduced into This study 
JLA513 (SH1000 hla:: IacZ hla+) (EryR, TetR) 
JLA548 htnl6:: Tn551 (teiA:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: IacZ hla+ E, TetR) 
JLA549 htnl7:: Tn551 (hypl:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: IacZ hla (EryR, TetR) 
JLA550 htnI8:: Tn551 (saeS:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: IacZ hla+ (EryR, TetR) 
JLA551 htnI9:: Tn551 (saeS:: Tn551) transduced into This study 
JLA513 (SH1000 h1a:: lacZ hla (EryR, TetR) 
JLA552 htn20:: Tn551(lysA:: Tn551) transduced into This study 
JLA513 (SH 1000 hla:: IacZ hla) (EryR, TetR) 
JLA553 htn2l :: Tn551 (pstC:: Tn551) transduced into This study 
JLA513 SH1000 hla:: IacZ hla (EryR, TetR) 
JLA554 SH1000 ahtl2:: Tn551 (yjbH-.: Tn551) (Ery) This study 
JLA555 SH1000 htn10:: Tn551 1 sC:: Tn551 (Ery) This study 
JLA556 SH1000 aht2:: Tn551 (ykuQ:: Tn551) (Er? ) This study 
JLA557 SH 1000 aht5:: Tn551 l sA:: Tn551) (EryR) This stud 
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Strain 
Cont. 
Relevant Genotype / Markers Source / Reference 
JLA558 SH1000 aht4:: Tn551 telA:: Tn551 E This study 
JLA559 SH1000 aht6:: Tn551 brn :: Tn551 E This study 
JLA560 SH1000 ahtl:: Tn551 rsbU:: Tn551 (Ery) This study 
JLA561 SH1000 htnl7:: Tn551 (h l:: Tn551 E This study 
JLA562 SH1000 htnl8:: Tn551 (saeS:: Tn551) E This study 
JLA563 SH1000 ahtl4:: Tn551 a B:: Tn551 E This study 
JLA564 SH1000 ahtl8:: Tn551 (saeR:: Tn551) (Ery) This study 
seg24 8325-4 asd:: Tn917 (E ) Wiltshire & Foster, 
2001 
JLA601 SH1000 asd:: Tn917 E This study 
segl0 8325-4 dapA:: Tn917 (E ) Wiltshire & Foster, 
2001 
JLA603 SH1000 da A:: Tn917 (E This study 
LES 153 SH1000 hi O:: Tn551 (EryR) Shaw, 2002 
JLA605 SH1000 hla:: lacZ hla hi O:: Tn551 Tet, E This study 
LES154 SH1000 ac1P:: Tn551 (Ery) Shaw, 2002 
JLA606 SH 1000 hia:: lacZhla+aciP:: Tn551 Tet , EryR) 
This study 
LES155 SH1000 norQ:: Tn551 E) Shaw, 2002 
JLA607 SH 1000 hla:: lacZhla+nor :: Tn551 Tet , Ery) This study 
MDW41 8325-4 lysC:: lacZ (E ) Wiltshire & Foster, 
2001 
JLA608 SH1000 l sC:: lacZ (E ) This study 
JLA609 SH 10001 sC:: lacZ si B:: tet E, Tet This study 
SPW2 8325-41 sA:: Tn917 E Watson et al., 1998 
JLA610 SH1000lysA:: Tn917 (E ) This study 
JLA611 SH 1000 l sA:: Tn917 si B:: tet (-E-r7, - Tet This study 
J68 SH1000 telA:: lacZ(E ) Lithgow & Foster, 
personal 
communication 
JLA612 SH1000 telA:: lacZ sigB:: tet (E , TetR) This stud 
Table 2.2 
S. aureus strains used in this study. 
EryR, erythromycin resistant; TetR, tetracycline resistant; Kann, kanamycin resistant; 
CdR, Cadmium resistant. 
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Strain Relevant Genotype / Markers Source / Reference 
DH5a supE44d lacU169 801acZ AMI 5) hsdR17 Hanahan, 1983 
recAl endAl gyrA96 thi-1 recAl 
TOP 10 One F mcrA A(mrr-hsdRMS-mcrBC) 4s 801acZ Invitrogen 
ShotTM AM15 AlacX74 recAl deoR araD139 A(ara- 
chemically leu)7697 galK rpsL (Str) endAl nupG 
competent cells 
Table 2.3 
E. coli strains used in this study. 
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2.4.2 Plasmids 
The plasmids used in this study are listed in table 2.4. Plasmid DNA was purified 
using QIAGEN plasmid kits (Chapters 2.11.2 and 2.11.3) in accordance with the 
manufacturer's instructions. Purified plasmid DNA was stored in TE buffer at -20 °C. 
2.4.3 Bacteriophage 
Bacteriophage 411 (Mani et al., 1993) was used for phage transduction of S. aureus 
(Chapter 2.9). This phage is a S. aureus-specific, temperate, transducing phage of 
serological group B, and requires Ca2+ ions for maintenance of infection in bacterial 
cells. 4 11 has an approximate genome size of 45 kb (Novick, 1991). 
2.5 Centrifugation 
A number of different centrifuges were used for the harvesting of cells and precipitated 
material. These were: i) Eppendorf microfuge 5415D; maximum volume -2 ml, 
maximum speed 13,200 rpm (10,000 g); ii) Centaur 2 centrifuge (Sanyo); maximum 
volume - 50 ml, maximum speed 5,000 rpm; iii) AvantiTM J251 (Beckman), maximum 
volumes and speeds dependent on the rotor used: JA-20; maximum volume - 50 ml, 
maximum speed 20,000 rpm (48,384 g); JA-14; maximum volume - 250 ml, maximum 
speed 14,000 rpm (30,074 g); JA-10.5; maximum volume - 500 ml, maximum speed 
10,000 rpm (18,480 g). 
All centrifugation was carried out at room temperature unless stated otherwise. 
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Plasmid Relevant Genotype / Markers Source / Reference 
pMUTIN4 Promoterless transcriptional lacZ fusion Vagner et al., 1998 
vector Am R, EryR) 
pMAL23 HindIII-BamHI insert in Hindlll-BamHl-cut M. Horsburgh, personal 
pMUTIN4 Am R, EryR) communication 
pCR-II-TOPO Vector for cloning via TOPO TA cloning Invitrogen 
method Am R, Kann 
pDG646 Vector carrying Ery cassette suitable for Guerout-Fleury et al., 
selection in Gram-positive bacteria (AmpR, 1995 
E 
pJA3 2.9 kb fragment comprising hla and This study 
approximately 1 kb of flanking DNA either 
side, introduced into pCR-II-TOPO via 
TOPO TA cloning (AmpR, Kann 
pJA4 1.6 kb Hindlll fragment containing Ery This study 
cassette from pDG646, in Hindlll-cut pJA3 
(Am 
R, KanR, EryR) 
pDG1513 Vector carrying Tet cassette suitable for Guerout-Fleury et al., 
selection in Gram-negative and positive 1995 
bacteria Am R, TetR 
pMOD(MCS) Cloning vector for introducing DNA into the Epicentre Technologies 
MCS of the EZ:: TN transposon (Amp') 
pMOD(tet) pMOD(MCS) containing a 1.5 kb Tet This study 
cassette fragment from pDG1513 inserted 
into the MCS of the EZ:: TN transposon 
Am R, TetR 
pMC4 2.3 kb Xbal-EcoRI PCR product containing Chan et al., 1998 
the upstream regulatory region and 5' end of 
sigB cloned into XbaI-EcoRI pAZ106 
Am EryR) 
pAISHI A derivative of pMUTIN4 in which the This study 
erythromycin-resistance cassette has been 
replaced with a tetracycline-resistance 
cassette Am R, TetR 
pPF4 2.2 kb HindIII-Scal fragment from Chan& Foster, 1998a 
pDU1212 containing the promoter and 5' 
coding region of the hla gene in Hindlll l 
Scal-cut pBK-CMV (KanR) 
pJA5 2.2 kb EcoRI-NotI fragment from pPF4 This study 
containing the promoter and 5' coding 
region of the hla gene in EcoRl / Notl-cut 
AISHI (R , TetR) 
RN3208 Vector carrying Tn551 Am 9 Cd ,E Kornblum et al., 
1986 
Table 2.4 
Plasmids used in this project. 
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2.6 Determination of bacterial cell density 
2.6.1 Spectrophotometric measurement (OD600) 
To quantify the bacterial yield of a culture, spectrophotometric measurements at 600 
nm (OD600), were performed. These measurements were taken using a Jenway 6100 
spectrophotometer. Where necessary, the culture samples were diluted 1: 10 in unused 
sterile culture medium to give a reading below 0.8 on this type of spectrophotometer. 
2.6.2 Direct cell counts (cfu) 
An alternative method for the quantification of cell numbers involved direct cell 
counts. Bacterial samples were serially diluted 1: 10 in PBS in duplicate. 100 µl 
samples of each dilution were spread using sterile glass beads onto duplicate BHI 
agar plates containing antibiotics where necessary. After overnight incubation at 
37 °C, the number of colony forming units (cfu) were determined. 
2.7 Growth experiments 
Strains were streaked from glycerol stocks onto BHI plates containing suitable 
antibiotics, as in Chapter 2.4.1.1.5 ml Bill (no antibiotics) in a sterile 30 ml universal 
tube was inoculated using a single colony and grown overnight at 37 °C, with aeration 
on a rotary shaker at 250 rpm. The overnight preculture was used to inoculate 100 ml 
pre-warmed BHI (no antibiotics, same batch as overnight preculture) in a 250 ml 
conical flask to an OD600 of 0.01. The 100 ml culture was grown at 37 °C in a Grant 
OLS 200 water-bath with linear shaking (equivalent to 250 rpm). For growth 
experiments without lacZ fusion analysis, culture OD600 was determined in duplicate 
over a period of 24 h. For growth experiments with lacZ fusion analysis, the 100 ml 
culture was grown to an OD600 of approximately 1.0 and used to inoculate a second 
250 ml conical flask containing 100 ml BHI (no antibiotics, same batch as overnight 
preculture) to an OD600 of 0.01. The use of exponential-phase precultures prevented 
carry-over of preformed ß-galactosidase from stationary phase cultures, as this would 
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affect lacZ fusion analysis results. The second 100 ml culture was then grown under 
the same conditions as the 100 ml preculture. At appropriate intervals over a 24 h 
period, culture OD600 was determined in duplicate and samples for ß-galactosidase 
assays were taken (Chapter 2.8). 
2.8 ß-galactosidase assays using MUG as a substrate 
Liquid culture samples were assayed for P-galactosidase (LacZ) production with 
MUG as substrate, using a method based on that developed by Youngman (1990). 
100 µl culture samples were collected in 1.5 ml microfuge tubes at regular intervals 
from cultures grown as in Chapter 2.7. Following centrifugation (11,000 g, 3 min), 
supernatants were discarded, and cell-pellets were snap-frozen in liquid nitrogen and 
stored at -70 °C for later analysis. The cell pellets were thawed at room temperature 
for 5 min and resuspended in 0.5 ml ABT buffer. 50 µl of freshly prepared MUG (4 
mg mr) was added and the reactions were mixed by gently inverting the tubes. The 
reactions were immediately incubated at 25 °C in a water-bath for exactly 60 min. 
During the reaction, MUG is hydrolysed to ß-D-galactopyranoside and 4- 
methylumbelliferone (MU) by the action of ß-galactosidase. MU is a fluorescent 
compound and is therefore a quantifiable indicator of P-galactosidase activity. The 
reaction between P-galactosidase and MUG was stopped by adding 0.5 ml 0.4 M 
Na2CO3, and gently inverting the tubes to mix. 
250 pi of each sample was pipetted into the top wells of a 96-well microtitre plate 
(Nunc). 225 µl of ABTN was added to each of the remaining wells to be used. 25 µl 
was removed from the 250 µl sample and diluted 1: 10 by mixing with 225 pl ABTN. 
Serial 1: 100 and 1: 1,000 dilutions were then performed. 25 µl was removed from the 
1: 1,000 dilution well to allow a consistent well volume of 225 µl. 
A fluorimeter (Victor2TM, Wallac) was used to measure the fluorescence of each 
sample (355 / 460 nm, 0.1 sec). The relationship between fluorescence and amount of 
MU was determined using a calibration curve (Chapter 2.8.1; Figure 2.1). This 
allowed the amount of MU in each 225 µl sample to be calculated using the equation 
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shown in Chapter 2.8.1. The amount of MU was then related to ß-galactosidase 
activity using the equation shown below and expressed in MUG units of P- 
galactosidase activity. 1 MUG unit of ß-galactosidase activity is defined as the 
amount of enzyme that catalyses the hydrolysis of 1 pmol of MUG per min, per ml of 
culture, per unit of optical density at 600nm (OD600). The background level of P- 
galactosidase activity measured from 8325-4 and SH1000 control samples was 
deducted from the ß-galactosidase activity of lacZ fusion strains. 
pmoles X (A / B) / (60 X OD600 X 0.1) = ß-galactosidase activity, min 1 ml'1 OD600' 
(MUG Units) 
Where; 
pmoles = pmoles MU (see Chapter 2.8.1 and Fig 2.1 for equation to determine 
amount of MU from calibration curve) 
A= Volume of assay (1.05, where cell pellets were resuspended in 0.5 ml ABT buffer 
and had 50 µl MUG and 0.5 ml Na2CO3 added) 
B= Volume of sample read in plate (ie. 0.225 where 225 µl sample read) 
60 = No. min incubated at 25 °C 
OD600 = OD600 of culture at given time-point 
0.1 = Volume of culture sampled (ie. 0.1 ml) 
2.8.1 ß-galactosidase assay calibration curve 
A calibration curve was prepared each time ß-galactosidase assays were performed. 
These were created with the fluorescent product (MU) diluted to a range of 
concentrations such that the final amount of MU in the 225 gl samples was 625,250, 
125,62.5,25,12.5 and 2.5 pmoles. An example of such a calibration curve is shown in 
Figure 2.1, for which the equation of the straight line was y= 1494.4 + 111.74x. For 
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Figure 2.1 
Calibration curve of amount of MU against units of fluorescence. 
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this example, the following equation was used to convert fluorescence readings into 
pmoles MU. 
[(Fluorescence*D - Background fluorescence] - 1494.4 = pmoles MU 
111.74 
D= dilution of samples in microtitre plate wells (eg. 10 for 1: 10 dilution) 
2.9 Phage techniques 
2.9.1 Preparation of phage lysates 
S. aureus strains were used to inoculate 5 ml BHI (containing relevant antibiotics) in a 
30 ml universal tube, and grown at 37 °C (unless otherwise stated) with 250 rpm rotary 
shaking until in log phase (OD600 0.2 - 0.5). 2-5 ml of cells were pelleted (4,000 rpm 
(Centaur 2), 3 min) and resuspended in 5 ml sterile BHI. 5 ml phage buffer and 100 Al 
phage 411 stock lysate (propagated using S. aureus 8325-4 or SH1000 cells) were 
added to give a cell: phage ratio of approximately 20: 1). The tubes were then incubated 
at 30 °C shaking slowly (50 rpm) for 2-4h, until clear. If cells failed to lyse in this 
time, they were left overnight (static) at 25 °C. Lysates were filter sterilised (0.2 µm 
pore size) and stored at 4 °C. The resulting lysates contained between 109 and 1010 pfu 
1T1rl. 
2.9.2 Determination of phage titres 
S. aureus 8325-4 or SH1000 was grown in 5 ml Bill at 37 °C with 250 rpm rotary 
shaking until log phase (OD600 - 0.5). Phage lysates were diluted in phage buffer to 
10"7.100 µl of diluted phage was mixed with 50 pl of 1M CaCI2 and 400 µl of culture, 
and were incubated for 10 min at room temperature. 5 ml of phage top agar (cooled to 
50 °C), was added to the phage mixture and used to overlay a pre-warmed (- 60 °C) 
phage bottom agar plate. After setting (10 min), plates were incubated overnight at 37 
°C, after which time the number of pfu m1' was determined. 
68 
CHAPTER 2; MATERIALS AND METHODS 
2.9.3 Phage transduction 
The recipient S. aureus strain was inoculated into 100 ml LK broth and incubated 
overnight at 37 °C with shaking (250 rpm). The cells were harvested by centrifugation 
(4,000 rpm (Centaur 2), 10 min), and resuspended in 5 ml sterile unused LK. 500 µl of 
cell culture was transferred to a sterile 30 ml universal tube. 500 µl of phage lysate 
and 1 ml LK (containing 10 mM CaC12) were then added. After gentle mixing the 
lysate/cell mixture was incubated statically for 25 min, followed by 15 min with 
shaking (250 rpm). The temperature used for incubation steps following addition of the 
lysate was 37 °C unless otherwise stated. 1 ml ice-cold 0.02 M sodium citrate was 
added and cells were harvested (5000 rpm (Centaur 2), 10 min) and resuspended in 1 
ml 0.02 M sodium citrate before being left on ice for 2 h. 
Using sterile glass beads, 100 µl and 200 µl aliquots of the lysate/cell mixture were 
spread onto 25 ml LK bottom agar plates containing 0.05 % (v/v) sodium citrate and 
inducing levels of Ery (0.15µg ml') where necessary. Plates were incubated for 90 
min, and overlaid with 5 ml LK top agar containing relevant antibiotics at 6X their 
normal selective concentration. After setting (10 min), plates were incubated for 24-72 
h. Any resulting colonies were considered putative phage transductants, and were 
patched onto separate Bill plates containing relevant selective antibiotics to ensure that 
they possessed the correct resistance profile. 
2.10 Transformation techniques 
2.10.1 Transformation of E. coli 
2.10.1.1 Preparation of E. coli competent cells (Hanahan, 1983) 
A single colony of E. coli DH5a cells from an overnight LB agar plate was inoculated 
into 1 ml of SOB and the cells were dispersed by vortexing. This was used to inoculate 
100 ml of pre-warmed SOB in a11 conical flask. The culture was incubated at 37 °C, 
with shaking (250 rpm), until an OD600 of 0.5 - 0.6 was reached. The culture was 
divided into 2X 50 ml centrifuge tubes and chilled on ice for 15 min. The cells were 
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then harvested by centrifugation (5,000 rpm (Centaur 2), 15 min, 4 °C), and the pellet 
was drained (removing all traces of supernatant with a pipette). After resuspension in 
33 ml of FSB (16.5 ml per pellet), the two cell suspensions were pooled and incubated 
on ice for 15 min. The cells were pelleted and drained as before, and resuspended in 8 
ml FSB and placed on ice. 280 µl of DMSO was added, the sample was mixed by 
swirling and the tube was incubated on ice for 5 min. A second 280 µl volume of 
DMSO was added as before and the tube was incubated on ice for a further 15 min. 
200 pl aliquots were pipetted into microfuge tubes, used immediately or snap-frozen 
using liquid nitrogen and stored at -70 T. The level of competence of the cells was 
determined by transformation with a suitable control plasmid (Chapter 2.10.1.2). 
2.10.1.2 Transformation of Hanahan competent E. coli cells by heat-shock 
An aliquot of frozen Hanahan competent cells (200 µl) (Chapter 2.10.1.1) was thawed 
on ice in a pre-chilled microfuge tube. Up to 50 ng of DNA (in a volume of up to 20 
µl) was added, and the mixture was incubated on ice for 45 min. The tube was then 
incubated at 42 °C for 90 sec and immediately returned to the ice for a further 2 min. 
800 µl SOC was added to the cells, which were incubated for 1 hr at 37 °C with 
shaking at 250 rpm to allow expression of plasmid encoded antibiotic resistance 
markers. A 200 µl aliquot of transformed cells were spread using sterile glass beads 
onto an LB agar plate containing appropriate antibiotics. The remainder of the mixture 
was then spun down and most of the supernatant was removed so that only 
approximately 200 µl remained. The pellet was then resuspended in the residual 
volume of supernatant and the whole of the sample was spread onto an LB agar plate 
as before. The plates were then incubated at 37 °C for 18 - 48 h. 
2.10.2 Transformation of S. aureus 
2.10.2.1 Preparation of S. aureus electrocompetent cells 
A single colony of S. aureus RN4220 was used to inoculate 10 ml B2 medium and 
incubated overnight at 37 °C with shaking (250 rpm). 2 ml of culture was used to 
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inoculate 11 of fresh B2 in a21 conical flask and grown at 37 °C with shaking (250 
rpm) until late log phase (OD600 0.5 - 1.0). Cells were harvested by centrifugation 
(5,000 rpm (Centaur 2), 10 min, 4°C) and washed on ice 3X with 300 ml prechilled 
sterile water (4 °C). Cells were then concentrated in a series of harvesting (5000 rpm 
(Centaur 2), 10 min, 4 °C), and gentle resuspension steps using the following volumes 
of 10 % (v/v) ice-cold glycerol: i) 100 ml; ii) 50 ml; and iii) 25 ml. All of the 
supernatant was removed after each spin. The cells were finally resuspended in 1.25 ml 
10 % (v/v) ice-cold glycerol. Cells were snap-frozen in liquid nitrogen and stored at - 
70 °C. The level of competence of the cells was determined by electroporation with a 
suitable control plasmid (Chapter 2.10.2.2). 
2.10.2.2 Transformation of S. aureus by electroporation 
5-20 µg of plasmid DNA was precipitated by isopropanol precipitation (Chapter 
2.11.4), and washed twice with 70 % (v/v) ice-cold (-20 °C) ethanol, ensuring the 
complete removal of salt. The DNA was then resuspended in 100 µl of sterile dH20 
and transferred to a 0.1 cm gap cuvette (BioRad). 2x 1010 -2x 1011 competent cells, 
which had been defrosted for 5 min at room temperature were then added to the 
cuvette. The plasmid/cell mix was electroporated at room temperature at 100 ohms, 25 
µF and 1.25 kV using a BioRad Gene Pulser. Cells were recovered by adding to the 
cuvette 1 ml of pre-warmed B2 (containing an inducing concentration of Ery, ie. 0.15 
µg ml"', where appropriate). Cells were then transferred to a sterile 2 ml microfuge 
tube and incubated at 37 °C with shaking (250 rpm) for 2 h. A 200 µl aliquot of 
recovered cells was spread using sterile glass beads onto a BHI plate containing 
appropriate antibiotics. The remainder of the mixture was then spun down and most of 
the supernatant was removed so that only approximately 200 µl remained. The pellet 
was then resuspended in the residual volume of supernatant and the whole of the 
sample was spread onto a BHI plate as before. The plates were then incubated at 
37°Cfor18-48 h. 
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2.11 DNA purification techniques 
2.11.1 Genomic DNA preparation 
Genomic DNA was isolated and purified from S. aureus using a QIAGEN DNeasyTM 
kit using a method based on the manufacturer's instructions. A single colony of S. 
aureus was used to inoculate 5 ml of BHI in a 30 ml sterile universal tube and grown 
overnight at 37 °C with shaking at 250 rpm. 1.25 ml of cells was harvested by 
centrifugation (4,000 rpm (Centaur 2), 15 min). 180 µl QIAGEN Buffer BI, 10 µl 
RNAse A (10 mg ml) and 5 µl lysostaphin (5 mg ml) were added and used to 
resuspend the cell pellet. After incubation at 37 °C for 30 min, the protocol was 
continued as per the manufacturer's instructions. Genomic DNA was eluted into 
clean 1.5 ml microfuge tubes using two 200 gl aliquots of buffer AE, and the two 
eluates were pooled. Genomic DNA was concentrated by isopropanol precipitation 
(Chapter 2.11.4). The DNA was dissolved in 20 gI QIAGEN Buffer EB overnight at 4 
°C, and stored at this temperature. 
2.11.2 Small scale plasmid preparation from E. coli 
A single colony of E. coli DH5a plasmid-bearing cells was used to inoculate 5 ml LB 
containing appropriate antibiotics. The culture was incubated overnight at 37 °C with 
shaking at 250 rpm, and the cells were harvested (4,000 rpm (Centaur 2), 5 min). 
Plasmid DNA (up to 20 µg) was isolated and purified using a QlAprep Spin Miniprep 
kit DNA purification system (QIAGEN) according to the manufacturer's instructions. 
Plasmid DNA was eluted using 50 µl of Buffer EB into a clean 1.5 ml microfuge tube 
and stored at -20 °C. 
2.11.3 Large scale plasmid preparation from E. coli 
Large amounts of plasmid DNA (up to 500 µg) were isolated from E. coli using a 
Plasmid Maxi kit DNA purification system (QIAGEN). A single colony of plasmid- 
containing cells of E. coli DH5a from an overnight LB agar plate containing 
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appropriate antibiotics was used to inoculate 5 ml LB broth containing antibiotics 
where necessary. The culture was grown for 8h at 37 °C with shaking at 250 rpm. 
The whole culture was used to inoculate 500 ml LB (containing appropriate 
antibiotics), and grown overnight at 37 °C with shaking at 250 rpm. The cells were 
harvested by centrifugation (6,000 g, 15 min, 4 °C). The protocol was then continued 
as per the manufacturer's instructions. Purified plasmid DNA was resuspended in an 
appropriate volume of TE and stored at -20 °C. 
2.11.4 Isopropanol precipitation of DNA 
DNA was precipitated by the addition of an equal volume of isopropanol and a 1/10 
volume of 3M sodium acetate (pH 5.2). The mixture was vortexed and incubated at 
room temperature for 2 min. The precipitated DNA was recovered by centrifugation 
(11,000 g, 10 min) and the pellet was washed with 500 µl ice-cold 70 % (v/v) ethanol. 
The DNA was pelleted by centrifugation (11,000 g, 5 min), and the 70 % (v/v) ethanol 
wash step was repeated. The pellet was air-dried, and the DNA was dissolved in an 
appropriate volume of TE and stored at -20 T. 
2.11.5 Gcl extraction of DNA using a QlAquick spin column 
DNA fragments were purified from agarose gels (Chapter 2.11.5) with a QlAquick Gel 
Extraction kit (QIAGEN) according to the manufacturer's instructions. Purified DNA 
was eluted into a clean 1.5 ml microfuge tube using 50 µ1 of Buffer EB and stored at - 
20 T. 
2.11.6 Purification of PCR products using a QIAquick spin column 
PCR products were purified using a QlAquick PCR Purification kit (QIAGEN), 
according to the manufacturer's instructions. Purified DNA was eluted into a clean 
1.5 ml microfuge tube using 30 µl Buffer EB and stored at -20 T. 
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2.11.7 Purification of dye-terminator sequencing reactions using a 
DyeEXTM spin column 
Unincorporated nucleotides and primers were removed from dye-terminator 
sequencing reactions using a DyeEXTM spin kit (QIAGEN) according to the 
manufacturer's instructions. 
2.12 Quantification of DNA 
To quantify the concentration of DNA in a solution, spectrophotometric measurements 
were performed at 260 nm An OD260 of 1 corresponds to approximately 50 µg mr' 
for double stranded DNA, and approximately 20 µg mr' for single stranded 
oligonucleotides. OD260 measurements were taken using a Shimadzu UV-2401PC 
spectophotometer. Alternatively, the concentration of DNA could be estimated by 
agarose gel electrophoresis (Chapter 2.13.5). This involved comparing the intensity of 
ethidium bromide stained bands to bands of molecular weight markers containing 
known amounts of DNA (Table 2.6). 
2.13 In vitro DNA manipulation techniques 
2.13.1 Polymerase chain reaction (PCR) techniques 
2.13.1.1 Primer design 
The primers used for PCR amplification were short synthetic oligonucleotides (19 - 32 
bp) that were based on DNA sequences from published studies or obtained from 
cloning vector information and S. aureus databases (http: //www. ncbi. nlm. nih. gov/ 
and http: //www. genome. ou. edu/staph. html). Suitable restriction sites were introduced 
where necessary at the 5' ends of primers to enable subsequent cloning. The primers 
used in this study are shown in Table 2.5. 
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Primer Primer sequence (5' 4 3') Source / Reference 
OL-78 TAT CTA CCA ATC TTT GAT AAT CTC GAT 
AAC 
Kullik & Giachino, 1997 
OL-79 GCT CTA GAG TTC AAG ACA TTA GAT G 
Tn2 CTC ACA ATA GAG AGA TGT CAC CGT C Watson et al., 1998 
JA-5 CCC AAG CTT GTC CCA TGA TTA GTG TTC This study 
JA-6 CGC GGA TCC ATG CAT GCT ATA TAT AC 
OL-32 CCG GTA CCC GGA TTT TAT GAC CGA TGA 
TGA AG 
M. Horsburgh, personal 
communication 
OL-33 CCG GTA CCT TAG AAA TCC CTT TGA GAA 
TGT TT 
FP-1 ATT CAG GCT GCG CAA CTG T Epicentre Technologies 
RP-1 GTC AGT GAG CGA GGA AGC GGA AG 
JA-7 CAT CGT GTC GAC CTG CAG ATA GTG TAC 
G 
This study 
JA-8 CAT CGT AGA TCT CTC TCT CCC AAA GTT 
G 
JA-9 CAT CGT AGA TCT CTC TCT AGC TTG AGG 
CAT C 
This study 
JA-10 CAT CGT CTC GAG GTT CAT GTA ATC ACT 
CCT TC 
Table 2.5 
Synthetic oligonucleotides used as primers for PCR amplification of DNA fragments 
in this project. 
Relevant restriction sites are underlined. 
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2.13.1.2 DNA amplification 
2.13.1.2.1 Taq polymerase 
Where accurate amplification was not required, standard PCR amplification reactions 
were performed using Taq polymerase (Promega). The following components were 
added, on ice, to a 0.5 ml thin-walled PCR tube. 
Template DNA 100 - 500 ng 
Forward primer 300 nM* 
Reverse primer 300 nM* 
I OX Taq PCR buffer (Promega) 10 µl 
MgC12 1.5 - 4.5 mM* 
dNTPs 0.2 mM* 
Taq DNA polymerase 0.5 µl (2.5 Units) 
dH2O to 100 µl 
*fmal concentration 
PCR amplification was carried out using an Eppendorf 5330 Mastercycler. The lid was 
heated to 106 °C for the duration of the PCR amplification, and the block was pre- 
heated to 95 T. The following thermal cycling programme of 30 cycles of steps 2-4 
was used: 
1) Denature 95 °C; 5 min 
2) Denature 95 °C; 30 sec 
3) Anneal 50-55 °C; 30 sec 
4) Extension 72 °C; t min (t=1 min kb' + 10 %) 
5) Extension 72 °C, 20 min 
PCR products were stored at -20 T. 
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2.13.1.2.2 Pwo polymerase 
DNA amplifications of <3 kb that required 3'-5' proof-reading activity were 
performed with Pwo polymerase (Roche). 
The following Master mixes were made on ice: 
Master mix 1: 
Template DNA 0.1 - 0.75 gg 
dNTPs 0.2 mM* 
Forward primer 300 nM * 
Reverse primer 300 nM * 
dH2O to 50 pl 
Master mix 2: 
lOX PCR buffer with 20 mM MgSO4 
Pwo polymerase 
dH2O 
*fmal concentration 
10 µ1 
0.5 µl (2.5 Units) 
to 50 µl 
Master mix 1 and 2 were combined on ice in a 0.5 ml thin-walled PCR tube and 
cycling immediately commenced. 
PCR amplification was performed using an Eppendorf 5330 Mastercycler. The lid was 
heated to 106 °C for the duration of the PCR amplification, and the block was pre- 
heated to 94 T. Once the tubes were added, the DNA was denatured at 94 °C for 2 
min, followed by 10 cycles of programme A, then 20 cycles of programme B: 
Programme A: 
Denature 94 °C; 15 sec 
Anneal 45-65 °C; 30 sec 
Extension 72 °C; t min (t = 45 sec kb-1) 
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Programme B: 
Denature 94 °C; 15 sec 
Anneal 45-65 °C; 30 sec 
Extension 72 °C; t min 
(t = (45 sec kb71) +5 sec per cycle) 
Once all the cycles were complete a final step of 72 °C for 7 min was added to allow 
complete extension of the primers. The PCR products were stored at -20 °C. 
2.13.1.2.3 Expand"m Long Template PCR system 
DNA amplifications of >3 kb, that required 3'-5' proof-reading activity were 
performed with the ExpandTM Long Template PCR system (Roche). This system is 
composed of a unique enzyme mix containing the thermostable Taq and Pwo 
polymerases, and is optimised for amplifying fragments of up to 27 kb in length. 
The following Master mixes were made on ice: 
Master mix 1: 
Template DNA 10 - 500 ng 
dNTPs 350 pM* 
Forward primer 300 nM* 
Reverse primer 300 nM* 
dH2O to 25 µl. 
Master mix 2: 
I OX PCR buffer with 1.75 mM MgC12 5 µ1 
ExpandTM polymerase 0.75 pl 
dH2O to 25 µl 
*final concentration 
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Master mix 1 and 2 were combined on ice in a 0.5 ml thin-walled PCR tube and 
cycling immediately commenced. 
PCR amplification was carried out using an Eppendorf 5330 Mastercycler. The lid was 
heated to 106 °C for the duration of the PCR amplification, and the block was pre- 
heated to 94 T. Once the tubes were added, the DNA was denatured at 94 °C for 2 
min, followed by 10 cycles of programme A, then 20 cycles of programme B: 
Programme A: 
Denature 94 °C; 10 sec 
Anneal 65 °C; 30 sec 
Extension 68 °C; t min (t = 40 sec kb-) 
Programme B: 
Denature 94 °C; 10 sec 
Anneal 50-55 °C; 30 sec 
Extension 68 °C; t min 
(t = (40 sec kb'') + 20 sec per cycle) 
Once all cycles were complete a final step of 68 °C for 7 min was added to allow 
complete extension of the primers. The PCR products were stored at -20 T. 
2.13.1.2.4 Direct genomic DNA sequencing 
Short (up to 700 bp) single read sequencing reactions were carried out on DNA 
flanking transposon insertions (Chapter 2.15) using the ABI Prism® BigDyeTM 
Terminator Cycle Sequencing Ready Reaction kit (version 2.0) (Perkin-Elmer). 
Genomic DNA was prepared and concentrated as in Chapter 2.11.1, and sheared by 
vigorous vortexing to aid binding of the primer to the target sequence. The following 
were combined in a 0.5 ml thin-walled PCR tube on ice: 
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Genomic DNA 2.5 µg 
Primer Tn2 3.2 pM (final concentration) 
BigDyeTM sequencing premix 16 pl 
dH2O to 40 pl 
PCR amplification was carried out using an Eppendorf 5330 Mastercycler. The lid was 
heated to 106 °C for the duration of the PCR amplification, and the block was pre- 
heated to 95 T. Once the tubes were added the DNA was denatured by heating at 95 
°C for 5 min before the following thermal cycling programme of 99 cycles was 
initiated: 
Denature 95 °C for 30 sec 
Anneal 55 °C for 20 sec 
Extend 60 °C for 4 min 
The PCR sequencing products were cleaned (to remove unincorporated nucleotides 
and primers) using a DyeEXTM Spin kit (QIAGEN) (Chapter 2.11.7). The samples 
were then dried in a heat-block at 55 °C for 3h and sequenced using an ABI 377 
sequencer by Dr Arthur Moir (Department of Molecular Biology and Biotechnology, 
University of Sheffield) and by MWG-BIOTECH. 
2.13.1.2.5 PCR screening of E. coli cells 
Putative E. coli transformants were patched using sterile toothpicks onto LB agar 
plates containing appropriate antibiotics and grown overnight at 37 °C. A small 
amount of each patched positive clone was transferred to a PCR tube containing the 
PCR mix as in Chapter 2.13.1.2.1 (minus the DNA). The PCR programme followed 
was as in Chapter 2.13.1.2.1 with the tubes heated to 95 °C initially for 10 min to 
ensure lysis of the cells and release of DNA. The PCR products were visualised by 
agarose gel electrophoresis (Chapter 2.13.5) and putative positive clones were chosen 
for further screening using small scale plasmid preparations (Chapter 2.11.2) and 
restriction digestions (Chapter 2.13.2). 
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2.13.2 DNA restriction 
DNA restriction digests were performed in volumes from 20 - 100 µl. They were 
prepared as follows: 
Restriction enzyme buffer 10 % (v/v) 
Restriction enzyme(s) up to 10 % (v/v) 
DNA up to 80 % (v/v) 
Where appropriate the reaction volume was made up with dH20. The restriction 
digests were incubated at 37 °C for between 2h and 16 h. Before digested DNA was 
used for further manipulation, it was purified using a QIAGEN PCR purification kit 
(Chapter 2.11.6) or separated using agarose gel electrophoresis (Chapter 2.13.5) and 
purified using a QlAquick gel extraction kit (Chapter 2.11.5). 
2.13.3 Alkaline phosphatase treatment of restriction-digested plasmids 
The 5' ends of plasmids digested with only one restriction enzyme were 
dephosphorylated using Calf Intestinal Alkaline Phosphatase (CIAP) (Promega) to 
reduce vector re-ligation in subsequent cloning steps. The following were added on 
ice: 
Digested plasmid DNA up to 5 µg 
l OX reaction buffer (Promega) 10 µl 
CIAP 0.01 U per pmol of ends* 
dH2O to 100 µl 
*the number of picomoles of ends for a given sample of digested plasmid was 
calculated using the following equation; 
(µg DNA / kb size of DNA) X 3.04 = pmol of ends 
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The mixture was incubated for 30 mins at 37 T. A second aliquot of CIAP (0.01 U 
per pmol of ends) was added and the sample was incubated for an additional 30 mins 
at 37 T. To stop the reaction, 2 µ1 of 0.5 M EDTA was added and the mixture 
incubated at 65 °C for 20 min. The DNA was purified and concentrated using a 
QIAquick PCR purification kit (Chapter 2.11.6) prior to use in a ligation reaction. 
2.13.4 DNA ligation 
The following were added on ice: 
Digested plasmid DNA 100 ng 
Digested DNA insert x ng* 
lOX DNA ligase buffer (Promega) 2 µl 
T4 DNA ligase (Promega) 1 µ1 
*the amount of insert added was calculated using the following equation to allow a 1: 1 
and 1: 3 molar ratio of vector: insert to be used; 
100 ng of plasmid X kb size of insert X molar ratio of insert = ng of insert 
kb size of plasmid plasmid 
The reaction was made up to 20 µl with dH2O and incubated overnight at 14 °C. The 
completed ligation mix was then used to transform E. coli (Chapter 2.10.1). 
2.13.5 Agarose gel electrophoresis 
DNA fragments were separated by horizontal gel electrophoresis using various size 
electrophoresis tanks (Life Technologies). Appropriate volumes of agarose gel (0.8 -4 
% (w/v) dissolved in TAE by microwaving) were submerged in suitable volumes of 
TAE electrophoresis buffer. The gel contained 0.2 pg ml'' ethidium bromide. DNA 
samples were mixed with 1/5t' their volume of 6X DNA loading buffer and loaded into 
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wells in the gel. The gel was run at 80 - 120 V for 1-2h and visualised by means of a 
UV transilluminator at 260 nm To estimate the sizes of DNA fragments, DNA 
markers were also loaded into the gel. These included pUC mix markers (MBI 
Fermentas), GenerulerTM 1 kb DNA ladder (MBI Fermentas), or ? genomic DNA 
double-digested with HindIII/EcoRI (MBI Fermentas) (Table 2.6). 
2.13.5.1 Agarose gel photography 
A permanent record of agarose gels was obtained by photographing the ethidium 
bromide-stained gels illuminated from below with UV light at 260 nm. A Kodak 203 
red-orange filter, and Polaroid 667 (ASA 3000) film were used. In addition, 
photographs were scanned using a UMAX Powerlook 1100 for a permanent electronic 
record. 
2.13.6 DNA cloning 
2.13.6.1 Construction of a tetracycline-resistant h! a cassette knock-out 
2.13.6.1.1 Attempt to clone a 2.9 kb hla insert into pMUTIN4 directly 
A 2.9 kb DNA fragment containing the whole 1 kb h1a gene and approximately 1 kb of 
flanking DNA was PCR-amplified from 8325-4 genomic DNA using the ExpandTM 
Long Template PCR system (Chapter 2.13.1.2.3). The primers, JA-5 and JA-6, 
introduced unique terminal Hindlll and BamHI restriction sites respectively. The PCR 
product was gel-extracted (Chapter 2.11.5), and both the PCR product and the vector 
(pMUTIN4) were cut with Hind ill overnight (Chapter 2.13.2). Following PCR 
purification (Chapter 2.11.6), the PCR product and pMUTIN4 were cut with BamHI 
overnight (Chapter 2.13.2). The two fragments were run on a 0.8 % (w/v) agarose gel 
(Chapter 2.13.5) to ensure they were of the correct size. The insert fragment and cut 
vector were then gel-extracted (Chapter 2.11.5), ligated (Chapter 2.13.4) and 
transformed into E. coli DH5a (Chapter 2.10.1). Transformants were selected on LB 
containing 50 jig mr' Amp. 
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DNA size markers (bp) 
pUC mix 1 kb DNA ladder X HindlIl/EcoRI 
1116 10,000 21,226 
883 8,000 5,148 
692 6,000 4,973 
501 5,000 4,268 
489 4,000 3,530 
404 3,500 2,027 
331 3,000 1,904 
242 2,500 1,584 
190 2,000 1,375 
147 1,500 947 
111 1,000 831 
110 750 564 
67 500 
34 250 
26 
19 
Table 2.6 
The size of DNA fragments used as size markers for agarose gel electrophoresis. 
*The 3,000 bp band of 1kb generuler contains - 147 ng DNA per 10 µl marker. 
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2.13.6.1.2 Attempt to clone a 2.9 kb lila insert into pMUTIN4, with an 
intermediate stage of cloning the lila insert into pCR-II-TOPO 
To ensure that both enzymes cut the vector DNA fully, plasmid pMAL23 (pMUTIN4 
containing a BamHI / HindIII insert) was cut with HindII1 and BamilI overnight 
(Chapter 2.13.2). The digest was run on a 0.8 % (w/v) agarose gel (Chapter 2.13.5) and 
the vector fragment was gel-extracted (Chapter 2.11.5). 
A 2.9 kb hla insert was prepared for cloning into the vector pCR-II-TOPO (Invitrogen) 
by PCR amplification, as described in Chapter 2.13.6.1.1. A sample of the PCR product 
was run on a1% (w/v) agarose gel (Chapter 2.13.5) and found to have no background 
banding. The PCR product was therefore used directly in the TOPO cloning reaction 
without purification, as gel extraction can interfere with the process. The TOPO TA 
cloning protocol was performed, according to the manufacturer's instructions; 
The following were added at room temperature; 
PCR product (hla insert) 0.5 -4 µl 
Linearised pCR-II-TOPO 1 µl 
Salt solution 1 µl 
Sterile water To 5 µl 
The reaction was mixed gently and incubated at room temperature for 5 min. 2 µl of the 
cloning reaction was then added to a vial of TOP 10 One ShotTM chemically competent 
E. coli cells (Invitrogen) on ice and mixed gently. Following incubation on ice for 30 
min, the reaction was heat-shocked at 42 °C for 30 sec. The tube was then returned 
back to the ice for 2 min. Following addition of 250 µl of room temperature SOC, the 
tube was shaken at 37 °C for 1 h. 10 - 50 µl from of the transformation mix was plated 
onto LB agar plates containing X-gal (Chapter 2.16.2) and 50 µg ml-1 Amp and 
incubated overnight at 37 T. 
Hundreds of transformants were produced, and 5 colonies were tested. Since pCR-II- 
TOPO has blue / white selection capabilities, all of the colonies selected for analysis 
were white. Plasmid DNA was prepared by small scale plasmid preparation (Chapter 
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2.11.2) using LB containing 50 pg mC-' Amp. Plasmid DNA was cut with Hindlll and 
BamHI together, or with KpnI for 3h (Chapter 2.13.2), and run on a1% (w/v) agarose 
gel (Chapter 2.13.5) to identify positive clones. 
Using plasmid DNA prepared from a positive clone, the hla insert was cut from the 
pCR-II-TOPO backbone by cutting overnight with HindIII and BamHI together 
(Chapter 2.13.2). The digest was run on a 0.8 % (w/v) agarose gel, and the hla insert 
was gel extracted (Chapter 2.11.5). The cut hla insert and pMUTIN4 vector backbone 
cut from pMAL23 were then ligated (Chapter 2.13.4) and transformed into E. coil 
DHSa (Chapter 2.10.1). Transformants were selected on LB containing 50 gg mr' 
Amp. 
2.13.6.1.3 Attempt to clone a counter-selectable erythromycin-resistance 
cassette into pJA3 
Plasmids pDG646 and pJA3 were cut with HindIIl overnight (Chapter 2.13.2). Digests 
were separated on a 0.8 % (w/v) agarose gel (Chapter 2.13.5). The 1.6 kb erythromycin 
resistance cassette (from pDG646) and the 6.9 kb pJA3 band were gel extracted 
(Chapter 2.11.5). HindIll-cut pJA3 was alkaline-phosphatase treated to prevent vector 
recircularisation (Chapter 2.13.3). The vector and insert fragments were then ligated 
(Chapter 2.13.4) and transformed into E. coli (Chapter 2.10.1). Transformants were 
selected on LB containing 50 pg ml 7' Amp, and then replica plated onto LB containing 
300 pg ml-' Ery. 
2.13.6.2 Cloning of a tetracycline-resistance cassette into pMOD(MCS) 
A 1.5 kb band comprising a tetracycline-resistance cassette was PCR amplified from 
pDG1513 using Pwo polymerase (Chapter 2.13.1.2.2). The primers, OL-32 and OL-33, 
both introduced flanking KpnI restriction sites. The 1.5 kb tetracycline-resistance 
cassette band was gel extracted (Chapter 2.11.5) from a 0.8 % (w/v) agarose gel 
(Chapter 2.13.5). The PCR product and the 2.5 kb vector pMOD(MCS) were then cut 
with KpnI overnight (Chapter 2.13.2), and the fragments resolved on a 0.8 % (w/v) 
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agarose gel (Chapter 2.13.5). The insert and vector were gel extracted (Chapter 2.11.5), 
ligated (Chapter 2.13.4) and transformed into E. coli DHSa (Chapter 2.10.1). 
Transformants were selected on LB containing 12.5 pg ml-1 Tet. Growth at 37 °C for 48 
h produced a single tetracycline-resistant colony. The colony was streaked onto an LB 
plate containing 50 µg mr1 Amp, and following growth at 37 °C overnight was found to 
be ampicillin resistant. Plasmid DNA was prepared by small scale plasmid preparation 
(Chapter 2.11.2) using LB containing 50 pg ml' Amp. Restriction mapping of the 
resulting plasmid DNA was then performed using Kpnl, BamHI and Scal (Chapter 
2.13.2). 
2.13.6.3 Construction of the lacZ reporter gene fusion vector pAISHI 
Inverse PCR amplification of pMUTIN4 was performed using the ExpandTM Long 
Template PCR system (Chapter 2.13.1.2.3) to amplify a 7.7 kb fragment containing the 
entire sequence of pMUTIN4, except for the erythromycin-resistance cassette. The 
primers used, JA-9 and JA-10 introduced BgIII and Xhol sites respectively. A 2.1 kb 
fragment containing a tetracycline-resistance cassette was PCR amplified from 
pDG1513 using the Pwo polymerase protocol described in Chapter 2.13.1.2.2. The 
primers used, JA-7 and JA-8 introduced Sail and BgIlI sites respectively. The PCR 
products were run on a 0.8 % (w/v) agarose gel (Chapter 2.13.5) and the 7.7 kb 
pMUTIN4 and 2.1 kb tetracycline-resistance cassette bands were gel extracted (Chapter 
2.11.5). The pMUTIN4 fragment was cut with BgIII and Xhol overnight, whilst the 
tetracycline-resistance cassette was cut with Sall and BgIII overnight (Chapter 2.13.2). 
The digests were resolved on a 0.8 % (w/v) agarose gel (Chapter 2.13.5), and the Bg1II / 
XhoI-cut pMUTIN4 and Sall / Bg11I-cut tetracycline-resistance cassette bands were gel 
extracted (Chapter 2.11.5), ligated (Chapter 2.13.4) and transformed into E. coli DH5a 
(Chapter 2.10.1). Transformants were selected on LB containing 12.5 pg ml-1 Tet and 
grown at 37 °C for 48 h. Colonies were streaked onto LB plates containing 50 µg mI-1 
Amp and grown at 37 °C overnight to ensure that they were ampicillin resistant. 
Plasmid DNA was prepared by small scale plasmid preparation (Chapter 2.11.2) using 
LB containing 50 µg ml-1 Amp. Restriction mapping of the resulting plasmid DNA was 
then preformed using HindIII, Gal / NcoI and Dral (Chapter 2.13.2). 
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2.13.6.4 Construction of an hla:: IacZ reporter gene fusion 
An hla:: lacZ reporter gene fusion was constructed in pAISH1 using a 2.2 kb EcoRl / 
NotI-flanked fragment (containing the 5' region of the hla gene and upstream 
regulatory sequences) from the plasmid pPF4. Plasmids pPF4 and pAISH1 were cut 
overnight with EcoRI (Chapter 2.13.2), and the digests passed through a PCR 
purification column (Chapter 2.11.6). The EcoRI-cut pPF4 and pAISHI were then cut 
overnight with Noll. The restriction products were resolved on a 0.8 % (w/v) agarose 
gel, and the 2.2 kb EcoRI / Noll-cut h1a promoter insert band (from pPF4) and the 9.8 
kb EcoRI / Notl-cut pAISH1 vector band were gel extracted (Chapter 2.11.5), ligated 
(Chapter 2.13.4) and transformed into E. coli DHSa (Chapter 2.10.1). Transformants 
were selected on LB containing 50 µg ml-1 Amp and grown at 37 °C overnight. 
Colonies were streaked onto LB plates containing 12.5 pg mr l Tet and grown at 37 °C 
overnight to ensure that they were tetracycline resistant. Plasmid DNA was prepared 
by small scale plasmid preparation (Chapter 2.11.2) using LB containing 50 µg ml-1 
Amp. Restriction mapping of the resulting plasmid DNA was then preformed using 
EcoRI / Noll and KpnI (Chapter 2.13.2). 
2.14 DNA Hybridisation techniques 
2.14.1 Labelling of DNA probes with digoxigenin 
DNA fragments were labelled by a random priming method using a commercially 
available digoxigenin (DIG) DNA labelling and detection kit (Roche). DNA to be 
labelled (up to 3 pg in a maximum of 15 µl EB in a microfuge tube) was denatured at 
100 °C for 10 min, then immediately chilled on ice for 10 min. The following 
components were added on ice; 
Random hexanucleotide mixture 2 µl 
dNTP labelling mixture (containing DIG-dUTP) 2 µl 
Klenow enzyme (2 units) 1 µl 
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The volume of the reaction was made up to 20 µl with dH2O. The reaction was 
incubated overnight at 37 °C, followed by purification using a QlAquick PCR 
purification kit (Chapter 2.11.6). The purified probe was then quantified (Chapter 
2.14.2). 
2.14.2 Quantification of DIG-labelled DNA probes 
The amount of DIG-labelled material in a volume of labelled DNA was determined by 
comparison to labelled control DNA of known concentration supplied in the DIG DNA 
labelling and detection kit (Roche). The sample DNA and the control DNA were diluted 
according to the manufacturer's instructions, using a single pre-dilution step to obtain 
an estimated concentration of 1 ng µl"1, followed by five serial 10-fold dilutions. 1 µl of 
each 10-fold dilution was spotted onto Hybond-N+ Extra (positively charged) nylon 
membrane (Amersham Life Sciences). The DNA was permanently bound to the 
membrane using a UV crosslinker (Chapter 2.14.4) and DIG-labelled DNA was then 
detected immunologically, using AP-linked anti-dioxygenin antibody (Chapter 2.14.6). 
The spot intensities of the control and probe dilutions were compared visually to 
estimate the concentration of the probe. 
2.14.3 Southern blotting 
Agarose gel electrophoresis of -1 µg samples of digested genomic DNA was 
performed and photographed as described in Chapters 2.13.5 and 2.13.5.1 with a 0.8 % 
(w/v) agarose gel. DIG-labelled X Hindill / EcoRI markers were loaded into the gel to 
estimate the size of DNA bands following development of the blot using AP- 
conjugated anti-DIG antibody. The gel was soaked in Southern depurination solution 
for 10 min and washed in dH2O. The gel was soaked in Southern denaturation buffer 
twice for 15 min and rinsed in dH2O. The gel was neutralised by soaking in Southern 
neutralisation buffer twice for 15 mins. The DNA was transferred from the gel to a 
Hybond-N+ Extra membrane by vacuum blotting at 60 mbar for 90 mins, using lOX 
SSC as the transfer buffer. 
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2.14.4 Fixing the DNA to the membrane 
DNA was fixed to the Hybond-N+ Extra nylon membrane with the use of a UV 
crosslinker (Amersham Life Sciences RPN 2500), 70 mJ / cm2; 15 sec). 
2.14.5 Prehybridisation and hybridisation 
Membranes to be probed with the DIG-labelled DNA were prehybridised for 2h at 68 
°C in pre-hybridisation solution (20 ml per 100 cm2 of membrane). Just prior to use, 
the labelled probe (Chapter 2.14.1) was denatured in a microfuge tube by placing the 
tube in a boiling water bath for 10 min. The labelled probe was immediately chilled on 
ice for 10 min and added to pre-heated hybridisation solution to give a final probe 
concentration of 5- 25 ng m1'. The membrane was then hybridised with the labelled 
probe overnight at 68 T. After hybridisation the solution was retained for future use 
and stored at -20 T. Unbound probe was removed by washing the membrane twice in 
2X wash solution for 5 min at room temperature. The membrane was then washed 
twice in 0.5X wash solution for 5 min at 68 °C. 
2.14.6 Colorimetric detection of DIG-labelled DNA 
The hybridised and washed membranes were equilibrated with washing buffer for 1 
min and then blocked for 30 min with gentle rocking in blocking solution. The 
membrane was then transferred to antibody solution containing a 1: 5,000 dilution of 
stock anti-DIG-AP antibody (Roche). After 30 min incubation with gentle rocking, the 
membrane was washed twice for 15 min with washing buffer. The membrane was 
equilibrated for 2 min with detection buffer before 10 ml colour substrate solution was 
applied to the membrane. This was then incubated in the dark to allow the membrane 
to develop. The presence of anti-DIG-AP bound to DIG-labelled DNA was visualised 
by the appearance of purple bands or spots. After the colour had developed 
sufficiently, the membrane was washed in 1X TE for 5 min to stop the reaction. The 
membrane was then air-dried, scanned using a UMAX Powerlook 1100 and stored in 
the dark. 
90 
CHAPTER 2: MATERIALS AND METHODS 
2.15 Transposon mutagenesis 
2.15.1 Transposon mutagenesis of 8325-4 using EZ:: TN(tet) 
Transposon mutagenesis of S. aureus 8325-4 using the Tn5-based EZ:: TN transposition 
system of Epicentre Technologies was performed using the following in vitro and in 
vivo methods. 
2.15.1.1 In vitro transposon mutagenesis 
Genomic DNA was prepared from S. aureus 8325-4 as described in Chapter 2.11.1. The 
DNA was sheared using a 23-gauge needle (Microlance) attached to a5 ml syringe. The 
reaction components were then added in the following order; 
EZ:: TN 10 X reaction buffer 1 µl 
Sheared 8325-4 genomic DNA 200 ng 
EZ:: TN(tet) transposon 1- 20 ng 
dH2O To 10 µ1 
EZ:: TN transposase 1 µl 
The reaction components were then incubated at 37 °C for 2 h. The reaction was 
stopped by adding 1 µl of EZ:: TN 10 X stop solution and heating 70 °C for 10 min. The 
reaction products were then electroporated into competent RN4220 cells (Chapter 
2.10.2), with selection on BHI agar plates containing 5 pg ml-' Tet. Plates were 
incubated at 37 °C for 48 h. 
2.15.1.2 In vivo transposon mutagenesis 
EZ:: TN(tet) transposomes were produced by adding the following; 
100 µg mr1 EZ:: TN(tet) transposon DNA 5 µl 
EZ:: TN transposase 10 µl 
100% glycerol 5 µl 
dH2O To 20 µl. 
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The components were mixed by vortexing and incubated for 30 min at room 
temperature. 1 µl of the reaction mixture was then electroporated into S. aurcus RN4220 
(Chapter 2.10.2). Cells were plated onto BHI agar plates containing 5 µg ml'' Tet, and 
incubated for up to 48 h at 37 T. 
2.15.2 Transposon mutagenesis of SH1000 hla:: lacZ using Tn551 
JLA514 (SH1000 hla:: lacZ h1a+ (Tet), pRN3208) (see Figure 5.7 for diagram of 
pRN3208) was streaked onto a BHI agar plate containing 250 µg ml"' CdC12 and 5 . tg 
ml"' Ery, and grown overnight at 30 T. A single colony was used to inoculate 100 ml 
BHI broth containing 250 µg ml"' CdC12 and 5 pg ml'' Ery, and grown overnight at 30 
°C in a Grant OLS 200 water-bath with linear shaking (equivalent to 250 rpm). 3 ml of 
culture was removed and the cells were harvested by centrifugation (10 min, 3000 rpm, 
Centaur 2) and resuspended in 100 ml BHI containing 5 pg ml'' Ery (which had been 
pre-equilibrated to either 42 or 43 °C). The culture was then grown at the relevant non- 
permissive temperature (ie. either 42 or 43 °C) in a Grant OLS 200 water-bath with 
linear shaking (equivalent to 250 rpm) until an OD600 of 0.3 - 0.4 was reached. 3 ml of 
culture was transferred to a fresh, pre-equilibrated 100 ml batch of Bill containing 5 
µg ml"' Ery, and grown at the same non-permissive temperature as before (le. either 42 
or 43 °C) in a Grant OLS 200 water-bath with linear shaking (equivalent to 250 rpm) 
for 12 h. The cells were harvested by centrifugation (10 min, 8000 rpm, Centaur 2) and 
resuspended in 4 ml BHI containing glycerol at a final concentration of 10 % (w/v). 
500 µl aliquots were transferred to 1.5 ml microfuge tubes, snap-frozen in liquid 
nitrogen and stored at -70 T. 
2.15.3 Transposon library evaluation and enumeration 
The efficiency of Tn917 insertion (see Chapter 4.2.1 for source of libraries) was 
determined by performing 10-fold serial dilutions of cells in PBS and plating 100 µl of 
the 103 - 107 dilutions onto BHI plates containing either Ery and Lin, or Ery, Lin and 
Tet (Chapter 2.6.2). Transposon insertion frequency was calculated by comparing the 
number of colonies on plates containing Ery and Lin (ie. cells containing Tn917, either 
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inserted into the chromosome, or carried by the plasmid pLTVI) with the number of 
colonies on plates containing Ery, Lin and Tet (ie. cells containing intact pLTV 1). 
Tn551 insertion into libraries produced in Chapter 2.15.2 was determined in the same 
way as for Tn917 insertion, except that CdC12 was used to select for the presence of 
pRN3208. See Figures 4.1 and 5.7 for diagrams of pLTV 1 and pRN3208 respectively. 
2.15.4 Transposon mutant library screening 
2.15.4.1 Screen to identify genes involved in the repression of Ilia in the 
presence of 1M NaCl 
An aliquot of Tn917 library X or Z (see Chapter 4.2.1) was suitably diluted in PBS to 
give - 100 colonies per BHI Ery Lin plate. After spreading with sterile glass beads, the 
plates were incubated overnight at 37 T. The colonies were replica plated onto rabbit 
blood plates containing 1M NaCI (Chapter 2.16.1) using sterile velvets and incubated 
overnight at 37 °C. Non-haemolytic colonies and colonies with a zone of haemolysis 
of increased diameter compared to the background colonies were patched onto a rabbit 
blood plate containing either 1M NaCI or no added NaCl, with 8325-4 as a control, 
and grown overnight at 37 °C to ensure reproducibility and NaCl-specificity of the 
mutant phenotype. The mutants were also patched onto BHI plates containing Tet to 
ensure that pLTV 1 had been cured from the cells. Mutations were transduced into 
8325-4 using 411-mediated transduction, with selection using Ery and Lin (Chapter 
2.9). 10 colonies per mutation were patched onto rabbit blood plates containing either 
no added NaCI or 1M NaCI with 8325-4 as a control and grown overnight at 37 °C. 
Linkage of the mutant phenotype to transposon insertion was determined by 
considering the percentage of the transductant colonies which demonstrated the same 
phenotype as the original mutant. 
2.15.4.2 Screen to identify genes involved in regulating hla:: lacZ 
transcription 
An aliquot of Tn551 library F1 or F4 (Chapter 2.15.2) was suitably diluted in PBS to 
give - 300 colonies per BHI agar plate (containing 600 mg r, X-Gal). After spreading 
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with sterile glass beads, the plates were incubated overnight at 37 T. Colonies 
demonstrating increased blue colouration compared to the surrounding background 
colonies were isolated. The plates were incubated for a further night at 37 °C, and re- 
screened to identify mutants demonstrating less blue colouration than the background 
colonies. The putative mutants were patched onto BHI agar plates containing 600 mg 
ri X-Gal to ensure the reproducibility of their phenotypes. The mutants were also 
patched onto BHI plates containing CdC12 to ensure that pRN3208 had been cured 
from the cells. Mutations were transduced into JLA513 (SH1000 hla:: lacZ (TetR)) 
using X11-mediated transduction, with selection using Ery and Lin (Chapter 2.9). 10 
colonies per mutation were patched onto BHI agar plates containing 600 mg 1"' X-Gal 
with JLA513 (SH1000 hla:: lacZ (TetR)) as a control, and grown overnight at 37 T. 
Linkage of the mutant phenotype to transposon insertion was determined as in Chapter 
2.15.4.1. 
2.15.4.3 Screen to identify genes involved in regulating hla:: IacZ 
transcription in the presence of 1M NaCI 
An aliquot of Tn551 library F1 or F4 (Chapter 2.15.2) was suitably diluted in PBS to 
give - 100 colonies per BHI Ery Lin plate. After spreading with sterile glass beads, the 
plates were incubated overnight at 37 T. The colonies were replica plated onto BHI 
agar plates (containing 1M NaCI and 2.4 g 1'1 X-Gal) using sterile velvets and 
incubated overnight at 37 °C. Colonies demonstrating increased blue colouration 
compared to the surrounding background colonies were isolated.. The plates were 
incubated for a further night at 37 °C, and re-screened to identify mutants 
demonstrating less blue colouration than the background colonies. The putative 
mutants were patched onto either BHI agar plates (containing 1M NaC1 and 2.4 g 1'1 
X-Gal) or onto BHI agar plates (containing no added NaC1 and 600 mg 1'1 X-Gal) to 
determine the reproducibility and NaC1-specificity of their phenotypes. The mutants 
were also patched onto BHI plates containing CdC12 to ensure that pRN3208 had been 
cured from the cells. Mutations were transduced into JLA513 (SH1000 hla:: lacZ 
(TetR)) as in Chapter 2.15.4.2 and linkage of the mutant phenotype to transposon 
insertion was determined as in Chapter 2.15.4.1 by plating onto BHI agar plates 
(containing 1M NaC1 and 2.4 g 1' X-Gal). 
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2.16 Qualitative analysis of virulence determinant expression on agar 
plates 
2.16.1 Analysis of a-haemolysin activity on rabbit blood plates 
Rabbit blood agar plates were prepared as described in Chapter 2.1.1.7. S. aureus 
strains were inoculated by patching colonies onto the test plate. After overnight 
incubation at 37 °C, a-haemolysin activity was visualised by a zone of clearing (lysis) 
around the patch of bacteria. 
2.16.2 Analysis of IacZ fusion expression on X-Gal plates 
ß-galactosidase activity was detected directly on solid media using the substrate X- 
Gal. X-Gal is hydrolysed by ß-galactosidase resulting in ß-D-galactopyranoside and 5- 
bromo-4-chloro-3-indolyl. The latter has a blue colouration and is thus a visible 
indicator of ß-galactosidase activity. Unless otherwise stated, 100 µl 20 mg ml' X-Gal 
solution was pipetted onto agar plates and spread across the surface with sterile beads. 
The beads were then removed and the plates were dried at 50 °C for 20 min. Plates 
were used immediately or stored at -4 °C for up to one week. 
2.16.3 Analysis of protease activity on milk plates 
Milk agar plates were prepared as described in Chapter 2.1.1.5. S aureus strains were 
inoculated by patching colonies onto the test plate. After overnight incubation at 37 
°C, protease activity was visualised by a zone of clearing (proteolysis) around the 
patch of bacteria. 
2.16.4 Plate photography 
Agar plates were photographed using a Nikon Coolpix 775 digital camera. Software 
used was Nikon View 4. 
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2.17 Sequence and database analysis 
2.17.1 Sequence analysis for cloning 
DNA sequences for cloning were obtained from the National Centre for Biotechnology 
Information (NCBI) database (http: //ncbi. nhn. nih. gov/), or from manufacturer's 
instructions (ie. supplied by Invitrogen and Epicentre for use of PCR-II-TOPO and 
pMOD(MCS) respectively). Putative open reading frames (ORFs) and restriction sites 
were identified in DNA sequences using the Gene Jockey II program (Biosoft) or the 
program Visual Cloning 2000 (Redasoft). Diagrammatic representations of DNA 
fragments and plasmids were prepared using Visual Cloning 2000 (Redasoft). 
2.17.2 Sequence and database analysis for the identification of genes 
inactivated by transposon mutagenesis 
Automated sequence data was edited and analysed using the Applied Biosystems 373A 
DNA sequencer data analysis program, and the sequence corresponding to the end of 
the transposon removed. The sequence was entered into a BLASTN search in the 
database of The Institute of Genomic Research (TIGR) (http: //tigr. org/tigr- 
scripts/CMR2/CMRHomePage. spl) against the S. aureus COL genome sequence to 
identify the position of transposon insertion (NB; the COL genome sequence was 
searched because the 8325 genome has not yet been annotated). The putative functions 
of the inactivated genes and their flanking genes were identified by entering their 
amino acid sequence from the TIGR website into a BLASTP search against the 
sequences of all other published genomes in the NCBI BLAST 
(http: //ncbi. nlm. nih. govBLAST) and/or TIGR website to identify putative 
homologues. The function of proteins for which homologues were identified in B. 
subtilis was further investigated using the SubtiList World-Wide Web Server v3.1 
(http: //genolist. pasteur. fr/SubtiList/). Genes were assigned accession numbers based on 
those of the COL database. The sequence of the genes inactivated by transposon 
mutagenesis and of flanking DNA containing surrounding genes of interest was 
extracted from the TIGR website and entered into a BLASTN search at the NCBI 
BLAST website in the S. aureus NCTC 8325 unfinished genome database to ensure 
that the sequence and position of the surrounding genes in COL is the same as that in 
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8325. This sequence was also inserted into the program Visual Cloning 2000 to allow 
a diagrammatic representation of the region and of the transposon insertion site to be 
made. 
2.18 Protein analysis techniques 
2.18.1 Growth of cultures for protein production 
S. aureus was grown in 5 ml BHI in a sterile 30 ml universal tube at 37 °C with rotary 
shaking (250 rpm) until an OD600 of 1.0 was reached. The culture was used to 
inoculate 100 ml Bill in a 250 ml conical flask to an OD600 of 0.01. The second culture 
was grown at 37 °C in a Grant OLS 200 waterbath with linear shaking (equivalent to 
250 rpm) until in stationary phase (14 h), unless otherwise stated. 
2.18.2 Quantification of a-haemolysin activity in liquid assays 
S. aureus was grown as in Chapter 2.18.1. Duplicate OD600 measurements were taken 
and, unless otherwise stated, 600 µl of culture was removed to a clean 1.5 ml 
microfuge tube and centrifuged (5,500 g, 1 min, 4°C). 500 µl of supernatant was 
transferred to a clean microfuge tube. 5 µl of PMSF was added to the supernatant and 
100 µl aliquots were snap-frozen in liquid nitrogen and stored at -70°C. 
Supernatant samples were defrosted at room temperature and placed on ice. Where 
stated, samples were concentrated and desalted using a YM-10 Centricon centrifugal 
filter device (Amicon Bioseparations) according to manufacturer's instructions. 100 Al 
supernatant was added to 900 µl haemolysin salts solution. 25 pl sterile defibrinated 
rabbit blood (E &0 laboratories) was added and the sample mixed by inversion. 
Following incubation at 37 °C for 15 mins, the sample was centrifuged (5,500 g, 1 
min, room temperature). The supernatant was transferred to a 1.5 ml plastic cuvette, 
and OD at 543 nm was measured (1 ml HA salts solution and 25 pl rabbit blood were 
incubated and centrifuged as above to create a blank). If the OD543 was not between 
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0.2 and 0.9 on the Jenway 6100 spectrophotometer, the assay was reperformed with 
less than 100 µl supernatant. 
One haemolysin unit was defined as the amount which caused an increase in OD543 of 
0.5 per minute due to erythrocyte lysis per OD600 unit of original culture, and was 
calculated using the equation shown below; 
Haemolysin units (HU) = (OD543 X 1000) / (V XTX OD600 XCX0.5) 
V= Volume of supernatant (ml) 
T= Duration of incubation at 37 °C (min) (ie. 15) 
C= Degree of concentration of supernatant using a Centricon column 
2.18.3 Preparation of exoprotein and total cellular protein samples from S. 
aureus cultures 
S. aureus was grown as in Chapter 2.18.1. Samples were taken at normalised volumes, 
such that 5 OD600 units of culture were removed (ie. x ml of culture removed =5/ 
OD600). The samples were immediately centrifuged (11,000 g, 5 min) and the 
supernatant removed to a clean microfuge tube. Supernatants and cell pellets were 
snap-frozen in liquid nitrogen and stored at -70 °C for future use. 
2.18.3.1 Exoproteins 
Culture supernatants (Chapter 2.18.3) were defrosted at room temperature and placed on 
ice. 0.1 volumes of 100 % (w/v) trichloroacetic acid (TCA) was added to each culture 
supernatant and mixed by vortexing. The mixture was incubated on ice for 30 min 
before centrifugation (11,000 g, 5 min) to recover the precipitated proteins. The 
supernatant was discarded and 500 µl acetone was used to wash to the pellet. Following 
resuspension of the pellet, the sample was centrifuged (11,000 g, 5 min) and the 
supernatant discarded. Washing with acetone was repeated twice more to ensure full 
removal of TCA. The supernatant was again removed and the pellet air-dried. The pellet 
98 
CHAPTER 2; MATERIALS AND METHODS 
was resuspended in 50 µl 1X Laemmli SDS-PAGE sample buffer and incubated at 100 
°C for 3 min before being cooled at room temperature for 3 mins. The sample was then 
centrifuged (5,000 g, 3 min) before 10 µl was loaded onto an SDS-PAGE gel (Chapter 
2.18.4). Samples were stored at -70 °C. 
2.18.3.2 Total cellular proteins 
Cell pellets (Chapter 2.18.3) were resuspended in 400 µl 1.5 mM Tris-HC1 (pH 6.8) and 
mixed by vortexing. 2 µl lysostaphin (5 mg nit) was added to the cell suspension and 
the mixture was incubated at 37°C for 30 min. 100 µl 5X SDS-PAGE sample buffer 
was added and the sample was incubated at 100 °C for 3 min before being cooled at 
room temperature for 3 min. The sample was then centrifuged (5,000 g, 3 min) before 
10 µl was loaded onto and SDS-PAGE gel (Chapter 2.18.4). Samples were stored at 
-70 °C. 
2.18.4 SDS-PAGE protein analysis 
Protein samples prepared from S. aureus were visualized using the Sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) system. The gels were cast 
using the BioRad Mini-Protean 3® cell system according to the manufacturer's 
instructions. 12 % (v/v) polyacrylamide gels were used for the resolving portion of the 
gel and 4% (v/v) polyacrylamide gels were used for the stacking portion of the gel 
(Chapter 2.2.9.2). 
Protein samples were applied to the wells in the gel using a pipette. Low molecular 
weight protein markers (Sigma) were loaded to enable determination of the approximate 
sizes of proteins in the samples. The gels were electrophoresed at 200 V for 
approximately 45 min, or until the blue dye front of the sample buffer was at the base of 
the gel plates. 
The gels were carefully removed from the apparatus and transferred to 50 ml Coomassie 
stain for 30 min at room temperature, with gentle rocking. The Coomassie stain was 
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removed after this time and the gels were washed 3X 5 min with 50 ml of destain 
solution at room temperature, with gentle rocking. After the third wash the gels were 
left in 50 ml destain solution until the blue bands of the proteins were apparent and the 
gel background was colourless. The destain was discarded and the gels were washed 
twice (10 min) with dH2O at room temperature with rocking. The d1120 was removed 
and replaced with 20 nil Gel-DryTM gel drying solution (Invitrogen) for 30 min. The gel 
was then removed from the solution and placed between two DryEaseTM minicellophane 
(Invitrogen) sheets which had been pre-soaked in gel-drying solution for 5 min. The 
sandwich was then fastened into a gel drying frame (Novex) and left to stand on the 
bench overnight to dry. For a permanent electronic record, protein gels were scanned 
using a UMAX Powerlook 1100. 
2.18.5 Western blotting 
2.18.5.1 Western blotting involving detection with alkaline-phosphatase 
conjugated secondary antibodies 
Western blotting was used to estimate the proportions of specific proteins in a 
preparation from S. aureus. Specific primary antibodies were used to probe samples 
fixed to polyvinylidene difluoride (PVDF) nylon membranes (BioRad), and detected 
using alkaline phosphatase (AP)-conjugated secondary antibodies. 
Exoproteins were prepared from S. aureus cultures (Chapter 2.18.3.1) and run on SDS- 
PAGE gels (Chapter 2.18.4). As the gel was running, a gel-sized piece of BioRad 
Immun-Blot PVDF membrane was placed in 100 % (v/v) methanol for 1-3 seconds. 
The PVDF membrane was then transferred to dH2O for 1-2 mins and to blotting buffer 
for 5- 10 mins. Gel-sized pieces of Whatman 3 mm filter paper were also pre- 
equilibrated in blotting buffer for 10 mins. Transfer of the proteins to the PVDF 
membrane was carried out using an LKB Bromma 2117 Multiphor II electrophoresis 
unit. The apparatus was assembled according to the manufacturer's instructions, and 
electrophoresis was performed for 1h at x mA (x mA = blot area in cm2 X 1.6). 
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The apparatus was disassembled and the PVDF membrane was placed in a container 
with 100 ml blocking solution. Pig serum (20 % v/v) (Sigma) was included in the 
blocking solution where stated. The container was rocked gently overnight at 4 °C. The 
membrane was then washed with 50 ml Western washing solution at room temperature 
for 2X 5 mins with rocking. 100 ml primary antibody solution (Chapter 2.2.9.6.4) was 
added and the membrane was incubated for 2h at room temperature with gentle 
rocking. The primary antibody was removed and the membrane washed once for 15 min 
and twice for 5 min with 50 ml Western washing solution at room temperature with 
rocking. The membrane was then placed in 100 ml specific secondary antibody solution 
for 1h with rocking at room temperature. The secondary antibody (Chapter 2.2.9.6.5) 
was raised against antibodies from the animal in which the primary originated (ie. since 
the primary antibodies were raised in rabbits, the secondary was goat-anti-rabbit). In 
addition, the secondary antibody was conjugated with AP to allow colourmetric 
detection. 
The secondary antibody was discarded and the membrane was washed once for 15 min 
and twice for 5 min with 50 ml washing solution at room temperature with gentle 
rocking. The membrane was then pre-equilibrated with AP buffer. The AP buffer was 
discarded and replaced with 10 ml colour substrate solution. The blot was then placed 
in the dark to allow the membrane to develop. The presence of proteins bound with 
primary antibodies was visualized by the development of purple bands. After sufficient 
time the membrane was washed with 25 ml TE for 5 min to stop the reaction. The 
membrane was then air-dried and stored in the dark. For a permanent electronic record, 
Western blots were scanned using a UMAX Powerlook 1100. 
2.18.5.2 Western blotting using the Enhanced Chemiluminescence (ECL) 
system (Amersham Pharmacia) 
The ECL Western blotting detection system was used to provide a highly sensitive non- 
radioactive method for the detection of specific proteins. 
Total cellular protein samples were prepared from S. aureus cultures (Chapter 2.18.3.2) 
and run on SDS-PAGE gels (Chapter 2.18.4). The resolved proteins were then blotted 
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onto PVDF membranes, probed with primary antibodies, detected with secondary 
antibodies and washed as in Chapter 2.18.5.1. However, the secondary antibodies used 
in the ECL system were horseradish peroxidase (HRP)-conjugated donkey-anti-rabbit 
antibodies (Chapter 2.2.9.6.5). Detection was performed according to the 
manufacturer's instructions, using a5 min exposure on Kodak MXB autoradiography 
film. Densitometric analysis of autoradiographs was performed by using ImageMaster 
3.01 software (Amersham-Panmacia). 
2.18.6 N-Terminal Sequencing 
Proteins under investigation were run on a 12 % (w/v) SDS-PAGE gel (Chapter 
2.18.4) and blotted onto a PVDF membrane (Chapter 2.18.5) as previously described. 
After the transfer procedure the membrane was soaked in dH20 for 5 min, followed by 
5 min soaking in methanol at room temperature. The membrane was then stained with 
coomassie blue staining solution for 1 min and then destained for 3x 5 min in destain 
solution. The blot was then dried protein side up, on blotting paper for Ih at room 
temperature. The protein under investigation was then carefully removed from the 
membrane and sequenced by Dr Arthur Moir (Department of Molecular Biology and 
Biotechnology, Sheffield University) using an ABI 476A sequencer. 
2.19 Murine subcutaneous lesion pathogenicity model 
A single colony of S aureus cells was used to inoculate 100 ml BHI in a 250 ml conical 
flask and grown at 37 °C with rotary shaking (250 rpm) in a waterbath. Cells were 
grown to stationary phase (15 h) and 50 ml of culture was harvested by centrifugation 
(4,000 rpm (Centaur 2), 10 min, 4 °C). The supernatant was discarded and the cells 
were resuspended in 50 ml PBS. The centrifugation and resuspension procedure was 
repeated and the cell suspension was adjusted to -' 5X 108 cfu ml"'. Female 6- to 8- 
week old BALB/c mice were inoculated subcutaneously with 200 µl cell suspension (-. 
1X 108 cfu). After 7 days, the mice were euthanized with CO2. Skin lesions were 
aseptically removed, snap-frozen in liquid nitrogen and stored at -70 T. The lesions 
were weighed, chopped, and homogenised in a mini-blender in 2.5 ml of PBS for 2 min. 
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After incubation on ice for 1 hr, the lesions were homogenised for a further 2 min. The 
total number of bacteria recovered from the lesions was determined by direct cell counts 
(Chapter 2.6.2) by plating out 200 µ1 of 10.1 to 10-6 dilutions on Bill agar. The 
statistical significance of the recovery of strains compared to SH1000 was evaluated 
using the Student t test. 
Handling, care and sacrificing of the mice, and the removal of lesions, was performed 
by Professor Eileen Ingham (Department of Biological Sciences, University of Leeds). 
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CHAPTER 3 
ANALYSIS OF THE EFFECTS OF NaCl ON VIRULENCE 
DETERMINANT EXPRESSION 
3.1 Introduction 
The fact that S. aureus frequently encounters niches containing high concentrations of 
NaCl is reflected by its ability to grow in the presence of up to 3.5 M NaC1(Scott, 1953; 
Armstrong-Buisseret et al., 1995). NaCI has been shown to have major effects on 
virulence determinant expression in S. aureus. When tested at a concentration of 1M or 
higher, NaCl repressed the expression of spa, hla, tst, eta, sec and Seb, whilst 
transcription of sspA was upregulated (Chapter 1.6.2.3.2; Chan & Foster, 1998a; Chan 
& Foster, 1998b; Lindsay & Foster; 1999, Ohlsen et al., 1997; Sheehan et al., 1992; 
Regassa & Betley, 1993; Genigeorgis & Sadler, 1966). These virulence determinant 
genes are also regulated by agr and/or sarA. However, the effects of NaCl on h1a, tst, 
sec, sspA and spa have been shown to occur independently of agr and/or sarA, and 1M 
NaCl has no significant effect on RNAIII or sarA expression (Chapter 1.6.2.3.2; Chan 
& Foster, 1998a; Chan & Foster, 1998b; Lindsay & Foster; 1999, Regassa & Betley, 
1993). As described in Chapter 1.6.2.3.2, this has led to the suggestion that NaCI- 
mediated control of virulence determinant transcription may involve a novel regulatory 
system (Chan and Foster, 1998a). 
The alternative transcription factor aB regulates the general stress response in B. subtilis 
and a number of other low-GC Gram-positive bacteria (Chapters 1.6.1.2 and 1.6.2.2.8). 
In S. aureus, aB has been shown to control the response to a number of environmental 
stresses (Chapter 1.6.2.2.8; Kullik et al., 1998; Chan et al., 1998; Gertz et al., 1999; 
Palma & Cheung, 2001; Kullik & Giachino, 1997). However, although aB has an 
important role in the NaC1-mediated stress response of B. subtilis (Voelker et al., 1995; 
Bernhardt et al., 1997), aB was not shown to be involved in resistance to osmotic shock 
in S. aureus by Chan et al. (1998). 
Determining the exact role of aB in S. aureus has been impeded, however, by the 
presence of an 11 bp deletion in the rsbU gene of the genetic lineage used most 
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frequently for molecular and physiological analysis of S. aureus, 8325-4 (Kullik & 
Giachino, 1997). Since rsbU is a positive regulator of aB function (Chapter 1.6.2.2.8), 
the rsbU mutation produces a strong defect in aB activity (Giachino et al., 2001). 
Horsburgh et al. (2002) constructed an rsbU} derivative of 8325-4, termed SH1000, by 
introducing intact rsbU from Newman into 8325-4 using a method that does not leave 
behind an antibiotic resistance marker. Unlike 8325-4, the phenotypic properties of 
SH1000 resemble those of clinical isolates, in that it is a low producer of Lila and SspA, 
and produces yellow colonies overnight due to pigmentation with staphyloxanthin 
(Horsburgh et al., 2002). Therefore, whereas 8325-4 was used as the wild-type strain of 
choice for the initial stages of this study, use of the recently available SHI000 was later 
favoured to allow a more representative impression of NaCl-mediated virulence 
determinant regulation in S. aureus and the role of aB to be obtained. 
The aims of this chapter were to analyse the effects of NaCl on virulence determinant 
expression and to further evaluate the role of known regulators in the NaCl-mediated 
stress response. 
3.2 Results 
3.2.1 The effect of NaCl on spa, hla and agr 
The effects of NaC1 on the representative virulence determinants hla and spa, and on the 
virulence regulator agr, were investigated to verify the published data (Chapter 
1.6.2.3.2). In their study into the effects of NaCI on hla, spa, tst and sarA transcription, 
Chan and Foster (1998a) found that BHI medium gave the highest toxin expression and 
the highest growth yield of a wide range of media, and so the following growth and 
reporter gene fusion experiments were performed in BHI. Furthermore, Chan and Foster 
(1998a) found that an NaC1 concentration of 1M was the maximum which did not 
significantly affect growth yield, and so this concentration was chosen for the following 
investigations of the NaC1-mediated stress response of S. aureus (unless otherwise 
stated). 
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Strains PC203 (8325-4 spa:: lacZ), PC322 (8325-4 hla:: lacZ) and SH101F7 (8325-4 agr 
[RNAIII]:: lacZ) were grown, as described in Chapter 2.7, in BHI containing no added 
NaCl (85.6 mM NaCl) and in BHI containing NaCl up to 1M (as stated in Figure 3.1). 
Growth was measured spectrophotometrically as OD600 (Chapter 2.6.1), and lacZ fusion 
expression was determined using MUG, as in Chapter 2.8. 
The presence of 1M NaCl was found to repress spa transcription by approximately 7- 
fold at t=1h (ie. 195 MUG units in BHI containing no added NaCl compared to 28 
MUG units in BHI containing 1M NaC1) (Figure 3.1 a). NaCl was also found to repress 
hla; as the concentration of NaCI was increased, transcription of hla decreased 
accordingly (Figure 3.1b). At t=5h, hla transcription was repressed (from 57,833 
MUG units in BHI containing no added NaCI) by 1.4-fold in BHI containing 200 mM 
NaC1(ie. to 40,724 MUG units), 3-fold in BHI containing 400 mM NaC1(ie. to 19,789 
units), 14-fold in BHI containing 900 mM NaCl (ie. to 4,040 MUG units), and was 
almost negligible in BHI containing 1M NaCl (ie. 156 MUG units). However, 
transcription of agr (RNA III) remained relatively unaffected by the presence of 1M 
NaCl, with an average 1.5-fold repression occurring throughout growth (Figure 3.1c). 
Cultures grown in BHI containing 1M NaCl showed a minor reduction in growth rate 
and final OD600 compared to cultures grown in BHI alone (Figures 3.1 a-c). 
3.2.2 The role of as in virulence determinant regulation and in the NaCl- 
mediated stress response 
3.2.2.1 Construction of relevant IacZ fusion strains by transduction, and 
confirmation of rsbU genotype of SH1000 sigB derivatives by PCR 
In order to allow the role of a-a in S. aureus to be investigated, a number of strains 
containing lacZ fusions were created by transduction. The sarA:: lacZ, agr (RNA 
III):: IacZ and hla:: lacZ fusions were transduced into SH1000 from PC161, SH101F7 
and PC322 respectively using 411. This produced the strains JLA311 (SH1000 
sarA:: lacZ), JLA341 (SH1000 agr (RNA III):: lacZ) and JLA371 (SH1000 hla:: lacZ). 
The sigB mutation was then transduced from PC400 using 4 11 into JLA311, JLA341 
and JLA371. Putative transductants were patched onto BHI agar plates containing the 
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Figure 3.1a 
Effect of 1M NaCl on spa:: lacZ transcription and growth in BHI. 
S. aureus PC203 (8325-4 spa:: lacZ) was grown in either BHI (0 and ") or BHI 
containing 1M NaCl (Q and  ) as described in Chapter 2.7. Growth was measured 
spectrophotometrically as OD600 (open symbols) (Chapter 2.6.1), and lacZ fusion 
expression was measured using MUG (closed symbols), as in Chapter 2.8. Results are 
representative of two independent experiments. 
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Figure 3.1b 
Effect of a range of concentrations of NaCl on hla:: lacZ transcription and growth in 
BHI. 
S. aureus PC322 (8325-4 hla:: lacZ) was grown in either BHI (0 and ") or BHI 
containing NaCl at a final concentration of 200 mM (s), 400 mM (A), 600 mm ("), 
700 mM (®), 800 mM (0), 900 mM (it) or 1M (0 and 0) as described in Chapter 2.7. 
Growth was measured spectrophotometrically as OD600 (open symbols) (Chapter 2.6.1), 
and lacZ fusion expression was measured using MUG (closed symbols), as in Chapter 
2.8. Results are representative of two independent experiments. 
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Figure 3.1c 
Effect of 1M NaCl on agr (RNA III):: lacZ transcription and growth in BHI. 
S. aureus SH101F7 (8325-4 agr (RNA III):: IacZ) was grown in either Bill (0 and 0) 
or BHI containing 1M NaCl (Q and  ) as described in Chapter 2.7. Growth was 
measured spectrophotometrically as OD600 (open symbols) (Chapter 2.6.1), and IacZ 
fusion expression was measured using MUG (closed symbols), as in Chapter 2.8. 
Results are representative of two independent experiments. 
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relevant antibiotics to ensure the correct resistance profile. However, due to the close 
proximity of rsbU to sigB in the sigB operon, it is possible that the mutation in rsbU 
will have been cotransduced with the sigB mutation into SH1000 from 8325-4 at a high 
frequency. Therefore, in order to ensure that the sigB strains produced in SH1000 were 
sigB, rsbU' and not sigB, rsbU, putative transductants were screened by the PCR 
method of Kullik and Giachino (1997). This involved using primers OL-78 and OL-79, 
which bound either side of the 11 bp deletion site in rsbU to produce a 77 bp fragment 
for rsbU strains and an 88 bp fragment for rsbU* strains, which could be resolved by gel 
electrophoresis on 4% (w/v) agarose gels (Figure 3.2). Despite the fact that the 
mutations in rsbU and sigB are separated by less than 3 kb, cotransduction was found to 
be only 80 %, which facilitated the isolation of the sigB, rsbÜ} derivatives JLA313 
(SH1000 sarA:: lacZ sigB), JLA343 (SH1000 agr (RNA III):: lacZ sigB) and JLA373 
(SH 1000 hla:: lacZ sigB). 
3.2.2.2 The effect of aB on hla, agr and sarA transcription 
Before the role of aB in the NaCl-mediated stress response was investigated, the general 
effects of aB on hla, sarA and agr were analysed. Initially, the effect of aB on the 
expression of an hla:: lacZ fusion was investigated. S. aureus JLA371 (SH1000 
hla:: lacZ), PC322 (8325-4 hla:: lacZ), JLA373 (SH1000 hla:: lacZ sigB) and PC4044 
(8325-4 hla:: lacZ sigB) were grown in BHI as described in Chapter 2.7. Growth was 
measured spectrophotometrically as OD600 (Chapter 2.6.1), and lacZ fusion expression 
was determined using MUG, as in Chapter 2.8. Transcription of the hla:: lacZ fusion 
was up to approximately 7.5-fold lower in JLA371 (SH1000 hla:: lacZ) than in the other 
three strains (ie. 14,201 MUG units, 104,844 MUG units, 80,923 MUG units and 
80,540 MUG units at t= 12 h for JLA371 (SH1000 hla:: lacZ), PC322 (8325-4 
hla:: lacZ), JLA373 (SH1000 hla:: lacZ sigB) and PC4044 (8325-4 hla:: lacZ sigB) 
respectively) (Figure 3.3a). This suggests that aB represses hla transcription. 
In order to determine the effects of aB on agr, the expression of agr (RNA III):: IacZ in 
S. aureus JLA341 (SH1000 agr (RNA III):: IacZ), SHIOIF7 (8325-4 agr (RNA 
III):: lacZ), JLA343 (SH1000 agr (RNA III):: IacZ sigB) and PC604 (8325-4 agr (RNA 
III):: IacZ sigB) in BHI was determined, as for the hla:: lacZ fusion strains. A reduction 
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Figure 3.2 
PCR to show intact r. ch(J in la(--Z fusion strains in the SH 1000 . eigB background. 
Genomic I)NA was prepared using a Qiagen DNeasy'M spin column (Chapter 
2.11.1). PCR amplification was based on the method of Kullik and Giachino (1997). 
and was performed using the general Taq polymerise protocol (Chapter 2.13.1.2.1). 
Primers used were OL-78 and OL-79. Products were separated by gel electrophoresis 
on 4% (w/v) agarose gels. 
Lane order; lane 1, pUC mix DNA size markers: lane 2.8325-4; lane 3. S111000. 
lane 4. JLA313 (S111000 sarA.: lacZsigB); lane 5. JLA343 (SH1000 ugr.. IacZ. sii /3): 
lane 6, .l LA373 (SH 
1000 hla.: lacZ sigB). 
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in agr (RNA III):: IacZ expression of up to 4.6-fold was observed during growth of 
JLA341 (SH1000 agr (RNA III):: lacZ) compared to the other three strains (ie. 3,177 
MUG units, 12,569 MUG units, 14,083 MUG units and 14,678 MUG units at t= 12 h 
for JLA341 (SH1000 agr (RNA III):: IacZ), SH101F7 (8325-4 agr (RNA III):: IacZ), 
JLA343 (SH1000 agr (RNA III):: lacZ sigB) and PC604 (8325-4 agr (RNA III):: lacZ 
sigB) respectively) (Figure 3.3b). This suggests that aB represses agr transcription. 
Furthermore, whilst a 4.4-fold repression of agr (RNAIII) transcription by aB can be 
demonstrated by comparing the data for JLA341 (SH1000 agr (RNA III):: lacZ) and 
JLA343 (SH1000 agr (RNA III):: lacZ sigB), the levels of agr (RNAIII) transcription in 
SH101F7 (8325-4 agr (RNA III):: IacZ) and PC604 (8325-4 agr (RNA III):: lacZ sigB) 
were very similar at t= 12 h. The same is true when comparing the hla:: lacZ 
transcription data of the two sigB+ strains with their sigB derivatives. This suggests that 
rsbU, which is defective in 8325-4 (Kullik & Giachino, 1997), is normally involved in 
the repression by aB of hla and agr (RNAIII) by way of its role in upregulating aB 
activity. Importantly, this indicates that data obtained regarding the effects of aB on 
virulence determinant expression in the SH1000 and 8325-4 backgrounds are not 
directly comparable. 
The P2 and P3 promoters of agr do not possess putative aB-dependent consensus 
sequences (Cheung et al., 1999). Therefore, the repression of agr by aB probably occurs 
indirectly. SarA can act as an activator of agr expression (Chien & Cheung 1998), and 
the sarP3 promoter is e -dependent (Deora et al., 1997; Manna et al., 1998; Miyazaki 
et al., 1999; Bischoff et al., 2001). Therefore, the possibility that the diminished level of 
agr (RNA III) was a consequence of reduced SarA expression was investigated. S. 
aureus JLA311 (SH 1000 sarA:: lacZ), PC 161 (8325-4 sarA:: lacZ), JLA313 (SH 1000 
sarA:: lacZ sigB) and PC4030 (8325-4 sarA:: lacZ sigB), were grown in BHI, and 
sarA:: lacZ expression and growth was measured as for the h1a:: lacZ fusion strains. 
Overall levels of sarA transcription in each of the four strains was found to be very 
similar (ie. 1,155 MUG units, 1,342 MUG units, 1,879 MUG units and 1,815 MUG 
units at t=4h for strains JLA311 (SH1000 sarA:: lacZ), PC161 (8325-4 sarA:: lacZ), 
JLA313 (SH1000 sarA:: lacZ sigB) and PC4030 (8325-4 sarA:: lacZ sigB) respectively) 
(Figure 3.3c). The aB-mediated reductions in expression of agr (RNA III) and hla are 
therefore likely to be SarA-independent. 
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Figure 3.3a 
Effect of a-B on hla:: lacZ transcription. 
S. aureus PC322 (8325-4 hla:: lacZ) (0 and "), JLA371 (SH1000 hla:: lacZ) (L and 
A), PC4044 (8325-4 hla:: lacZ sigB) (0 and  ) and JLA373 (SH1000 hla:: lacZ sigB) 
(O and f) were grown in Bill as described in Chapter 2.7. Growth was measured 
spectrophotometrically as OD600 (open symbols) (Chapter 2.6.1), and lacZ fusion 
expression was measured using MUG (closed symbols), as in Chapter 2.8. Results are 
representative of two independent experiments. 
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Figure 3.3b 
Effect of & on agr (RNA III):: lacZ transcription. 
S. aureus SH101F7 (8325-4 agr (RNA III):: lacZ) (0 and "), JLA341 (SH1000 agr 
(RNA III):: lacZ) (L and A), PC604 (8325-4 agr (RNA III):: lacZ sigB) (0 and  ) and 
JLA343 (SH1000 agr (RNA III):: IacZ sigB) (0 and f) were grown in BHI as 
described in Chapter 2.7. Growth was measured spectrophotometrically as OD600 (open 
symbols) (Chapter 2.6.1), and lacZ fusion expression was measured using MUG (closed 
symbols), as in Chapter 2.8. Results are representative of two independent experiments. 
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Figure 3.3c 
Effect of o-B on sarA:: lacZ transcription. 
S. aureus PC161 (8325-4 sarA:: lacZ) (0 and "), JLA311 (SH1000 sarA:: lacZ) (0 and 
A), PC4030 (8325-4 sarA:: lacZ sigB) (0 and  ) and JLA313 (SH1000 sarA:: lacZ 
sigB) (O and f) were grown in BHI as described in Chapter 2.7. Growth was 
measured spectrophotometrically as OD600 (open symbols) (Chapter 2.6.1), and lacZ 
fusion expression was measured using MUG (closed symbols), as in Chapter 2.8. 
Results are representative of two independent experiments. 
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3.2.2.3 The effect of aB on SarA protein levels 
The finding that the repression by aB of agr (RNAIII) and hla is likely to be SarA- 
independent (Chapter 3.2.2.2) contrasts with the report by Bischoff et al. (2001) that 
sarA transcription is increased in two rsbU' strains compared to their sigB derivatives. 
Consequently, the SarA protein levels during growth of strains SH1000, MJH502 
(SH1000 sigB), 8325-4 and PC400 (8325-4 sigB) were determined by Western blotting. 
Strains were grown as in Chapter 2.18.1 and samples were removed at 3,5, and 7 h. 
Total cellular proteins were prepared as in Chapter 2.18.3.2, resolved by SDS-PAGE 
(Chapter 2.18.4), and blotted (Chapter 2.18.5). Detection was performed with rabbit 
anti-SarA primary antibodies (Blevins et al., 1999) using the ECL system (Chapter 
2.18.5.2). 20 % (v /v) pig serum was included in the blocking solution. Densitometric 
analysis of autoradiographs was performed, as in Chapter 2.18.5.2. At the time-points 
analysed, the levels of SarA were very similar for each of the strains (Figure 3.4). 
Therefore, when the lacZ reporter assay was used or when protein levels were detected 
by Western blotting, the levels of SarA and temporal regulation of SarA were found to 
be very similar for strains 8325-4, SH1000 and their sigB mutant derivatives. 
3.2.2.4 The effect of aB on hla and agr transcription in a sarA background 
To confirm the apparent lack of a role for SarA in the overall negative effect of aB on 
the expression of hla and agr (RNA III) transcription (Chapters 3.2.2.2 and 3.2.2.3), a 
sarA mutation was introduced into hla:: lacZ and agr (RNA III):: IacZ reporter strains by 
411-mediated transduction. This produced the strains JLA375 (SH1000 hla:: lacZ 
sarA), JLA376 (8325-4 hla:: lacZ sigB sarA), JLA377 (SH1000 hla:: lacZ sigB sarA) 
JLA345 (SH1000 agr (RNA III):: IacZ sarA), and JLA347 (SH1000 agr (RNA 
III):: lacZ sigB sarA). 
Strains JLA375 (SH1000 hla:: lacZ sarA), PC3221 (8325-4 hla:: lacZ sarA), JLA377 
(SH1000 hla:: lacZ sigB sarA) and JLA376 (8325-4 hla:: lacZ sigB sarA) were used to 
analyze the effects of oB on hla expression in a sarA background. Strains JLA345 
(SH 1000 agr (RNA III):: lacZ sarA), PC600 (8325-4 agr (RNAIII):: IacZ sarA), JLA345 
(SH1000 agr (RNA III):: IacZsarA) and PC602 (8325-4 agr (RNAIII):: IacZsigB sarA) 
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Figure 3.4 
Level of SarA protein in different strains. 
5 
(A) Equivalent amounts of total cellular protein (OD(, oo of culture, 0.1), isolated after 
lysostaphin digestion of cells from cultures grown for 3,5, and 7 h, were blotted and 
probed with purilied immunoglobulin G antibodies raised against SarA (Blevins el al.. 
1999) using the ECL system (Chapter 2.18.5.2). Strains used were SII1000, MJI1502 
(SII1000 . sigß), 
8325-4, PC400 (8325-4 sigB), and SH1002 (SH1000 sarA). (B) SarA 
signals on the blot were quantified by densitometry (Chapter 2.18.5.2). The relative 
signal level for each lane was compared to the maximum signal level obtained. The 
results are representative of three independent experiments. 
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were used to analyze the effects of d on agr (RNAIII) expression in a sarA 
background. Strains were grown in BHI as described in Chapter 2.7. Growth was 
measured spectrophotometrically as OD600 (Chapter 2.6.1), and lacZ fusion expression 
was determined using MUG, as in Chapter 2.8. The sarA mutation was found to 
decrease the expression of both of the reporters, as expected (compare data shown here 
and in Figures 3.3a and 3.3b). However, transcription of hla remained lower in the 
SH1000 sarA background than in the 8325-4 sarA background and the sigB derivatives 
(ie. 74 MUG units, 1,519 MUG units, 2,072 MUG units and 1,094 MUG units at t= 12 
h for strains JLA375 (SH1000 hla:: lacZ sarA), PC3221 (8325-4 hla:: lacZ sarA), 
JLA377 (SH1000 hla:: lacZ sigB sarA) and JLA376 (8325-4 hla:: lacZ sigB sarA) 
respectively) (Figure 3.5a). Similarly, transcription of agr (RNA III) remained lower in 
the SH 1000 sarA background than in the 8325-4 sarA background and the sigB 
derivatives (ie. 102 MUG units, 2,594 MUG units, 1953 MUG units and 2549 MUG 
units at t= 12 h for strains JLA345 (SH1000 agr (RNA III):: IacZsarA), PC600 (8325-4 
agr (RNAIII):: lacZ sarA), JLA345 (SH1000 agr (RNA III):: lacZ sarA) and PC602 
(8325-4 agr (RNAIII):: IacZ sigB sarA) respectively) (Figure 3.5b). Since the repression 
of agr (RNAIII) and h1a transcription by aB was not relieved by the mutation of sarA, 
the decrease in agr (RNAIII) and hla transcription in SH1000 was not due to the 
activity of SarA. 
3.2.2.5 Investigation of the role of Rot and SarHI as the effector of the 
repression of agr and hla by ßB 
In Chapters 3.2.2.2,3.2.2.3 and 3.2.2.4, the level of SarA was shown not to be the 
effector of the repression of agr (RNAIII) and hla by ßB. The sequence of the S. aureus 
genome has revealed a wide array of SarA homologues, including SarH1 (Tegmark et 
al., 2000), and Rot (McNamara et al., 2000) (Chapter 1.6.2.2.3). Rot has been shown to 
repress hla transcription in an agr background (McNamara et al., 2000; Said-Salim et 
al., 2003). Furthermore, sarH1 has a crB-dependent promoter, has been shown to bind to 
the P3 promoter of the agr operon, and represses hla at the level of transcription in a 
sarA background (Tegmark et al., 2000). Therefore, the possibility that either rot or 
sarHi might act as the intermediate between aß and agr was determined by 
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Figure 3.5 
Effect of a Bon hla:: IacZ and agr (RNAIII):: lacZ transcription in a sarA background. 
(A) hla:: lacZ transcription of strains PC3221 (8325-4 hla:: lacZ sarA) (0 and "), 
JLA375 (SH1000 hla:: lacZ sarA) (A and A), JLA376 (8325-4 hla:: lacZ sigB sarA) 
(0 and  ) and JLA377 (SH1000 hla:: lacZ sigB sarA) (O and f). (B) agr (RNA 
III):: IacZ transcription of strains PC600 (8325-4 agr (RNAIII):: IacZ sarA) (0 and 40), 
JLA345 (SH1000 agr (RNA III):: IacZ sarA) (0 and A), PC602 (8325-4 agr 
(RNAIII):: lacZ sigB sarA) (Q and  ) and JLA347 (SH1000 agr (RNA III):: IacZ sigB 
sarA) (O and f). Strains were grown in BHI as described in Chapter 2.7. Growth was 
measured spectrophotometrically as OD600 (Chapter 2.6.1) (open symbols), and lacZ 
fusion expression was determined using MUG, as in Chapter 2.8 (closed symbols). 
Results are representative of two independent experiments. 
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investigating the effects of mutation of these genes on hla:: lacZ transcription. A 
cassette knock-out of rot was transferred from PM783 to PC322 (8325-4 hla:: lacZ) and 
JLA371 (SH1000 hla:: lacZ) by 411-mediated transduction. This produced the strains 
JLA378 (8325-4 hla:: lacZ rot) and JLA379 (SH1000 hla:: lacZ rot) respectively. 
Similarly, the sarHi mutation was transduced from strain SMH1005 to JLA512 (8325-4 
hla:: lacZ) and JLA513 (SH1000 hla:: lacZ) to create JLA380 (8325-4 hla:: lacZ sarHi ) 
and JLA381 (SH1000 hla:: lacZ sarHi). Strains were grown in BHI as described in 
Chapter 2.7. Growth was measured spectrophotometrically as OD600 (Chapter 2.6.1), 
and IacZ fusion expression was determined using MUG, as in Chapter 2.8. 
Transcription of hla:: lacZ was found to be reduced by approximately 1.9-fold (t = 10 h) 
in the presence of the rot mutation in the Sill 000 background (ie. 16,007 MUG units 
and 8,650 MUG units for strains JLA371 (SH1000 hla:: lacZ) and JLA379 (SH1000 
hla:: lacZrot) respectively) (Figure 3.6a). Therefore, Rot is unlikely to be the effector of 
the repression of agr and hla by aB, since inactivation of rot failed to relieve the 
repression of hla:: lacZ transcription by aB. Furthermore, since a similar minor 
reduction in hla:: lacZ transcription of approximately 1.3-fold was found to occur in the 
presence of the rot mutation in the 8325-4 background (ie. 111,596 MUG units and 
87,285 MUG units at t= 10 h for strains PC322 (8325-4 hla:: lacZ) and JLA378 (8325- 
4 hla:: lacZ rot) respectively) (Figure 3.6b), this suggests that the effects of rot on hla 
occur independently of the levels of aB activity. 
Transcription of hla:: lacZ was found to be increased by approximately 1.6-fold (t = 10 
h) in the presence of the sarH1 mutation in the SH1000 background (ie. 10,148 MUG 
units and 16,034 MUG units for strains JLA513 (SH1000 hla:: lacZ) and JLA381 
(SH1000 hla:: lacZ sarHl) respectively) (Figure 3.7a). Consequently, sarHi is also 
unlikely to be the mediator of the effect on agr (RNAIII) and hla by aB, since 
inactivation of sarHi failed to relieve the repression of hla:: lacZ by aB to any 
significant extent. Furthermore, hla:: lacZ transcription was found to be increased by 
approximately 1.5-fold at t= 10 h in the presence of the sarHi mutation in 8325-4 (ie. 
53,136 MUG units and 78,541 MUG units for strains JLA512 (8325-4 hla:: lacZ) and 
JLA380 (8325-4 hla:: lacZ sarHi) respectively) (Figure 3.7b), suggesting that the 
effects of sarHi on hla occur independently of aB. 
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Figure 3.6 
Effect of rot on hla:: lacZ transcription in SH1000 and 8325-4. 
(A) hla:: lacZ transcription of strains JLA371 (SH1000 hla:: lacZ) (0 and ") and 
JLA379 (SH1000 hla:: lacZrot) (0 and  ). (B) hla:: lacZ transcription of strains PC322 
(8325-4 hla:: lacZ) (0 and ") and JLA378 (8325-4 hla:: lacZ rot) (Q and  ). Strains 
were grown in BHI as described in Chapter 2.7. Growth was measured 
spectrophotometrically as OD600 (Chapter 2.6.1) (open symbols), and IacZ fusion 
expression was determined using MUG, as in Chapter 2.8 (closed symbols). Results are 
representative of a minimum of two independent experiments. 
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Figure 3.7 
Effect of sarHi on hla:: lacZ transcription in SH1000 and 8325-4. 
(A) hla:: lacZ transcription in strains JLA371 (SH1000 hla:: lacZ) (0 and ") and 
JLA379 (SH1000 hla:: lacZrot) (0 and  ). (B) hla:: lacZ transcription in strains PC322 
(8325-4 hla:: lacZ) (0 and ") and JLA378 (8325-4 hla:: lacZ rot) (Q and  ). Strains 
were grown in BHI as described in Chapter 2.7. Growth was measured 
spectrophotometrically as OD600 (Chapter 2.6.1) (open symbols), and IacZ fusion 
expression was determined using MUG, as in Chapter 2.8 (closed symbols). Results are 
representative of two independent experiments. 
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3.2.2.6 The role of 6B in virulence determinant regulation in response to 
NaCl-mediated stress 
In order to investigate the role of o-B in virulence determinant regulation in response to 
NaCI-mediated stress, JLA371 (SH1000 hla:: lacZ), JLA373 (SH1000 hla:: lacZ sigB), 
JLA341 (SH1000 agr (RNAIII):: IacZ) and JLA343 (SH1000 agr (RNAIII):: IacZ sigB) 
were grown in BHI containing 700 mM NaCl as described in Chapter 2.7. Growth was 
measured spectrophotometrically as OD600 (Chapter 2.6.1), and lacZ fusion expression 
was determined using MUG, as in Chapter 2.8. The results obtained were compared 
with Figures 3.3a and 3.3b, for which the data was produced simultaneously with this 
set of experiments. 
In BHI containing no added NaCl (Figure 3.3a), hla:: lacZ transcription was 5.6-fold 
lower in JLA371 (SH1000 hla:: lacZ) compared to JLA373 (SH1000 hla:: lacZsigB) (ie. 
14,201 and 80,923 MUG units respectively at t= 12 h). However, in BHI containing 
700 mM NaCl (Figure 3.8a), hla:: lacZ transcription was approximately 85-fold lower in 
JLA371 than in JLA373 (ie. 68 and 5,777 MUG units respectively at t= 12 h). This 
suggests that the level of repression of hla transcription by aB increases greatly in the 
presence of 700 mM NaCl. 
In BHI containing no added NaCl (Figure 3.3b), agr (RNAIII):: lacZ transcription was 
4.5-fold lower in JLA341 (SH1000 agr (RNAIII):: lacZ) compared to transcription in 
JLA343 (SH1000 agr (RNAIII):: lacZ sigB), (ie. 3,177 and 14,678 MUG units 
respectively at t= 12 h). Similarly, in BHI containing 700 mM NaCl (Figure 3.8b), agr 
(RNAIII):: lacZ transcription was 7.2-fold lower in JLA341 than in JLA343 (ie. 1,989 
and 14,393 MUG units respectively at t= 12 h). This indicates that the level of 
repression of agr (RNAIII) transcription by aB does not increase significantly in the 
presence of NaCl-mediated stress. 
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Figure 3.8 
Effect of aß on hla:: lacZ and agr (RNAIII):: IacZ transcription during growth in Bill 
containing 700 mM NaCl. (A) hla:: lacZ transcription in strains JLA371 (SHI000 
hla:: lacZ) (0 and  ) and JLA373 (SH1000 hla:: lacZ sigB) (0 and "). (B) agr 
(RNAIII):: lacZ transcription in strains JLA341 (SH1000 agr (RNAIII):: lacZ) (0 and 
 ) and JLA343 (SH1000 agr (RNAIII):: IacZsigB) (0 and "). Strains were grown in 
BHI containing 700 mM NaCl as described in Chapter 2.7. Growth was measured 
spectrophotometrically as OD600 (Chapter 2.6.1) (open symbols), and IacZ fusion 
expression was determined using MUG, as in Chapter 2.8 (closed symbols). Results are 
representative of two independent experiments. 
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3.3 Discussion 
Transcriptional analysis using lacZ reporter gene fusions showed that 1M NaCl 
repressed spa and hla in S. aureus 8325-4. However, only a minor effect on the 
transcription of agr (RNA III) was identified. This supports the findings of Lindsay and 
Foster (1999) and of Chan & Foster (1998a) that 1M NaC1 represses spa and hla in an 
agr-independent manner, and confirms the suggestion of Chan and Foster (1998a) that 
in the presence of NaCl, a novel regulatory system might assume control of genes which 
are also regulated by agr and/or sarA. 
However, an alternative explanation for the effects of NaCI on virulence determinant 
and agr expression might be that NaCI prevents the binding of RNAIII to its target sites. 
This would prevent the upregulation of extracellular virulence determinants (eg. hla) 
during the post-exponential growth phase, resulting in a low level of expression 
throughout growth, despite the fact that agr (RNA III) transcription remains unaffected. 
However, the finding that 1M NaCI repressed the transcription of the cell surface- 
associated protein spa suggests that this is not the case; spa is normally repressed by agr 
during the post-exponential growth phase, and so if NaCI prevented RNAIII from 
binding to its target sites, spa would not be repressed after the post-exponential growth 
phase, and would therefore remain highly expressed. Since spa was found to be 
repressed throughout growth in the presence of 1M NaCl, this suggests that NaCI does 
not interfere with RNAIII interactions, and so the effects of NaCl on the binding of 
RNAIII were not analysed further. 
In the investigation of the effects of aB on hla, agr (RNAIII) and sarA, aB was found to 
repress hla transcription. This is in accordance with the findings of a number of other 
researchers (Cheung et al., 1999; Nicholas et al., 1999; Giachino et al., 2001; Ziebandt 
et al.; Horsburgh et al., 2002). For example, Horsburgh et al. (2002) have shown the 
level of Hla to be greatly reduced in stationary-phase exoprotein samples from SH 1000 
compared to 8325-4, and demonstrated a decrease in Hla activity in SH1000. aB has 
also been shown to repress several other agr-dependent virulence determinants, 
including ß-haemolysin (Ziebandt et al., 2001), proteases (Ziebandt et al., 2001; 
Horsburgh et al., 2002) and enterotoxin B (Ziebandt et al., 2001). The mechanism for 
this is likely to involve repression of agr by aB, since a large reduction in agr (RNA III) 
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transcription in SH1000 was observed, compared to 8325-4 and the sigB derivatives. 
However, Cheung et al., (1999) demonstrated that the transcription of RNAII and 
RNAIII of the agr locus was unaltered by mutation of sigB. Nevertheless, this 
discrepancy is probably due to the use of the rsbU 8325-4 derivative RN6390 in the 
studies by Cheung et al. (1999). Furthermore, the data presented here is supported by 
the findings of Bischoff et al. (2001), who showed by Northern blot and reporter gene 
fusion analysis that the transcription of agr (RNA III) was higher in the sigB derivatives 
of the rsbU} strains MSSA1112, Newman and GP268 compared to their sigB' parents. 
The repression of agr by aB probably occurs indirectly, since the P2 and P3 promoters 
of agr do not possess aB-dependent consensus sequences (Cheung et al., 1999). The 
most obvious candidate for mediating the reduction in agr levels was SarA, which is a 
known activator of agr expression (Chien & Cheung, 1998; Chien et al., 1998; 
Heinrichs et al., 1996). Furthermore, the sarP3 promoter has been shown to be aB- 
dependent (Deora et al., 1997; Manna et al., 1998; Miyazaki et al., 1999; Bischoff et al., 
2001). However, when a sarA:: lacZ reporter fusion (which measures expression from 
all three sar promoters (Chan & Foster, 1998a)) was assayed or when the amount of 
SarA protein was determined by Western blotting in SH1000,8325-4 and their all 
mutant derivatives, the levels were found to be very similar. This suggests that aB had 
little or no effect on SarA under the conditions studied here. This is in accordance with 
the results of Blevins et al. (1999), who reported that SarA is expressed constitutively. 
In their analysis of SarA levels during different stages of growth of RN6390 and clinical 
isolate UAMS-1, these authors observed no variation between the strains (Blevins et al., 
2002). It may be possible to extend this observation to strains 8325-4, SH1000 and their 
sigB mutant derivatives. However, this finding contrasts with the observations of 
Bischoff et al. (2001). In the studies of these authors, expression of a sarA:: lux fusion 
reporter strain was found to be higher in the rsbW strains MSSA1112 and Newman 
than in the rsbU strain BB255 or in sigB derivatives of any of the three strains grown in 
LB. Similarly, Karlsson and Arvidson (2002) showed that in a group of 92 non-isogenic 
clinical isolates, strains which possessed higher aB-activity also demonstrated higher 
levels of sarA mRNA in BHI. Furthermore, Gertz et al. (2000) showed that there was 
decreased SarA expression in a sigB mutant of S. aureus COL grown in minimal 
medium by using two-dimensional electrophoresis. Alternatively, Cheung et al. (1999) 
showed that SarA levels were elevated in a sigB mutant of S. aureus RN6390. The 
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reason for the difference in sarA expression between these studies and the data 
presented here is unclear. However, since different strains, media, and growth 
conditions were used, we cannot exclude the possibility that genetic or environmental 
differences had an effect. Therefore, it is important to study a number of environmental 
conditions to determine the effect of oBon SarA expression. 
The crB-dependent sar promoter, P3 (Bayer et al., 1996; Manna et al., 1998), is most 
active during the late exponential growth phase in strains with a wild-type rsbU locus 
(Bischoff et al., 2001). SarA represses its own transcription via the proximal P1 
promoter but not via the more distal P3 promoter (Chakrabarti & Misra, 2000). 
Therefore, the failure to observe increased expression of SarA despite the presence of a 
d promoter may be due to the autoregulatory capacity of SarA (Blevins et al., 1999; 
Chackrabarti & Misra, 2000) maintaining constant protein levels. It can therefore be 
hypothesized that under certain environmental conditions where a° activity increases, 
resulting in a concomitant reduction in SarA repression, SarA autoregulation increases 
and maintains the level of SarA. 
Since under the conditions studied here the SarA protein level was found to be 
relatively constant during growth irrespective of the rsbU or sigB genotype, SarA is 
unlikely to be the mediator for the repression of agr (RNAIII) and hla by a°. 
Furthermore, neither of the two SarA homologues investigated, Rot or SarH1, is likely 
to be the missing effector, as their inactivation failed to increase the transcription of hla. 
This agrees with the findings that the transcription of agr is unaffected by mutation of 
sarH1, and that the repression of hla by sarHi only occurs in a sarA mutant (Tegmark 
et al., 2000). Furthermore, inactivation of rot has been found to increase h1a 
transcription only in an agr background (McNamara et al., 2000). Therefore, in an 
attempt to identify the missing component(s), a transposon mutant library screen using 
Tn551 was performed in Chapter 5. 
Analysis of the role of aB in the NaC1-mediated stress response indicated that the level 
of repression of hla transcription by aB is greatly increased in the presence of 700 mm 
NaCI compared to the level of repression in the absence of added NaCl. This suggests 
that aB might play a role in regulating hla in the presence of NaCI-mediated stress. 
However, the level of repression of agr (RNAIII) transcription by aB was not 
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significantly increased in the presence of 700 mM NaCl. Overall this data indicates that 
aB might be involved in the agr-independent repression of lila (and possibly therefore 
of other virulence determinants) in BHI containing 700 mM NaCl. This conflicts with 
the findings of Chan et al. (1998), who could not identify a role for a° in resistance to 
osmotic shock in S. aureus. However, a possible explanation for the difference in results 
may be the use of the rsbU strain 8325-4 by Chan et al. (1998). Furthermore, an has 
been shown to be required for the activation of biofilm formation in S. aureus and S. 
epidermidis in response to NaCI-mediated stress (Rachid et al., 2000; Knobloch et al., 
2001). This indicates that aB might have a similar role in regulating the NaCI-mediated 
stress response in S. aureus as it does in B. subtilis (Chapters 1.6.1.2 and 1.6.2.2.8). 
However, due to the absence of the environmental stress pathway genes rsbR, rsbS, 
rsbT and rsbX from the S. aureus aB operon (Chapter 1.6.2.2.8), the mechanisms by 
which aB senses NaC1 in S. aureus will differ from those operating in B. subtilis. 
However, inactivation of sigB did not completely prevent the repression of hla by NaCI- 
mediated stress, since hla:: lacZ transcription was reduced by 14-fold in JLA373 
(SH1000 hla:: lacZ sigB) in BHI containing 700 mM NaCl (Figure 3.8a) compared to 
transcription in BHI containing no added NaCl (Figure 3.3a) (ie. 5,777 and 80,923 
MUG units respectively at t= 12 h). The data presented in Figure 3.1b and of Chan and 
Foster (1998a) corroborates this, since NaCl was found to repress hla:: lacZ 
transcription in the rsbU strain 8325-4. This suggests that although 6° may be involved 
in the regulation of virulence determinants in response to NaCI-mediated stress in S. 
aureus, additional regulatory components might exist. A possible explanation for this 
may be that NaCl is an extremely important environmental parameter affecting the 
survival of S. aureus, and consequently the mechanisms involved in sensing and 
responding to it will be complex. Therefore, in order to identify novel components 
involved in virulence determinant regulation in response to NaCI-mediated stress, 
transposon mutant library screens were performed using Tn917 and Tn551 in Chapters 
4 and 5 to identify genes that are required to repress the activity or transcription of hla 
in the presence of 1M NaCl. 
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CHAPTER 4 
IDENTIFICATION AND CHARACTERISATION OF GENES INVOLVED IN 
REGULATING a"IIAENIOLYSIN ACTIVITY IN RESPONSE TO NaCl 
4.1 Introduction 
Insights into the mechanisms of infection have been obtained by the characterisation of 
mutants with altered virulence determinant expression or which are attenuated in 
pathogenicity. Transposon mutagenesis has been used extensively in this process, and 
has contributed to the discovery of major virulence determinant regulators in S. aureus, 
including agr, sarA and sae (Recsei et al., 1986; Cheung et al., 1992; Giraudo et al., 
1994). 
Transposons are mobile genetic elements that can insert into host DNA. One of the 
transposons used most extensively in genetic research is Tn917 (Tomich et al., 1980; 
reviewed in Youngman, 1990). Tn917 was fast identified in an isolate of Enterococcus 
faecalis and is a member of the Tn3 family of replicative transposable elements 
(Tomich et al., 1979; Shaw & Clewell, 1985). Tn917 is plasmid-associated and has a 
number of features that make it particularly useful as a genetic tool. The transposon 
exhibits a high degree of insertional randomness in a broad host range and creates 
extremely stable insertional mutations (Youngman, 1990). Furthermore, Tn917 has 
been modified such that it carries a promoterless lacZ gene that can be fused to the 
regulatory elements of chromosomal genes in order to give a quantitative measure of 
promoter activity (Perkins & Youngman, 1986). Additional modification by Camilli et 
al. (1990) produced the plasmid pLTVI (Figure 4.1). This comprises Tn917 carried by 
a highly temperature-sensitive derivative of the vector pE194Ts to allow improved 
recovery of chromosomal insertions (Camilli et al., 1990). In addition, the transposition 
frequency of Tn917 held on pLTVI is high (Camilli et al., 1990), allowing insertion 
libraries to be generated on a relatively small scale. 
Although pLTVI was initially constructed for use in L. monocytogenes (Camilli et al., 
1990), it has also been used in Gram-positive bacteria, including B. subtilis and B. 
cereus (Clements & Moir 1998; Behravan et al., 2000). This system has also been 
utilised successfully in S. aureus, where it has permitted the identification of, for 
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tet 
M13 on 
Figure 4.1 
Physical map of pLTV 1, the vector carrying a transposition-proficient derivative 
of Tn917. 
Regions coloured in red are part of the transposable element, whilst the remainder 
of the vector is coloured in green. Features of this map; erm, erythromycin- 
resistance gene; MCS, multiple cloning site; bla, pBR322 ß-lactamase gene; 
ColElrep, ColEl origin of replication; cat, an S. aureus pC194-derived 
chloramphenicol acetyltransferase gene; M13 on, origin of replication for single- 
stranded DNA synthesis; lacZ, promoterless lacZ gene from E. coli with 
translation initiation signals derived from B. subtilis; tet, a tetracycline resistance 
gene from pAMa 101; Ts rep, pE 194Ts temperature-sensitive replicon. 
Adapted from Camilli et al. (1990) and Youngman (1990). 
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example, sarA, an, additional genes involved in virulence, and genes required for 
starvation survival (Cheung et al., 1992; Fournier & Hooper, 2000; Coulter et al., 1998; 
Lammers et al., 2000; Vriesema et al., 2000; Wiltshire & Foster, 2001; Watson et al., 
1998). Tn917 has been shown to insert into the S. aureus genome with a relatively high 
degree of randomness (Coulter et al., 1998), and is therefore a useful tool in the genetic 
analysis of S. aureus. 
This chapter describes the use of Tn917 in a screen to identify genes involved in 
regulating Hla activity in the presence ofNaCl-mediated stress. 
4.2 Results 
4.2.1 Tn917 mutagenesis of S. aureus 8325-4 
The plasmid pLTV1 (Figure 4.1) is 20.6 kb in length, and comprises the transposon 
Tn917 (which carries an erythromycin-resistance gene) and additional flanking 
sequences containing a tetracycline-resistance marker and a temperature-sensitive 
Gram-positive origin of replication. The copy number of pLTV 1 decreases at high 
temperatures, with replication being totally inhibited at temperatures above 37 °C 
(Villafane et al., 1987). Consequently, by growing cells at a temperature above 37 °C in 
the presence of erythromycin, cells containing a chromosomal Tn917 insertion can be 
selected since resistance to erythromycin (carried by Tn917) will remain, whilst 
resistance to tetracycline (carried by pLTV 1) will be lost. Two Tn917 libraries, X and 
Z, were created in 8325-4 by Wiltshire and Foster (2001). The suitability of these 
libraries for use in screening was evaluated. 
4.2.1.1 Enumeration and evaluation of Tn917 libraries 
Only libraries with > 90 % transposon insertion are considered useful for screening. 
Libraries with a lower percentage insertion would contain a high proportion of cells in 
which Tn917 remained on pLTV 1, and so screening would have to be performed on a 
larger scale. Using the method described in Chapter 2.15.3, libraries X and Z were 
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found to have a transposon insertion frequency of 94.6 % and 95 % respectively (ie. 2.2 
X 109 and 5.75 X 108 cfu mrI of Ery resistant cells respectively, and 1.2 X 108 and 2.9 
X 107 cfu ml' Ery and Tet resistant cells respectively). Libraries X and Z were therefore 
deemed suitable for use in screening. 
4.2.2 Screen to identify mutants with altered Hla activity in response to 
NaCI 
In Chapter 3,1 M NaCl was shown to strongly repress hla transcription in BHI broth. 
Therefore, a transposon mutant library screen was performed to identify mutants that 
were still able to produce Hla on rabbit blood plates containing NaCl, as signified by a 
zone of haemolysis of greater diameter surrounding the colony than for the background 
colonies. These mutants would contain Tn917 inserted into a gene potentially involved 
in repressing hla in the presence of NaCI-mediated stress. However, the mechanism by 
which hla transcription is lowered in the presence of NaCl might involve reduced 
activation of hla transcription in the presence of NaCI than in its absence. Therefore, 
mutants that were non-haemolytic were also screened for on the rabbit blood plates 
containing NaCl. 
4.2.2.1 Screen development 
4.2.2.1.1 Identification of the most appropriate concentration of NaCl to add 
to the rabbit blood plates 
In order to determine the most suitable concentration of NaC1 to add to the rabbit blood 
plates, plates were made at a final NaCl concentration of 85.6 mm (no added NaCI), 
250 mM, 500 mM, 750 mM and 1M (Chapter 2.1.1.7). 8325-4 from a fresh overnight 
BHI plate was streaked onto each of the plates in duplicate and grown overnight at 
37 °C. The diameters of 3 colonies and their zones of haemolysis were measured on 
each plate and the average values calculated. The zones of haemolysis were found to 
decrease in diameter as the concentration of NaC1 increased, although the diameters of 
the colonies remained approximately the same (Table 4.1). A final concentration of 1M 
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Concentration of 
NaCI (mM) 
Average colony 
diameter (mm) 
Average diameter of 
zone of haemolysis (mm) 
85.6 (no added NaCl) 0.9 2.6 
250 0.9 2.4 
500 0.9 1.7 
750 0.9 1.6 
1000 0.8 1.3 
Table 4.1 
The affect of NaCI on the colony diameter and Hla-mediated haemolysis of 8325-4 on 
rabbit blood plates. 
Rabbit blood plates were made at a final NaCl concentration of 85.6 mM (no added 
NaCl), 250 mM, 500 mM, 750 mM and 1M (Chapter 2.1.1.7). 8325-4 from a fresh 
overnight BHI plate was streaked onto each of the plates in duplicate and grown 
overnight at 37 T. Growth and Hla-mediated haemolytic activity were measured as 
colony diameter and diameter of the zone of haemolysis respectively (mm). Average 
diameters were calculated after measuring 3 colonies and their zones of haemolytis per 
plate on duplicate plates. 
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NaCI was chosen at which to make the plates, as this gave a zone of haemolytis that 
was sufficiently reduced in size to allow mutants expressing increased levels of Hla in 
the presence of NaCl to be easily identified. Furthermore, since the colonies were still 
slightly haemolytic on the 1M NaCI rabbit blood plates, non-haemolytic mutants could 
also be screened for. 
4.2.2.1.2 Effect of 1M NaCl on Hla activity 
As shown in Table 4.1, the zones of haemolysis surrounding S. aureus colonies 
decreased in diameter as the concentration of NaCI in rabbit blood plates was increased. 
To show that this was caused solely by NaCI repressing Hla expression, and not by 
NaCI preventing Hla from causing haemolysis on the plates, the following control was 
performed. Supernatants from duplicate 12 h S. aureus 8325-4 cultures grown in 5 ml 
BHI or 5 ml BHI containing 1M NaCl were filter-sterilised (0.2 µm pore size). The 
supernatants were diluted in PBS as shown in Figure 4.2, and 10 µl was spotted onto a 
rabbit blood plate containing no added NaCl and onto a rabbit blood plate containing 1 
M NaCl. After incubation overnight at 37 °C, the supernatant of the BHI culture 
containing no added NaCI was as haemolytic on the rabbit blood plate containing 1M 
NaCl as it was on the rabbit blood plate containing no added NaCl at each of the 
corresponding dilutions (Figure 4.2). This suggests that NaCI present in the plate 
containing 1M NaCl had no effect on Hla activity. Furthermore, only the undiluted 
spots of the supernatants from the cultures grown in BHI containing 1M NaCI caused 
haemolysis on either type of rabbit blood plate; the lower dilutions were non-haemolytic 
(results not shown). Overall, this suggests that 1M NaCI represses the production of 
Hla, but does not prevent Hla from causing haemolysis on rabbit blood plates. 
Consequently, rabbit blood plates can be used to examine the effects of NaCI on Hla 
expression. 
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Figure 4.2 
Haemolysis caused by an 8325-4 BHI culture supernatant at various dilutions on 
(A) a rabbit blood plate containing IM NaCl and on (B) a rabbit blood plate 
containing no added NaCl. 
S. aureus 8325-4 was grown for 12 h in 5 ml BHI in a sterile universal tube at 
37 °C with 250 rpm rotary shaking. Cells were removed by centrifugation (4,000 
rpm (Centaur 2), 5 min), and the supernatant was filter-sterilized (0.2 µm pore 
size). The supernatant was then diluted using PBS and 10 µl was spotted onto a 
rabbit blood plate and onto a rabbit blood plate containing 1M NaCl. Dilutions 
used were; 1) neat, 2) 1/25,3) 1/50,4) 1/75,5) 1/100,6) 1/125,7) 1/150,8) 1/175 
and 9) 1/200. The plates were then incubated overnight at 37 °C. Results are 
representative of two independent experiments. 
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4.2.2.2 Primary screen 
Since cells from libraries X and Z were unable to grow when plated directly from 
glycerol stocks onto rabbit blood plates containing 1M NaCl, the transposon mutant 
libraries were first diluted using PBS to give - 100 colonies per plate and recovered on 
BHI agar plates containing Ery and Lin. After growth overnight at 37 °C, colonies were 
replica plated onto rabbit blood plates containing 1M NaCI and grown overnight at 
37 T. The plates were then screened to identify non-haemolytic mutants and mutants 
with a zone of haemolytis of increased diameter compared to the background colonies. 
6,500 colonies were screened in total (-. 3,500 from library X and - 3,000 from library 
Z). 39 mutants were selected, of which 23 were non-haemolytic and 16 displayed 
increased haemolytic activity (Table 4.2). 
4.2.2.3 Secondary screen 
To ensure that the phenotypes of the Tn917 mutants were reproducible, the strains were 
patched onto rabbit blood plates containing 1M NaCl, with 8325-4 as a control. All of 
the mutants that were selected for their non-haemolytic phenotype displayed wild-type 
levels of haemolysis (results not shown) and were therefore discarded. However, all of 
the 16 mutants selected for increased haemolytic activity compared to the background 
colonies demonstrated the same mutant phenotype compared to 8325-4 and therefore 
passed the screen (Table 4.2). 
The 16 mutants were patched onto BHI agar plates containing Ery and Lin and onto 
BHI agar plates containing Tet to determine whether Tn917 was inserted into the 
genome of the cells or carried on pLTV I. All of the mutants were Ery resistant and Tet 
sensitive, and therefore possessed chromosomal Tn917 insertions. Furthermore, when 
patched onto rabbit blood plates containing no added NaCl, all of the mutants displayed 
a similar level of haemolytic activity to 8325-4 (results not shown). This suggests that 
the effects of the genes mutated by Tn917 are NaCI-specific. The inactivated genes 
were therefore designated han 1-16 (genes involved in repressing Hla activity in the 
presence of NaC1). 
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4.2.2.4 Tertiary screen 
To determine whether the increased haemolytic activity of the han mutants compared to 
8325-4 displayed on rabbit blood plates containing 1M NaCl was caused by Tn917 
insertion or by point mutations, the Tn917 insertions were transferred into 8325-4 via 
411-mediated transduction, as described in Chapter 2.9.3. For each mutation, all 10 
transductants tested displayed a similar level of increased haemolytic activity as the 
donor mutant strain when patched onto rabbit blood plates containing 1M NaCl (Table 
4.2), and demonstrated similar levels of haemolysis to 8325-4 on rabbit blood plates 
containing no added NaCl (data not shown). Therefore, 100 % linkage of the mutant 
phenotype to the transposon insertion was demonstrated for all 16 mutants. The strain 
names of a representative transductant per han mutation are shown in Table 4.2. 
A diagrammatic summary of the screening protocol and results is presented in Figure 
4.3. 
4.2.3 Characterisation of han mutants 
4.2.3.1 Direct genomic DNA sequencing to identify genes inactivated by 
Tn917 
To identify the genes inactivated by Tn917 in the han mutants, direct sequencing of 
genomic DNA was performed as in Chapter 2.13.1.2.4. The primer used, Tn2, was a 25 
bp oligonucleotide (Table 2.5) which binds 106 bp upstream of the lacZ end of the 
transposon. Consequently, the sequencing reaction proceeds through this end of the 
transposon and into the S. aureus genomic DNA. The sequence corresponding to the 
lacZ end of Tn917 was removed, and the remaining data was used to identify the 
position of Tn917 insertion in the S. aureus genome. The sequence of S. aureus 
genomic DNA is held in two main databases (Chapter 2.17.2); the NCBI BLAST 
website contains unannotated S. aureus 8325 genomic DNA sequence, whilst the TIGR 
website contains annotated genomic DNA sequence of strains including S. aureus COL. 
Due to its increased versatility, the TIGR database was first used to identify the position 
of Tn917 insertion in the S. aureus COL genome. Alignments of the sequencing 
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6,500 Tn917 mutants in 8325-4 background 
(ý 3,500 from library X and - 3,000 from library Z) 
Cells recovered on BHI Ery Lin 
(37 °C overnight) 
100 colonies per plate 
I 
Colonies replica plated onto rabbit blood plates containing IM NaCl 
(37 °C overnight) 
T 
or which were non-haemoly_ tic 
were selected 
(Primary screen) 
Colonies with increased haemolysis 
39 putative Tn917 mutants 
- 16 mutants displaying increased haemolytic activity 
- 23 non-haemolytic mutants 
I 
Colonies patched onto rabbit blood plates containing iM NaCI 
to ensure reproducibility of mutant phenotype (37 °C overnight) 
(Secondary screen) 
16 putative mutants displaying increased haemolytic activity 
Mutations transduced into 8325-4 to check linkage of mutant 
phenotype to the transposon insertion. 10 transductants per strain 
patched onto rabbit blood plates containing IM NaCl (37 °C overnight) 
(Tertiary screen) 
T 
16 putative mutants displaying increased haemolytic activity 
Figure 4.3 
Diagrammatic representation of the screen performed to identify Tn917 mutants in 
the 8325-4 background that were non-haemolytic or that displayed increased 
haemolytic activity compared to the background colonies on rabbit blood plates 
containing 1M NaCl, and which may therefore contain Tn917 insertions in genes 
involved in regulating Hla in response to NaCl. 
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reaction data with the COL DNA sequence are shown in Appendix A. 2. Flanking ORFs 
were identified, and the putative function of the gene products were determined based 
on homology to proteins in other organisms (Chapter 2.17.2 and Appendix A. 2.1 - 
A. 2.9). Genes were assigned accession numbers based on those of the COL database. 
Finally, the COL genomic DNA sequence containing the inactivated genes and their 
surrounding genes of interest was extracted from the TIGR website and compared to the 
8325 sequence in the NCBI BLAST database to ensure that the sequence and position 
of the genes in COL is the same as it is in 8325. For each region compared, the COL 
and 8235 genomic DNA sequence was 99 - 100 % identical (data not shown). The 
genes inactivated by Tn917 are shown in Table 4.2, and are diagramatically represented 
with their surrounding genes of interest in Figure 4.4. 
In total, 9 genes were found to have been inactivated by Tn917 in the 16 mutants. 
Where a gene contained more than one insertion, Tn917 was found to have inserted in 
exactly the same site for each mutation within the gene. In each case, the mutants with 
identical Tn917 insertion sites were derived from the same library (Table 4.2), and are 
therefore likely to be siblings. 
In JLA401 (8325-4 hanl) and JLA410 (8325-4 han10), Tn917 was found to have 
inserted into SA1896, at base 105 of the 555 bp gene. However, protein sequence 
analysis revealed no significant homology to a known protein (Figure A. 2.1), and so a 
putative function for the gene could not be assigned. The gene was therefore designated 
unkl (unknown protein 1). 
In JLA402 (8325-4 han2), JLA403 (8325-4 han3), JLA405 (8325-4 han5), JLA406 
8325-4 han6), JLA 407 (8325-4 han7) and JLA408 (8325-4 han8), Tn917 was found to 
have inserted into SA1908, at base 856 of the 1383 bp gene. Protein sequence analysis 
demonstrated homology to CitG, the Class-II fumarate hydratase (fumarase), of B. 
subtilis (66 % identity over 460 amino acids). 
In JLA404 (8325-4 han4), Tn917 was found to have inserted into SA1418, at base 124 
of the 342 bp gene. However, protein sequence analysis revealed no significant 
homology to a known protein (Figure A. 2.3), and so a putative function for the gene 
could not be assigned. The gene was therefore designated unk2 (unknown protein 2). 
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In JLA409 (8325-4 han9), Tn917 was found to have inserted into SA1384, at base 242 
of the 1644 bp gene. Protein sequence analysis demonstrated homology to the glycine 
betaine transporter OpuD of B. subtilis (56 % identity over 496 amino acids). 
In JLA411 (8325-4 hanl1), Tn917 was found to have inserted into SA1551, at base 
1,394 of the 1,647 bp gene. Protein sequence analysis demonstrated homology to a 
number of alpha-1,4-glucosidases and oligo-1,6-glucosidases, including the exo-alpha- 
1,4-glucosidase homolog YugT of B. subtilis (56 % identity over 549 amino acids). 
In JLA412 (8325-4 hanl2), Tn917 was found to have inserted into SA1414, at base 294 
of the 699 bp gene. Protein sequence analysis demonstrated homology to a number of 
oligopeptide ABC (ATP-binding cassette) transporter ATP-binding proteins, including 
OppF of Fusobacterium nucleatum (31 % identity over 223 amino acids). Analysis of 
the DNA surrounding the inactivated gene identified the presence of an operon 
comprising three other oligopeptide ABC transporter genes. Furthermore, the gene 
inactivated by Tn917 in JLA412 was found to be 4 genes downstream of the gene 
inactivated by Tn917 in JLA404 (8325-4 han4 (unk2)). 
In JLA413 (8325-4 hanl3), Tn917 was found to have inserted into SA1059, at base 898 
of the 1008 bp gene. Protein sequence analysis demonstrated homology to the 
conserved hypothetical protein YkrP of B. subtilis (35 % identity over 278 amino acids). 
Although the function of YkrP was unknown in the Subtilist database (Chapter 2.17.2), 
the protein sequence of SA1059 also showed homology to a putative integral membrane 
protein of Streptomyces coelicolor (25 % identity over 296 amino acids) and 
acetyltransferases, including the acetyltransferase nodulation protein No1L of 
Mesorhizobium loti (23 % identity over 309 amino acids). 
In JLA414 (8325-4 hanl4), Tn917 was found to have inserted into SA1265, at base 
1078 of the 1242 bp gene. Protein sequence analysis demonstrated homology to the 
endopeptidase resistance / peptidoglycan biosynthesis protein eprH of S. aureus (100 % 
identity over 414 amino acids). 
In JLA415 (8325-4 hanl5) and JLA416 (8325-4 hanl6), Tn917 was found to have 
inserted into SA1395, at base 1202 of the 1206 bp gene. Protein sequence analysis 
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Figure 4.4 a-c 
Position of Tn917 insertions in han mutants, and surrounding genes of interest for (A) 
hanl and han10 (unkl), (B) han2, han3, han5, han6, han7 and han8 (citG), and (C) 
han 12 (oppF) and han4 (unk2). 
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Figure 4.4 d-f 
Position of Tn917 insertions in han mutants, and surrounding genes of interest for (D) 
hang (opuD), (E) han 11 (yugT), and (F) han 13 (ykrP). 
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Figure 4.4 g-h 
Position of Tn917 insertions in han mutants, and surrounding genes of interest for (G) 
han 14 (eprH) and (H) han 15 and han 16 (yubA). 
Figure 4.4 a-h 
Position of Tn917 insertions in han mutants, and surrounding genes of interest. 
Genes inactivated by Tn917 are presented in red, and the position of Tn917 insertion is 
indicated (7). Flanking genes of interest are shown in green. The approximate size of 
each DNA fragment is shown in the bottom right-hand corner of each diagram. The 
information for each mutation was obtained by analysing sequence data (Chapter 
2.17.2) from strains derived by transduction of the han mutations into an 8325-4 
background (see Table 4.2 for strain names). 
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demonstrated homology to the conserved hypothetical protein YubA of B. subtilis (40 
% identity over 366 amino acids). Although the function of YubA was unknown in the 
Subtilist database (Chapter 2.17.2), the protein sequence of SA1395 also showed 
homology to conserved hypothetical proteins and membrane proteins, including a 
conserved hypothetical membrane protein from Listeria monocytogenes EGD-e (38 % 
identity over 367 amino acids). 
4.2.3.2 Analysis of the effects of han mutations on virulence determinant 
expression in the presence and absence of NaCI-mediated stress 
4.2.3.2.1 Haemolytic activity of han mutants on rabbit blood plates containing 
either no added NaCI or 1M NaCl 
Photographs showing the haemolysis of a representative mutant for each gene 
inactivated by Tn917, compared to 8325-4, on rabbit blood plates containing either no 
added NaC1 or 1M NaCl are presented in Figure 4.5. Mutation of unkl, citG and oppF 
led to greatly increased haemolytic activity compared to 8325-4 on rabbit blood plates 
containing 1M NaCl, whilst mutation of unk2, opuD, yugT, ykrP, eprH and yubA led to 
slightly increased haemolysis in the presence of 1M NaCl. Scores for the level of 
haemolysis for each of the mutants, compared to 8325-4, are shown in Table 4.2. On 
rabbit blood plates containing no added NaCl, each of the mutants demonstrated a 
similar level of haemolytic activity to 8325-4. 
4.2.3.2.1.1 Determination of whether the increased haemolysis of han mutants 
on rabbit blood plates containing 1M NaCI is due to increased Hla 
expression, or due to the increased production of another haemo- 
lytic factor 
4.2.3.2.1.1.1 Construction of a tetracycline-resistant hia cassette knock-out 
To determine whether the increased haemolytic activity of the han mutants on rabbit 
blood plates containing 1M NaCI is due to increased Hla expression or due to the 
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5 6 6 c 
7 I 
Figure 4.5 
Haemolytic activity of representative han mutants compared to 8325-4 on (A) a 
rabbit blood plate containing 1M NaCl and on (B) a rabbit blood plate containing no 
added NaCl. 
Plates were patched with strains 1) 8325-4,2) JLA401 (8325-4 hanl (unkl)), 3) 
JLA404 (8325-4 han4 (unk2)), 4) JLA402 (8325-4 han2 (citG)), 5) JLA409 (8325-4 
han9 (opuD)), 6) JLA411 (8325-4 hanl l (yugT)), 7) JLA412 (8325-4 han12 (oppF)). 
8) JLA413 (8325-4 hanl3 (ykrP)), 9) JLA414 (8325-4 hanl4 (eprH)), and 10) 
JLA415 (8325-4 han15 (yubA)) and incubated overnight at 37 °C. Results are 
representative of two independent experiments. 
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Table 4.2 
Summary of the phenotypic and sequence analysis results for the Tn917 han mutants. 
a Haemolytic activity on rabbit blood plates containing 1M NaCI, during primary (1°), 
secondary (2°) and tertiary (3°) screens, compared to the background colonies for the 
primary screen and to 8325-4 for the secondary and tertiary screens (++ = slightly 
increased haemolytic activity. +++ = greatly increased haemolytic activity (see Figure 
4.5)). 
b S. aureus gene number according to the TIGR S. aureus COL database (Chapter 
2.17.2). 
Highest BLASTP hit against a named gene (Chapters 2.17.2 and A. 2). 
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increased production of another haemolytic factor, attempts were made to construct a 
tetracycline-resistant hla cassette knock-out. This would be transduced into the 
erythromycin-resistant Tn917 mutants to determine whether their mutant phenotype is 
dependent on the production of Hla. A cassette knock-out of hla and an hla:: lacZ fusion 
have already been constructed (O'Reilly et al., 1986; Chan & Foster, 1998a). However, 
since these both carry erythromycin-resistance markers, they cannot be used to 
determine whether the han genes inactivated by Tn917 specifically affect hla without 
first constructing cassette knock-outs of the genes using a selectable marker other than 
erythromycin-resistance. 
The initial strategy to construct a tetracycline-resistant hla cassette knock-out aimed to 
clone a HindIIl / BamHI-flanked 2.9 kb PCR product (containing the whole 1 kb hla 
gene and approximately 1 kb of flanking DNA) into HindIII / BamHI-cut pMUTIN4. 
The resulting plasmid would then be cut with KpnI (to remove an - 600 bp fragment 
from within hla) and ligated to a KpnI-flanked tetracycline resistance cassette, PCR 
amplified from pDG1513 using primers OL-32 and OL-33. 
Attempts to clone the hla insert into pMUTIN4 (Chapter 2.13.6.1.1) produced hundreds 
of ampicillin-resistant E. coli DH5a transformants. However, when 60 transformants 
were tested by colony PCR screening (Chapter 2.13.1.2.5) with the primers used to 
amplify the hla insert (ie. JA-5 and JA-6), none were found to contain the hla insert. 
Plasmid DNA was prepared from 5 transformants grown in LB containing 50 µg mrl 
Amp (Chapter 2.11.2). The plasmid DNA was cut with BamHI (Chapter 2.13.2) and run 
on a1% (w/v) agarose gel (Chapter 2.13.5). The presence of a single - 8.6 kb band 
showed that all 5 transformants contained recircularised pMUTIN4 (data not shown). 
This suggests that either BamHl or Hindlll had not cut the vector DNA when it was 
being prepared for ligation. However, when the same pMUTIN4 stock was cut with 
either BamHI or Hindlll (Chapter 2.13.2) and run on a1% (w/v) agarose gel (Chapter 
2.13.5), both enzymes were found to be capable of cutting pMUTIN4 (data not shown). 
To ensure that both HindIIl and BamHI cut the vector DNA fully, plasmid pMAL23 
(pMUTIN4 containing a HindIIl / BamHI insert) was cut with HindIIl and BamHI 
(Chapter 2.13.6.1.2). Since this removed the insert, the vector DNA was known to have 
been cut fully with both enzymes. Additionally, the 2.9 kb hla insert was cloned into 
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the vector pCR-II-TOPO to create the plasmid pJA3 (Chapter 2.13.6.1.2) (Figure 4.6). 
Construction of pJA3 was verified by restriction mapping with HindIII / BamHI or with 
Kpnl (Chapter 2.13.6.1.2) (data not shown). The h1a insert was then cut from the pCR- 
II-TOPO backbone using HindIII and BamHI (Chapter 2.13.2). Since a discrete 2.9 kb 
insert band was produced, both enzymes were shown to have fully cut the h1a insert 
DNA (data not shown). However, attempts to clone the h1a insert into the pMUTIN4 
vector backbone cut from pMAL23 (Chapter 2.13.6.1.2) yielded no E. coli DH5a 
transformants. 
Therefore, a new cloning strategy was developed whereby construction of the h1a 
cassette knock-out would be completed in pJA3. A counter-selectable erythromycin- 
resistance cassette would be introduced into the vector backbone of pJA3, since the 
kanamycin-resistance cassette present on the pCR-II-TOPO backbone is not suitable for 
selection in Gram-positive organisms. The Kpnl-flanked tetracycline resistance cassette 
could then be used to insertionally inactivate h1a. However, the MCS of pCR-II-TOPO 
contains a KpnI site, and a site for its isoschizomer Asp718. Nevertheless, these sites 
could be removed by digesting pJA3 with Hindlll, which cuts at the start of the h1a 
insert and in the MCS upstream of the KpnI and Asp718 sites. HindIll-cut pJA3 was 
therefore ligated to the HindII1-flanked erythromycin-resistance cassette cut from 
pDG646 (Chapter 2.13.6.1.3) to create the plasmid pJA4 (Figure 4.7). Transformation 
of the ligation reaction into E. coli DH5a (Chapter 2.13.6.1.3) yielded a single 
erythromycin-resistant colony. Plasmid DNA was prepared from this colony by large 
scale plasmid preparation (Chapter 2.11.3). Restriction mapping by double-cutting with 
BamHI and Hindlll identified the correct 1.6 kb Ery cassette band, the 2.9 kb hla insert 
band, and the remaining 4 kb vector backbone band (Figure 4.7, restriction fragment 
data not shown). Restriction mapping with KpnI yielded the correct 600 bp band from 
within hla (Figure 4.7, restriction fragment data not shown). However, instead of 
producing a single 7.9 kb band representing the remaining plasmid, an - 2.7 kb and an 
5.2 kb band were produced (Figure 4.7, restriction fragment data not shown). This 
suggests that Hindlll had not cut at the site upstream of KpnI in the pCR-II-TOPO MCS 
when preparing pJA3 for ligation with the Ery cassette, and consequently the KpnI site 
had not been removed. Due to time restrictions, attempts to construct the tetracycline- 
resistant h1a cassette knock-out were abandoned. 
149 
Cl IAP"I'ER 4 
PCR product 
H AK insertion site 
MCS 
+ 
hla insert PCR product 
2.9 kb 
C 
bla 
HAKH 
IacZ llI f 
r. r. 
UU 
B r. ý. 0a l-n 
HsK Ke ß 
hla 
N 
fl on lacZ B 
Figure 4.6 
Construction of pJA3. 
(A) pCR-II-TOPO and (B) a 2.9 kb hla insert were used to create (C) pJA3. Features of 
this diagram; IacZ, promoterless ß-galactosidase gene; fl ori, fl origin of replication; 
kan, kanamycin resistance cassette; bla, (3-lactamase gene; pUC ori, pUC origin of 
replication; hla, whole h1a gene plus -1 kb flanking DNA. Relevant restriction sites; A, 
Asp718; B, BamHl; H, HindIII; K, KpnI. The site where the h1a insert was introduced 
into the pCR-II-TOPO MCS is shown in blue. Not to scale. 
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Figure 4.7 
Construction of pJA4. 
(A) HindIII-cut pJA3 and (B) an erythromycin-resistance cassette (cut from pDG646 
using Hindlll) were used to construct (C) pJA4 (Cl; diagram of desired pJA4, C2; 
actual pJA4 produced). 
Features of this diagram; lacZ, promoterless (3-galactosidase gene; fl on, fl origin of 
replication; kan, kanamycin resistance cassette; bla, ß-lactamase gene; pUC on, pUC 
origin of replication; ery, erythromycin-resistance cassette from pDG646; h1a, whole 
h1a gene plus -1 kb flanking DNA. Relevant restriction sites; A, Asp718; B, BamHl; 
H, Hindlll; K, KpnI. The region which should be removed from pJA3 by cutting with 
HindIIl are shown in (A). Not to scale. 
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4.2.3.2.1.1.2 Haemolytic activity of han mutants in an agr background on rabbit 
blood plates containing either no added NaCl or 1M NaCl 
Since attempts to construct a tetracycline-resistant hla knock-out were unsuccessful 
(Chapter 4.2.3.2.1.1.1), it was not possible to determine whether the mutant phenotype 
of the Tn917 han mutants was dependent specifically on Hla, or on another haemolytic 
factor. Therefore, the agr mutation from PC6911 (8325-4 agr) was transferred by ý11- 
mediated transduction to JLA401 (8325-4 hanl (unk! )), JLA402 (8325-4 han2 (citG)), 
JLA404 (8325-4 han4 (unk2)), JLA409 (8325-4 han9 (opuD)), JLA411 (8325-4 han l! 
(yugT)), JLA412 (8325-4 han12 (oppF)), JLA413 (8325-4 hanl3 (ykrP)), JLA414 
(8325-4 han14 (eprB)) and JLA415 (8325-4 han15 (yubA)). This produced the strains 
JLA417 (8325-4 han! (unkl) agr), JLA418 (8325-4 han2 (citG) agr), JLA419 (8325-4 
han4 (unk2) agr), JLA420 (8325-4 han9 (opuD) agr), JLA421 (8325-4 hanll (yugT) 
agr), JLA422 (8325-4 han12 (oppF) agr), JLA423 (8325-4 hanl3 (ykrP) agr), JLA424 
(8325-4 han14 (eprB) agr) and JLA425 (8325-4 han15 (yubA) agr) respectively. The 
agr strains were patched onto rabbit blood plates containing either no added NaCI or 1 
M NaCl, with 8325-4 and PC6911 (8325-4 agr) as controls. After incubation overnight 
at 37 °C, all of the agr han mutants were found to be non-haemolytic on both types of 
rabbit blood plate (data not shown). This indicates that the increased haemolytic activity 
of the han mutants on rabbit blood plates containing 1M NaC1 is due to the increased 
production of an agr-dependent virulence determinant, and is not caused by, for 
example, an increase in the production of acid. Furthermore, 10 µ1 spots of purified 100 
ng µl"1 SspA (Chapter 2.3) were unable to lyse rabbit blood plates containing either no 
added NaC1 or 1M NaCl, but were able to cause a zone of proteolysis on milk plates 
following incubation overnight at 37 °C (data not shown). Additionally, JL140 (8325-4 
hla) was found to be completely non-haemolytic on a rabbit blood plate containing 1M 
NaCl, whilst 8325-4 was slightly haemolytic (data not shown). 
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4.2.3.2.2 Quantitative measurement of haemolytic activity of han mutants in 
BHI containing either no added NaCl or 1M NaCl 
To quantitatively compare the haemolytic activity of the han mutants to that of 8325-4, 
haemolytin assays were performed using samples obtained from 8325-4, JLA401 
(8325-4 han! (unkl)), JLA402 (8325-4 hang (citG)), JLA404 (8325-4 han4 (unk2)), 
JLA409 (8325-4 han9 (opuD)), JLA411 (8325-4 han! 1 (yugT)), JLA412 (8325-4 han12 
(oppF)), JLA413 (8325-4 hanl3 (ykrP)), JLA414 (8325-4 han14 (eprH)) and JLA415 
(8325-4 han 15 (yubA)) grown in BHI containing either no added NaCI or 1M NaCI for 
14 h (Chapter 2.18.1). All of the mutants demonstrated a similar level of haemolytic 
activity to 8325-4 when grown in Bill containing no added NaCl; the mutants expressed 
between 3277 HU and 3922 HU, whilst 8325-4 expressed 3527 HU (Figure 4.8). 
However, attempts to measure the haemolytic activity of samples taken from strains 
grown in BHI containing 1M NaCI gave readings below the level of accuracy of the 
spectrophotometer (data not shown). 
To determine whether NaC1 present in the samples interfered with the ability of Hla to 
lyse the rabbit erythrocytes, solid NaC1 was added to a 100 µl aliquot of supernatant 
from 8325-4 (grown in BHI containing no added NaCl) to give a final concentration of 
1 M. The sample was incubated on ice for 15 min to allow the NaCl to dissolve and 
interact with Hla. The haemolytic activity of this sample and of a 100 µl aliquot of 
untreated supernatant from the same tube was then measured. The experiment was 
performed in duplicate. The haemolytic activity of untreated supernatant and of 
supernatant supplemented with NaC1 was 2769 HU and 2174 HU respectively. This 
suggests that NaC1 may prevent Hla from lysing rabbit erythrocytes in liquid assays to a 
minor degree. However, the extent to which NaCI affected the haemolytin assay is not 
sufficient to account for the inability to detect haemolytic activity in samples taken from 
the han mutants grown in Bill containing 1M NaC1 if they were able to over-express 
Hla compared to 8325-4 under these conditions to the same extent as they did on rabbit 
blood plates containing 1M NaCl. This indicates that the inability to measure the 
haemolytic activity of the samples obtained from han mutants grown in BHI containing 
1M NaC1 was most likely due to the expression of a low level of Hla under these 
conditions. 
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Figure 4.8 
Haemolytic activity of han mutants and 8325-4 grown in BHI containing no added NaCl. 
The haemolytic activity of samples taken from 8325-4, JLA401 (8325-4 hanl (unkl)), 
JLA402 (8325-4 han2 (citG)), JLA404 (8325-4 han4 (unk2)), JLA409 (8325-4 han9 
(opuD)), JLA411 (8325-4 hanll (yugT)), JLA412 (8325-4 han12 (oppF)), JLA413 
(8325-4 han13 (ykrP)), JLA414 (8325-4 han14 (eprH)) and JLA415 (8325-4 han15 
(yubA)) grown in BHI for 14 h was measured as described in Chapter 2.18.2. 
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To establish whether the haemolytic activity of the han mutants grown in Bill 
containing 1M NaC1 could be quantified after desalting and concentrating the samples, 
1.5 ml supernatant from cultures of 8325-4, JLA401 (8325-4 hanl (unkl)) and JLA402 
(8325-4 han2 (citG)) was passed through a Centricon YM-10 centrifugal filter device 
(Chapter 2.18.2) until only - 50 µl liquid remained. Following resuspension in 
haemolysin salts solution to give a final volume of 300 µl, the haemolytic activity of the 
samples was quantified as in Chapter 2.18.2. However, assay of these samples could 
not reproduce the increased haemolytis of JLA401 (8325-4 han! (unkl) and JLA402 
(8325-4 han2 (citG)) compared to 8325-4 observed on rabbit blood plates containing 1 
M NaCl, since 8325-4, JLA401 (8325-4 hanl (unkl)) and JLA402 (8325-4 han2 (citG)) 
and were found to have a haemolytic activity of 59,39 and 31 HU respectively. 
To determine whether a difference in the haemolysis of the han mutants and 8325-4 
could be identified by using a lower concentration of NaCl, samples were taken from 
8325-4, JLA401 (8325-4 han! (unkl)) and JLA402 (8325-4 han2 (citG)) grown in BHI 
containing 700 mM NaCl. However, assay of these samples gave readings below the 
level of accuracy of the spectrophotometer (data not shown). Furthermore, samples 
taken from cultures grown in BHI containing 500 mM NaCI did not show a significant 
difference between the haemolytic activity of 8325-4, JLA401 (8325-4 hanl (unkl)) 
and JLA402 (8325-4 han2 (citG)). These strains had a haemolytic activity of 1039,978 
and 1112 HU respectively. 
4.2.3.2.3 Determination of the expression of Hla, SspA and other exoproteins 
by han mutants in BHI containing either no added NaCI or 1M NaCI 
using exoprotein gel and Western blot analysis 
To determine whether the increased expression of Hla (or another factor responsible for 
the increased haemolytic activity of the han mutants, compared to 8325-4, on rabbit 
blood plates containing 1M NaC1) could be demonstrated in the presence of NaCl- 
mediated stress in liquid culture, Western blotting (using antibodies raised against Hla 
and SspA) and exoprotein gel analysis was performed. Culture supernatants samples 
were taken from cultures of 8325-4, JLA401 (8325-4 han! (unk! )), JLA402 (8325-4 
han2 (citG)), JLA404 (8325-4 han4 (unk2)), JLA409 (8325-4 han9 (opuD)), JLA411 
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(8325-4 hanll (yug7)), JLA412 (8325-4 han12 (oppF)), JLA413 (8325-4 hanl3 
(ykrP)), JLA414 (8325-4 han14 (eprH)) and JLA415 (8325-4 han15 (yubA)) grown in 
Bill containing either no added NaCl or 1M NaCl after 14 h. Exoproteins were 
prepared as described in Chapter 2.18.3.1, separated on 12 % (w/v) SDS-PAGE gels as 
in Chapter 2.18.4, and probed with antibodies as in Chapter 2.18.5 where appropriate. 
In all of the strains the level of Hla was decreased, whilst the level of SspA and AurA 
was increased, in BHI containing 1M NaCl compared to BHI containing no added 
NaCl. Furthermore, the exoprotein profiles of the han mutants were similar to those of 
8325-4 in BHI containing no added NaCl. However, no difference in the amount of Hla, 
SspA, or any other exoprotein expressed by the han mutants, compared to 8325-4, could 
be identified when grown in BHI containing 1M NaCl. Examples of gels and blots for 
JLA401 (8325-4 hanl (unkl)), JLA404 (8325-4 han4 (unk2)) and JLA402 (8325-4 
han2 (cite)), are shown in Figure 4.9. 
Exoprotein gel analysis suggested that samples taken from BHI cultures containing 1M 
NaCl contained significantly lower amounts of a number of proteins, including hla, than 
samples from BHI cultures containing no added NaCl (Figure 4.9a). To determine 
whether this is because NaCl present in the exoprotein samples interferes with the TCA 
precipitation of the proteins or their running on SDS-PAGE gels, NaCl crystals were 
added to an exoprotein sample removed from an 8325-4 culture (grown in BHI 
containing no added NaCl) to give a final concentration of 1 M. The sample was 
prepared and run on an SDS-page gel under standard conditions alongside an untreated 
sample removed from the same culture (Chapter 2.18.4). The intensity of the protein 
bands for the NaCI-treated sample was found to be similar to that of the untreated 
sample (Figure 4.10). Consequently, this suggests that NaCl present in the samples does 
not interfere with the preparation or running of the proteins. Instead, the low levels of 
proteins observed are probably a result of reduced protein production by the strains 
when grown in BHI containing 1M NaCl. 
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Figure 4.9 
The effect of han mutations on the expression of 11la, SspA and other exoproteins. 
(A) Exoprotein gels, (B) Hla Western blots and (C) SspA Western blots för 8325-4. 
JLA401 (8325-4 hanl (unkl )), JLA404 (8325-4 han4 (unk2)) and JLA402 (8325-4 
han2 (ciiG)). Samples were removed after 14 h from cultures grown in Bill containing 
either no added NaCl (-) or 1M NaCl (+) and prepared as described in Chapter 2.18.3.1. 
Proteins were separated on 12 % (w/v) SDS-PAGE gels as described in Chapter 2.18.4 
and probed with relevant antibodies as described as in Chapter 2.18.5 where 
appropriate. Lanes contain exoproteins from 1.0 or 0.2 OD600 units of culture 
supernatant for exoprotein gels and Western blots respectively. Results are 
representative of a minimum of two independent experiments. Sizes of Sigma low 
molecular weight markers are shown. 
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Figure 4.10 
Control to determine whether NaCI present in the exoprotein samples interferes with 
the TCA-precipitation of proteins or their separation on SDS-PAGE gels. 
Two exoprotein samples were removed from a 14 h culture of 8325-4 grown in 13111. 
One sample was left untreated (1), whilst NaCl crystals were added the other sample 
to give a final concentration of IM (2). The samples were prepared and separated on 
an SDS-PAGE gel, as described in Chapter 2.18. Lanes contain exoproteins from 1.0 
OD600 unit of culture supernatant. Results are representative of two independent 
experiments. Sizes of Sigma low molecular weight markers are indicated. 
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4.2.3.3 Analysis of the effects of han mutations on growth in Bill containing 
either no added NaCl or 2M NaCl 
1M NaCl has been shown to significantly repress virulence determinant expression in 
S. aureus (Chapter 1.6.2.3.2). However, 1M NaCI only reduces the growth rate and 
final cell yield of S. aureus to a minor extent (Chapter 3.2.1), and S. aureus is able to 
grow in the presence of up to 3.5 M NaCI (Scott, 1953; Armstrong-Buisseret et al., 
1995). Therefore, a concentration of 2M NaC1 was used to determine the effects of han 
mutations on growth in the presence of NaCl. 8325-4, JLA401 (8325-4 han! (unk! )), 
JLA402 (8325-4 han2 (citG)), JLA404 (8325-4 han4 (unk2)), JLA409 (8325-4 han9 
(opuD)), JLA411 (8325-4 hanl1 (yug7)), JLA412 (8325-4 han12 (oppF)), JLA413 
(8325-4 hanl3 (ykrP)), JLA414 (8325-4 han14 (eprl-J)) and JLA415 (8325-4 han15 
(yubA)) were grown in BHI (with a5 ml BHI preculture containing no added NaCl), in 
BHI containing 2M NaC1 (with a5 ml BHI preculture containing 2M NaCl) (NaC1- 
adaptation), and in BHI containing 2M NaCI (with a5 ml BHI preculture containing no 
added NaCl) (NaCI-shock) (Chapter 2.7). Growth was measured spectrophotometrically 
as OD60o at regular intervals over a 24 h period (Chapter 2.6.1). JLA401 (8325-4 han! 
(unkl)), JLA404 (8325-4 han4 (unk2)), JLA411 (8325-4 hanl l (yug7)), JLA412 (8325- 
4 han12 (oppF)), JLA413 (8325-4 han13 (ykrP)), JLA414 (8325-4 han14 (eprH)) and 
JLA415 (8325-4 han15 (yubA)) displayed similar levels of growth to 8325-4 under all 
three conditions (full data not shown). These mutants reached an OD600 of 8-8.8,3.4 - 
3.8 and 3.0 - 3.4 at t= 10 h in BHI containing no added NaCl, under NaC1 adaptation 
and in the presence of NaC1 shock respectively, whilst 8325-4 reached an OD600 of 
approximately 8.54,3.75 and 3.40 at t= 10 h under the three respective conditions. 
The growth of JLA402 (8325-4 han2 (citG)) was similar to that of 8325-4 in BHI 
containing no added NaCI and under NaCI adaptation, reaching an OD600 of 8.00 and 
3.50 at t= 10 h under the two respective conditions (Figure 4.1la). However, a minor 
growth defect for JLA402 (8325-4 han2 (citG)) was observed in the presence of NaC1- 
shock (ie. a maximum of 1.6-fold lower growth for JLA402 at t=9h; 1.75 and 2.81 
OD600 units respectively). 
The growth of JLA409 (8325-4 han9 (opuD)) was similar to that of 8325-4 in BHI 
containing no added NaCI, reaching an OD600 of 8.79 at t= 10 h (Figure 4.11b). 
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Growth of (A) JLA402 (8325-4 han2 (c/t O)) (Q,   and L) and (B) JLA409 (8325-4 
hang (opal))) (Q,   and[]), compared to 8325-4 (O, " and p) in BHI (with a5 ml BHI 
preculture containing no added NaCl) (open symbols), in BHI containing 2M NaCl (with 
a5 ml BHI preculture containing 2M NaCl) (NaCI-adaptation) (black symbols), and Bill 
containing 2M NaCl (with a5 ml Bill preculture containing no added NaCl) (NaCI- 
shock) (grey symbols). Strains were grown at 37 °C as described in Chapter 2.7. Growth 
was measured spectrophotometrically as OD600 (Chapter 2.6.1). Results are 
representative of two independent experiments. 
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However, JLA409 (8325-4 han9 (opuD)) was found to have a growth defect compared 
to 8325-4 under NaCl adaptation (ie. a maximum of 3-fold lower growth in JLA409 
than in 8325-4 at t=7h; 0.455 and 1.29 OD600 units respectively). Nevertheless, the 
final growth yield of JLA409 (8325-4 han9 (opuD)) was similar to that of 8325-4 in the 
NaCI-adaptation experiment (ie. 5.26 and 6.165 OD600 units respectively at t= 24 h). In 
the presence of NaCl shock, the growth defect of JLA409 (8325-4 han9 (opuD)) was 
greatly increased (ie. a maximum of 16-fold lower growth in JLA409 than in 8325-4 at t 
= 24 h; 0.345 and 5.68 OD600 units respectively). Furthermore, this shows that in the 
presence of NaCI-shock, the final growth yield of JLA409 (8325-4 han9 (opuD)) was 
much lower than in 8325-4. 
4.3 Discussion 
A screen of - 6,500 Tn917 mutants identified 9 genes, mutation of which led to 
increased haemolytic activity compared to 8325-4 on rabbit blood plates containing 1M 
NaCl, but which did not affect haemolytic activity on rabbit blood plates containing no 
added NaCl. Consequently, these genes may be involved in repressing virulence 
determinant expression in the presence of NaCl. In Chapter 3, it was shown that 
virulence determinant repression in response to NaCl in S. aureus is likely to occur via 
two pathways, one which involves aB and one that is aB-independent. Since the screen 
was performed in the 8325-4 background, which has a reduced level of aB activity 
compared to most clinical strains (Giachino et al., 2001), the genes identified here are 
likely to act via the aB-independent pathway. Furthermore, two different phenotypes 
were demonstrated for the mutants (either slightly increased or greatly increased 
haemolytis on rabbit blood plates containing 1M NaCI). This suggests that the genes 
may function at different levels of the same aB-independent pathway, or via two 
separate e -independent pathways. 
The genes identified encode fumarase (CitG), a glycine betaine transporter (OpuD), an 
exo-alpha-1,4-glucosidase (YugT), an oligopeptide ABC transporter ATP-binding 
protein (OppF), a protein homologous to putative integral membrane proteins and 
acetyltransferases (YkrP), a protein involved in endopeptidase resistance and 
peptidoglycan biosynthesis (EprH), a conserved hypothetical membrane protein 
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(YubA), and two proteins for which a putative function could not be defined (Unkl and 
Unk2). 
Fumarase (fumarate hydratase) is a Krebs cycle enzyme involved in the interconversion 
of fumarate and L-malate. Interestingly, fumarase activity has been shown to increase in 
Pseudomonas aeruginosa in response to iron deprivation (Hassett et al., 1997). 
Furthermore, fumarase activity increases in the leaves of Phaeseoulus vulgaris in 
response to NaC1-mediated stress (Hernandez et al., 1993). Additionally, fumarate 
directly inhibits transcription of the c1cABD operon (encoding enzymes of a 
chloroaromatic biodegradative pathway) in Pseudomonas putida, and acts as a signal 
molecule in the regulation of phototaxis in Halobacterium salinarum, and in metabolic 
signalling and chemotaxis in E. coli (reviewed by Marwan & Oesterhelt, 2000). 
Therefore, it is possible that in S. aureus, fumarate acts as a signal molecule in the 
NaCI-mediated stress response, and that fumarase is involved in regulating the level of 
this signal. Consequently, the inactivation of fiunarase by Tn917 would have interfered 
with the ability of S. aureus to signal the presence of NaCl in rabbit blood plates 
containing 1M NaCl, resulting in altered Hla production. 
Interestingly, other Krebs cycle enzymes have been isolated in transposon mutant 
library screens to identify genes involved in S. aureus virulence. These include 
oxoglutarate dehydrogenase (odhB) and aconitase (citB) (Mei et al., 1997; Coulter et al., 
1998). Mei et al. (1997) suggested that because respiratory activity is essential for 
capsule production during some stages of S. aureus growth in vitro, and since capsule 
size can have significant effects on virulence, it may be possible that mutations in genes 
encoding Krebs cycle enzymes have an indirect effect on virulence via capsule 
production. 
EprH is an endopeptidase resistance gene of S. aureus, and is involved in peptidoglycan 
biosynthesis (DeHart et al., 1995; Sugai et al., 1997; Sugai et al., 1998). In the 
peptidoglycan of staphylococci, peptide units of individual glycan chains are covalently 
linked by pentapeptide-forming interpeptide chains; in S. aureus the interpeptide chain 
is composed of pentaglycine (Schleifer & Khandler, 1972; Sugai et al., 1998). Certain 
strains of staphylococci produce glycylglycine endopeptidase, which specifically digests 
the gly-gly bond in the interpeptide chains of S. aureus peptidoglycan (Sugai et al., 
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1997; Sugai et al., 1998). Resistance of the producing strains to lysis by the enzyme 
involves altering the amino acid composition of the interpeptide chains by increasing 
the serine content and decreasing the glycine content (DeHart et al., 1995; Sugai et al., 
1997; Sugai et al., 1998). EprH has been shown to transfer serine to the interpeptide 
chains (Sugai et al., 1997). Glycine residues are added by FemA and FemB (Sugai et 
al., 1997; Stranden et al., 1997). Major changes occur in the S. aureus cell wall when 
grown in defined medium containing 2.5 M NaCl (Vijaranakul et al., 1995). These 
include an increased cell size and shortened peptidoglycan interpeptide bridge (Chapter 
1.6.2.3.1.2). Alterations in the composition of the peptidoglycan interpeptide bridge 
have mainly been attributed to disturbance of the glycine addition process (Vijaranakul 
et al., 1995). Therefore, disruption of the ability to add both glycine and serine to the 
interpeptide bridge in the eprH mutant grown on rabbit blood plates containing 1M 
NaCl would have led to a significant defect in peptidoglycan structure. This would have 
affected the fitness of the cell, potentially leading to the altered virulence determinant 
production observed. 
In addition, femA and femB have been identified in the pathogenicity screens of Mei et 
al. (1997), Coulter et al. (1998) and Lammers et al. (2000). Since FemA, FemB and 
EprH are members of the same family involved in adding amino acids to the 
peptidoglycan (Sugai et al., 1997), this may support the possible role of EprH in S. 
aureus virulence determinant regulation identified here. 
The oligopeptide transporter identified in the Tn917 mutant library screen is a member 
of the ABC family of transporters that are involved in importing and exporting a range 
of compounds in a variety of organisms (Higgins, 1992). Oligopeptide permeases 
typically comprise a high affinity substrate-binding protein (which is extracellular, but 
bound to the membrane), two permease proteins (which form a solute-specific channel) 
and one or two ATP-binding proteins (which provide energy for the system and 
sometimes serve a regulatory role) (Saier et al., 1993). Importantly, a role for 
oligopeptide transporters and oligopeptides in signalling and gene regulation has been 
established. For example, uptake of the cCF10 sex phermone via an oligopeptide 
permease system is involved in controlling conjugation in E. faecalis (Leonard et al., 
1996). Oligopeptide permeases have also been shown to play a role in virulence, 
affecting the ability of Streptococcus pneumoniae to adhere to eukaryotic cells (Cundell 
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et al., 1995). Additionally, uptake of an oligopeptide signalling molecule(s) via the 
spoOK oligopeptide transporter is involved in the induction of sporulation and 
competence in B. subtilis (Rudner et al., 1991, Magnuson et al., 1994; Solomon et al., 
1995). 
Interestingly, it has been suggested that cell wall peptides can signal the onset of 
stationary phase and initiate sporulation in B. subtilis and a number of other bacteria, 
and that the inability of opp mutants to take up and accumulate these cell wall peptides 
may be responsible for their sporulation defects (Perego et al., 1991; Saier et al., 1993). 
An association between the accumulation of cell wall components in Myxococcus 
xanthus and sporulation has been reported (Shimkets & Kaiser, 1982). Since major 
changes in the structure of the S. aureus cell wall occur when grown in medium 
containing 2.5 M NaCI (Vijaranakul et al., 1995), it is possible to envisage a system 
whereby oligopeptides released from the peptidoglycan in the presence of NaCI- 
mediated stress are taken up by an oligopeptide transporter and act to signal that the 
conditions are inappropriate for virulence determinant production. This is supported by 
the fact that components of oligopeptide transporters have also been isolated in 
transposon mutant library screens to identify genes involved in S. aureus pathogenesis 
(Mei et al., 1997; Coulter et al., 1998; Vriesema at el., 2000). However, analysis of the 
genes surrounding the ATP-binding protein inactivated by Tn917 indicates that the 
oligopeptide transporter isolated in this study does not posses a ligand-binding protein. 
This is either because the system does not require a ligand-binding protein for substrate 
uptake, or because the transporter is involved in efflux (Saier et al., 1993). If the latter 
is correct, then the mechanism by which the oligopeptide transporter functions in 
controlling the NaCI-mediated stress response is unclear. Whether the transporter 
functions in oligopeptide uptake or efflux could be determined through the use of toxic 
peptide analogues (eg. tri-L-ornithine), which will prevent growth only if the system is 
involved in oligopeptide uptake (Barak et al., 1973). 
Since the construction of a tetracycline-resistant hla cassette knock-out proved difficult, 
it was not possible to demonstrate conclusively that the haemolytic factor overexpressed 
by the han mutants, compared to 8325-4, on rabbit blood plates containing 1M NaCl 
was Hla. However, the haemolytic factor was shown to be an agr-dependent virulence 
determinant. Purified protease (SspA) was unable to cause haemolytis on rabbit blood 
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plates containing either no added NaCI or 1M NaCl. Furthermore, an erythromycin- 
resistant hla cassette knock-out was completely non-haemolytic on a rabbit blood plate 
containing 1M NaCl, whilst 8325-4 was slightly haemolytic. Overall, this suggests that 
the virulence determinant over-expressed by the han mutants on rabbit blood plates 
containing 1M NaCI is likely to be Hla. 
Quantification of haemolytic activity using liquid assays showed that the han mutants 
demonstrated the same level of haemolytic activity as 8325-4 when grown in BHI 
containing no added NaCl. However, the increased haemolytic activity of the han 
mutants compared to 8325-4 observed on rabbit blood plates containing 1M NaCl 
could not be demonstrated using samples taken from BHI cultures containing 1M 
NaCl. Similarly, exoprotein gels, Hla Western blots and SspA Western blots showed 
that the han mutants expressed the same level of Hla and SspA as 8325-4 when grown 
in BHI containing either no added NaCl or 1M NaCl. 
Analysis of the growth of the han mutants showed that the unkl, unk2, yugT, oppF, 
ykrP, eprH and yubA mutants demonstrated wild-type levels of growth in BHI 
containing either no added NaCI or 2M NaCI (under NaC1-adaptation or NaC1-shock 
conditions). The effect of citG mutation on growth in the presence and absence of NaCI 
was also investigated. Analysis of the TIGR genome database (Chapter 2.17.2) indicates 
that S. aureus possesses only one fumarase gene, which has been inactivated here by 
Tn917. Fumarase is a Krebs cycle enzyme, and so in order to be able to metabolise and 
grow at all, the citG mutant may possibly resort to using the glyoxylate shunt, whereby 
isocitrate is converted to malate, thus bypassing the section of the Krebs cycle involving 
fumarase (Figure 4.12). Since this would result in the production of less NADH and 
therefore less ATP, a small reduction in growth rate would presumably occur. 
However, no appreciable growth defect was observed for the citG mutant in BHI 
containing no added NaCl, or under NaCI adaptation with 2M NaCl. This agrees with 
the finding that inactivation of genes encoding other Krebs cycle enzymes which can be 
bypassed by the glyoxylate shunt (eg. oxoglutarate dehydrogenase) has little impact on 
the growth rate of S. aureus under unstressed conditions (Coulter et al., 1998). 
However, the citG mutant was found to have a minor growth defect upon NaCl-shock in 
BHI containing 2M NaCl. This suggests that a severe NaCI-mediated stress coupled 
with the defect in metabolism affects growth. 
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Diagram of the Krebs cycle, including the glyoxylate shunt pathway. 
Reproduced from Neidhardt et al. (1990) 
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The opuD mutant was found to have similar growth to 8325-4 in BHI containing no 
added NaCl. However, a growth defect for the opuD mutant was observed under 
conditions of NaCI-adaptation in BHI containing 2M NaCl. This probably occurred 
because the mutant was defective in its ability to take up glycine betaine (which relieves 
the growth inhibition caused by high osmolarity (Chapter 1.6.2.3.1.1.2; Pourkomailian 
& Booth, 1992)) from the Bill broth. Since the inactivation of the glycine betaine 
transporter identified here reduced the growth rate of the mutant in the presence of 2M 
NaCl, this suggests that Tn917 had inactivated the low affinity glycine betaine 
transporter of S. aureus (which is involved in glycine betaine uptake during periods of 
osmotic stress), rather than the high affinity glycine betaine transporter (whose activity 
is increased by signals other than osmolarity) (Chapter 1.6.2.3.1.1.2; Pourkomailian & 
Booth, 1992). Additionally, the results suggest that although other S. aureus transporters 
are involved in the uptake of compatible solutes in the presence of osmotic shock 
(Chapter 1.6.2.3.1.1.2), opuD is likely to play a major role in osmoprotection in the 
initial response to osmotic stress. However, under conditions of NaCI-adaptation, the 
opuD mutant was found to reach a similar final growth yield to 8325-4. This suggests 
that the mutant was able to increase the uptake of compatible solutes by other 
transporters in order to recover from its growth defect. A more pronounced growth 
defect was observed for the opuD mutant under conditions of NaCl-shock in Bill 
containing 2M NaCl. Under these conditions, the mutant was unable to overcome its 
growth defect and reach a similar final growth yield to 8325-4 after 24 hours. This 
presumably occurred due to the inability of other compatible solute transporters to 
compensate for the inactivation of opuD under these conditions. 
The genes identified here provide an interesting insight into the &3-independent 
regulation of virulence determinant expression in response to NaC1-mediated stress. 
However, the ability to analyse the altered haemolytic activity of the han mutants 
appears to be largely limited to qualitative work on solid media. It has been suggested 
that NaCl may be important in regulating virulence determinant expression in the 
development of the commensal state in the human nose and on the skin (Lindsay & 
Foster, 1999). Consequently, the presence of a solid surface may be required for these 
genes to mediate a response to NaCl. Furthermore, it is possible that additional 
environmental factors (eg. aeration) may act in concert with the NaC1-stress signal in 
order to stringently regulate virulence determinant expression. The fact that these 
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conditions would not have been the same in BHI broth as they were on rabbit blood 
plates may have prevented the mutant phenotypes from being reproduced in liquid 
culture. However, only - 6,500 mutants were screened, since a large number of mutants 
with relevant phenotypes were isolated from the colonies already screened. Complete 
coverage of the genome requires the screening of approximately 5 times the total 
number of genes present. Since S. aureus possesses -2,700 genes (Baba et al., 2002), 
complete genome coverage would involve screening -13,500 mutants. Therefore, it is 
possible that further screening might permit the identification of novel mutants for 
which an NaC1-mediated phenotype can be reproduced in liquid culture. As the scope 
for further analysis of the han mutants was limited, these strains were not characterised 
further. 
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CHAPTER 5 
DEVELOPMENT OF AN ALTERNATIVE TRANSPOSON MUTANT 
LIBRARY SCREENING STRATEGY 
5.1 Introduction 
In Chapter 4, Tn917 mutagenesis of S. aureus 8325-4 was used to identify genes with a 
putative role in regulating haemolysin production in response to NaCl. However, the 
usefulness of transposon mutagenesis in S. aureus is restricted by a major limitation. 
The main transposons used for research in S. aureus (ie. Tn917 and Tn551) both carry 
an erythromycin-resistance gene, as do the main vectors used for lacZ reporter gene 
fusion construction in S. aureus (ie. pMUTIN4 and pAZ106) (Youngman, 1990; Wu et 
al., 1999; Vagner et al., 1998; Kemp et al., 1991). Furthermore, many of the cassette 
knock-outs of S. aureus genes have also been constructed using erythromycin-resistance 
cassettes. In this study, such resistance marker incompatibility has prevented pre- 
constructed erythromycin-resistant cassette knock-outs (eg. of hla (O'Reilly et al., 
1986)) and lacZ fusions (eg. the hla:: lacZ fusion (Chan & Foster, 1998a)) from being 
used in conjunction with the Tn917-inactivated han genes. Additionally, it would be 
extremely useful to be able to perform transposon mutagenesis screens directly in lacZ 
reporter gene fusion strains to identify factors affecting the transcription of a specific 
gene, especially where the product of that gene cannot easily be assayed. Two potential 
solutions could allow the problem of selectable marker incompatibility between S. 
aureus transposons and lacZ fusions/cassette knockouts to be overcome. Firstly, 
alternative transposons carrying selectable markers other than erythromycin resistance 
could be evaluated for use in S. aureus. Alternatively, a lacZ fusion vector carrying a 
selectable marker other than erythromycin resistance could be constructed. 
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5.2 Results 
5.2.1 Evaluation of the EZ:: TN transposition system for use in S. aureus 
The EZ:: TN transposition system, produced by Epicentre Technologies, is based on the 
Tn5 transposition system developed by Goryshin & Reznikoff (1998) and Goryshin et 
al. (2000). All information regarding this system has been obtained from the Epicentre 
Technologies website (http: //www. epicentre. com) unless otherwise stated. Tn5 
(reviewed by Reznikoff, 1993) is a composite transposon comprising three antibiotic 
resistance genes flanked by two nearly identical IS50 elements, of which IS50R encodes 
the transposase. However, it has been shown that inverted 19 bp sequences present at 
the outside ends of the IS50 elements (ie. the OE sequences) are the only sequences 
required for the transposase to facilitate Tn5 transposition (Goryshin & Reznikoff, 
1998). The DNA between the 19 bp OE sequences plays no role in transposition 
(Goryshin & Reznikoff, 1998), and the fact that any sequence can make up this region 
(provided that a source of transposase is available) has been exploited in the EZ:: TN 
transposition system. The EZ:: TN transposon, carried on the cloning vector 
pMOD(MCS), consists of the 19 bp OE sequences flanking a MCS into which any piece 
of DNA (eg. any selectable marker) can be introduced. The transposon, either cut from 
the vector DNA using suitable restriction enzymes or amplified by PCR, can be 
incubated with purified Tn5 transposase in order to generate a transposome. 
Transposition can then be achieved in vitro by incubating transposomes with genomic 
DNA fragments and introducing the products into cells by electroporation. 
Alternatively, electroporation of transposomes into suitable recipient cells can be used 
to achieve transposition in vivo. The position of transposon insertions can be identified 
in resulting mutants using sequencing primers provided by Epicentre Technologies. 
A 1000-fold increase in the transposition efficiency of a prototype of the system has 
been achieved by engineering three mutations into the transposase gene and multiple 
changes into the 19 bp transposase recognition sequences (Goryshin & Reznikoff, 
1998). This has allowed high frequency, independent transposon insertion into single 
random sites to be achieved through in vivo use of the prototype system in E. coil, S. 
typhimurium and Proteus vulgaris (Goryshin et al., 2000). The EZ:: TN system has also 
been used successfully for the in vivo transposition of the Gram-positive bacterium 
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Mycobacterium smegmatis (Derbyshire et al., 2000). Consequently, the suitability of the 
EZ:: TN transposition system for use in S. aureus was investigated. However, although 
versions of the EZ:: TN containing tetracycline and kanamycin resistance markers have 
been developed by Epicentre Technologies, these are not suitable for selection in Gram- 
positive organisms. As a result, it was necessary to first clone an appropriate selectable 
marker into the EZ:: TN transposon. 
5.2.1.1 Insertion of a tetracycline-resistance cassette into the EZ:: TN 
transposon 
A 1.5 kb KpnI-flanked tetracycline-resistance cassette, PCR-amplified from pDG1513, 
was cloned into the KpnI-cut 2.5 kb vector pMOD(MCS), as described in Chapter 
2.13.6.2 (Figure 5.1). Restriction mapping with KpnI, BamHI and Scal gave bands of 
the expected size (data not shown). Furthermore, the restriction profile produced by 
digestion with ScaI indicated that the tetracycline-resistance cassette was inserted in the 
same orientation as the ampicillin resistance gene and origin of replication of 
pMOD(MCS) (data not shown). The 4kb plasmid produced was termed pMOD(tet), and 
the EZ:: TN transposon containing the tetracycline-resistance cassette will be referred to 
as the EZ:: TN(tet) transposon. 
5.2.1.2 Generation of EZ:: TN(tet) transposon free from the pMOD(MCS) 
backbone of pMOD(tet) 
The effectiveness of the EZ:: TN transposition system is dependent on the efficiency of 
introducing DNA into host cells by electroporation (Derbyshire et al., 2000). The first 
stage of transposome production therefore involved producing EZ:: TN(tet) transposon 
free from the pMOD(MCS) backbone of pMOD(tet). This should increase the 
efficiency of electroporation of the transposomes into S. aureus cells for in vivo 
transposition, due to the shorter length of the DNA fragments. Furthermore, the 
efficiency of electroporating in vitro transposition products into S. aureus cells will be 
increased due to a smaller amount of contaminating backbone DNA being present 
amongst the genomic DNA / transposon fragments. Two methods can be used to obtain 
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Figure 5.1 
Construction of pMOD(tet). (A) Kpnl-cut pMOD(MCS) and (B) a Kpnl-cut PCR 
product containing the tetracycline-resistance cassette amplified from pDG1513 were 
used to construct (C) pMOD(tet), a vector carrying the Tn5-based EZ:: TN(tet) 
transposon. 
Regions coloured in red on the plasmids are part of the transposable element, whilst the 
remainder of the vector backbone is coloured in green. The 19 bp outside end (OE) 
sequences mark the ends of the transposon, and are represented by red triangles. 
Additional features; on, origin of replication; amp, ampicillin-resistance gene; let, 
tetracycline-resistance gene; MCS, multiple cloning site. Restriction sites; K, KpnI; Ba, 
BamHl; S, ScaI; Bg, Bgll; H, HaeII. Not to scale. 
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EZ:: TN(tet) transposon free from the pMOD(MCS) backbone. Firstly, the transposon 
can be amplified from pMOD(tet) by PCR using the primers FP-1 and RP-1 (Epicentre 
Technologies). However, attempts to PCR amplify the EZ:: TN(tet) transposon sequence 
using Pwo polymerase (Chapter 5.2.1) were unsuccessful, even when pMOD(tet) was 
first cut with NdeI to prevent plasmid supercoiling from interfering with the PCR 
reaction (data not shown). 
An alternative strategy to obtain EZ:: TN(tet) transposon free from the pMOD(MCS) 
backbone involves cutting the transposon from the vector backbone using suitable 
restriction enzymes. pMOD(tet) was therefore digested overnight with BglI and HaeII 
(Chapter 5.2.1), which cut 49 bp and 54 bp outside the 19 bp OE sequences of the 
EZ:: TN(tet) transposon respectively (Figure 5.1). The digestion products were resolved 
on a 0.8 % (w/v) agarose gel (Chapter 2.13.5), and the 1.7 kb excised EZ:: TN(tet) 
transposon fragment was gel purified (Chapter 2.11.5) to reduce vector background. 
5.2.1.3 In vitro EZ:: TN(tet) transposition into S. aureus 8325-4 genomic 
DNA 
The in vitro transposition of the EZ:: TN(tet) transposon into sheared 8325-4 genomic 
DNA was performed as described in Chapter 2.15.1.1. The reaction buffer used 
contained Mg 2+ ions required for transposase activity. The transposition products were 
electroporated into competent RN4220 cells (Chapter 2.10.2.2), with selection on BHI 
agar plates containing 5 µg ml-1 Tet. However, after growth at 37 °C for 48 h, no 
colonies were produced. The lack of transposon mutants was unlikely to have been 
caused by low cell competence, as electroporation of 500 ng pMC4 (ie. the suicide 
vector pAZ106 containing the upstream regulatory region and 5' end of sigB (Chan et 
al., 1998)) into the RN4220 cells (Chapter 2.10.2.2) yielded approximately 50 colonies 
on BHI agar plates containing Ery and Lin. Since in vitro EZ:: TN(tet) transposition into 
S. aureus 8325-4 genomic DNA was unsuccessful, the electroporation of the 
EZ:: TN(tet) transposon into S. aureus RN4220 for in vivo transposition was attempted. 
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5.2.1.4 In vivo transposition of EZ:: TN(tet) into S. aureus RN4220 
In vivo transposition by electroporating EZ:: TN(tet) transposomes into RN4220 
competent cells was performed as described in Chapter 2.15.1.2. Introduction of TnS- 
based transposomes into E. coli for in vivo transposition was found to be most efficient 
when the transposomes were used in the absence of Mg 2+ (Goryshin et al., 2000); this 
prevents transposition from occurring in vitro and consequently increases the number of 
active transposomes present in the cells. Two methods were used to limit the exposure 
of the transposomes to Mg2+ outside the cells during electroporation. Firstly, the 
samples were immediately electroporated following addition of the transposomes to the 
RN4220 cells. Alternatively, Mg2+ was removed from the RN4220 cell samples prior to 
transposome addition by adding 50 µl 0.5 M EDTA to a 100 µl aliquot of cells and 
washing the samples twice with 100 µl 10 % (v/v) glycerol to remove the EDTA- 
chelated Mg 2+. The cells were then resuspended in 100 µl 10 % (v/v) glycerol and used 
in the electroporation. In vivo transposition using the immediate electroporation method 
produced hundreds of tetracycline-resistant colonies, whilst the Mg2+ removal method 
produced none. 
5.2.1.5 Southern blot to determine the randomness of EZ:: TN(tet) 
transposition in the S. aureus genome 
Southern blotting was performed to determine the randomness of EZ:: TN(tet) 
transposon insertion in the tetracycline-resistant RN4220 mutants produced by in vivo 
transposon mutagenesis in Chapter 5.2.1.4. Genomic DNA was prepared from 10 
randomly chosen EZ:: TN(tet) mutants and from RN4220 using a QIAGEN DNeasyTM 
kit (Chapter 2.11.1). Genomic DNA was cut with Sall or Hindlll overnight. A DIG- 
labelled probe was prepared using the EZ:: TN(tet) transposon DNA fragment cut from 
pMOD(tet) using BgII and HaeII (Chapters 5.2.1.2 and 2.14.1) (Figure 5.1). Southern 
blotting was performed, as described in Chapter 2.14.3. 
The Southern blots (Figure 5.2) showed that in all of the mutants a single hybridising 
band was present which was absent in RN4220. However, in all of the mutants, the 
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Figure 5.2 
Southern blots showing the randomness of' EZ:: TN(tet) insertion in 10 RN4220 
mutants produced by in vivo mutagenesis. 
Position of EZ:: TN(tet) insertion in (A) Sall-cut genomic DNA and (11) //indlll-cut 
genomic DNA from 1) RN4220 and 2-11) 10 randomly chosen RN4220 EZ:: 'I'N(tet) 
mutants. JLA501-JI. A510. 
Genomic DNA was prepared using a QIAGEN DNeasy" kit (Chapter 2.1 1.1) and cut 
with Sall or HindIIl overnight (Chapter 2.13.2). A DIG-labelled probe was prepared 
using the EZ:: TN(tet) transposon DNA fragment cut from pMOD(tet) using 13811 and 
HaeII (Chapters 5.2.1.2 and 2.14.1). Southern blotting was then performed. as 
described in Chapter 2.14.3. Sizes of DIG-labelled ?. Hindill / EcoRl markers are 
shown. 
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band sizes were identical. This suggests that the EZ:: TN(tet) transposon has inserted 
into the same position in the S. aureus genome in all of the mutants analysed. 
5.2.2 IacZ fusion construction using a selectable marker other than 
erythromycin-resistance 
5.2.2.1 Construction of a IacZ fusion vector carrying a tetracycline- 
resistance marker 
Since the EZ:: TN transposition system was found to be unsuitable for use in S. aureus 
(Chapter 5.2.1.5), a lacZ fusion vector carrying a tetracycline-resistance marker was 
constructed in order to overcome the selectable marker incompatibility between the 
erythromycin-resistant transposons and IacZ reporter gene fusions. The 8.6 kb plasmid 
pMUTIN4 (Vagner et al., 1998) has routinely been used to construct lacZ reporter gene 
fusions in S. aureus (Chan & Foster, 1998a) (Figure 5.3). The vector carries a modified 
E. coli lacZ reporter gene that can be used to quantitatively measure gene expression in 
both Gram-positive and Gram-negative bacteria. There are ColEl replication sequences 
and a ß-lactamase resistance gene (AmpR) for amplification in E. coli. An 
erythromycin-resistance gene is present for selection in Gram-positive bacteria. 
The erythromycin-resistance cassette of pMUTIN4 was replaced with a tetracycline 
resistance cassette, as described in Chapter 2.13.6.3 (Figure 5.3). Restriction mapping 
with Hindlll, Cial / NcoI and Dral produced bands of the expected size (data not 
shown). The resulting plasmid was termed pAISH1. 
5.2.2.2 Construction of an hla:: IacZ reporter gene fusion in pAISHI 
In order to be able to perform transposon mutagenesis screens directly in an hla:: lacZ 
reporter gene fusion strain, an hla:: lacZ fusion was created in the vector pAISH1. A 2.2 
kb EcoRl / Notl fragment containing the promoter and 5' coding region of hla was cut 
from the plasmid pPF4 and cloned into EcoRI / NotI-cut pAISH1, as described in 
Chapter 2.13.6.4 (Figure 5.4). The 2.2 kb hla fragment was the same as that cloned into 
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Figure 5.3 Construction of pAISHI. (A) a 7.7 kb BgIII / XhoI-cut inverse PCR product 
containing the entire sequence of pMUTIN4 (except for the erythromycin-resistance 
cassette) and (B) a Sall / BgIII-cut PCR product containing a tetracycline-resistance 
cassette amplified from pDG 1513 were used to construct (C) the vector pAISHI. 
Features; Pspac, an IPTG inducible promoter; MCS, a multiple cloning site containing the 
unique sites Hindlll, EcoRI, Noll, SacII and BamHl, in both pMUTIN4 and pAISHI; 
lacZ, a promoterless E. coli ß-galactosidase gene; lacl, a repressor of the Pspac promoter; 
on ColEl, a ColEl origin of replication; amp, ampicillin resistance gene; ery, an 
erythromycin-resistance gene; let, a tetracycline-resistance gene. Annealing sites of the 
PCR primers JA-9 and JA- 10 are indicated. Relevant restriction sites, B, BgIII; C, Clal; D, 
Dral; H; HindIIl; N, NcoI; S, Sall. Not to scale. 
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Figure 5.4 
Construction of pJA5. (A) EcoRI / Noil-cut pAISHI and (B) a 2.2 kb fragment containing - 400 
bp of the 5' coding region of hla and - 1.8 kb of upstream sequence, cut from pPF4 using EcoRI 
and Noll were used to construct (C) the plasmid pJA5. 
Features; Pspac, an IPTG inducible promoter; MCS, a multiple cloning site; lacZ, a 
promoterless E. coli ß-galactosidase gene; lad, a repressor of the Pspac promoter; on ColE 1, a 
ColE1 origin of replication; amp, ampicillin resistance gene; tet, a tetracycline-resistance gene. 
Relevant restriction sites; E, EcoRl; K, KpnI; N, NotI. Not to scale. 
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EcoRI / Nod-cut pMUTIN4 by Chan & Foster (1998a) to construct the hla:: lacZ fusion 
present in strain PC322. 
Restriction mapping with EcoRI / Noll and KpnI produced bands of the expected size 
(data not shown). The plasmid produced was named pJA5. 
5.2.2.3 Construction of hla:: lacZ fusion S. aureus strains using pJA5 
In order to construct an hla:: lacZ fusion in S. aureus, plasmid pJA5 was electroporated 
into S. aureus RN4220 (Chapter 2.10.2.2) (Figure 5.5). Transformants were selected on 
BHI agar plates containing X-Gal (Chapter 2.16.2) and 5 µg ml-1 Tet. Following growth 
at 37 °C for 24 h, one tetracycline-resistant, blue colony was produced. The construct 
was transferred into the 8325-4 and SH1000 backgrounds using 411-mediated phage 
transduction (Chapter 2.9). Selection was performed at 37 °C overnight on BHI agar 
plates containing X-Gal (Chapter 2.16.2) and 5 µg ml-1 Tet. Genomic DNA was 
prepared from 8325-4, from the blue, tetracycline-resistant RN4220 colony, and from a 
blue, tetracycline-resistant transductant in the 8325-4 and SH 1000 background (Chapter 
2.11.1). Genomic DNA was cut with EcoRI overnight (Chapter 2.13.2). A DIG-labelled 
probe was prepared using the 2.2 kb h1a promoter insert fragment cut from pPF4 with 
EcoRI and Notl (Chapters 2.14.1 and 2.13.6.4). Southern blotting was performed as 
described in Chapter 2.14.3. 
The expected 5.5 kb EcoRI hybridising fragment for a wild-type, hla+ strain (Figure 
5.5a) was obtained for 8325-4 (Figure 5.5b). The expected 14.8 kb and 2.7 kb EcoRI 
hybridising fragments for a strain containing an hla:: lacZ fusion next to a functional 
copy of hla, as introduced by pJA5 (Figure 5.5a), were obtained for the blue, 
tetracycline-resistant RN4220,8325-4 and SH1000 samples tested (Figure 5.5b). The 
strains produced were named JLA511 (RN4220 hla:: lacZ), JLA512 (8325-4 hla:: lacZ) 
and JLA513 (SH1000 hla:: lacZ). When patched onto rabbit blood plates (Chapter 
2.16.1) alongside RN4220,8325-4 and SH1000 and grown overnight at 37 °C, JLA511 
(RN4220 hla:: lacZ), JLA512 (8325-4 hla:: lacZ) and JLA513 (SH1000 hla:: lacZ) were 
found to produce levels of haemolysis identical to their respective parents (data not 
shown). 
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Figure 5.5 
Construction of an hla:: lacZ fusion in RN4220,8325-4 and SH 1000. 
(A) Diagram showing the integration of pJA5 into the S. aureus RN4220 chromosome to 
give JLA511 (RN4220 hla:: lacZ) (not to scale). The construct was transferred into the 
8325-4 and SH1000 backgrounds using X11-mediated phage transduction (Chapter 2.9). 
This produced strains JLA512 (8325-4 hla:: lacZ) and JLA513 (SH1000 hla:: lacZ). The 
sizes of the relevant EcoRl restriction fragments are indicated. Please note that the box 
representing the 2.2 kb hla promoter insert introduced by pJA5 comprises - 400 bp of the 
5' coding region of hla and - 1.8 kb of upstream sequence, whereas the box representing 
the functional hla gene present on the S. aureus genomic DNA comprises the entire 
coding region of hla and - 1.8 kb of upstream sequence (B) Southern blot of S. aureus 
8325-4 (lane 1), JLA511(RN4220 hla:: lacZ) (lane 2), JLA512 (8325-4 h/a:: lacZ) (lane 3) 
and JLA513 (SH 1000 hla:: lacZ) (lane 4) genomic DNA cut with EcoRI and probed with a 
digoxygenin-labelled 2.2 kb EcoRI / Not! hla promoter insert from pPF4 (Chapters 2.14 
and 2.13.6.4). The sizes of A. HindIII-EcoRI markers are indicated. Not to scale. 
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5.2.2.4 Quantitative ß-galactosidase assay data produced by the hla:: lacZ 
fusions constructed with tetracycline-resistant and erythromycin- 
resistant selectable markers 
To confirm that the hla:: lacZ fusion (TetR) constructed in this study produces similar ß- 
galactosidase assay data to the published hla:: lacZ fusion (EryR) created by Chan & 
Foster (1998a), strains JLA513 (SH1000 hla:: lacZ (TetR)) and JLA371 (SH1000 
hla:: lacZ (EryR)) were grown in BHI as described in Chapter 2.7. Growth was measured 
spectrophotometrically as OD600 (Chapter 2.6.1), and hla:: lacZ fusion expression was 
measured using MUG, as described in Chapter 2.8. 
The two hla:: lacZ fusions were found to produce very similar ß-galactosidase assay 
data (Figure 5.6); JLA513 (SH1000 hla:: lacZ (TetR)) and JLA371 (SH1000 hla:: lacZ 
(EryR)) expressed 13,543 and 15,411 MUG units at t= 14 h respectively. The maximum 
difference between the two strains was 1.9-fold at t=5h (3,075 and 1,596 MUG units 
for JLA513 (SH1000 hla:: lacZ (TetR)) and JLA371 (SH1000 hla:: lacZ (EryR)) 
respectively). 
5.2.3 Screen of Tn551 mutant libraries in hla:: IacZ SH1000 to identify 
genes regulating hla expression 
In Chapter 3, it was shown that aB represses agr and hla, and that neither sarA, rot nor 
sarHl functions as an intermediate in this pathway. Since the identity of the missing 
effector(s) remains unknown, a transposon mutant library screen was performed in the 
SH1000 background to identify mutants in which hla:: lacZ expression is increased, as 
determined by increased blue colouration compared to the background colonies on BHI 
agar plates containing X-Gal. In such mutants, the transposon might have inactivated 
the missing repressor, thus preventing ßB from repressing agr, and consequently 
allowing the transcription of hla:: lacZ to be de-repressed. Alternatively, a more 
complex regulatory system might occur, whereby d upregulates a repressor which 
functions indirectly by down-regulating an activator of agr. Therefore, mutants that 
were less blue than the background colonies were also isolated in order to identify 
putative activators involved in the pathway. In order to allow colonies that were either 
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Figure 5.6 
Comparison of ß-galactosidase assay data produced by the hla:: lacZ fusions constructed 
with tetracycline-resistant and erythromycin-resistant selectable markers. 
S. aureus JLA513 (SH1000 hla:: lacZ (TetR)) (0 and ") and JLA371 (SH1000 
hla:: lacZ (EryR)) (Q and  ) were grown in BHI as described in Chapter 2.7. Growth 
was measured spectrophotometrically as OD600 (open symbols) (Chapter 2.6.1), and 
IacZ fusion expression was measured using MUG (closed symbols), as in Chapter 2.8. 
Results are representative of two independent experiments. 
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more or less blue than the background colonies to be screened for, a range of 
concentrations of X-Gal to be added to the BHI agar plates, including a final 
concentration of 200,400,600 and 800 mg t', were tested. Colonies of JLA513 
(SH1000 hla:: lacZ (TetR)) demonstrated a suitable level of blue colouration to allow 
both more and less blue Tn551 mutants to be identified on BHl agar plates containing a 
final concentration of 600 mg r X-Gal (data not shown). 
The transposon used in the screen performed in Chapter 4 was Tn917, carried by the 
plasmid pLTV 1. However, this version of Tn917 carries a promoterless lacZ gene, and 
is consequently unsuitable for screening in an hla:: lacZ background. Therefore, the 
transposon Tn551 was used. Tn551 is a 5.3 kb transposon which was first identified in 
S. aureus on the plasmid p1258 (Mitsuhashi et al., 1963). Like Tn917, Tn551 is a 
member of the Tn3 transposon family. Indeed, the nucleotide sequence of Tn551 was 
found to be 99.8 % identical to that of unmodified Tn917, and the genetic organisation 
of the two transposons was also found to be the same (Wu et al., 1999). TnSS1 has been 
used extensively in S. aureus, where it has facilitated the identification of the global 
regulators agr and sae (Recsei et al., 1986; Giraudo et al., 1994). Tn551 has also been 
used in S. aureus for chromosome and plasmid mapping (Pattee et al., 1977). 
The delivery vector used to introduce Tn551 into S. aureus in this study was the 
plasmid pRN3208 (Figure 5.7), a 20 kb derivative of p1258 (Kornblum et al., 1986). 
The section of pRN3208 originating from p1258 carries a cadmium-resistance gene and 
a ß-lactamase gene, and Tn551 itself contains an erythromycin-resistance gene. In 
addition, pRN3208 has a temperature-sensitive replicon which only allows replication 
up to - 30 T. Consequently, by growing cells at a temperature above 30 °C, cells 
containing a chromosomal Tn551 insertion can be selected, since resistance to 
erythromycin (carried by Tn551) will remain, whilst resistance to cadmium (carried by 
pRN3208) will be lost. 
5.2.3.1 Tn551 mutagenesis of SH1000 hla:: lacZ 
The plasmid pRN3208 was introduced into JLA513 (SH1000 hla:: lacZ (TetR)) by 411- 
mediated transduction (Chapter 2.9), with selection on BHI agar plates containing 250 
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blu 
cd 
eyy Tn551 
Figure 5.7 
Physical map of pRN3208, the vector carrying Tn551. 
Regions coloured in red are part of the transposable element, whilst the remainder 
of the vector is coloured in green. Features of this map; bla, ß-lactamase gene; cd; 
cadmium-resistance gene; ery, erythromycin-resistance gene; Ts, a temperature- 
sensitive replicon. 
Adapted from Fairhead (1998). 
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µg m14 CdC12. Transductants were also patched onto BHI agar plates containing 5 µg 
ml"' Ery and 5 gg ml"1 Tet. All incubation stages were performed at 30 T. The resulting 
strain was named JLA514 (SH1000 hla:: lacZ (TetR), pRN3208). Transposon 
mutagenesis of this strain was performed as described in Chapter 2.15.2. 
5.2.3.1.1 Enumeration and evaluation of Tn551 libraries in SH1000 hla:: lacZ 
Four Tn551 libraries were created using two different plasmid-curing temperatures (ie. 
either 42 or 43 °C). Libraries F1 and F2 were cured of pRN3208 at 42 °C, whereas F3 
and F4 were grown at a non-permissive temperature of 43 °C. However, enumeration 
(Chapter 2.15.3) showed that only libraries F1 and F4 had a Tn551 insertion frequency 
> 90 % and were therefore deemed suitable for screening (Table 5.1). 
5.2.3.2 Primary screen 
Libraries F1 and F4 were diluted using PBS to give - 300 colonies per plate, and spread 
onto BHI agar plates containing 600 mg 171 X-Gal. Following growth overnight at 37 °C, 
the plates were screened to identify mutants that were more blue than the background 
colonies. The plates were then incubated for a further night at 37 °C and re-screened to 
identify mutants that were less blue than the background colonies. 
In total, - 8,400 colonies were screened (- 4,050 from library 171 and - 4,350 from 
library F4). 158 mutants were selected, of which 62 were more blue than the 
background colonies, and 96 were less blue (Table 5.2a). 
5.2.3.3 Secondary screen 
To ensure that the phenotypes of the Tn551 mutants were reproducible, the strains were 
patched onto BHI agar plates containing 600 mg 1' X-Gal, with JLA513 (SH1000 
hla:: lacZ (TetR)) as a control. 4 of the more blue Tn551 mutants and 46 of the less blue 
mutants displayed wild-type levels of blue colouration, and were therefore discarded 
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Library Plasmid curing 
temperature 
(°C) 
Mean cfu m1" 
Ery-resistant 
Mean cfu ml" 
Ery and Cd- 
resistant 
% Tn551 
insertion 
Fl 42 7.50 X 1011 1.10 X 10 98.5 
F2 42 3.20 X 10 1.25 X 10 60.9 
F3 43 4.10 X 10 1.15 X 10 72.0 
F4 43 3.45 X 1010 6.50 X 10 98.1 
Table 5.1 
Enumeration of Tn551 libraries in SH1000 hla:: lacZ. 
Mean cfu m1' were calculated from the results of at least two experiments where 
colonies were plated onto BHI agar plates containing either erythromycin (Ery) or 
erythromycin and cadmium chloride (Ery and Cd) (Chapter 2.15.3). Details of the 
libraries used for screening are shown in bold. Results are representative of two 
independent experiments. 
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(results not shown). The remaining 58 more blue and 50 less blue mutants demonstrated 
reproducible phenotypes compared to JLA513 (SH1000 hla:: lacZ (TetR)), and 
therefore passed the screen (Table 5.2a). These mutants were patched onto Bill plates 
containing Ery and Lin and onto BHI plates containing CdC12 to determine whether 
Tn551 was inserted into the genome of the cells or carried on pRN3208. All of the 
mutants were Ery resistant and CdCI2 sensitive, and therefore possessed chromosomal 
Tn551 insertions. 13 more blue and 5 less blue representative mutants were selected for 
further analysis. The genes inactivated in these mutants were designated aht 1-18 (genes 
affecting hla transcription). 
5.2.3.4 Tertiary screen 
To determine whether the phenotypes displayed by the aht mutants on Bill agar plates 
containing 600 mg r' X-Gal were caused by Tn551 insertion or by point mutations, the 
Tn551 insertions were transferred into JLA513 (SH1000 hla:: lacZ (TetR)) via 411- 
mediated transduction, as described in Chapter 2.9. For each mutation, all 10 
transductants tested displayed a similar level of increased or decreased blue colouration 
to the donor mutant strain when patched onto BHI agar plates containing 600 mg 11 X- 
Gal with JLA513 (SH1000 hla:: lacZ (TetR)) as a control (Table 5.2). Therefore, 100 % 
linkage of the mutant phenotype to the transposon insertion was demonstrated for all 18 
mutants analysed. The strain names of a representative transductant per aht mutation are 
shown in table 5.2a. 
A diagrammatic summary of the screening protocol and results is presented in Figure 
5.8. 
5.2.3.5 Direct genomic DNA sequencing to identify genes inactivated by 
T n551 
To identify the genes inactivated by Tn551, direct sequencing of genomic DNA was 
performed as in Chapter 2.13.1.2.4. The primer was the same as that used for 
sequencing the genomic DNA of the Tn917 han mutants in Chapter 4.2.3.1 (ie. primer 
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8,400 Tn551 mutants in SH 1000 hla:: lacZ background 
(- 4,050 from library Fl and - 4,350 from library F4) 
Plating onto BHI plates containing 600 mg I-1 X-Gal 
(37 °C for up to 48 h) 
300 colonies per plate 
T 
colouration compared to 
the background colonies 
were selected 
(Primary screen) 
or decreased blue 
Colonies with increased 
Colony 
158 putative Tn551 mutants 
- 62 mutants displaying increased blue colouration 
- 96 mutants displaying decreased blue colouration 
I 
Colonies patched onto BHI plates containing 600 mg I-1 X-Gal 
to ensure reproducibility of mutant phenotype (37 °C overnight) 
(Secondary screen) 
108 putative Tn551 mutants 
- 58 mutants displaying increased blue colouration 
- 50 mutants displaying decreased blue colouration 
- 18 representative mutants selected for further analysis 
Mutations transduced into JLA513 (SH 1000 hla:: lacZ(TetR)) 
to check linkage of mutant phenotype to the transposon insertion. 
10 transductants per strain patched onto BH1 plates containing 
600 mg I-1 X-Gal (37 °C overnight) 
(Tertiary screen) 
V 
18 representative putative Tn551 mutants 
- 13 mutants displaying increased blue colouration 
-5 mutants displaying decreased blue colouration 
Figure 5.8 
Diagrammatic representation of the screen performed to identify Tn551 mutants in 
the JLA513 (SH 1000 hla:: IacZ (TetR)) background that displayed either increased or 
decreased blue colouration compared to the background colonies on BHI agar plates 
containing 600 mg 1' X-gal, and which may therefore contain Tn551 insertions in 
genes involved in mediating the regulation of hla. 
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Tn2). The sequences of Tn917 and Tn551 are 100 % identical in the region where 
primer Tn2 anneals. 
Database analysis was used to identify the Tn551-inactivated genes and the genes 
surrounding them in the S. aureus COL genome, as described in Chapter 4.2.3.1. 
Alignments of the sequencing reaction data against the COL DNA sequence are shown 
in Appendix A. 2.10 - A. 2.20. Homology of the products of the inactivated genes to 
other proteins is also shown in Appendix A. 2.10 - A. 2.20. As described in Chapter 
2.17.2, the sequence of the region of COL genomic DNA containing the transposon- 
inactivated gene and surrounding genes of interest was extracted from the TIGR website 
and compared to the 8325 sequence in the NCBI BLAST database to ensure that the 
sequence and position of the genes in COL is the same as it is in 8325. For each region 
compared, the COL and 8235 genomic DNA sequence was 99 - 100 % identical, unless 
otherwise stated (data not shown). The genes inactivated by Tn551 are listed in Table 
5.2a, and are diagrammatically represented with their surrounding genes of interest in 
Figure 5.10. In total, 8 genes were found to have been inactivated by Tn551 in the 18 
mutants. 
5.2.3.5.1 Mutations resulting in increased hla:: lacZ expression 
In JLA515 (SH1000 hla:: lacZ ahtl), JLA521 (SH1000 hla:: lacZ aht7), JLA522 
(SH1000 hla:: lacZ ah18) and JLA523 (SH1000 hla:: lacZ aht9), Tn551 was found to 
have inserted into intergenic DNA, at base 2123979 of the S. aureus COL genome. The 
insertion is 238 bp downstream of pemK. However, the start codon of SA2057 is at base 
2123864 of the S. aureus COL genome, 115 bp downstream of the Tn551 insertion site. 
Therefore, it is possible that the Tn551 insertion might be in a region regulating the 
transcription of SA2057, or that an alteration in the structure of the DNA caused by the 
presence of Tn551 might affect the expression of SA2057. Protein sequence analysis 
showed that SA2057 demonstrated homology to RsbU, the upregulator of cs activity of 
S. aureus COL (99 % identity over 333 amino acids). The sequence of the region 
flanking the transposon insertion, represented diagrammatically in Figure 5.10, was 
found to be 99 % identical in 8325 and COL, except for the 11 bp deletion in rsbU of 
8325, as discussed in Chapter 3.1 (data not shown). 
190 
In JLA516 (SH1000 hla:: lacZ aht2) and JLA517 (SH1000 hla:: lacZ aht3), Tn551 was 
found to have inserted into SA1432 at base 256 of the 717 bp gene. Protein sequence 
analysis demonstrated homology to the tetrahydrodipicolinate acetyltransferase YkuQ 
of S. aureus 8325-4 (100 % identity over 239 amino acids). 
In JLA518 (SH1000 hla:: lacZ aht4), Tn551 was found to have inserted into SA1441 at 
base 881 of the 1134 bp gene. Protein sequence analysis demonstrated homology to the 
tellurite resistance protein TeIA of R. sphaeroides (33 % identity over 342 amino acids). 
In JLA519 (SH1000 hla:: lacZ aht5), Tn551 was found to have inserted into SA1435 at 
base 1224 of the 1263 bp gene. Protein sequence analysis demonstrated homology to 
the diaminopimelate decarboxylase LysA of S. aureus 8325-4 (100 % identity over 421 
amino acids). 
In JLAS20 (SH1000 hla:: lacZ aht6), Tn551 was found to have inserted into SA1443 at 
base 1221 of the 1341 bp gene. Protein sequence analysis demonstrated homology to 
the branched-chain amino acid carrier protein BrnQ of S. aureus RN450 (84 % identity 
over 429 amino acids). 
In JLA524 (SH1000 hla:: lacZ ahtl0) and JLA525 (SH1000 hla:: lacZ aht11), Tn551 
was found to have inserted into SA1006 at base 762 of the 804 bp gene. Additionally, in 
JLA526 (SH1000 hla:: lacZ ahtl2) and JLA527 (SH1000 hla:: lacZ ahtl3), Tn551 was 
found to have inserted into SA1006 at base 159. Protein sequence analysis demonstrated 
homology to the hypothetical protein YjbH of B. subtilis (31 % identity over 261 amino 
acids). However, the function of YjbH was unknown in the Subtilist database. 
5.2.3.5.2 Mutations resulting in decreased hla:: lacZ expression 
In JLA528 (SH1000 hla:: lacZ ahtl4), JLA529 (SH1000 hla:: lacZ ahtl5), JLA530 
(SHI000 hla:: lacZ ahtl6) and JLA531 (SH1000 hla:: lacZ ahtl7), Tn551 was found to 
have inserted into SA2023 at base 331 of the 621 bp gene. Protein sequence analysis 
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demonstrated homology to the accessory gene regulator protein AgrB of S. aureus 
8325-4 (99 % identity over 189 amino acids). 
In JLA532 (SH1000 h1a:: lacZ aht18), Tn551 was found to have inserted into SA0766 at 
base 414 of the 684 bp gene. Protein sequence analysis demonstrated homology to the 
response regulator SaeR of S. aureus (100 % identity over 228 amino acids). 
The characterisation of these mutants is described in Chapter 5.2.5. 
5.2.4 Screen of a TnSS1 mutant library in SH1000 hla:: lacZ to identify 
mutants with altered hla transcription in response to NaCl 
As described in Chapter 4, screening of Tn917 mutant libraries identified 16 putative 
8325-4 mutants demonstrating increased haemolytic activity compared to 8325-4 on 
rabbit blood plates containing 1M NaCl. However, it was not possible to determine 
whether the haemolytic factor for which activity was affected in the mutants was hla in 
particular, as the published hla cassette knock-out and hla:: lacZ reporter gene fusion 
(O'Reilly et al., 1986; Chan & Foster, 1998a) cannot be used in conjunction with the 
Tn917 mutations because the selectable markers of all of these constructs are 
erythromycin-resistance cassettes (Chapter 4.2.3.2.1.1.1). Therefore, the approach 
presented here involved screening Tn551 mutants in the JLA513 (SH1000 hla:: lacZ 
(TetR)) background in order to identify genes specifically affecting the transcription of 
hla in response to NaCl. Colonies were isolated which demonstrated either increased or 
decreased hla:: lacZ transcription, as determined by either increased or decreased blue 
colouration compared to the background colonies on BHI agar plates containing 1M 
NaCl. 
In order to allow mutants that were either more or less blue than the background 
colonies to be screened for, a range of concentrations of X-Gal to be added to the BHI 
agar plates containing IM NaCl was tested. This included a final X-Gal concentration 
of 0.4,0.8 and 2.4 g 1"I. JLA513 (SH 1000 hla:: lacZ (TetR)) demonstrated a suitable, 
level of blue colouration to allow both more and less blue Tn551 mutants to be 
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identified on Bill agar plates containing 1M NaCl and a final concentration of 2.4 g 1"1 
X-Gal (data not shown). 
5.2.4.1 Primary screen 
Cells from libraries F1 and F4 were unable to grow when plated directly from glycerol 
stocks onto BHI plates containing 1M NaCl. Therefore, the transposon mutant libraries 
were first diluted using PBS to give - 100 colonies per plate and recovered on BHI agar 
plates containing Ery and Lin.. Following growth overnight at 37 °C, colonies were 
replica plated onto BHI agar plates (containing 1M NaCI and 2.4 g 1' X-Gal) and 
grown overnight at 37 T. The plates were then screened to identify mutants that were 
more blue than the background colonies. Following incubation for a further night at 37 
°C, the plates were re-screened to identify mutants that were less blue than the 
background colonies. 
In total, - 6,250 colonies were screened (- 3,750 from library F1 and - 2,500 from 
library F4). 27 mutants were selected, of which 25 were more blue than the background 
colonies, whilst 2 were less blue (Table 5.2b). 
5.2.4.2 Secondary screen 
To ensure that the phenotypes of the Tn551 mutants were reproducible, the strains were 
patched onto BHI agar plates (containing 1M NaCI and 2.4 g 1' X-Gal), with JLA513 
(SH 1000 hla:: lacZ (TetR)) as a control. 5 of the more blue Tn551 mutants and 1 of the 
less blue mutants displayed wild-type levels of blue colouration (results not shown), and 
were therefore not studied further here. The remaining 20 more blue mutants and 1 less 
blue mutant demonstrated reproducible phenotypes compared to JLA513 (SH1000 
hla:: lacZ (TetR)), and therefore passed the screen (Table 5.2b). 
The 21 mutants that passed the secondary screen were patched onto BHI agar plates 
containing Ery and Lin and onto BHI agar plates containing CdC12 to determine whether 
TnSSI was inserted into the genome of the cells or carried on pRN3208. All of the 
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mutants were Ery resistant and CdCl2 sensitive, and therefore possessed chromosomal 
Tn551 insertions. 
The mutant displaying decreased blue colouration on BHI agar plates containing 1M 
NaCl and 2.4 g 1"1 X-Gal demonstrated a wild-type level of colouration when patched 
onto a BHI agar plate containing 600 mg 1"1 X-Gal. However, when patched onto Bill 
agar plates containing 600 mg 1"1 X-Gal, all of the mutants selected for increased blue 
colouration demonstrated a similar degree of blue colouration as they did on BHI agar 
plates containing 1M NaCl and 2.4 g 171 X-Gal. This suggests that the effects of the 
genes mutated by Tn551 which lead to increased blue colouration are not NaCI-specific. 
However, it was decided to further characterise the mutants and identify the genes 
inactivated, as they could potentially still provide a useful insight into the NaCI- 
mediated regulation of virulence determinant expression in S. aureus. Furthermore, the 
mutants displayed altered hla:: lacZ transcription on Bill agar plates containing no 
added NaCl. Consequently, the genes identified might add to the list of genes mediating 
the repression of agr and hla by & as screened for by virtue of altered hla:: lacZ 
transcription on Bill agar plates in Chapter 5.2.3. The genes inactivated in the mutants 
isolated on BHI agar plates containing 1M NaCI and 2.4 g 1"1 X-Gal were designated 
hin 1-21 (genes affecting hla transcription identified by screening on BHI plates 
containing NaCl). 
5.2.4.3 Tertiary screen 
To determine whether the phenotypes displayed by the htn mutants on BHI agar plates 
(containing 1M NaCl and 2.4 g 171 X-Gal) and on BHI agar plates (containing 600 mg 
1.1 X-Gal) were caused by Tn551 insertion or by point mutations, the mutations were 
transferred into JLA513 (SH 1000 hla:: lacZ (TetR)) via 4) 11-mediated transduction, as 
described in Chapter 2.9. For the mutations leading to increased blue colouration, all 10 
transductants tested displayed a reproducible mutant phenotype compared to the donor 
mutant strain when patched onto BHI agar plates (containing 1M NaC1 and 2.4 g 1.1 X- 
Gal) and onto BHI agar plates (containing 600 mg t' X-Gal) (Table 5.2b). Therefore, 
100 % linkage of the mutant phenotype to the transposon insertion was demonstrated 
for all 20 mutants displaying increased blue colouration. However, for the mutation 
194 
CHAPTER 5 
causing decreased blue colouration (ie. htn2l), all 10 of the transductants displayed 
wild-type levels of blue colouration when patched onto BHI agar plates (containing 1M 
NaCl and 2.4 g t' X-Gal) and on BHI agar plates (containing 600 mg r, X-Gal). Since 0 
% linkage of the mutant phenotype to the transposon insertion was demonstrated, htn2l 
failed the tertiary screen. The strain names of a representative transductant per htn 
mutation are shown in Table 5.2b. 
A diagrammatic summary of the screening protocol and results is presented in Figure 
5.9. 
5.2.4.4 Direct genomic DNA sequencing to identify genes inactivated by 
T n551 
To identify the genes inactivated by Tn551, direct sequencing of genomic DNA was 
performed as in Chapter 2.13.1.2.4, using the primer Tn2. Database analysis was used to 
identify the Tn551-inactivated genes and the genes surrounding them in the S. aureus 
COL genome, as described in Chapter 4.2.3.1. Alignments of the sequencing reaction 
data against the COL sequence are shown in Appendix A. 2.10 -A. 2.20. Homology of 
the products of the inactivated genes to other proteins is also shown in Appendix A. 2.10 
- A. 2.20. As described in Chapter 2.17.2, the sequence of the region of COL genomic 
DNA containing the transposon-inactivated gene and surrounding genes of interest was 
extracted from the TIGR website and compared to the 8325 sequence in the NCBI 
BLAST database to ensure that the sequence and position of the genes in COL is the 
same as it is in 8325. For each region compared, the COL and 8325 genomic DNA 
sequence was 99 - 100 % identical, unless otherwise stated (data not shown). The genes 
inactivated by Tn551 are listed in Table 5.2b, and are diagrammatically represented 
with their surrounding genes of interest in Figure 5.10. In total, 6 genes were found to 
have been inactivated by Tn551 in the 20 mutants. 
In JLA533 (SH1000 hla:: IacZ htnl), JLA534 (SH1000 hla:: IacZ htn2), JLA535 
(SH1000 h1a:: lacZhtn3), JLA536 (SH1000 hla:: lacZhtn4), JLA537 (SH1000 hla:: lacZ 
htn5), JLA538 (SH1000 hla:: IacZ htn6), JLA539 (SH1000 hla:: lacZ htn7), JLA540 
(SH1000 hla:: lacZhtn8), JLA541 (SH1000 h1a:: lacZhtn9) and JLA546 (SH1000 
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6,250 Tn551 mutants in SH 1000 hla:: lacZ background 
(- 3,750 from library F1 and - 2,500 from library F4) 
Cells recovered on BHI Ery Lin 
100 colonies per plate 
Colonies replica plated onto BHI plates containing IM NaCl and 2.4 g I-1 
I X-GaI (37 °C for up to 48 h) 
I Colonies with increased I 
or decreased blue 
colouration compared to 
the background colonies 
were selected 
(Primary screen) 
27 putative Tn551 mutants 
- 25 mutants displaying increased blue colouration 
-2 mutants displaying decreased blue colouration 
IF 
Colony 
Colonies patched onto BHI plates containing IM NaCl and 2.4 g I-1 X-Gal 
to ensure reproducibility of mutant phenotype (37 °C overnight) 
(Secondary screen) 
21 putative Tn551 mutants 
- 20 mutants displaying increased blue colouration 
-1 mutant displaying decreased blue colouration 
T 
Mutations transduced into JLA513 (SH 1000 hla.: lacZ (TetR)) 
to check linkage of mutant phenotype to the transposon insertion. 
10 transductants per strain patched onto BHI plates containing 
IM NaCl and 2.4 g 1-1 X-Gal (37 °C overnight) 
(Tertiary screen) 
20 putative T n551 mutants displaying increased blue colouration 
Figure 5.9 
Diagrammatic representation of the screen performed to identify Tn551 mutants in the 
JLA513 (S111000 hla:: lacZ (Tet1z)) background that displayed either increased or 
decreased blue colouration compared to the background colonies on BHI agar plates 
containing 1M NaCl and 2.4 g 1-' X-gal, and which may therefore contain Tn551 
insertions in genes involved in regulating h1a transcription in response to NaCl. 
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hla:: lacZ htnl4), Tn551 was found to have inserted into base 2123979 of the S. aureus 
COL genome. The position of insertion is identical to that in JLA515 (SH1000 
hla:: lacZ ahtl), JLA521 (SH1000 hla:: lacZ aht7), JLA522 (SH1000 hla:: lacZ ah18) 
and JLA523 (SH1000 hla:: lacZ aht9) (Chapter 5.2.3.5). The hin mutants therefore also 
possess a Tn551 insertion that may affect the transcription of rsbU. 
In JLA542 (SH1000 hla:: lacZ htnl0), Tn551 was found to have inserted into SA1428 at 
base 328 of the 1203 bp gene. Protein sequence analysis demonstrated homology to the 
type II aspartokinase, LysC, of S. aureus 8325-4 (99 % identity over 401 amino acids). 
In JLA543 (SH1000 hla:: lacZ htnl1), JLA544 (SH1000 hla:: lacZ htnl2), JLA545 
(SH1000 hla:: lacZ htnl3) and JLA552 (SH1000 hla:: lacZ htn20), Tn551 was found to 
have inserted into SA1435 at base 1224 of the 1263 bp gene. The position of insertion is 
identical to that in JLA519 (SH1000 hla:: lacZ aht5) (Chapter 5.2.3.5). The htn mutants 
therefore also possess a Tn551 insertion in lysA. 
In JLA547 (SH1000 hla:: lacZ htnl5) and JLA548 (SH1000 hla:: lacZ htnl6), Tn551 
was found to have inserted into SA1441 at base 881 of the 1134 bp gene. The position 
of insertion is identical to that in JLA518 (SH1000 hla:: lacZ aht4) (Chapter 5.2.3.5). 
The htn mutants therefore also possess a Tn551 insertion in telA. 
In JLA549 (SH1000 hla:: lacZ htnl7), Tn551 was found to have inserted into base 
1466658 of the S. aureus COL genome. The insertion is 198 bp downstream of SA1452 
(encoding the type 2 phosphatidic acid phosphatase Pap2) and 593 bp upstream of 
SA1451 (the DNA-binding response regulator ArIR). It is possible that an alteration in 
the structure of the DNA caused by the presence of Tn551 might affect the transcription 
of these genes. However, when the DNA sequence between ar1R and pap2 was entered 
into a BLASTX search in the NCBI BLAST website (Chapter 2.17.2), 100 % identity to 
a 57 amino acid hypothetical protein of the S. aureus strains Mu50 and N315 was 
demonstrated within the region indicated in Figure 5.10g. However, no homology to a 
protein of known function could be shown. The position of Tn551 insertion is at base 51 
of this gene. It is most likely that the mutant phenotype of JLA549 (SH1000 hla:: lacZ 
htnl7) is caused by Tn551-inactivation of the hypothetical protein, which will be 
referred to as Hyp1. 
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Figure 5.10 a-c 
Position of Tn551 insertions and surrounding genes of interest for (A) ahil, ah17, ah18, 
aht9, hin 1, htn2, htn3, htn4, hm5, htn6, htn7, hm8, hm9 and hin 14 (hyp 1), (B) hin 10 
(lysC ), ah12 and ah13 (ykuQ) and ah15, hin 11, hm 12, hm 13, htn20 (lysA), and (C) aht4, 
hin 15 and hin 16 (telA) and aht6 (brnQ). 
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Figure 5.10 d-f 
Position of Tn551 insertions and surrounding genes of interest for (D) aht10, aht11, aht12 
and ah113 (yjbH), (E) ahtl4, aht15, aht16 and aht17 (agrB), and (F) htnl8 and htnl9 
(saes), and aht18 (saeR). 
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Figure 5.10 g 
Position of Tn551 insertions and surrounding genes of interest for hin 17 (hyp 1). 
Figure 5.10 a-g 
Position of Tn551 insertions in aht and htn mutants, and surrounding genes of interest. 
Genes inactivated by Tn551 are presented in red, and the position of Tn551 insertion is 
indicated (Y). Flanking genes of interest are shown in green. The approximate size of each 
DNA fragment is shown in the bottom right-hand corner of each diagram. The 
information for each mutation was obtained by analysing sequence data (Chapter 2.17.2) 
from strains derived by transduction of the aht and hin mutations into JLA513 (SH1000 
hla:: lacZ Jet')) (see Tables 5.2a and 5.2b for strain names). 
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In JLA550 (SH1000 hla:: lacZ htnl8) and JLA551 (SH1000 hla:: lacZ htnl9), Tn551 
was found to have inserted into SA0765 at base 238 of the 1053 bp gene. Protein 
sequence analysis demonstrated homology to the histidine protein kinase SaeS of S. 
aureus Newman (89 % identity over 353 amino acids). 
Many of the mutants isolated in this screen contain a transposon insertion in either the 
same base or in the same operon as an aht mutant (Chapter 5.2.3). Therefore, a 
representative mutant for each of the genes identified in the aht and htn screens was 
characterised, and collectively referred to as the Tn551 mutants. 
5.2.5 Characterisation of the Tn551 mutants 
5.2.5.1 hla:: IacZ transcription in the Tn551 mutants in the presence of 
either no added NaCl or 1M NaCl 
5.2.5.1.1 hla:: lacZ transcription of Tn551 mutants on BHI plates containing 
X-gal and either no added NaCI or 1M NaCI 
Photographs showing the blue colouration of a representative clone for each Tn551 
mutant, compared to JLA513 (SH1000 hla:: lacZ (TetR)), on BHI agar plates containing 
either 1M NaCI and 2.4 g 1"1 X-gal or no added NaCI and 600 mg 1'1 X-gal are 
presented in Figure 5.11. Scores for the level of blue colouration of the mutants on both 
types of plate are shown in Table 5.2. Blue colouration was estimated on a scale of 0- 
6. 
Wild-type JLA513 (SH1000 hla:: lacZ (TetR)) demonstrated a level of blue colouration 
of 3 on BHI containing no added NaCI and 600 mg 1'1 X-gal, and 1 on BHI containing 1 
M NaCl and 2.4 g 171 X-gal. JLA526 (SH1000 hla:: lacZ aht12 (yjbH)) was found to 
have a level of 4 on both types of plate. JLA542 (SH1000 hla:: lacZ htn10 (IysC)), 
JLA516 (SH1000 hla:: lacZ aht2 (ykuQ)), JLA519 (SH1000 hla:: lacZ aht5 (lysA)), 
JLA518 (SH1000 hla:: lacZ aht4 (telA)) and JLA520 (SH1000 hla:: lacZ aht6 (brnQ)) 
were found to have a level of 5 on both types of plate. Additionally, JLA515 (SH1000 
hla:: IacZ ahtl (rsb b)) was found to have a level of 6 on both types of plate. These 
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Figure 5.11 
hla:: lacZ transcription of representative aht and hin mutants, compared to JLA513 
(SH 1000 hla:: lacZ Jet')), as determined by blue colouration on (A) a BHI agar plate 
containing IM NaCl and 2.4 g l-' X-gal, and on (B) a BHI agar plate containing no 
added NaCl and 600 mg 1-' X-gal. 
Plates were patched with strains 1) JLA513 (SH 1000 hla:: lacZ (TetR)), 2) JLA526 
(SH1000 hla:: lacZ ahtl2 (yjbH)), 3) JLA542 (SH1000 hla:: lacZ htnl0 (lysC)), 4) 
JLA516 (SHI000 hla:: lacZ aht2 (ykuQ)), 5) JLA519 (SH1000 hla:: lacZ aht5 (lysA)), 
6) JLA518 (SH1000 hla:: lacZ aht4 (telA)), 7) JLA520 (SH1000 hla:: lacZ aht6 
(brnQ)), 8) JLA515 (SH1000 hla:: lacZ ahtl (rsbU)), 9) JLA549 (SH1000 hla:: lacZ 
hin l7 (hypl)), 10) JLA550 (SH 1000 hla:: lacZ hin l8 (saes)), 11) JLA528 (SH 1000 
hla:: lacZ aht14 (agrB)), and 12) JLA532 (SH1000 hla:: lacZ aht18 (saeR)) and 
incubated overnight at 37 °C. Results are representative of two independent 
experiments. 
202 
CHAPTER5 
O\ ON 00 
t+l M en N N T M en en ý -, o--, -, ON as ON ON en " r-I I* - - r+ - 00 00 00 00 
ý 
M 
N 
M 
\ 
M 
ý 
\ 
M 
M 
W') 
'i 
N 
Z 
--ý 
M 
C', 
N 
M 
N 
f+) 
N 
M 
N 
00 
N 
S'D 
00 
N 
ý. 
00 
_ 
00 
.. w 
00 
00 
00 
00 
00 
00 
.r 
0ý0 
00 
N 
00 
V 
'r 
`i 
O 
ý 
O 
ý 
O O O O O O O O 
ýJ 
O 
`/ 
O 
`/ 
O O 
ý 
"0 ON 
O, 
O 
. -. 
O 
. -. 
M 
M 
O 
"--ý 
., T 
00 
ON 
(21% 
ON 
a*, 
Cý 
Oý 
- 
en 
- 
M 
. 
M 
- 
M ý ý ý ON 
O 
ý 
IT IT 
O 
U 
N 
M 
o0 
N 
en 
0o 
ý 
p 
N 
en 
00 
ýýýjj 
: -y 
a 
O 
U 
a 
O 
U 
a 
O 
U 
N 
en 
o0 
N 
en 
00 
N 
en 
00 
N 
en 
00 
Y il L ý "O ý ý -O iL i. i. . 1. 
ö iD CS CS C h O O CS tl CS h h h h C CS C CS C 
r ý ý Lý C-i 
ý 
w 
CO 
w 
ý O 
cqs 
b y y b b b b 
wcv 
0 4 
. 
V. 
v 
. 
V. 
- -8 cv° o 
Lý' 
ö ö ö 
0 0 
ö 
, 
4) 
ö 
1. 
d> 
ö 
it 
ö 
5 
N 
ö 
OL) 
N 
ö 
4)n 
N 
ö 
un 
N 
ö 
Q 
w 
`" 
N 
r. ý 
y 
H H 
aý 
N 
H 
, 
 
ö 
Ä 
. 
1. 
cq 
w 0 
ö 
N 
u; 
cf . 
0 
ö 
N 
c,., 
0 
ö 
öcV n N 
rx 
Q. 
ý 
x 
_a 
ä 
x 
u. 
ä 
x 
a 
i 
x 
Q 
ý' 
¢ 
6 
ý'' 
°i 
Ü 
¢ 
C 
°'n 
ý'' 
°i 
Ü 
¢ 
a 
on 
°i 
Ü 
¢ 
ý 
N 
R. 
x 
10 ý: ) 01 Ol 01 ZZ) ao : Z)o : 1-, 
o 
ýzo tt: 
o 
Q: ý Q1 Qi Cý CA4 
p 
ý 
C/j 0ý0 
l- 
k/'t 
fQOýj 
V1 
N 
m 
ý 
C% 
N 
M 
ý 
C¢/ý 
- 
ý 
CQ/] 
Vl 
en 
ý 
C/ý 
M 
ý 
C/ý 
t- 
V1 
fQOý] 
C! ý 
r- 
v1 
tQOý 
C/ý 
l- 
H 
(QOý] 
Vl 
I'D 
0 
O 
C¢/] 
ýO 
0 
O 
C¢/ý 
%O 
0 
O 
ý 
1ý0 
O 
O 
!ý 
M 
N 
Co 
ý 
M 
N 
fQOý 
V] 
M 
N 
fQOý] 
C/ý 
en 
N 
O 
V] 
%O 
1ý0 
Ö 
! 
ý/ý 
u 
Cd 
z 
pq 
Vý2 
ýo N " tn tn 'o 'o 'o er d' v --t O O O O 0 
öU en ýo V) tn tn tn tn ýo ýo 110 v v v v - - 
z 
Qý 
0 N 10 vl W, v) V'1 W, 10 "O 10 It 'It --ý "r -" "ý O 
ý O 
_ 7 CQ 
7 °. ý ýo W) W., V1 kn ýn ýO ýO ýO et rt "" "-+ r. -- O 
ä º, w w w w w w w w w w w w w w w w w w 
00 
ö 
cl ö .ý fi b en ti 
,ý 
V1 
LRILÜ+ 
ýýý]], 
ýf 
V] 
t3 I-y ý 
ý 
vl 
Qý 
ti 
1.0 
W) 
Q 
ý-a-+ 
ý 
v'1 
Q 
00 
V1 
, 
Q] 
Fi 
ON 
W') 
Q 
ºa-. 
C. 
N 
v1 
Q 
- 
N 
vl 
Q 
N 
N 
V1 
, 
Q]ý 
en 
N 
V) 
Q 
ti 
N 
W) 
N 
vl 
Qý 
ý-ý-. 
.O N 
WI) 
Qý 
r- 
N 
W*) 
Qý 
00 
N 
1ýýi 
ýr 
0N 
N 
ý 
O 
M 
Vl 
Qý 
- 
en 
vl 
Qý 
ti 
N 
M 
V1 
Q 
V 
-Z 
IN 
0ý0 
-. et 203 
CHAPTER 5 
ý 
, -. M 
M 
I-M 
N 
en 
en 
e \ 
ON O\ 
.. M 
M 
M 
N 
M 
M 
o \ 
orn 
O\ 
ý. 
M 
M 
N 
M 
en 
0 \ 
ON ON 
.. en 
M 
M 
N 
en 
M 
o \ 
a\ 
O, 
ý. M 
en 
N 
en 
en 
e \ 
ON ON 
.. M 
en 
t2 
N 
en 
en 
o \ 
ON 
O, 
ý. M 
en 
ý 
N 
M 
en 
e \ 
a\ 01 
.. M 
en 
" 
N 
en 
en 
e \ 
orn 
Cý 
.. M 
M 
N 
Q 
M 
M 
o \ 
ON oý 
^" Ö 
O 
O 
0 \ 
ON 
C, 
^ N 
, 
. -. 
N 
ý. s 
ý 
O 
O 
--" 
^ N 
zt 
. -. 
N 
ý 
ý 
O 
O 
- 
^ N 
Vý 
. --ý N 
ý 
o 
O 
O 
- 
M 
M 
N 
M 
e \ 
m 
o, 
N 
11, 
W) 
"-+ 
e \ 
t+) 
M 
N 
V) 
ý+ 
o \ 
en 
M 
i: z t` 
ý 
O 
O 
"-+ 
en 
W-) 
M 
o \ 
Cý 
00 
r^) 
Vl 
") 
M 
o \ 
ON 
00 
_^ (4 
- 
. --i 
N 
ý 
O 
O 
. -" 
P 
rbA 
ý 
O 
U 
Cs 
ý 
O 
U 
O 
ra 
O 
U 
Q 
r.. 
a 
O 
U 
O 
a 
O 
U 
O 
ra 
O 
U 
O 
a 
O 
U 
ts 
ý 
O 
U 
O 
r-a 
O 
U 
Q 
Eli 
17 
MN 
h 
00 
C 
Cli 
IT In 
N 
00 
GS 
Ld 
IT kn 
M 
00 
C 
r1i 
ý 
M 
00 
C 
Ci 
-3 
O 
U 
C 
r6 
h 
ts p 
5 
ZS 
ö 
h 
C4 
ý 
CT 
clý 
0 Z 
CS 
C4 
O 
Z 
CS 
C-i 
M 
o0 
toi 
0 0 ) a ý En d d Cd Cd 
ý n 
cC 
Ö Ö 
w 
Ö 
w 
Ö 
w 
Ö 
0 
Ö 
ý''i 
w 
ti 
w 
t 
w 
'ii 
w 
5 
8 8 8 w 
o 
a 
o 
a 5 
0 
0 
0 
5 
ý 
o 
ý 
w 
Cd 
W 
O 
Ö 
V 
n: 
cd 
W 
O 
Ö 
N 
rz! 
Cl 
_ 
W 
O 
Ö 
rx 
Cl 
N 
W 
O 
Ö 
*C; 
u; 
Cl 
W 
O 
Ö 
*C4 
rx 
cd 
G 
W 
O 
Ö 
14 
rx 
cd 
m 
W 
O 
Ö 
*C4 
a 
Cl 
N 
W 
O 
Ö 
n: 
cd 
y 
W 
O 
Ö 
z 
y 
03 
-k O 
Q 
-O 
Cd 
0 
Ö 
. 
G^ ý 
s 
A 
O 
Cd 
0 
Ö 
s 
2 
A 
-O 
Ö 
s E 
A 
Cl 
vi 
W 
O 
Ö 
"a 
0. ' 
0 
Cd 
ý 
0 
ý 
E-ý 
a) 
(n 
U' 
0 
"ý 
E-ý 
ö 
}' 
x 
- 
*O 
$. 
0 
v 
H 
].. ý" 
. 
ý 
O 
Ä+ 
0 
b 
h 
ý.. ý" 
^rJ 
ILI 
.ý Ö 
S 
ý 
A 
aýi -o -D -O -o -O "D -O -O -O ti h 
ý. 
ý 
.hý. 
ý ti 
.,. ý, 
-o i2 ... °' ý. °' 
R a> 
y 
d 
tiýy 
a 10 -0 tv 13 10 
c 
OA 
n 
WI) 
O 
tn 
t- 
Vl% 
O 
tY] 
r- 
V) 
O 
tn 
r- 
vi 
O 
C/] 
tý 
v1 
O 
V] 
t- 
V1 
O 
(Y] 
r- 
v) O 
(n 
r- 
v1 
O 
Cn 
r- 
vl 
O 
CI] 
00 
N 
ý_ 
t/) 
v) 
en 
ef 
C40 
v) 
en 
et 
Cl) 
tn 
en 
ef 
V1 
r- v1 
O 
Cl) 
. -" t7 
et 
(n 
"-ý 
cr 
Cl) c 
V1 
ýO 
[ý 
cn 
W') 
ýD 
t` 
Cl) 
v) 
en 
'ct 
V] 
O 
ýve 
OÖ "d u 
a5 Ü 
cýd Cd 
Z. ýD 10 ýO ýD o ýD 110 %lo I'D tn V) V) V) ýo W) V's N N N v'º 
Ö M 
ý10 ý0 \1D ýD %10 %lD ýD ýo ýD W) wl, kn tn 10 W) W) N N N cn 
^ 
. cUd 
0z 
cy \1D %o ýD 1%O \O IC IC NO ýD v') v) W) c/'1 ýO cn " N N N v'1 
CQ ý ý ý ýD ýD `D ýD ýD ', 0 \4D 10 v) v1 In v) ýD cn v1 N N N "I 
.iý w w w w w w w 
t 
w 
et 
w . -. ý w w w w w w w w w w w 
oO 
ö 
.., 
ýcs±± 
. fl 
_M 
v 
.aýh 
ti 
4. 
en 
m 
'd- 
h tn 
vMi 
\, o 
N 
t- 
h 
00 
h 
0ý 
h 
O 
h 
"-+ h 
N 
W 
en 
h 
et 
ý 
v) 
h 
\ýD 
N t- N 00 ý 
0N O 
N ý ý 
N 
N 
wÖ 
N K1 'ci' %n 'D tý 00 01 
O 
. -. 
-+ 
. --ý 
N 
. --i 
M 
... 
ý 
. -+ 
ýn 
. -ý 
ýD 
. -r 
t` 
... 
00 
... . --i 
00 
204 
Table 5.2 
Summary of the phenotypic and sequence analysis results for the (A) aht and (B) hin 
Tn551 mutants. 
a hla:: lacZ transcription, as determined by blue colouration on BHI agar plates 
(containing either 600 mg r, X-Gal or 1M NaCl and 2.4 g r, X-gal) during primary 
(1°), secondary (2°) and tertiary (3°) screens. Blue colouration was compared to the 
background colonies for the primary screen and to JLA513 (SH1000 hla:: lacZ (TetR)) 
for the secondary and tertiary screens. Blue colouration scale =0-6, where JLA513 
(SH1000 hla:: lacZ (TetR)) =3 on the BHI agar plate containing 600 mg 1"i X-Gal and 1 
on the BHI agar plates containing 1M NaCl and 2.4 g 1' X-gal (see Figure 5.11)). 
b S. aureus gene number according to the TIGR S. aureus COL database (Chapter 
2.17.2). 
Highest BLASTP hit against a named gene (Chapter 2.17.2 and Appendix A. 2.10 - 
A. 2.20). 
d Gene for which Tn551 insertion is not within the ORF, but may be in a regulatory 
region controlling transcription. 
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mutants therefore demonstrated a higher level of hla:: lacZ transcription than JLA513 
(SH1000 hla:: lacZ (TetR)) on both types of plate. 
JLA549 (SH1000 hla:: lacZhtn17 (hypl)) and JLA550 (SH1000 hla:: lacZhtn18 (saes)) 
displayed a level of blue colouration of 2 on both types of plate, and therefore 
demonstrated a higher level of hla:: lacZ transcription than JLA513 (SH1000 hla:: lacZ 
(TetR)) on BHI containing 1M NaCl and 2.4 g r' X-gal and a lower level of hla:: lacZ 
transcription on BHI containing no added NaCl and 600 mg ri X-gal. JLA528 (SH1000 
hla:: lacZ ahtl4 (agrB)) displayed a level of blue colouration of 1 on BHI containing no 
added NaCl and 600 mg 1' X-gal, and a level of blue colouration of 0 on BHI 
containing 1M NaCl and 2.4 g r, X-gal, and therefore demonstrated a lower level of 
hla:: lacZ transcription than JLA513 (SH1000 hla:: lacZ (TetR)) on both types of plate. 
JLA532 (SH1000 hla:: lacZ aht18 (saeR)) displayed a level of blue colouration of 0 on 
both types of plate, suggesting that hla:: lacZ was either not being transcribed, or was 
being transcribed to an extremely low level in this mutant. 
5.2.5.1.2 hla:: lacZ transcription of Tn551 mutants in BHI broth containing 
either no added NaCl or 1M NaCl 
JLA542 (SH1000 hla:: lacZ htn10 (IysC')), JLA516 (SH1000 hla:: lacZ aht2 (ykuQ)), 
JLA519 (SH1000 hla:: lacZ aht5 (IysA)), JLA518 (SH1000 hla:: lacZ aht4 (telA)) and 
JLA520 (SH1000 hla:: lacZ aht6 (brnQ)) demonstrated a similar level of blue 
colouration to each-other on BHI agar plates containing no added NaCI and 600 mg 1"1 
X-gal (Chapter 5.2.5.1.1). The level of blue colouration of the mutants observed on BHI 
agar plates containing no added NaCl and 600 mg 171 X-gal remained similar when 
patched onto BHI agar plates containing 1M NaCl and 2.4 g 1"1 X-gal (Chapter 
5.2.5.1.1). On both types of plate, the level of blue colouration of these Tn551 mutants 
was higher than that of JLA513 (SH1000 hla:: lacZ (TetR)) (Chapter 5.2.5.1.1). In order 
to quantitatively measure the level to which hla:: lacZ transcription was increased in the 
mutants, the representative mutant JLA542 (SH1000 hla:: lacZ htn10 (lysC)) and 
JLA513 (SH1000 hla:: lacZ (TetR)) were grown in BHI containing either no added 
NaCl or 700 mM NaCl, as described in Chapter 2.7. Growth was measured 
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spectrophotometrically as OD600 (Chapter 2.6.1), and hla:: lacZ fusion expression was 
measured using MUG, as described in Chapter 2.8. 
In BHI containing no added NaCl (Figure 5.12), hla:: lacZ transcription was found to be 
up to 3.5 times greater in JLA542 (SH1000 hla:: lacZ htnl0 (IysC)) than in JLA513 
(SH1000 hla:: lacZ (TetR)) (ie. 12,028 and 3,398 MUG units respectively at t=7 h). 
However hla:: IacZ transcription was found to be very similar in JLA542 (SH 1000 
hla:: lacZ htn10 (IysC)) and JLA513 (SH1000 hla:: lacZ (TetR)) when grown in BHI 
containing 700 mM NaC1 (Figure 5.12) (ie. 191 and 193 MUG units respectively at t= 
7h). This suggests that the increased hla:: lacZ transcription observed for JLA542 
(SH1000 hla:: lacZ htnl0 (IysC)) on BHI agar plates containing 1M NaC1 and 2.4 g 1'1 
X-gal could not be reproduced in liquid culture. Due to time constraints, the levels of 
hla:: lacZ transcription in the other Tn551 mutants were not quantified using MUG. 
5.2.5.2 Determination of the expression of Hla, SspA and other exoproteins 
by the TnSS1 mutants in BHI containing either no added NaCl or 1 
M NaCl using exoprotein gel and Western blot analysis 
To allow the effects of the Tn551 mutations on the expression of virulence determinants 
and other exoproteins to be analysed in the absence of (3-galactosidase production by the 
hla:: lacZ fusion, the Tn551 mutations present in JLA526 (SH1000 hla:: lacZ aht12 
(yjbH)), JLA542 (SH1000 hla:: lacZ htnlO (lysC)), JLA516 (SH1000 hla:: lacZ aht2 
(ykuQ)), JLA519 (SH1000 hla:: lacZ aht5 (IysA)), JLA518 (SH1000 hla:: lacZ aht4 
(telA)), JLA520 (SH1000 hla:: lacZ aht6 (brnQ)), JLA515 (SH1000 hla:: lacZ ahtl 
(rsbU)), JLA549 (SH1000 hla:: lacZ htnl7 (hypl)), JLA550 (SH1000 hla:: lacZ htnl8 
(saes)), JLA528 (SH1000 hla:: lacZ ahtl4 (agrB)), and JLA532 (SH1000 hla:: lacZ 
ahtl8 (saeR)) were transferred into SH1000 via 411 mediated transduction. This 
produced the strains JLA554 (SH1000 aht12 (yjbH)), JLA555 (SH1000 htn10 (IysC)), 
JLA556 (SH1000 aht2 (ykuQ)), JLA557 (SH1000 aht5 (lysA)), JLA558 (SH1000 aht4 
(telA)), JLA559 (SH1000 aht6 (brnQ)), JLA560 (SH1000 ahtl (rsbll)), JLA561 
(SH1000 htn17 (hypl)), JLA562 (SH1000 htnl8 (saeS)), JLA563 (SH1000 ahtl4 
(agrB)) and JLA564 (SH1000 aht18 (saeR)) respectively. Strains were grown in BHI 
containing either no added NaCI or 1M NaCl, as described in Chapter 2.18.1. Culture 
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Figure 5.12 
The effect of lysC on hla:: lacZ transcription in BHI containing either no added NaCl or 
700 mM NaCl. 
S. aureus JLA513 (SH1000 hla:: lacZ (TetR)) (0 and ") and JLA542 (SH1000 
hla:: lacZ htn10 (IysC)) (0 and  ) were grown in BHI containing no added NaC1 as 
described in Chapter 2.7. Additionally, JLA513 (SH1000 hla:: lacZ (TetR)) (0 and A) 
and JLA542 (SH1000 hla:: lacZ htn10 (IysC)) (O and f) were grown in BHI 
containing 700 mM NaCl. Growth was measured spectrophotometrically as OD600 
(open symbols) (Chapter 2.6.1), and IacZ fusion expression was measured using MUG 
(closed symbols), as in Chapter 2.8. Results are representative of two independent 
experiments. N. B. A and f merge with baseline. 
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supernatants were removed after 14 h and exoprotein samples prepared as described in 
Chapter 2.18.3.1. Proteins were separated on 12 % (w/v) SDS-PAGE gels as described 
in Chapter 2.18.4. For Western blots, membranes were blocked with 20 % (v/v) pig sera 
to reduce non-specific binding, and probed with relevant antibodies as described in 
Chapter 2.18.5. 
The level of Hla and SspA was greater in JLA554 (SH1000 aht12 (yjbH)), JLA555 
(SH1000 htn10 (lysC)), JLA556 (SH1000 aht2 (ykuQ)), JLA557 (SH1000 aht5 (lysA)), 
JLA558 (SH1000 aht4 (telA)), JLA559 (SH1000 aht6 (brnQ)) and JLA560 (SH1000 
ahtl (rsbU)) than in SH1000 when grown in BHI containing no added NaCl (Figure 
5.13). The difference was most pronounced in JLA555 (SH1000 htn10 (lysC)), JLA556 
(SH1000 aht2 (ykuQ)), JLA558 (SH1000 aht4 (telA)), JLA559 (SH1000 aht6 (brnQ)), 
and JLA560 (SH1000 ahtl (rsbU)). 
The level of Hla and SspA was lower in JLA561 (SH1000 htnl7 (hypl)), JLA562 
(SH1000 htn18 (saes)), JLA563 (SH1000 aht14 (agrB)), and JLA564 (SH1000 aht18 
(saeR)) than in SH1000 when grown in BHI containing no added NaCI (Figure 5.14). 
Indeed, (SH1000 htnl8 (saes)), JLA563 (SH1000 aht14 (agrB)), and JLA564 (SH1000 
aht18 (saeR)) expressed virtually no detectable Hla. 
However, an altered level of Hla and SspA compared to SH1000 could not be 
demonstrated for any of the Tn551 mutants when cultures were grown in BHI 
containing 1M NaCl (data not shown). 
5.2.5.3 Analysis of the effects of the Tn551 mutations on growth in BHI 
containing either no added NaCI or 2M NaCI 
To determine the effects of the Tn551 mutations on growth, JLA554 (SH1000 aht12 
(yjbH)), JLA555 (SH1000 htn10 (lysQ), JLA556 (SH1000 aht2 (ykuQ)), JLA557 
(SH1000 aht5 (lysA)), JLA558 (SH1000 aht4 (telA)), JLA559 (SH1000 aht6 (brnQ)), 
JLA560 (SH1000 ahtl (rsbV)), JLA561 (SH1000 htnl7 (hypl)), JLA562 (SH1000 
htnl8 (saes)), JLA563 (SH1000 aht14 (agrB)) JLA564 (SH1000 ahtl8 (saeR)) and 
SH1000 were grown in either BHI containing no added NaCl or in BHI containing 2M 
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Figure 5.13 
The effect of the Tn551 mutations on the production of I Ila, SspA and other exoproteins. 
(A) Exoprotein gel, (B) Hla Western blot and (C) SspA Western blot for 1) SII1000,2) 
JLA554 (SH1000 ahtl2 (yjhH)), 3) JLA555 (S111000 htn10 (lvsC)). 4) JLA556 (SH1000 
ah12 (vkuQ)), 5) JLA557 (SH 1000 uht5 (1ysA)), 6) JLA558 (SH 1000 aht4 (telA)), 7) 
JLA559 (SH 1000 aht6 (brnQ)) and 8) JLA560 (SH1000 All (rshU)). Culture supernatant 
was removed after 14 h from cultures grown in BHI containing no added NaCl and 
exoprotein samples prepared as described in Chapter 2.18.3.1. Proteins were separated on 
SDS-PAGE gels as described in Chapter 2.18.4. For Western blots, membranes were 
blocked with 20 % (w/v) pig sera and probed with relevant antibodies as described as in 
Chapter 2.18.5.1. Lanes contain exoproteins from 1.0 or 0.2 OD60() units of culture 
supernatant for exoprotein gels and Western blots respectively. Results are representative 
of a minimum of two independent experiments. Sizes of Sigma low molecular weight 
markers are shown. 
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The effect of the Tn551 mutations on the production of Hla, SspA and other exoproteins. 
(A) Exoprotein gel, (B) Hla Western blot and (C) SspA Western blot lbr 1) S111000,2) 
JLA561 (SH1000 hinl7 (hypl )), 3) JLA562 (SHI000 htnl8 (sues)), 4) JLA563 (5111000 
ah114 (ugrB)), and 5) JLA564 (SHI000 ahtl8 (saeR)). Culture supernatant was removed 
after 14 h from cultures grown in BHI containing no added NaCI and exoprotein samples 
prepared as described in Chapter 2.18.4. For Western blots, membranes were blocked with 
20 % (w/v) pig sera and probed with relevant antibodies as described as in Chapter 
2.18.5.1. Lanes contain exoproteins from 1.0 or 0.2 OD60() units of culture supernatant for 
exoprotein gels and Western blots respectively. Results are representative of a minimum 
of two independent experiments. Sizes of Sigma low molecular weight markers are shown. 
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NaC1 under the NaC1-shock conditions described in Chapter 4.2.3.3. Growth was 
measured spectrophotometrically as OD600 at regular intervals over a 24 h period 
(Chapter 2.6.1). 
JLA555 (SH1000 htn10 (lysC)), JLA556 (SH1000 aht2 (ykuQ)), JLA557 (SH1000 aht5 
(lysA)), JLA558 (SH1000 aht4 (telA)), JLA559 (SH1000 aht6 (brnQ)), JLA560 
(SH1000 ahtl (rsbU)), JLA561 (SH1000 htnl7 (hypl)), JLA562 (SH1000 htnl8 
(saes)), JLA563 (SH1000 ahtl4 (agrB)) and JLA564 (SH1000 ahtl8 (saeR)) displayed 
similar levels of growth to SH1000 under both conditions tested. The mutants reached 
an OD600 of 8.33 - 9.45 and 3.02 - 4.89 at t= 10 h (full data not shown) in BHI 
containing no added NaCl and in the presence of NaCI-shock respectively, whilst 
SH1000 reached an OD600 of 8.97 and 4.28 at t= 10 h under the two respective 
conditions. The growth of JLA559 (SH1000 aht6 (brnQ)) is shown in Figure 5.15a as 
an example (OD600 = 9.01 and 3.22 at t= 10 h under the two respective conditions). 
JLA554 (SH1000 ahtl2 (yjbH)) was found to have slightly slower exponential phase 
growth than SH1000 in BHI containing no added NaCI (ie. a maximum of 1.9 fold 
lower growth; 1.2 and 2.23 OD600 units respectively at t=3 h) (Figure 5.15b). 
Nevertheless, JLA554 (SH1000 aht12 (yjbH)) reached a similar growth yield to 
SH1000 after 5h (OD600 = 6.74 and 6.78 respectively). However, JLA554 (SH1000 
ahtl2 (yjbH)) was found to have a significant growth defect under NaCI-shock 
conditions (a maximum of 8.3-fold lower growth in JLA554 than in SH1000; 0.425 and 
3.54 OD600 units respectively at t=9 h). 
5.2.5.4 Analysis of the effects of saeS and saeR on pathogenicity in a murine 
subcutaneous abscess model 
JLA562 (SH1000 htnl8 (saeS)) and JLA564 (SH1000 aht18 (saeR)) have been shown 
to produce less Hla and SspA than SH1000 (Chapters 5.2.5.1.1 and 5.2.5.2). The effects 
of saeS and saeR on virulence were determined using a murine subcutaneous abscess 
model of infection, as described in Chapter 2.19.10 mice were inoculated per strain (cfu 
= 9.2 X 107 for SH1000,4.10 X 107 for JLA562 (SH1000 htn18 (saeS)) and 6X 107 for 
JLA564 (SH1000 aht18 (saeR))). The number of cfu recovered per lesion are shown 
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Figure 5.15 
Growth (OD600) of (A) JLA559 (SH1000 aht6 (brnQ)) (Q and  ) and (B) JLA554 
(SH1000 aht12 (yjbI)) (0 and  ) compared to SH1000 (0 and ") in BHI containing 
no added NaCl (open symbols) and in BHI containing 2M NaCl under NaCI-shock 
conditions (closed symbols). Strains were grown at 37 °C as described in Chapter 2.7. 
Results are representative of two independent experiments. 
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in Figure 5.16. The statistical significance of the recovery of strains was evaluated using 
the Student t test with a5% confidence limit. P values of 0.0122 and 0.0115 were 
obtained for JLA562 (SH1000 htnl8 (saeS)) and JLA564 (SH1000 aht18 (saeR)) 
respectively, suggesting that the attenuation of the mutants is statistically significant. 
5.3 Discussion 
In this Chapter, possible methods to overcome the problem of selectable marker 
incompatibility between the commonly used S. aureus transposons (ie. Tn917 and 
Tn551) and pre-constructed lacZ fusions and knockouts were investigated. During 
evaluation of the EZ:: TN(tet) transposition system for use in S. aureus, transposon 
mutants were obtained by the in vivo transposition method, but not by in vitro 
transposition. This may have occurred because the efficiency of the system is limited by 
the ability to electroporate DNA into host cells. Using the in vitro method, the large 
fragments of target genomic DNA containing the EZ:: TN(tet) transposon would have 
been electroporated into S. aureus RN4220 cells at a significantly lower frequency than 
the EZ:: TN(tet) transposome alone, as used in the in vivo transposition method. 
Alternatively, the ability of the genomic DNA fragments containing the transposon to 
recombine with the host DNA following electroporation into the cells may have limited 
the success of the in vitro transposition method. This could be tested by performing the 
in vitro transposition method using pMC4 instead of genomic DNA, as pMC4 has 
previously been shown to be capable of recombining with host DNA in S. aureus (Chan 
et al., 1998). 
However, Southern blotting of the transposon mutants obtained by in vivo transposition 
suggested that the EZ:: TN(tet) transposon had inserted into the same position in all of 
the colonies analysed. This may have been caused either by a defect in the EZ:: TN(tet) 
transposome or by the presence of a hotspot for insertion in the S. aureus genome. A 
prototype of the EZ:: TN transposition system has been used to produce random 
insertions in E. coli, S. typhimurium and Proteus vulgaris (Goryshin et al., 2000), and 
the EZ:: TN system has been used successfully in Mycobacterium smegmatis 
(Derbyshire et al., 2000). However, the EZ:: TN transposition system is Tn5-based, and 
hotspots for Tn5 insertion have been identified using pBR322 as a target (Nag et al., 
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Figure 5.16 
The effect of saeS and saeR on pathogenicity in a murine subcutaneous abscess 
model of infection. 
10 female 6- to 8-week old BALB/c mice were inoculated per S. aureus strain, as 
described in Chapter 2.19. After 7 days, the mice were euthanized with CO2. skin 
lesions were aseptically removed and homogenised, and viable bacteria were 
counted after dilution and growth on BHI agar plates. Crosses represent the 
cfu/lesion for individual mice, whilst bars represent the mean cfu/lesion for each S. 
aureus strain. 
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1985). It has been noted that Tn5 inserts preferentially into G/C-rich DNA, and that 
additional features such as degenerate DNA sequences or particular topological 
structures may direct Tn5 to preferred sites (reviewed by Berg et al., 1989). For 
example, the frequency of Tn5 transposition has been shown to be reduced in strains 
lacking DNA gyrase or topoisomerase (Isberg & Syvanen, 1982; Sternglanz et al., 
1981). An initial insight into whether a particular DNA sequence and/or putative 
topological conformation is present which creates a strong hotspot for insertion in this 
area of the S. aureus genome could be obtained by sequencing the DNA flanking the 
EZ:: TN(tet) transposon insertions. 
In order to allow erythromycin-resistant transposon-mediated mutations to be used in 
conjunction with lacZ fusions without encountering the problem of resistance marker 
incompatibility, the vector pAISH1 was constructed. This vector carries a tetracycline- 
resistant selectable marker, and was used to construct an hla:: lacZ fusion. As shown in 
Figure 5.5, the resulting hla:: lacZ fusion strains contain an intact copy of hla plus a 
truncated copy transcriptionally fused to the lacZ gene. The hla:: lacZ fusion is stably 
inserted into the S. aureus chromosome and therefore does not require maintenance by 
the addition of antibiotics, which may alter toxin production (Doss et al., 1993). 
Furthermore, the hla:: lacZ fusion is in single copy so as not to titrate-out regulatory 
elements. The tetracycline-resistant hla:: lacZ fusion was found to give very similar ß- 
galactosidase assay data to the published erythromycin-resistant hla:: lacZ fusion 
constructed in pMUTIN4 by Chan & Foster (1998a). This is to be expected, since the 
two vectors, pAISH1 and pMUTIN4, differ only in terms of their Gram-positive 
selectable marker. Furthermore, identical hla promoter inserts were used to produce the 
IacZ fusions in both plasmids. 
A screen of - 8,400 Tn551 mutants in the SH1000 hla:: lacZ background identified 6 
genes which may mediate the repression of agr and hla by o-a. These genes were 
designated aht (genes affecting h1a transcription). Mutants containing Tn551 insertions 
affecting the transcription of agrB and potentially of rsbU were also isolated, suggesting 
that the screen was capable of identifying suitable genes. Mutants containing Tn551 
insertions in genes encoding tetrahydrodipicolinate acetyltransferase (YkuQ), 
diaminopimelate decarboxylase (LysA), a tellurite-resistance protein (TeIA), a 
branched-chain amino acid carrier protein (BrnQ), and a conserved hypothetical protein 
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(YjbH) were isolated by virtue of their increased blue colouration on BHI X-gal plates 
compared to the wild-type. Therefore, the genes inactivated by Tn551 in these mutants 
may have a repressive effect on hla, and it is possible that these genes may be 
upregulated by aB in order to repress agr/hla. The repression of agr by aB has also been 
shown to result in a reduction in protease transcription (Horsburgh et al., 2002). A 
screen of Tn551 mutants in SH1000 to identify genes involved in this pathway by virtue 
of increased protease activity compared to background colonies identified genes 
including lysA, telA and brnQ (Shaw, 2002), thus supporting the data presented here. 
However, in order to verify the role of the aht genes in the repression of agr and hla by 
aB, it would be necessary to determine whether their transcription is affected by aß 
(Chapter 6.2.3) and whether they affect the transcription of agr (eg. by performing 
Northern blots). 
A mutant containing a Tn551 insertion in the response regulator saeR was also 
identified in the screen to identify aht genes, and was non-blue on BHI X-gal. The two- 
component sensor/regulator system saeS/saeR is known to activate the transcription of 
h1a and of several other virulence determinants, including hlb, coa and spa (Giraudo et 
al., 1994; Rampone et al., 1996; Giraudo et al., 1997; Goerke et al., 2001). However, 
Giraudo et al. (1997) have shown that the sae locus has no effect on agr transcription, 
and so the effects of saeR on virulence determinant expression are likely to occur 
independently of agr. 
A screen of - 6,250 Tn551 mutants to identify genes involved in regulating hla 
transcription in response to NaCl revealed 5 genes. The genes were designated htn 
(genes affecting lila transcription identified by screening on BHI plates containing 
NaCI), and encode aspartokinase II (LysC), diaminopimelate decarboxylase (LysA), a 
tellurite-resistance protein (TeIA), a hypothetical protein (Hypl) and a sensor kinase 
(SaeS). The screen was performed in the aB-proficient SH1000 hla:: lacZ background, 
and was therefore capable of identifying genes constituting both the a"-dependent and 
aB-independent pathways involved in repressing hla in response to NaCl (Chapter 3.3). 
None of the genes identified here were found in the Tn917 screen performed in the aB- 
deficient 8325-4 background in Chapter 4. Therefore, it is possible that the genes 
identified in this Chapter may be involved in the aB-dependent pathway. Indeed, 
mutants carrying Tn551 insertions potentially affecting rsbU transcription were isolated 
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in this screen. However, it is also possible that differences in the ability of Tn917 and 
Tn551 to insert within different regions of the genome may have caused different genes 
to be identified in the two screens. 
Interestingly, ykuQ, lysC and lysA are all located within the dap operon (Figure 5.1Ob). 
The dap operon consists of 8 genes, six of which are involved in the biosynthesis of the 
amino acids lysine, methionine, threonine and isoleucine (Wiltshire & Foster, 2001). 
Since these amino acids derive the majority of their carbon atoms from L-aspartate, they 
are referred to as the aspartate family of amino acids. The two "common-pathway" 
enzymes aspartokinase II (lysC) and aspartate semialdehyde dehydrogenase (asd) are 
involved in the biosynthesis of all four aspartate family amino acids. However, 
dihydrodipicolinate synthase (dapA), dihydrodipicolinate reductase (dapB), 
tetrahydrodipicolinate acetyltransferase (ykuQ) and diaminopimelate decarboxylase 
(lysA) are only involved in the biosynthesis of lysine. The two remaining genes of the 
dap operon, which do not have a role in aspartate family amino acid biosynthesis, are 
hipO and dal. These genes encode hippurate hydrolase and alanine racemase 
respectively. Hippurate hydrolase cleaves benzoylglycine (hippuric acid) into benzoic 
acid and glycine (Hani & Chan, 1995). Alanine racemase interconverts L-alanine and 
D-alanine, providing D-alanine for bacterial cell wall synthesis (Wasserman et al., 
1984). 
Since many of the aht and htn mutants contained Tn551 insertions in either the same 
genes or in the same operons as each other, representative clones from both screens 
were characterised together to determine their phenotypes in both the presence and 
absence of NaCI-mediated stress. In the SH1000 hla:: lacZ background, mutants 
containing Tn551 insertions in ykuQ, lysC, lysA, telA, brnQ, and yjbH demonstrated a 
similar level of blue colouration on BHI X-gal plates containing no added NaCl as they 
did on BHI X-gal plates containing 1M NaCl. On both types of plate, the level of blue 
colouration of the mutants was greater than that of the wild-type. Since the phenotype of 
these mutants appears to be NaC1-independent, it is unclear how these genes may 
function in the regulation of h1a transcription in response to NaCl. However, since the 
mutants were more blue than the wild-type on BHI X-gal containing no added NaCl, 
this suggests that they act as repressors of hla transcription in the absence of NaC1- 
mediated stress. Therefore, it is possible that the genes may serve to repress hla 
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transcription from a maximal level to a submaximal level in the absence of NaC1- 
mediated stress, and that this level of repression is increased further in order to produce 
an even lower level of hla transcription in the presence of NaCl-mediated stress. 
Therefore, inactivation of the genes using Tn551 would result in hla transcription 
returning to the maximal level in both the presence and absence of NaCl, causing the 
mutants to have a higher level of hla:: lacZ transcription than the wild-type under both 
conditions. This effect was observed on the BHI X-gal plates. In Chapter 3, aB was 
shown to repress hla to a submaximal level in the absence of added NaCl, and to 
increase this level of repression even further in the presence of NaCI-mediated stress. 
This would further suggest that the genes may be part of the pathway involved in the 
aB-dependent repression of hla in response to NaCl. This could be confirmed by using 
lacZ reporter gene fusions to the genes to determine whether their transcription is 
altered in the presence or absence of NaCI and whether or not their transcription is 
affected by aB in the presence of NaCl. 
Whereas the degree of blue colouration of wild-type SH1000 hla:: lacZ was lower on 
BHI X-gal plates containing 1M NaC1 than it was on BHI X-gal plates containing no 
added NaCl, the saeS mutant demonstrated a similar level of blue colouration on both 
types of plate. This may suggest that the inactivation of saeS by Tn551 has prevented 
the mutant from sensing NaCl and repressing hla transcription appropriately. Indeed, 
although the saeS/saeR two-component sensor-regulator system is known to activate the 
transcription of a number of virulence determinant genes (Giraudo et al., 1994; 
Rampone et al., 1996; Giraudo et al., 1997; Goerke et al., 2001), details of the 
environmental signals which sae regulates these genes in response to have not yet been 
published. The data presented here indicates that sae may be important in sensing NaCl 
in order to allow virulence determinants to be expressed to an appropriate level. This 
could be confirmed by determining whether the level of phosphorylation of SaeS is 
reduced in the presence of NaCl. 
However, the ability to confirm the putative roles ofykuQ, lysC, lysA, telA, brnQ, yjbH, 
saeR and saeS in the NaCI-mediated regulation of hla has been limited by the fact that 
exoprotein gels, Western blots, and the quantification of hla:: lacZ transcription using 
MUG assays showed that the phenotypes of the mutants displayed on Bill X-gal plates 
containing 1M NaCI could not be reproduced in liquid cultures of BHI supplemented 
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with NaCl. This effect was also demonstrated by the han mutants isolated in Chapter 4. 
Again, this suggests that a number of environmental conditions (which are different in 
liquid culture and on plates) may interact with the NaCI-stress signal in order to allow 
virulence determinant expression to be stringently regulated. 
Nevertheless, the phenotypes displayed by the Tn551 mutants on BHI X-gal plates 
containing no added NaCI were found to be reproducible in liquid cultures of BHI. 
Exoprotein gels and anti-Hla Western blots showed that mutation of ykuQ, lysC, lysA, 
telA, brnQ, yjbH and rsbU in the SH1000 background led to an increase in the level of 
Hla compared to wild-type SH1000 during growth in BHI containing no added NaCl. 
MUG assays showed that hla:: lacZ transcription was up to 3.5 X greater in the IysC 
mutant than in wild-type hla:: lacZ SH1000 in BHI containing no added NaCl. 
Additionally, mutation of hypl, saeS, agrB and saeR resulted in a reduction in the level 
of Hla compared to the wild-type in BHI containing no added NaCl. Consequently, the 
level of Hla. expression by the mutants in BHI containing no added NaCl was found to 
match the degree of blue colouration of the mutants in the SHIM hla:: IacZ 
background compared to the wild-type on BHI X-gal plates containing no added NaCl. 
Additionally, exoprotein gels and anti-SspA Western blots showed that the mutations 
had a similar effect on the level of SspA in BHI containing no added NaCl as was 
observed for the level of Hla. This suggests that the Tn551-inactivated genes may be 
involved in the regulation of virulence determinants in addition to hla. 
Analysis of the effects on growth of the Tn551 mutations in the SH1000 background 
indicated that the ykuQ, lysC, lysA, telA, rsbU, hypl, saeS, agrB and saeR mutants 
displayed levels of growth similar to the wild-type in BHI containing either no added 
NaC1 or under NaC1-shock conditions in BHI containing 2M NaCl. However, yjbH was 
found to have a slightly lower exponential phase growth rate than SHIM in BHI 
containing no added NaCl. A significant growth defect was also observed for the yjbH 
mutant under NaCI-shock conditions. The brnQ mutant was not found to have a 
significant growth defect under either condition. However, a brnQ:: Tn917 mutant in the 
RN450 background has previously been shown to have an extremely long lag phase (60 
to 70 h compared to the 6h lag phase of the parent strain) in defined medium containing 
2.5 M NaC1(Vijaranakul et al., 1997; Vijaranakul et al., 1998). However, differences in 
media, growth conditions and the S. aureus background used may account for the 
220 
CHAPTER 5 
phenotypic differences observed between the brnQ mutant isolated here and the 
published mutant strain. 
The use of a murine subcutaneous abcess model showed that the mutation of saeS and 
saeR in the SH1000 background led to statistically significant attenuation of virulence. 
This agrees with the finding of Giraudo et al. (1996) that an saeR:: Tn551 mutant had 
reduced virulence compared to the parent strain following intraperitoneal injection into 
mice. In addition, the lower P value obtained for the attenuation of the saeR mutant 
suggests that the mutation of saeR leads to greater attenuation than the inactivation of 
saeS. This is in accordance with the levels of blue colouration of the two mutants in the 
SH1000 h1a:: lacZ background on BHI X-gal plates and the results of exoprotein gels 
and Western blots using anti-Hla antibodies, which suggest that the saeR mutant 
expresses lower levels of Hla than the saeS mutant. Since mutations in saeR are polar 
on saeS, this suggests that genes in addition to saeS may be able to interact with saeR in 
order to regulate virulence determinant expression. 
Interestingly, many of the aht and htn genes have also been isolated in published 
transposon mutagenesis screens performed to identify genes involved in virulence. This 
is discussed in Chapter 6, and adds further weight to the finding that these genes are 
involved in virulence determinant regulation. 
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CHAPTER 6 
CHARACTERISATION OF SVS REGION GENES 
6.1 Introduction 
In Chapter 5, two Tn551 mutant library screens performed to isolate genes involved in 
the regulation of hla in the presence and absence of NaC1-mediated stress were 
described. In particular, mutants containing a Tn551 insertion in genes encoding 
aspartokinase II (lysC), tetrahydrodipicolinate acetyltransferase (ykuQ), 
diaminopimelate decarboxylase (lysA), a tellurite-resistance protein (telA) and a 
branched-chain amino acid transporter (brnQ) were found to demonstrate increased 
hla:: lacZ transcription on BHI X-gal plates containing either no added NaC1 or 1M 
NaCl. These genes are clustered together within a particular region of the S. aureus 
genome (ie. between gene numbers SA1428 and SA1445) (Table 5.2) (Figure 6.4). 
Indeed, the genes lysC, ykuQ and lysA form part of the dap operon, which is involved in 
the biosynthesis of the aspartate family amino acids lysine, threonine, isoleucine and 
methionine. The genes present within the 8-gene dap operon, and their functions, are 
discussed in Chapter 5.3. 
Interestingly, many genes within and around this region of the S. aureus genome have 
been repeatedly identified in published transposon mutagenesis screens performed to 
identify S. aureus genes involved in either pathogenesis, virulence determinant 
regulation or starvation survival (Table 6.1). Screening with Tn917-1acZ in a model 
system mimicking S. aureus bacteraemia showed that lysC, asd (aspartate-semialdehyde 
dehydrogenase) and dapA (dihydrodipicolinate synthase) are induced by growth in 
serum (Wiltshire & Foster, 2001). A Tn917-based STM screen to identify genes 
affecting growth and survival in multiple infection environments found that the 
inactivation of asd, ykuQ and lysA leads to attenuation (Coulter et al., 1998). The genes 
asd and lysA were also isolated in a screen to identify genes important for S. aureus 
survival and virulence through the use of Tn917-based STM in a murine model of 
bacteraemia (Mei et al., 1997). Lammers et al. (2000) showed that lysC, asd, dapA and 
lysA are important in bovine mastitis by screening Tn917-IacZ libraries to identify 
genes that are expressed during growth in milk. The genes lysC, asd, dapB, lysA and 
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lysC SA1428 * * * * * 
asd SA1429 * * * * * 
dapA SA1430 * * 
dapB SA1431 * 
ykuQ SA1432 * * * 
hipO SA1433 * 
lysA SA1435 * * * * * * * 
aclP SA1439 * 
telA SA 1441 * * * 
brnQ SA 1443 * * * * 
noiQ SA 1445 * * 
Table 6.1 
Genes within hotspot region identified in transposon mutant library screens. SA 
numbers represent the gene number according to the TIGR S. aureus COL database. 
Wiltshire et al. (2001); a screen performed using Tn917-lacZ in a model system 
mimicking S. aureus bacteraemia to identify genes induced by growth in serum. Coulter 
et al. (1998); a Tn917-based STM screen to identify genes affecting growth and 
survival in multiple infection environments. Mei et al. (1997); a screen to identify S. 
aureus virulence genes through the use of Tn917-based STM in a murine model of 
bacteraemia. Lammers et al. (2000); a screen involving the use of Tn917-lacZ to 
identify genes important in bovine mastitis. Vriesema et al. (2000); a screen using 
T017-lacZ to identify genes whose expression is increased upon interaction with 
human endothelial cells. Watson et al. (1998); a Tn917 screen to identify genes 
involved in starvation survival or recovery. Shaw (2002); a Tn551 screen to identify 
genes involved in the repression of agr and proteases by aB. Fairhead (1998); a Tn551 
screen to identify genes involved in the regulation of agr. 
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brnQ were isolated in a screen of T017-lacZ mutants to identify genes whose 
expression is increased upon interaction with human endothelial cells (Vriesema et al., 
2000). A Tn551 library screen to identify genes involved in the repression of agr and 
proteases by aB by virtue of increased protease activity on milk plates identified lysC, 
ykuQ, hipO (hippurate hydrolase), lysA, ac1P (acylphosphatase), telA, brnQ and norQ 
(nitric-oxide reductase) (Shaw, 2002). The genes brnQ and norQ were isolated in a 
Tn917 library screen to identify genes involved in the regulation of agr (Fairhead, 
1998). In addition, lysA and telA were isolated in a Tn917-based screen to identify 
genes involved in starvation survival (Watson et al., 1998). 
Consequently, it is possible that this region of the genome may represent a cluster of 
genes of fundamental importance to the virulence and survival of S. aureus. The region 
will therefore be referred to as the SVS (S. aureus virulence and survival) region. 
However, it may be the case that it is an alteration in DNA topology caused by 
transposon insertion within the SVS region, rather than the loss of actual gene function, 
that causes the phenotypes. Alternatively, it is possible that a hotspot for transposon 
insertion is present within the SVS region and that the phenotypes of the mutants might 
be an artifact, thus causing the genes to be mis-represented in the transposon 
mutagenesis screens. Therefore, representative transposon mutants were analysed in 
order to characterise this region of the genome more fully. 
6.2 Results 
6.2.1 Characterisation of virulence determinant expression in mutants 
containing transposon insertions within the SVS region 
In Chapter 5, the inactivation of lysC, ykuQ, lysA, telA and brnQ by Tn551 in the 
S1l1000 hla:: lacZ background led to increased blue colouration on BHI X-gal plates. 
To determine whether transposon insertions anywhere within the SVS region are able to 
cause increased hla:: lacZ transcription on BHI X-gal plates, a representative clone for 
each available transposon-inactivated SVS region gene was analysed. The effect of the 
transposon insertions on protease expression was also investigated. 
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In preparation for these experiments, the asd and dapA mutations were transferred from 
seg24 and seg10 respectively to SH1000 by 411-mediated transduction. This produced 
the strains JLA601 (SH1000 asd) and JLA603 (SH1000 dapA). The hipO, ac1P and 
norQ mutations were transduced into JLA513 (SH1000 hla:: lacZ) from LES153, 
LES154 and LES155 respectively to produce JLA605 (SH1000 hla:: lacZ hipO), 
JLA606 (SH1000 hla:: lacZ aciP) and JLA607 (SH1000 hla:: lacZ norQ). 
6.2.1.1 hla:: lacZ transcription on BHI X-gal plates 
To estimate the level of hla:: lacZ transcription in the SVS region mutants, JLA513 
(SH1000 hla:: lacZ), JLA373 (SH1000 hla:: lacZ sigB), PC322 (8325-4 hla:: lacZ), 
JLA542 (SH1000 hla:: lacZ htn10 (IysC)), JLA516 (SH1000 hla:: lacZ aht2 (ykuQ)), 
JLA605 (SH1000 hla:: lacZ hipO), JLA519 (SH1000 hla:: lacZ aht5 (lysA)), JLA606 
(SH1000 hla:: lacZ ac1P), JLA518 (SH1000 hla:: lacZ aht4 (telA)), JLA520 (SH1000 
hla:: lacZ aht6 (brnQ)) and JLA607 (SH1000 hla:: lacZ norQ) were patched onto BHI 
X-gal plates containing 600 mg r, X-gal and grown overnight at 37 T. 
The results of this experiment are shown in Figure 6.1. The level of blue colouration of 
the strains was estimated on a scale of 0-6, as in Chapter 5.2.5.1.1. Wild-type JLA513 
(SH1000 hla:: lacZ) demonstrated a level of blue colouration of 3. JLA542 (SH1000 
hla:: lacZ htn10 (lysC)), JLA516 (SH1000 hla:: lacZ aht2 (ykuQ)), JLA605 (SH1000 
hla:: lacZ hipO), JLA519 (SH1000 hla:: lacZ aht5 (IysA)), JLA606 (SH1000 hla:: lacZ 
ac1P), JLA518 (SH1000 hla:: lacZ aht4 (telA)), JLA520 (SH1000 hla:: lacZ ah16 
(brnQ)) and JLA607 (SH1000 hla:: lacZ norQ) demonstrated a level of S. JLA373 
(SH1000 hla:: lacZsigB) and PC322 (8325-4 hla:: lacZ) were found to have a level of 6. 
6.2.1.2 Protease activity on milk plates 
To qualitatively estimate the level of protease expression in the SVS region mutants, 
SH1000, MJH502 (SH1000 sigB), 8325-4, JLA555 (SH1000 htn10 (lysC)), JLA601 
(SH1000 asd), JLA603 (SH1000 dapA), JLA556 (SH1000 aht2 (ykuQ)), LES153 
(SH1000 hipO), JLA557 (SH1000 aht5 (IysA)), LES154 (SH1000 aciP), JLA558 
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Figure 6.1 
hia:: lacZ transcription of SVS region mutants, compared to JLA513 (SH1000 
hia:: lacZ), as determined by blue colouration on BHI X-gal plates. 
Strains 1) JLA513 (Sill 000 hla:: lacZ), 2) JLA373 (SH 1000 hla:: lacZ sigß), 3) PC322 
(8325-4 hla:: lacZ), 4) JLA542 (SH1000 hla:: lacZ htn10 (lysf), 5) JLA516 (SHI000 
hla:: lacZ aht2 (ykuQ)), 6) JLA605 (SHI000 hla:: lacZ hipO), 7) JLA519 (SHI000 
hlu.: lacZ ah15 (lysA)), 8) JLA606 (SHI000 hla:: lacZ ac1P), 9) JLA518 (SH1000 
hla:: lacZ ah14 (telA)), 10) JLA520 (SHI000 hla:: lacZ aht6 (brnQ)) and 11) JLA607 
(SH1000 hla:: lacZ norQ) were patched onto BHI agar plates containing 600 mg 1-' X- 
gal and incubated overnight at 37 °C. Results are representative of two independent 
experiments. 
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(SH1000 aht4 (telA)), JLA559 (SH1000 brnQ)) and LES155 (S111000 norQ). were 
patched onto milk plates (Chapter 2.16.3) and incubated overnight at 37 T. 
The results of this experiment are shown in Figure 6.2. Wild-type S1i1000 demonstrated 
little visible proteolytic activity. 8325-4, JLA555 (SH1000 htn10 (lysC)), JLA601 
(SH1000 asd), JLA603 (SH1000 dapA), JLA556 (SH1000 aht2 (ykuQ)), LES153 
(SH1000 hipO), JLA557 (SH1000 aht5 (lysA)), LES154 (SH1000 aciP), JLA558 
(SH1000 aht4 (telA)), JLA559 (SH1000 brnQ)) and LES155 (S1i1000 norQ) were 
found to be proteolytic. However the level of proteolytic activity of these mutants was 
slightly less than that demonstrated by MJH502 (SH1000 sigB). 
6.2.2 Direct genomic DNA sequencing and hla:: lacZ transcription of htn21 
(SH1000 hla:: lacZ htn21) 
The mutant htn2l was isolated in the screen of Tn551 mutants in the JLA513 (SH1000 
hla:: lacZ) background performed to identify genes involved in the regulation of hla in 
the presence of NaCI-mediated stress (Chapter 5.2.4). htn21 demonstrated less blue 
colouration than the background colonies on a BHI X-gal plate containing 1M NaCI 
and 2.4 g r, X-gal (Chapter 5.2.4). However, this phenotype was not reproduced 
following transduction of the mutation into JLA513 (SH1000 hla:: lacZ) to create the 
strain JLA553 (SH1000 hla:: lacZhtn21) (Chapter 5.2.4). 
Direct sequencing of htn2l genomic DNA and analysis of the resulting data was 
performed as in Chapter 4.2.3.1. Alignment of the sequencing reaction data against the 
COL sequence is shown in Appendix A. 2.21. Tn551 was found to have inserted into 
SA1423 at base 832 of the 924 bp gene. Homology of the product of the inactivated 
gene to other proteins is shown in Appendix A. 2.21. Homology to the phosphate ABC 
transporter permease PstC of Halobacterium sp. NRC-1 was demonstrated (50 % 
identity over 253 amino acids). 
JLA513 (SH1000 hla:: lacZ), htn2l (SH1000 hla:: lacZ htn2l), and JLA553 (SH1000 
hla:: lacZ htn2l (pstC)) were patched onto BHI X-gal plates containing 600 mg 1'1 
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Figure 6.2 
Protease activity of SVS region mutants, compared to SH1000, on a milk plate. 
Strains 1) SHIM, 2) MJH502 (SH 1000 sigB) 3) 8325-4,4) JLA555 (SH 1000 hin 10 
(lysC. )), 5) JLA601 (SHI000 asd), 6) JLA603 (SHI000 dapA), 7) JLA556 (SHI000 
aht2 (ykuQ)), 8) LES153 (SH1000 hipO), 9) JLA557 (SHI000 aht5 (lysA)), 10) 
LES154 (SH 1000 ac1P), 11) JLA558 (SH 1000 aht4 (telA)), 12) JLA559 (SH 1000 
hrnQ)) and 13) LES155 (SHI000 norQ) were patched onto a milk plate (Chapter 
2.16.3) and incubated overnight at 37 T. Results are representative of two independent 
experiments. 
228 
Cl {APTER 6 
X-gal. The level of blue colouration of the strains is shown in Figure 6.3. This gives a 
qualitative estimate of hla:: lacZ transcription in the strains. 
The mutant htn2l (SH1000 hla:: lacZ htn2l) was found to be non-blue, whilst JLA553 
(SH1000 hla:: lacZ htn2l (pstC)) demonstrated a level of blue colouration similar to the 
wild-type. Therefore, mutation of pstC does not result in the increased blue colouration 
shown by the SVS mutants analysed in Chapter 6.2.1.1. The genes for which 
inactivation by Tn551 is known to cause increased blue colouration in the JLA513 
(SH1000 hla:: lacZ) background are between SA1426 and SA1445. Therefore, psiC 
(SA1423) represents a possible boundary upstream of these genes whereby Tn551 
insertion does not result in the phenotype demonstrated by the other SVS region 
mutants. Similarly, in Chapter 5.2.5.1.1, the inactivation of hypl was shown to cause 
JLA549 (SH1000 hla:: lacZ htnl7 (hypl)) to demonstrate less blue colouration than 
JLA513 (SH1000 hla:: lacZ) (ie. blue colouration scores of 2 and 3 respectively). 
Consequently, hypl (next to SA1452) represents a possible downstream border of the 
SVS region. A diagram of the SVS region, which is approximately 35 kb in length, is 
shown in Figure 6.4. 
6.2.3 The effect of as on lysC, lysA and telA transcription 
In Chapter 6.2.1.1, inactivation of genes within the SVS region by Tn551 was shown to 
result in increased hla:: lacZ transcription. A possible explanation for this phenotype is 
that the normal function of the SVS region genes is to act as intermediates in the 
repression by aB of agr (and also of hla). Therefore, transposon-mediated inactivation 
of the SVS genes would prevent aB from repressing agr, thus allowing hla transcription 
to be derepressed. In order to test this hypothesis, lacZ reporter gene fusion assays were 
used to determine whether aB regulates the transcription of the three representative SVS 
region genes lysC, lysA and telA. 
The lysC:: lacZ reporter gene fusion was transduced from MDW41 (Wiltshire & Foster, 
2001) into SH1000 and MJH502 (SH1000 sigB) by 411-mediated transduction. This 
produced the strains JLA608 (SH1000 lysC:: lacZ) and JLA609 (SH1000 lysC:: lacZ 
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Figure 6.3 
hla:: lacZ transcription of S. aureus strains, as determined by blue colouration on BHI 
X-gal plates. 
Strains 1) JLA513 (SH 1000 hla:: lacZ), 2) htn2l (SH 1000 hla.. IacZ htn2l) (isolated 
from primary screen in Chapter 5.2.4.1) and 3) JLA553 (SH1000 hla:: lacZ htn21 
(pstC)) (created by transduction of htn2l into JLA513 (SH 1000 hla:: lacZ) in Chapter 
5.2.4.3) were patched onto a BHI agar plate containing 600 mg 1-1 X-gal and incubated 
overnight at 37 °C. Results are representative of two independent experiments. 
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Figure 6.4 
The 35 kb SVS region of the S. aureus genome. 
The genes displayed in red have been repeatedly identified in transposon mutant library 
screens as being involved in S. aureus virulence and survival. Transposon-mediated 
inactivation of these genes has been shown to result in increased blue colouration in the 
JLA513 (SH1000 hla:: lacZ) background on BHI X-gal plates containing 600 mg 1"1 
X-gal. Genes for which transposon-mediated inactivation has been shown not to result 
in this phenotype are represented in blue. Genes for which no known transposon 
mutants were available are shown in green. 
This diagrammatic representation of the SVS region was created by extracting the DNA 
sequence of the entire region from the S. aureus COL database in the TIGR website 
(Chapter 2.17.2). This sequence was compared to the S. aureus 8325 sequence in the 
NCBI BLAST database. The two sequences were shown to be - 99 % identical (data 
not shown). Protein functions and gene names were based on the protein sequence 
analysis shown in Appendix A. 2.10-21, and on information from the COL database in 
the TIGR website. Genes have been assigned numbers based on those of the COL 
genome. 
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sigB) respectively. SPW2 contains Tn917 inserted into lysA (Watson et al., 1998). The 
version of Tn917 used to create SPW2 was carried on the vector pLTV 1 and contains a 
promoterless lacZ gene (Chapter 4.1). In SPW2, Tn917 is inserted in the correct 
orientation to create a lacZ fusion to the lysA promoter (Watson et al., 1998). The 
Tn917-mediated lacZ fusion was transduced from SPW2 to SH1000 and to MJH502 
(SH1000 sigB) to produce JLA610 (SH1000 lysA:: Tn917) and JLA611 (SH1000 
IysA:: Tn917 sigB) respectively. The telA:: lacZ reporter gene fusion was transduced 
from J68 (Lithgow & Foster, unpublished) to MJH502 (SH1000 sigB) to produce 
JLA612 (SH1000 telA:: lacZsigB). 
JLA608 (SH1000 lysC:: lacZ), JLA609 (SH1000 lysC:: lacZ sigB), JLA610 (SH1000 
lysA:: Tn917), JLA611 (SH1000 lysA:: Tn917 sigB), J68 (SH1000 telA:: lacZ) and 
JLA612 (SH1000 telA:: lacZ sigB) were grown in BHI, as described in Chapter 2.7. 
Growth was measured spectrophotometrically as OD600 (Chapter 2.6.1), and lacZ 
reporter gene fusion expression was measured using MUG, as described in Chapter 2.8. 
The transcription of the lysC:: lacZ fusion in JLA609 (SH1000 lysC:: lacZ sigB) was 
1.4-fold higher than in JLA608 (SH1000 IysC:: lacZ) at t= 10 h (ie. 685 and 486 MUG 
units respectively) (Figure 6.5a). Similarly, the transcription of the lysA:: lacZ fusion in 
JLA611 (SH1000 lysA:: Tn917 sigB) was 0.9-fold lower than in JLA610 (SH1000 
lysA:: Tn917) at t= 10 h (ie. 881 and 978 MUG units respectively) (Figure 6.5b). The 
transcription of the telA:: lacZ fusion in JLA612 (SH1000 te1A:: lacZ sigB) was 0.96- 
fold lower than in J68 (SH1000 telA:: lacZ) at t= 10 h (ie. 1611 and 1675 MUG units 
respectively) (Figure 6.5c). This suggests that aB is unlikely to regulate lysC, lysA or 
telA. 
6.2.4 The effect of transposon insertions within the SVS region on aB 
activity 
In Chapter 6.2.3, aB was shown not to regulate the transcription of three representative 
genes within the SVS region. Therefore, the normal roles of the SVS region genes are 
unlikely to involve functioning as intermediates in the repression by 6 of agr (and 
also of hla). Alternatively, however, the SVS region genes may act upstream of 
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Figure 6.5a 
The effect of aB on lysC:: lacZ transcription. 
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S. aureus JLA608 (SHI000 lysC:: lacZ) (0 and ") and JLA609 (SH1000 lysC:: lacZ 
sigB) (0 and  ) were grown in BHI as described in Chapter 2.7. Growth was measured 
spectrophotometrically as OD600 (open symbols) (Chapter 2.6.1), and lacZ fusion 
expression was measured using MUG (closed symbols) as in Chapter 2.8. Results are 
representative of two independent experiments. 
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Figure 6.5b 
The effect of a° on lysA:: lacZ transcription. 
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S. aureus JLA610 (SH1000 lysA:: Tn917) (0 and ") and JLA611 (SH1000 
lysA:: Tn917 sigB) (0 and  ) were grown in BHI as described in Chapter 2.7. Growth 
was measured spectrophotometrically as OD600 (open symbols) (Chapter 2.6.1), and 
lacZ fusion expression was measured using MUG (closed symbols) as in Chapter 2.8. 
Results are representative of two independent experiments. 
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Figure 6.5c 
The effect of aB on telA:: lacZ transcription. 
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S. aureus J68 (SH1000 telA:: lacZ) (0 and ") and JLA612 (SH1000 telA:: lacZ sigB) 
(0 and  ) were grown in BHI as described in Chapter 2.7. Growth was measured 
spectrophotometrically as OD600 (open symbols) (Chapter 2.6.1), and lacZ fusion 
expression was measured using MUG (closed symbols) as in Chapter 2.8. Results are 
representative of two independent experiments. 
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this pathway and themselves activate aB, thus allowing aB to repress agr and hla 
through unknown intermediates. Inactivation of the SVS region genes by transposon 
insertion would therefore prevent aB from being activated. Consequently, agr would be 
derepressed, allowing hla to be transcribed at a high level. In order to test this 
hypothesis, the effects of the SVS region genes on aB activity were examined. As 
described in Chapter 1.6.2.2.8, aB is mainly regulated at the level of activity of the SigB 
protein, rather than at the level of transcription. Although no assay to directly measure 
the activity of aB is available, the level of aB activity can be estimated from the 
expression of two aB-dependent markers. These are the production of alkaline shock 
protein 23 (Asp23) (Kullik et al., 1998; Gertz et al., 1999; Miyazaki et al., 1999; 
Giachino et al., 2001), and the yellow pigment staphyloxanthin (Kullik et al., 1998; 
Giachino et al., 2001). The asp23 gene has a single aB-dependent promoter (Kullik et 
al., 1998; Gertz et al., 1999; Miyazaki et al., 1999), and sigB mutants lack 
staphyloxanthin, resulting in the loss of the characteristic yellow colony colouration of 
S. aureus (Kullik et al., 1998; Giachino et al., 2001). 
6.2.4.1 The use of Asp23 production as a measure of aB activity 
To determine the effects of Tn551-inactivation of the SVS region genes on aB using 
Asp23 expression as a marker of aB activity, SH1000, MJH502 (SH1000 sigB), and the 
representative SVS region mutants JLA555 (SH1000 htn10 (IysC)), JLA558 (SH1000 
aht4 (IelA)) and JLA559 (SH1000 brnQ)) were grown in BHI for 14 h as described in 
Chapter 2.18.1. Total cellular protein samples were prepared as in Chapter 2.18.3.2, and 
separated on SDS-PAGE gels as in Chapter 2.18.4. 
Although the molecular mass of Asp23 is predicted to be 19.2 kDa, Asp23 was found to 
have an apparent molecular mass of 23 kDa on protein gels (Kullik et al., 1998). An 
21 kDa band was identified which was present in large amounts in SH1000 but which 
was weakly expressed in MJH502 (SH1000 sigB), JLA555 (SH1000 htnl0 (lysC)), 
JLA558 (SH1000 aht4 (telA)) and JLA559 (SH1000 brnQ)) (Figure 6.6). N-terminal 
sequencing (Chapter 2.18.6) of this protein revealed the amino acid sequence 
VDNNXAXQAYDXQ. The assigned amino acids showed 100 % identity to the 
sequence of Asp23 of S. aureus (Chapter 2.17.2). 
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Figure 6.6 
The effect of SVS region genes on aß activity, as determined by the production of Asp23. 
Strains 1) SIl1000,2) MJ11502 (SHI000 sigB), 3) JLA555 (SHI000 htn10 (lvsO), 4) 
JLA558 (SII1000 uh14 (te/A)) and 5) JLA559 (Sl{1000 brnQ)) were grown in BHI for 14 
h as described in Chapter 2.18.1. Total cellular protein samples were prepared as in 
Chapter 2.18.3.2, and separated on 12 % (w/v) SDS-PAGE gels as in Chapter 2.18.4. 
Lanes contain total cellular proteins from 0.1 OD600 unit of culture. Results are 
representative of two independent experiments. Sizes of Sigma low molecular weight 
makers are shown. 
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6.2.4.2 The use of staphyloxanthin production as a measure of UB activity 
To determine the effect of Tn551-inactivation of the SVS region genes on aB using 
staphyloxanthin production as a marker of aB activity, SH1000, MJH502 (SH1000 
sigB), JLA555 (SH1000 htn10 (lysC)), JLA601 (SH1000 asd), JLA603 (SH1000 dapA), 
JLA556 (SH1000 aht2 (ykuQ)), LES153 (SH1000 hipO), JLA557 (SH1000 aht5 
(IysA)), LES154 (SH1000 aciP), JLA558 (SH1000 aht4 (telA)), JLA559 (SH1000 
brnQ)) and LES155 (SH1000 norQ) were patched onto BHI agar plates and incubated 
overnight at 37 T. 
The results of this experiment are shown in Figure 6.7. The degree of staphyloxanthin 
production can be visualised as the level of yellow colouration of the strains. All of the 
SVS region mutants produced less staphyloxanthin than wild-type SH1000, as shown 
by paler colouration. No yellow colouration was observed for MJH502 (SH1000 sigB). 
6.2.5 The role of DNA topology in the SVS phenotype 
Transposon insertion into genes of apparently unrelated function within the SVS region 
has been shown to result in almost identical mutant phenotypes (Chapters 6.2.1 and 
6.2.4). Therefore, it is possible that the phenotypes demonstrated by the SVS region 
mutants result from a general alteration in DNA topology caused by the physical 
insertion of transposon DNA within the SVS region, rather than the loss of actual gene 
function. To determine whether the insertion of exogenous DNA within the SVS region 
can cause an increase in protease activity similar to that resulting from transposon 
insertion, SH1000, JLA555 (SH1000 htn10 (IysC)) and JLA608 (SH1000 lysC:: lacZ) 
were patched onto a milk plate and grown overnight at 37 T. Whereas in JLA555 
(SH1000 htn10 (IysC)) IysC has been inactivated by Tn551, JLA608 (SH1000 
lysC:: lacZ) possesses a functional copy of IysC and contains an additional exogenous 
promoterless ß-galactosidase gene fused to a second IysC promoter. 
JLA608 (SH1000 lysC:: lacZ) did not demonstrate the same increase in protease activity 
compared to SH1000 as JLA555 (SH1000 htn10 (lysC)) (Figure 6.8). 
f 
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Figure 6.7 
The effects of SVS region gene mutation on a' activity, as determined by production of 
the yellow pigment staphyloxanthin. 
Strains 1) SHIM, 2) MJH502 (SH 1000 sigB), 3) JLA555 (SH 1000 htn 10 (lysC)), 
4) JLA601 (SH 1000 asd), 5) JLA603 (SH 1000 dapA), 6) JLA556 (SH 1000 aht2 
(ykuQ)), 7) LES153 (SH1000 hipO), 8) JLA557 (SHI000 ah15 (lysA)), 9) LES154 
(SH 1000 ac1P), 10) JLA558 (SH 1000 aht4 (telA)), 11) JLA559 (SH 1000 hrnQ)) and 
12) LES155 (SH1000 norQ) were patched onto BHI agar plates and incubated 
overnight at 37 °C. Results are representative of two independent experiments. 
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Figure 6.8 
Determination of whether the phenotypes resulting from transposon insertion within 
the SVS region are caused by alterations in DNA topology. 
Strains 1) SH1000,2) JLA555 (SH1000 htn10 (lysC)) and 3) JLA608 (SHI000 
lysC:: lacZ) were patched onto a milk plate and grown overnight at 37 °C. Results are 
representative of two independent experiments. 
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6.3 Discussion 
The genes IysC (SA1428), asd (SA1429), dapA (SA1430), ykuQ (SA1432), hipO 
(SA1433), IysA (SA1435), ac1P (SA1439), telA (SA1441), brnQ (SA1443) and norQ 
(SA1445) are clustered together within the SVS region of the S. aureus genome, and 
have been repeatedly identified in transposon mutant library screens as being involved 
in S. aureus virulence and survival. The inactivation of these genes was found to result 
in increased hla:: lacZ transcription to a similar level in each of the mutants. However, 
Tn551-mediated inactivation of the genes encoding the phosphate ABC transporter 
permease protein PstC (SA1423) and the hypothetical protein Hypl (immediately 
upstream of SA1551) did not increase hla:: lacZ transcription. Therefore, pstC 
(SA1423) and hypl (immediately upstream of SA1551) represent the possible upstream 
and downstream borders of the SVS region. However, transposon mutants containing 
insertions between SA1424 - SA1427 and SA1446 - SA1551 were not available. 
Consequently, the actual boundaries within which Tn551 insertion causes the 
phenotypes displayed by the tested SVS region mutants could not be determined. 
Furthermore, it would be also important to investigate the effects of inactivation of 
dapB, dal, SA1436, cspD, SA1438, SA1440, SA1442 and SA1444 on hla:: lacZ 
transcription to determine whether inactivation of all of the genes within the SVS region 
results in the same phenotype. However, no transposon mutants containing insertions 
within these genes were available to be tested. 
In addition to increasing hla:: lacZ transcription, inactivation of lysC, asd, dapA, ykuQ, 
hipO, lysA, ac1P, telA, brnQ and norQ was found to increase protease activity and 
decrease the activity of a-B. Therefore, it is possible that a function of the genes within 
the SVS region is to activate aB activity, allowing aB to repress agr (and hla, proteases 
and perhaps other agr-upregulated virulence determinants). However, the effect of 
inactivation of the representative SVS region genes on the level of hla:: lacZ 
transcription, and on the activity of proteases and aB, was slightly less than that 
resulting from the inactivation of sigB. This suggests that a level of redundancy exists in 
the interaction of the SVS region genes with e. 
As described in Chapter 1.6.2.2.8, B. subtilis possesses a number of genes involved in 
upregulating aB activity (ie. rsbP, rsbQ, rsbR, rsbS, rsbT and rsbX) that are absent from 
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the S. aureus genome (Kalman et al., 1990; Wise and Price, 1995; Wu et al., 1996). In 
B. subtilis, the Rsb proteins regulate a13 activity in response to signals detected by two 
separate pathways; RsbP and RsbQ constitute the energy stress pathway, whilst RsbS, 
RsbT, RsbR and RsbX form part of the environmental stress pathway (reviewed by 
Price, 2002). It is possible that the SVS region genes may replace the functions of the 
missing rsb genes. Alternatively, it is possible that the pathway(s) by which & is 
activated in S. aureus are fundamentally different to those in B. subtilis, and that the 
SVS region genes play a role in upregulating & activity via a novel mechanism. It is 
conceivable that the SVS region genes may be involved in activating a° activity in S. 
aureus in response to different signals to those in B. subtilis, as the environmental 
conditions encountered by the soil bacterium B. subtilis and the human pathogen S. 
aureus will presumably differ greatly. 
The SVS region includes the 8-gene dap operon which is involved in the biosynthesis of 
the aspartate family amino acids (Chapter 5.3; Wiltshire & Foster, 2001). The branched- 
chain amino acid transporter brnQ (Vijaranakul et al., 1997; Vijaranakul et al., 1998) is 
also present within the SVS region. Furthermore, although telA has been implicated in 
tellurite-resistance, it has been proposed that this might occur as a secondary effect of a 
particular metabolic function rather than through the action of a distinct resistance 
determinant (Taylor, 1999). Indeed, a telA mutant was isolated in a Tn917 mutant 
library screen to identify genes involved in stationary-phase amino acid starvation 
survival (Watson et al., 1998). Therefore, a number of genes within the SVS region may 
have roles in amino acid biosynthesis and uptake. S. aureus and other bacteria adapt to 
amino acid limitation via the stringent response (reviewed by Cashel & Rudd, 1987). 
This involves the synthesis of (p)ppGpp by rel (Gentry et al., 2000; Cassels & Knowles, 
1995). (p)ppGpp inhibits RNA polymerase, resulting in a rapid reduction in the 
synthesis of housekeeping gene mRNA to conserve the limited stock of amino acids 
(Vogel & Jensen, 1994). Conversely, in E. coli, (p)ppGpp has been shown to upregulate 
the synthesis of proteins involved in amino acid biosynthesis or uptake (Barker et al., 
2001). An additional way to provide a supply of amino acids during amino acid 
starvation could be to upregulate the expression of virulence determinants (eg. 
haemolysins and proteases) that could potentially scavenge amino acids from the host or 
surrounding environment. This may explain why, in the SVS region mutants containing 
transposon insertions within genes involved in amino acid biosynthesis/uptake (which 
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would have possessed a lower pool of their respective amino acid(s)), a-haemolysin and 
protease expression was increased. 
However, the SVS region genes (including the dap operon genes, brnQ and telA) have 
been shown to upregulate aB activity. Therefore, the increased expression of these 
amino acid biosynthesis/uptake genes following amino acid starvation would potentially 
lead to an increase in aBactivity, resulting in a concomitant increase in the repression of 
agr and virulence determinant expression. Consequently, the pathway(s) by which 
inactivation of genes with putative functions in amino acid biosynthesis/uptake within 
the SVS region might lead to increased virulence determinant expression in S. aureus 
remain unclear. Additional work to determine the effects of amino acid starvation on the 
expression of these genes in S. aureus is required. It would also be useful to determine 
whether genes located outside of the SVS region that have a putative role in amino acid 
biosynthesis/uptake or other functions have similar effects on h1a transcription and the 
activity of proteases and o-B. 
Furthermore, is it important to note that although a number of genes within the SVS 
region have putative functions in amino acid biosynthesis/uptake, some of the genes 
(eg. norQ and ac1P) are likely to have roles in unrelated processes. However, the 
inactivation of these genes results in almost identical mutant phenotypes to those 
displayed by the amino acid biosynthesis/uptake SVS region mutants. This raises two 
questions. Firstly, are the phenotypes displayed by the SVS region mutants artifacts? It 
is possible that the increased hla:: lacZ transcription observed is caused by a defect in 
the hla:: lacZ reporter gene fusion of the mutants. However, this is extremely unlikely 
since the distance between hla (SA1173) and the SVS region is too great for such a 
defect to have been co-transduced with the transposon insertions when creating the 
strains in the SH10000 hla:: lacZ background to verify the mutant's phenotypes 
(Chapters 5.2.3.4 and 5.2.4.3) (ie. hla is -' 250 kb away from the SVS region and 411 is 
only capable of transducing up to 45 kb of DNA (Novick, 1991)). Nevertheless, it is 
possible that the mutations affect the stability or activity of (3-galactosidase, causing an 
inaccurate estimate of hla transcription to be obtained. However, the altered protease 
and crB activity of the mutants was demonstrated using methods that did not rely on lacZ 
reporter gene fusion expression. Furthermore, the mutant phenotypes are unlikely to be 
caused by insertion of the specific sequences of Tn551 or Tn917 within the S. aureus 
244 
CHAPTER6 
genome, since the insertion of Tn551 into pstC and hypl did not result in increased 
hla:: IacZ transcription. 
Interestingly, attempts to create a collection of mutants containing transposon insertions 
in all of the genes of the S. aureus genome identified the region between genes SA1400 
and SA1455 as a hotspot for the insertion of Tn551 and Tn917 (Horsburgh, 2002). This 
area contains the SVS region. Consequently, the SVS region genes will have been over- 
represented in the pool of transposon mutants screened in this study. However, the SVS 
region mutants display an altered phenotype (ie. increased hla:: lacZ and protease 
expression and reduced aB activity) and are therefore valid mutants regardless of the 
presence of the hotspot. No reason why this region acts as a hotspot could be identified 
in studies by Horsburgh (2002). 
The second question posed by the finding that Tn551 or Tn917-mediated inactivation of 
genes of possibly unrelated function within the SVS region results in almost identical 
phenotypes is; are the phenotypes caused by the loss of actual gene function, or by a 
more general effect such as a change in DNA topology resulting from the physical 
insertion of transposon DNA within the region? A strain containing a promoterless IacZ 
gene inserted after the IysC promoter did not display the same increased level of 
protease activity as the lysC:: Tn551 mutant. This suggests that the insertion of the DNA 
fragment carrying the promoterless lacZ gene was unable to cause a change in DNA 
topology that results in the mutant phenotype. Therefore, it is likely that the mutant 
phenotype is caused by loss of gene function. However, to verify this more 
conclusively, mutants containing intergenic transposon insertions in the SVS region 
could be analysed to determine whether they possess the mutant phenotype. However, 
no such mutants were available. Alternatively, complementation could be used to show 
that the return of the function of the inactivated SVS region genes results in restoration 
of the wild-type phenotype. Complementation of the dap operon, brnQ and telA 
mutations are currently being performed (J. Lithgow, personal communication). 
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CHAPTER 7 
GENERAL DISCUSSION 
7.1 Introduction 
This study focussed on the pathways by which the virulence determinants of S. aureus 
are regulated in the presence and absence of NaCl-mediated stress. The experimental 
results obtained have been discussed in detail at the end of each chapter. However, 
models of the regulatory pathways that control virulence determinant expression under 
the two conditions, based on the findings of this study and of published research, are 
proposed here to provide an overview of the key points. 
7.2 S. aureus virulence determinant regulation in the absence of NaCI- 
mediated stress 
Previous studies have shown that in the absence of NaCI-mediated stress, agr 
upregulates the extracellular virulence determinants (eg. hla and sspA), and represses 
the surface-associated virulence determinants (Recsei et al., 1986, Morfeldt et al., 1988; 
Peng et al., 1988). The agr locus is upregulated by sarA (Chien & Cheung, 1998; Chien 
et al., 1998; Heinrichs et al., 1996) and positively autoregulates itself via the 
autoinducing peptide (AIP) (Ji et al., 1995, Lina et al., 1998). This study showed that al' 
indirectly represses the transcription of agr. aB was also shown to repress hla 
transcription, possibly as a result of reduced agr expression. It has been suggested that 
the increased transcription of hla observed in a sigB background of S. aureus RN6390 
occurred via an elevated level of SarA (Cheung et al., 1999). However, in this study, 
transcriptional and Western blot analysis showed that SarA is not an intermediate in the 
repression by aB of agr or hla. Additionally, the sarA homologues sarHi and rot are 
unlikely to function in this pathway. The genes mediating the repression of agr and hla 
by al' therefore remain unknown. 
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Tn551 mutagenesis identified a number of genes that upregulate aB activity, and which 
consequently repress hla transcription and protease activity. These genes include lysC, 
encoding aspartokinase II; ykuQ, encoding tetrahydrodipicolinate acetyltransferase; 
lysA, encoding diaminopimelate decarboxylase; brnQ, encoding a branched-chain 
amino acid carrier protein; and telA, encoding a tellurite-resistance protein. The genes 
are clustered together within the SVS region of the S. aureus genome. Transposon 
insertions within this region have been found to affect the virulence and survival of S. 
aureus in a large proportion of published transposon mutant library screens (Wiltshire 
& Foster, 2001; Coulter et al., 1998; Mei et al., 1997; Lammers et al., 2000 Vriesema et 
al., 2000; Shaw, 2002; Watson et al., 1998). Other genes within the SVS region were 
also found to upregulate the activity of aB and to repress the activity of proteases and 
the transcription of hla. These genes include asd, encoding aspartate-semialdehyde 
dehydrogenase; dapA, encoding dihydrodipicolinate synthase; hipO, encoding hippurate 
hydrolase; aciP, encoding acylphosphatase; and norQ, encoding nitric-oxide reductase. 
Many of the genes within the SVS region have putative roles in amino acid 
biosynthesis/uptake. However, it is unclear whether these genes affect virulence 
determinant expression via the stringent response. In addition, the functions of many 
other genes within the region are predicted to be unrelated to amino acid accumulation. 
However, the finding that all of the available mutants with transposon insertions in SVS 
region genes displayed similar phenotypes was unlikely to be an artifact or due to 
transposon insertion altering DNA topology within the region. The pathway(s) by which 
transposon insertions within the SVS region affect virulence determinant expression 
remain undetermined. 
In the absence of NaC1-mediated stress, other environmental signals may affect 
virulence determinant expression via aB (possibly through the SVS region genes), or via 
aB-independent pathway(s). In this and other studies, the sensor/regulator system 
saeS/saeR has been shown to upregulate h1a (Giraudo et al., 1994; Giraudo et al., 1996; 
Goerke et al., 2001). This is likely to occur independently of agr, since Giraudo et al. 
(1997) have shown that sae has no effect on agr transcription. 
The proposed regulatory pathways controlling virulence determinant expression in the 
absence of NaCl-mediated stress are represented diagramatically in Figure 7.1. 
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Environmental signals (other than NaC l-mediated stress) 
+ +1-? 
I Sensor/regulators and/or other mechanisms? 
+/ - 
lysC, as4 dapA, ykuQ hipO, 
lysA, aciP, telA, brnQ, norQ 
(and other SVS region genes? ) 
Extracellular 
virulence 
determinants 
(eg. hla and sspA) 
Surface- 
associated 
virulence 
determinants 
Figure 7.1 
Proposed model for the regulation of S. aureus virulence determinants in the absence of 
NaCl-mediated stress (+ and -= positive and negative regulation respectively, AIP = 
autoinducing peptide). 
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7.3 S. aureus virulence determinant regulation in the presence of NaCI- 
mediated stress 
In this study, lacZ fusion analysis showed that 1M NaCI represses the transcription of 
h1a and spa, but has no significant effect on agr transcription. This agrees with the 
findings of Chan & Foster (1998a) and Lindsay and Foster (1999), and suggests that 
virulence determinants, which are usually regulated by agr, might come under the 
control of a novel regulatory system in the presence of a high concentration of NaCl. 
Indeed, the repression of h1a transcription by & increased in the presence of 700 mM 
NaCl. This indicates that aB plays a role in virulence determinant regulation in response 
to NaCI in S. aureus. However, h1a was repressed by 700 mM NaCl in a sigB 
background. Overall, this suggests that the regulation of virulence determinant 
transcription in response to NaCI in S. aureus occurs via both &3-dependent and &- 
independent pathways. 
Tn917 mutant library screening identified a number of novel genes involved in 
regulating virulence determinant expression in response to NaCl, including citG, 
encoding fumarase; opuD, encoding a glycine betaine transporter; yugT, encoding exo- 
alpha- 1,4-glucosidase; oppF, encoding an oligopeptide ABC transporter ATP-binding 
protein; ykrP, encoding a protein homologous to putative integral membrane proteins 
and acetyltransferases; eprH, encoding a protein involved in endopeptidase resistance 
and peptidoglycan biosynthesis; yubA, encoding a conserved hypothetical membrane 
protein; and unkl and unk2, encoding proteins for which putative functions could not be 
defined. Tn917-mediated inactivation of these genes partially de-repressed the activity 
of an agr-dependent haemolytic factor (probably Hla) in the presence of 1M NaCl, but 
had no effect in the absence of added NaCl. These genes are likely to be involved in the 
aB-independent pathway by which virulence determinants are regulated in response to 
NaCl, rather than the aB-dependent pathway, as the screen was performed in the 8325-4 
background. As discussed in Chapter 3.1,8325-4 possesses a defect in rsbU, a gene 
involved in the upregulation of aB activity (Kullik & Giachino, 1997). 
The SVS region genes tested were found to have putative roles in the c r'-dependent 
regulation of virulence determinant expression in response to NaCl. It is possible that 
the genes upregulate aB to a greater extent in the presence than in the absence of NaCl- 
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mediated stress. aB would therefore be able to repress hla to a greater extent than in the 
absence of the NaCl signal, perhaps via a novel regulator which assumes control in the 
presence of NaCl of otherwise agr-regulated virulence determinants. It is possible that 
the aB-dependent and aB-independent pathways converge on a common regulator in 
order to alter virulence determinant expression in response to NaCl, or that the two 
pathways mediate their effects via two completely separate mechanisms. Lindsay and 
Foster (1999) have shown that NaCI upregulates sspA. It is unknown whether the genes 
isolated in the transposon mutagenesis screens are involved in this process. 
The NaCI-stress signal is probably detected via sensor/regulator system(s) and/or other 
sensory mechanism(s). For example, Tn551-mediated inactivation of saeS, the sensor 
component of a sensor/regulator system, was found to prevent hla transcription from 
being repressed appropriately in the presence of NaCl. It is therefore possible that saeS 
may play a role in sensing NaCl. The fact that the phenotypes displayed by the 
transposon mutants on agar plates supplemented with NaCl could not be reproduced in 
liquid culture containing added NaCI is interesting. This suggests that S. aureus 
evaluates and responds to the NaCl signal in relation to additional environmental 
parameters (eg. aeration) in order to allow virulence determinant expression to be 
regulated in a sensitive, sophisticated manner. 
The proposed regulatory pathways controlling virulence determinant expression in the 
presence of NaC1-mediated stress are represented diagramatically in Figure 7.2. 
7.4 Concluding remarks 
This study investigated the regulation of S. aureus virulence determinant expression in 
the presence and absence of NaCl-mediated stress. The role of known regulators was 
assessed, and novel regulatory components were identified by transposon mutagenesis. 
Under both conditions, virulence determinant regulation was found to be complex, 
involving a number of putative pathways. This highlights the fact that the stringent 
control of virulence determinant expression in response to the prevailing conditions is 
of fundamental importance to this highly versatile pathogen. 
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NaCl stimulus (and other environmental signals? ) 
/'+/_? \+/_? 
I saes/saeR? 
+? 
lysC, asd, dapA, ykuQ, hipO, 
lysA, aciP, teLl, brn a norQ 
(arid other SVS region genes? ) 
1 
aB 
'+' 
hla (and the majority of 
extracellular and 
surface-associated 
virulence determinants? ) 
Other sensor/regulators 
and/or other mechanisms? 
citG, opuD, yugT, oppF, ykrP, 
eprH, yubA, unk] and unkt 
sspA (and other 
proteases? ) 
Figure 7.2 
Proposed model for the regulation of S. aureus virulence determinants in the presence 
of NaCI-mediated stress (+ and -= positive and negative regulation respectively. 
+ and 
-= increased level of positive and negative regulation compared to that occurring in the 
absence of NaCI-mediated stress respectively). 
251 
CHAPTER 7: DISCUSSION 
7.5 Future directions 
During this study, transposon mutant library screening isolated novel genes with 
putative roles in the regulation of S. aureus virulence determinants in the presence and 
absence of NaCI-mediated stress. However, the ability to further analyse the roles of 
these genes in the NaCI-mediated stress response is limited by the fact that the 
phenotypes displayed by the mutants in the presence of NaCI are not reproducible in 
liquid culture and are therefore difficult to quantify. However, it may be possible to 
identify proteins that bind to the hla promoter in the presence of NaCI by affinity 
chromatography. 
Experiments to further characterise the roles of the SVS region genes in virulence 
determinant regulation in the absence of NaCl-mediated stress could be performed. For 
example, whether the SVS region genes tested control & activity by acting upstream or 
downstream of rsbU could be determined by Northern blot analysis. Furthermore, 
although the phenotypes of many SVS region mutants were analysed in this study, 
mutations in a number of SVS region mutants were unavailable during this project. The 
effects of these genes on ß° activity and the expression of hla and proteases could be 
examined to determine whether all of the genes within the region have the same 
function. 
Whether the phenotypes of the SVS region mutants are caused by lowered amino acid 
pools could be investigated by determining whether the phenotypes can be 
complemented by the addition of the respective amino acid(s). It would also be 
interesting to ascertain whether genes involved in amino acid biosynthesis/uptake that 
reside outside of the SVS region have the same effects of c activity and virulence 
determinant expression. 
Finally, complementation by introducing a functional copy of the genes/operons 
inactivated in the mutants could be used to further clarify whether the mutant 
phenotypes are caused by loss of gene function or alterations in DNA topology. 
Complementation of the dap operon, brnQ and telA mutations is currently being 
performed by J. Lithgow (Sheffield University). 
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APPENDIX 
A. 1 Growth media 
A. 1.1 BHI 
Component Weight (g 1" ) 
Calf brain infusion solids 12.5 
Beef heart infusion 
solids 
5.0 
Proteose peptone 10.0 
Glucose 2.0 
Sodium chloride 5.0 
Di-Sodium phosphate 2.5 
Table A. 1.1 
List of ingredients of BHI (Oxoid) 
A. 1.2 Blood agar base 
Component Weight (g fl) 
Proteose peptone 15.0 
Liver digest 2.5 
Sodium chloride 5.0 
Yeast extract 5.0 
Agar 12.0 
Table A. 1.2 
List of ingredients of Blood agar base (Oxoid) 
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A. 2 Sequence analysis 
The following Figures show the alignments of genomic DNA sequencing reaction data 
with S. aureus COL DNA to identify the site of transposon insertion (Chapter 2.17.2). 
Genes were assigned numbers according to the S. aureus COL database. Results of 
BLASTP searches to identify putative homologues (Chapter 2.17.2) are also shown. 
Please note that the sequences corresponding to the terminus of the transposon have 
been removed from the sequencing reaction data. Sequence data therefore only shows S. 
aureus genomic DNA sequence. Putative homologues have been allocated NCBI 
accession numbers, and where possible, the top 5 hits are shown. Hits against S. aureus 
proteins are shown only where the function of the protein has been determined by 
experimentation, rather than by homology to other proteins. Identity = percentage and 
number of identical amino acids. 
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Figure A. 2.1 
JLA401 (8325-4 hanl (unkl)) 
Identities = 100 % (215/215) 
Query: 215 CTCCTTTCTTCTTATATAACAATTCTTCTAACATGATATGTTACTATTGAATTACTGAAC 156 
I11111II11111111I1111111111I11111111111IIIIIIIIIIIIIIIIIIIII 
SbjCt: 1950039 CTCCTTTCTTCTTATATAACAATTCTTCTAACATGATATGTTACTATTGAATTACTGAAC 1950098 
Query: 155 CTGAGTTAGTTATAATCTAACTTATATTGAAAAGAGATGAGGCGTAAGATATGTTTTTAT 96 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
SbjCt: 1950099 CTGAGTTAGTTATAATCTAACTTATATTGAAAAGAGATGAGGCGTAAGATATGTTTTTAT 1950158 
Query: 95 GTAAAAGACAAATTGATATCAATGCACGATTTGGTTTGCCTAGAATTGCATTTATGAGTG 36 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
Sbjct: 1950159 GTAAAAGACAAATTGATATCAATGCACGATTTGGTTTGCCTAGAATTGCATTTATGAGTG 1950218 
Tn917 
Query: 35 CAGTTGCAACCATCATTATGTTTTTAGTTAGTTAT 1 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
Sbjct: 1950219 CAGTTGCAACCATCATTATGTTTTTAGTTAGTTAT 1950253 
Tn917 was found to have inserted into the same base in JLA410 (8325-4 han10 (unkl)) 
as in JLA401 (8325-4 haul (unkl)). 
The transposon insertion was in SA1896. BLASTP hits against the protein sequence of 
SA1896 are shown in the table below. 
Accession Protein Organism Identity Expect 
no. 
NC_002570 BH 1182, unknown B. halodurans 27 % le-1 1 
(48/175) 
NC_003210 1mo2218, unknown L. monocyt- 22 % 8e-09 
o genes EGD-e (39/175) 
NC_003212 1in2321, unknown L. innocua 26 % 2e-07 
47/180 
NC_004193 Conserved hypothetical O. iheyensis 23 % 6e-07 
protein 42/182 
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Figure A. 2.2 
JLA402 (8325-4 han2 (citG)) 
Identities = 100 % (229/229) 
Query: 229 CTGGTTTATAAACATTCAATTCAAAGTTACCTTGTGAACTTGCGAAGCCAACAACTGTAT 170 
IIIIIIIIIIIIIIIII11111IIIIIIII11111111II111111111111111IIIII 
Sbjct: 1963868 CTGGTTTATAAACATTCAATTCAAAGTTACCTTGTGAACTTGCGAAGCCAACAACTGTAT 1963927 
Query: 169 CATTACCCATTACTTGGACTGCAACCATTGTTAACATTTCACATTGTGTAGGATTAACTT 110 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIilll11111111111111111111111 
Sbjct: 1963928 CATTACCCATTACTTGGACTGCAACCATTGTTAACATTTCACATTGTGTAGGATTAACTT 1963987 
Query: 109 TACCAGGCATAATTGATGAACCTGGTTCATTTTCAGGGATAGAAATTTCTGCCAAACCAG 50 
1111111111111111111111111IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
SbjCt: 1963988 TACCAGGCATAATTGATGAACCTGGTTCATTTTCAGGGATAGAAATTTCTGCCAAACCAG 1964047 
Tn917 
1 =ý17 
Query: 49 CTCGTGGCCCTGAAGCCAACCATCTCACATCATTAGCAATTTTCATTAA 1 
111111111111111111111111111111111111111II11111111 
Sbjct: 1964048 CTCGTGGCCCTGAAGCCAACCATCTCACATCATTAGCAATTTTCATTAA 1964096 
Tn917 was found to have inserted into the same base in JLA403 (8325-4 han3 (citG)), 
JLA405 (8325-4 han5 (citG)), JLA406 (8325-4 han6 (citG)), JLA407 (8325-4 han7 
(citG)), JLA408 (8325-4 han8 (citG)) as in JLA402 (8325-4 han2 (citG)). 
The transposon insertion was in SA1908. BLASTP hits against the protein sequence of 
SA1908 are shown in the table below. 
Accession Protein Organism Identity Expect 
no. 
NC_000964 Fumarate hydratase, Class-II B. subtilis 66 % e-176 
(fumarase), CitG (307/460) 
NC_000921 Fumarase H. pylori J99 61 % e-163 
284/461 
NC_003210 Similar to fumarate hydratase L. monocyt- 63 % e-162 
o genes EGD-e 289/456 
NC 
_002163 
Fumarate hydratase, Class II C. jejuni 60 % e-161 
fumarase) (280/461) 
NC_000913 Fumarate hydratase class II E. coli K12 60 % e-157 
(Fumarase), FumC 277/458 
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Figure A. 2.3 
JLA404 (8325-4 han4 (unk2)) 
Identities = 98 % (236/240) 
Te917 
0 
Query: 1 TAATAGAAAACTAATTAATAAACTCATAATCGCTAAAAATGCAGCGTATCCTAATAATGG 60 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII11111111111111IIII 
Sbjct: 1429162 TAATAGAAAACTAATTAATAAACTCATAATCGCTAAAAATGCAGCGTATCCTAATAATGG 1429221 
Query: 61 TTGATATTTTATATCTTGAAAATTTGGAATAAAAAATGCAAGCACACCTAATATAACAAA 120 
IIIIIIII111111111111111111IIIIIIIIIIIIIIIIIIIIIIII1111111111 
SbjCt: 1429222 TTGATATTTTATATCTTGAAAATTTGGAATAAAAAATGCAAGCACACCTAATATAACAAA 1429281 
Query: 121 TGTAATTACTGCAGATACAAACCATTTATTTAAAACTAAGCAACAGAATATTGTTAATAA 180 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
Sbjct: 1429282 TGTAATTACTGCAGATACAAACCATTTATTTAAAACTAAGCAACAGAATATTGTTAATAA 1429341 
Query: 181 AATCATTATTAANNGTTGTGATCCATAAATAATTAGGCATATNGAATAATGNCATATTCA 240 
IIIIIIIIIIII IIIIIIIIIIIIIIIIIIIIIIIIIIII 11111111 11111111 
Sbjct: 1429342 AATCATTATTAAT-GTTGTGATCCATAAATAATTAGGCATATCGAATAATGTCATATTCA 1429400 
The transposon insertion was in SA1418. BLASTP hits against the protein sequence of 
SA1418 are shown in the table below. 
Accession Protein Organism Identity Expect 
no. 
NC_003902 Conserved hypothetical X campestris 40 % 3.1 
protein pv campestris (20/50) 
str. ATCC33913 
NC_003919 Conserved hypothetical X axonopodis 40 % 3.1 
protein v. citri str. 306 (20/50) 
NC_004193 Hypothetical protein O. iheyensis 32 % 6.9 
(25/78) 
NC_003551 Uncharacterized protein M. kandleri 36 % 9.0 
AV19 (23/63) 
NC_003902 Conserved hypothetical X campestris 40 % 3.1 
protein pv. campestris (20/50) 
str. ATCC33913 
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Figure A. 2.4 
JLA409 (8325-4 han9 (opuD)) 
Identity = 100 % (240/240) 
Tn917 
0 
Query: 1 AACTAGGTAAACCAAATGACAAACCTGAGTTTAATACAATTTCATGGTTTGCTATGTTGT 60 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
SbjCt: 1388637 AACTAGGTAAACCAAATGACAAACCTGAGTTTAATACAATTTCATGGTTTGCTATGTTGT 1388696 
Query: 61 TTAGTGCTGGTATGGGGATAGGTTTGGTGTTTTATGGTGCAGCTGAACCGATGGCGCACT 120 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII111111111 
Sbjct: 1388697 TTAGTGCTGGTATGGGGATAGGTTTGGTGTTTTATGGTGCAGCTGAACCGATGGCGCACT 1388756 
Query: 121 TTGCTACGCCACCTACAGCAGATCCCAAAACTACTGAAGCTTATACTGAAGCTCTACGTT 180 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
Sbjct: 1388757 TTGCTACGCCACCTACAGCAGATCCCAAAACTACTGAAGCTTATACTGAAGCTCTACGTT 1388816 
Query: 181 CAACATTTTTCCATTGGGGATTCCATGCTTGGGCTGTTTATGGTGTTGTTGCGTTAGCGT 240 
II11111111111IIIIII1111111111111111IIIIIItItII11111I11111111 
Sbjct: 1388817 CAACATTTTTCCATTGGGGATTCCATGCTTGGGCTGTTTATGGTGTTGTTGCGTTAGCGT 1388876 
The transposon insertion was in SA1384. BLASTP hits against the protein sequence of 
SA1384 are shown in the table below. 
Accession Protein Organism Identity Expect 
no. 
000964 NC Glycine betaine transporter B. subtilis 56 % e-150 
_ OpuD (278/496) 
NC_003212 Glycine betaine transporter L. innocua 56 % e-141 
BetL 285/506 
NC_003210 Glycine betaine transporter L. monocyt- 48 % e-144 
BetL o genes EGD-e (284/506) 
004116 NC Transporter, BCCT family S. agalactiae 51 % e-122 
_ protein 2603 WR 265/518 
NC_003995 BCCT, BCCT family B. anthracis 48 % e-116 
transporter A2012 243/504 
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Figure A. 2.5 
JLA411 (8325-4 hanll (yugT)) 
Identity = 100 % (211/211) 
Query: 211 AAATTAACTTTGGCATCATAATTAAATAGCTTTACTTCTCCATGGCTTAAATCAAATGGT 152 
I111111I11111111vIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
Sbjct: 1586876 AAATTAACTTTGGCATCATAATTAAATAGCTTTACTTCTCCATGGCTTAAATCAAATGGT 1586935 
Query: 151 ACAGTTAATTCTGCTTCGTGGTTAGTAAGATTACCTACAATAAGAACTTGCTTTTCATTT 92 
IIII111IIIIIIIIII111IIIIIII111111111111111I11111111111111111 
Sbjct: 1586936 ACAGTTAATTCTGCTTCGTGGTTAGTAAGATTACCTACAATAAGAACTTGCTTTTCATTT 1586995 
Query: 91 AATGTTCTCGTGTACGCAAAAACTTGTGAATTTTCAGCATCTACTAAATCAAATTGACCA 32 
111111111IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
Sbjct: 1586996 AATGTTCTCGTGTACGCAAAAACTTGTGAATTTTCAGCATCTACTAAATCAAATTGACCA 1587055 
Tn917 
Query: 31 TATACGTATACATCATTAGACTTTCTTAATT 1 
IIIIIIII11111111111IIIIIIIIIIII 
Sbjct: 1587056 TATACGTATACATCATTAGACTTTCTTAATT 1587086 
The transposon insertion was in SA1551. BLASTP hits against the protein sequence of 
SA1551 are shown in the table below. 
Accession Protein Organism Identity Expect 
no. 
NC_003366 Exo-alpha-1,4-glucosidase C. perfringens 59 % e-188 
(329/555) 
000964 NC Exo-alpha-1,4-glucosidase B. subtilis 56 % e-180 
_ homolog YugT (308/549) 
002570 NC Oligo-1,6-glucosidase B. halodurans 53 % e-173 
_ (296/556) 
NC_003210 Similar to oligo-1,6- L. monocyt- 47 % e-154 
glucosidase o genes EGD-e 261/554 
NC_000964 Oligo-1,6-glucosidase B. subtilis 48 % e-152 
268/555 
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Figure A. 2.6 
JLA412 (8325-4 han12 (oppF)) 
Identity = 100 % (240/240) 
Tn917 
IIZ7Z, 7 
Query: 1 AGTTAGACCTCTGTAATAATATAACGCTTCTTTTAATGAGGTCTCAATCGTCCAATCAGG 60 
IIIIIIIIIIIIIIIIIIII1111111111111111111111IIIII1111111111111 
SbjCt: 1425892 AGTTAGACCTCTGTAATAATATAACGCTTCTTTTAATGAGGTCTCAATCGTCCAATCAGG 1425951 
Query: 61 GTTAAAGCTAGTTAAAGGGTGTTGGAAAATCGGTAACACAGCATTGTCACTTAAGTAAAT 120 
IIII1111111IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII111111 
Sbjct: 1425952 GTTAAAGCTAGTTAAAGGGTGTTGGAAAATCGGTAACACAGCATTGTCACTTAAGTAAAT 1426011 
Query: 121 CTCTCCTTTAACAGGTTTAAACAAGCCAAGAACCAATGAAGCGAGCGTACTTTTACCACA 180 
III 11111lIIIIIIIIII111111111III11111111111111111111111111111 
Sbjct: 1426012 CTCTCCTTTAACAGGTTTAAACAAGCCAAGAACCAATGAAGCGAGCGTACTTTTACCACA 1426071 
Query: 181 GCCACTTTCGCCTAAAATACCAACATTTTCTCCATCAGGTATAGTAATATTGATATCTTG 240 
IIIIIIIIIII111111IIIIIIII1111111111111111IIIIIIIIIIIIIIIIIII 
SbjCt: 1426072 GCCACTTTCGCCTAAAATACCAACATTTTCTCCATCAGGTATAGTAATATTGATATCTTG 1426131 
The transposon insertion was in SA1414. BLASTP hits against the protein sequence of 
SA1414 are shown in the table below. 
Accession Protein Organism Identity Expect 
no. 
NC_003305 Oligopeptide ABC transporter, A. tumefaciens 37 % le-32 
ATP binding protein str. C58 (81/218) 
NC000921 ABC transporter, ATP-binding H. pylori J99 34 % le-32 
protein (87/249) 
NC_004113 ABC transporter ATP-binding T. elongatus 33 % 2e-30 
protein BP-1 80/242 
NC_003047 Putative ATP-binding protein S. meliloti 37 % 5e-32 
of oligopeptide ABC (82/218) 
transporter 
NC_003454 Oligopeptide ABC transporter F. nucleatum 31 % 5e-30 
ATP-bindin protein OppF ATCC 25586 (70/223) 
1 
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Figure A. 2.7 
JLA413 (8325-4 han13 (ykrP)) 
Identity = 96 % (231/240) 
Tn917 
',; ý7 
Query: 1 AAAGATAAGTCATTAATGATATAGGATTATCGAATGGGTACCATTCAAATCCTCTAACAA 60 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
SbjCt: 1066017 AAAGATAAGTCATTAATGATATAGGATTATCGAATGGGTACCATTCAAATCCTCTAACAA 1066076 
Query: 61 TGCCAATAATTAAACCATGTAATAAATATACGTATAGCGTACGACTACCAATATAAGTAT 120 
III11111111IIIIIIIIIIIIIIIIIIIIIII111111111I111111IIIII11111 
Sbjct: 1066077 TGCCAATAATTAAACCATGTAATAAATATACGTATAGCGTACGACTACCAATATAAGTAT 1066136 
Query: 121 ATAATNTTTTCTTTGNNGACATTAAATTTAGAAACGCAGTCATTGCGANTAATATAATTC 180 
Hill 111111111 11111111111 
SbjCt: 1066137 ATAATTTTTTCTTTGTTGACATTAAATTTAGAAACGCAGTCATTGCGATTAATATAATTC 1066196 
Query: 181 CATATAANATAAGNNGTTTAAAAGGACTGAATATACTNNGTCCTTCATTTTCAAGTGAAG 240 
IIIIIII IIIII IIIIIIIIIIIIIIIIIIIIII IIIIIIIIIIIIIIIIIIIII 
Sbjct: 1066197 CATATAATATAAGTCGTTTAAAAGGACTGAATATACTCTGTCCTTCATTTTCAAGTGAAG 1066256 
The transposon insertion was in SA1059. BLASTP hits against the protein sequence of 
SA1059 are shown in the table below. 
Accession Protein Organism Identity Expect 
no. 
NC_003210 Similar to B. subtilis YkrP L. monocyt- 40 % 3e-56 
protein ogenes EGD-e (113/281) 
NC_000964 Conserved hypothetical B. subtilis 35 % le-49 
protein YkrP (100/278) 
003888 NC Putative integral membrane S. coelicolor 25 % 5e-26 
_ protein A3 2 (75/296) 
NC_002678 Acetyltransferase, M loti 23 % le-09 
modulation protein NoIL (73/309) 
NC_003030 O-actetyl transferase related C. acetobutylicum 23 % 6e-08 
protein 71/296 
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Figure A. 2.8 
JLA414 (8325-4 han14 (eprH)) 
Identity = 100 % (228/228) 
Query: 228 AGTTAAATATGCAATTATCTAGTATTAATAATAGAATTAGTAAAACCGAAGAACTAATAT 169 
IIIIIIIIIII111111IIIIIIIIIIIIII11111IIIIIIIII1111111I1111111 
Sbjct: 1274971 AGTTAAATATGCAATTATCTAGTATTAATAATAGAATTAGTAAAACCGAAGAACTAATAT 1275030 
Query: 168 TTGAAGATGGACCTGTTTTGGATTTAGCTGCTGCTTTATTTATATGTACTGATGATGAAG 109 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
SbjCt: 1275031 TTGAAGATGGACCTGTTTTGGATTTAGCTGCTGCTTTATTTATATGTACTGATGATGAAG 1275090 
Query: 108 TTTATTATCTATCAAGTGGATCAAATCCGAAATATAATCAGTATATGGGTGCATATCATC 49 
IIIII11111111111111IIIIIIIIIIIIIIIIIIIIIIIIIIIIII11111111111 
Sbjct: 1275091 TTTATTATCTATCAAGTGGATCAAATCCGAAATATAATCAGTATATGGGTGCATATCATC 1275150 
Tn917 
0 
Query: 48 TACAATGGCATATGATAAAATATGCAAAATCACATAATATTAATAGGT 1 
11111111I111111111111111111111111111111111111111 
Sbjct: 1275151 TACAATGGCATATGATAAAATATGCAAAATCACATAATATTAATAGGT 1275198 
The transposon insertion was in SA1265. BLASTP hits against the protein sequence of 
SA1265 are shown in the table below. 
Accession Protein Organism Identity Expect 
no. 
AB015195.1 EprH S. aureus MW2 100% 0.0 
(414/414) 
AJ250765.1 Alanine adding enzyme MurN S. pneumoniae 26 % 2e-30 
(110/416) 
NC_003028 Beta-lactam resistance factor S. pneumoniae 26 % 2e-30 
(110/416) 
NC_004116 Beta-lactam resistance factor S. agalactiae 24 % 7e-28 
2603 V/R (102/416) 
NC_002737 Putative peptidoglycan S. pyogenes M1 24 % 6e-27 
branched peptide synthesis GAS (101/416) 
protein, alanine adding 
enzyme 
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Figure A. 2.9 
JLA415 (8325-4 han15 (yubA)) 
Identity = 100 % (239/239) 
Query: 239 TTTCACCAAATATCATGGGTAAAACACTTAAGATTCATCCACTTACAATCATTTTCATTT 180 
IIIII111111IIIII111111111IIIIIIIIIIII1111IIIIIIIIIIIIIIIIIII 
SbjCt: 1404538 TTTCACCAAATATCATGGGTAAAACACTTAAGATTCATCCACTTACAATCATTTTCATTT 1404597 
Query: 179 TACTGTGTGCAGGCAAATTGCTTGGTATTGTAGGCGTTATTTTAGGTATTCCGGGATATG 120 
111111IIIIIII111111111111111111111IIIIIIIIIIIIIIIIIIII111111 
Sbjct: 1404598 TACTGTGTGCAGGCAAATTGCTTGGTATTGTAGGCGTTATTTTAGGTATTCCGGGATATG 1404657 
Query: 119 CTATTTTAAAAGTATTAGTTACTCATTTATTCCAATTATTTAAACGTCGATACAATCGTT 60 
IIII111111IIIII11111111111IIIIIIIIIIIIIIII1111111I11111I1111 
SbjCt: 1404658 CTATTTTAAAAGTATTAGTTACTCATTTATTCCAATTATTTAAACGTCGATACAATCGTT 1404717 
Tn917 
Query: 59 TCTATGGTAATGATGTAGGTGAATATGATATTAAAGAAAGTAATAAAATAGT 1 
111111111111IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
Sbjct: 1404718 TCTATGGTAATGATGTAGGTGAATATGATATTAAAGAAAGTAATAAAATAGT 1404769 
Tn917 was found to have inserted into the same base in JLA416 (8325-4 han16 (yubA)) 
as in JLA415 (8325-4 han15 (yubA)). 
The transposon insertion was in SA1395. BLASTP hits against the protein sequence of 
SA1395 are shown in the table below. 
Accession Protein Organism Identity Expect 
no. 
NC_003210 Conserved hypothetical L. monocyt- 38 % 3e-79 
membrane protein ogenes EGD-e (142/367) 
NC_000964 Conserved hypothetical B. subtilis 40 % 4e-79 
protein YubA 149/366 
NC003212 Conserved hypothetical L. innocua 38 % 2e-78 
membrane protein 142/367 
NC_003995 UPF0118, Domain of B. anthraces 35 % 3e-62 
unknown function DUF20 A2012 (132/376) 
NC_004116 Membrane protein, putative S. agalactiae 30 % 2e-56 
2603V/R 120/390 
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Figure A. 2.10 
JLA515 (SH1000 hla:: lacZhla+ahtl (rsbU)) 
Identity = 93 % (224/240) 
Tn531 
0 
Query: 1 CTGTAGATTATACTTTTAAGCTNNNNNNNNCTTTAGGATGGAATNTCTAAAGCCTAAAAA 60 
III11111 IIIIIIIIIIIII 11111111111I11 11111111111III 
SbjCt: 2123979 CTGTAGATGATACTTTTAAGCTAAAAAAAACTTTAGGATGGAATACCTAAAGCCTAAAAA 2124038 
Query: 61 ACTTACNACATCCTTTTATAATAAAAAATATGAATATCATANCTGGTATTTGCTAAAATC 120 
11111 III 1111111111111111111IIIIIIIIIIII IIIIIIIIIIIIIIIIII 
SbjCt: 2124039 ACTTAAGACATCCTTTTATAATAAAAAATATGAATATCATAACTGGTATTTGCTAAAATC 2124098 
Query: 121 TTTGTTNATAAGAAAATTCTTCGTNCAGAATTTAGAAATAGTTATAATTATTATAAAGTT 180 
111111 IIItII111I1I1I111 IIIIIIIIIIIIIIIIIIII11111111111IIII 
Sbjct: 2124099 TTTGTTTATAAGAAAATTCTTCGTACAGAATTTAGAAATAGTTATAATTATTATAAAGTT 2124158 
Query: 181 ATTGNCTTTTATATCAATATTTTATTTATCTCTGAAAAATACATATAATAGACGCCTAAT 240 
IIII IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
Sbjct: 2124159 ATTGTCTTTTATATCAATATTTTATTTATCTCTGAAAAATACATATAATAGACGCCTAAT 2124218 
Tn917 was found to have inserted into the same base in JLA521 (SH1000 hla:: IacZ 
hla+ aht7 (rsbU)), JLA522 (SH1000 hla:: IacZ hla+ aht8 (rsbU)), JLA523 (SH1000 
hla:: IacZ hla+ aht9 (rsbU)), JLA533 (SH1000 hla:: IacZ hla+ htnl (rsbU)), JLA534 
(SH1000 hla:: lacZ hla+ htn2 (rsbU)), JLA535 (SH1000 hla:: IacZ hla+ htn3 (rsbU)), 
JLA536 (SH1000 hla:: IacZ hla+ htn4 (rsbU)), JLA537 (SH1000 h1a:: lacZ hla+ htn5 
(rsbU)), JLA538 (SH1000 h1a:: lacZ hla+htn6 (rsbU)), JLA539 (SH1000 hla:: lacZ hla+ 
htn7 (rsbU)), JLA540 (SH 1000 hla:: lacZhla+htn8 (rsb U)), JLA541 (SH 1000 hla:: lacZ 
hla+ htn9 (rsbU)) and JLA546 (SH1000 hla:: IacZ hla+ htnl4 (rsbU)) as in JLA515 
(SH1000 hla:: lacZhla+ahtl (rsbU)). 
The transposon insertion was in a putative regulatory region of SA2057. BLASTP hits 
against the protein sequence of SA2057 are shown in the table below. 
Accession Protein Organism Identity Expect 
no. 
CAA71065.1 Sigma factor aB regulation S. aureus COL 99 % e-178 
protein RsbU (332/333) 
AF359562.1 Sigma factor as regulation S. epidermidis 84 % e-155 
protein RsbU (282/333) 
BAA19307.1 Sigma factor aB regulation B. subtilis 37 % 2e-54 
protein RsbU (126/332) 
AAN75461.1 RsbU L. 39% e-57 
mono to eves 129/330 
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Figure A. 2.11 
JLA516 (SH1000 h1a:: lacZ hla+ aht2 (ykuQ:: Tn551)) 
Identity = 98 % (217/221) 
Query: 221 AATATATAAGTGATGCTAAAA-GTCTACACCAATAAAAGTATATTTAAATNGTAATTTTG 163 
II1111111111111111111 IIIIIIIIIIIIIIIIIIIIIIIIIIII 111111111 
SbjCt: 1444528 AATATATAAGTGATGCTAAAAAGTCTACACCAATAAAAGTATATTTAAATGGTAATTTTG 1444587 
Query: 162 AAGGCATCACATATCCAGAAAGTTTTAAAGTATTTGGTTCANAACAATCTAAAGTAATCT 103 
1111111111111111111111111111111111111IIII IIIIIIIIIIIIIIIIII 
SbjCt: 1444588 AAGGCATCACATATCCAGAAAGTTTTAAAGTATTTGGTTCAGAACAATCTAAAGTAATCT 1444647 
Query: 102 TTTGTGAAGCGGATGATTGAAAACCTTTTTACGAAGCATATGGTAGTCAATTCGAAGATA 43 
IIIIIIIIIIIIIIIIIII IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
Sbjct: 1444648 TTTGTGAAGCGGATGATTGGAAACCTTTTTACGAAGCATATGGTAGTCAATTCGAAGATA 1444707 
Tn551 
0 
Query: 42 TAGAAATTGAAATGGATCGTCGCAATTCTGCTATTCCATTAA 1 
IIIIIIII1111IIIIIIIIIIII1111111IIIIIIIIIII 
Sbjct: 1444708 TAGAAATTGAAATGGATCGTCGCAATTCTGCTATTCCATTAA 1444749 
Tn917 was found to have inserted into the same base in JLA517 (SH 1000 hla:: lacZ hla+ 
aht3 (ykuQ:: Tn551)) as in JLA516 (SH1000 hla:: IacZhla+aht2 (ykuQ:: Tn551)). 
The transposon insertion was in SA1432. BLASTP hits against the protein sequence of 
SA1432 are shown in the table below. 
Accession no. Protein Organism Identity Expect 
AF306669.1 Tetrahydrodipicolinate S. aureus 100 % e-120 
acetyltransferase YkuQ 8325-4 (239/239) 
9866 F6 Tetrahydrodipicolinate B. subtilis 60 % 2e-64 
_ succinylase homolog YkuQ (142/233) 
NP_470347.1 Similar to tetrahydro- L. innocua 57 % 9e-63 
dipicolinate succinylase (136/236) 
BAB81615.1 Probable tetrahydro- C. perfringens 58 % 3e-60 
di icolinate succinylase str. 13 (133/228) 
AAM24087.1 Tetrahydrodipicolinate N- T. 55 % 6e-58 
succin ltransferase ten con ensis 126/229 
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Figure A. 2.12 
JLA518 (SH1000 hla:: lacZ h1a+ aht4 (teL4)) 
Identity = 96 % (231/240) 
Tn551 
Query: 1 ATGATTTNTTAACAGCAAATGCTGAAATGTTGAAACANAATGCGATTGAAACTGCAACAG 60 
1111111 IIIIIIIIIIIIIIIII111111111111 III1111111111111111111 
SbjCt: 1452361 ATGATTTATTAACAGCAAATGCTGAAATGTTGAAACAAAATGCGATTGAAACTGCAACAG 1452420 
Query: 61 NCCCCCGNGCGTGGCATTGTTGATCTTGATACATTGAAACGTACACAGCGTAACATTATT 120 
I I111111111111111111111111111IIIIIIIIIIIIIIIIIIIIIIII 
Sbjct: 1452421 AAAAT-GAGCGTGGCATTGTTGATCTTGATACATTGAAACGTACACAGCGTAACATTATT 1452479 
Query: 121 GAGACAATTGAAGAAACATTAATTATTCAACAACACGGTCGCGAAGAACGACAATTAGCT 180 
111111IIIIIIIIIIIIIIIIIIIIIIIIIIIIIII11111IIIIIIIIIIIIIIIIII 
Sbjct: 1452480 GAGACAATTGAAGAAACATTAATTATTCAACAACACGGTCGCGAAGAACGACAATTAGCT 1452539 
Query: 181 GAAAAAGAATTACAACAATTAGAACAAGATTTAAAGTCACATTTAGTGAACATCAAAGGA 240 
IIIIIIIIIIIIIIIIIIIIIIIIIII1111111IIIIIIIIIIIIIIIIIIIIIIIIII 
Sbjct: 1452540 GAAAAAGAATTACAACAATTAGAACAAGATTTAAAGTCACATTTAGTGAACATCAAAGGA 1452599 
Tn917 was found to have inserted into the same base in JLA547 (SH1000 hla:: lacZ hla+ 
hin 15 (telA)) and JLA548 (SH1000 hla:: lacZ hla+ htn16 (telA)) as in JLA518 (SH1000 
hla:: IacZ hla+ aht4 (telA)). 
The transposon insertion was in SA1441. BLASTP hits against the protein sequence of 
SA1441 are shown in the table below. 
Accession Protein Organism Identity Expect 
no. 
NC_004461 Tellurite resistance protein S. epidermidis 66 % e-107 
(248/375) 
NC_004668 Tellurite resistance protein E. faecalis 50 % 4e-75 
(171/342) 
AAB93480.1 Tellurite resistance protein R. sphaeroides 33 % 6e-50 
TeIA 115/342 
AAA98154.1 Tellurite resistance protein, K aerogenes 28 % le-36 
Te1A (106/370) 
AE015943.1 Tellurite resistance protein C. tetani 27 % 9e-36 
101/365 
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Figure A. 2.13 
JLA519 (SH1000 hla:: IacZ hla+ aht5 (lysA)) 
Identity = 98 % (201/205) 
Query: 205 TGTAACTATAGCTGGAAAATTATGTGAGTCTTGGTGATTATCATTATTAAAGACGCTAAA 146 
IIIIIII11111111111111I111111111 111111 IIIIIIIIIIIIIIIIIIIII 
SbjCt: 1448609 TGTAACTATAGCTGGAAAATTATGTGAGTCT-GGTGAT-ATCATTATTAAAGACGCTAAA 1448666 
Query: 145 TTACCTTCATCAGTCAAACGTGGAGACCTATCTTGCTATATTATCAACTGGTGCATATCA 86 
111111111111111111111111111 111111111111111111111III11111III 
Sbjct: 1448667 TTACCTTCATCAGTCAAACGTGGAGAC-TATCTTGCTATATTATCAACTGGTGCATATCA 1448725 
Query: 85 TTACTCTATGCCATCCAATTACAATCAAATGCAAAAGCCTTCTGTGTTTTTCTTAAAAGA 26 
IIIIIIIIII IIIIIIIIIIIIIIIIIIIIIIIIIIII111111111111111111111 
Sbjct: 1448726 TTACTCTATGGCATCCAATTACAATCAAATGCAAAAGCCTTCTGTGTTTTTCTTAAAAGA 1448785 
Tn551 
Query: 25 TGGCAAAGCACGTGAAGTTATAAAG 1 
111111I1111111IIIIIIIIIII 
Sbjct: 1448786 TGGCAAAGCACGTGAAGTTATAAAG 1448810 
Tn917 was found to have inserted into the same base in JLA543 (SH1000 hla:: lacZ hla+ 
htnll (lysA)), JLA544 (SH1000 hla:: lacZ hla+ htnl2 (lysA)), JLA545 (SH1000 
hla:: lacZ hla+ htnl3 (lysA)) and JLA552 (SH1000 hla:: lacZ hla+ htn20 (lysA)) as in 
JLA519 (SH1000 hla:: lacZ hla+ aht5 (lysA)). 
The transposon insertion was in SA1435. BLASTP hits against the protein sequence of 
SA1435 are shown in the table below. 
Accession no. Protein Organism Identity Expect 
AF306669_8 Diaminopimelate S. aureus 100 % 0.0 
decarboxylase LysA 8325-4 (421/421) 
BAA12662.1 Diaminopimelate B. subtilis 49 % e-115 
decarboxylase LysA (210/423) 
AH1318 Diaminopimelate L. mono- 46 % e-106 
decarboxylase homolog LysA cytogenes (200/427) 
EGD-e 
AAM2351 1.1 Diaminopimelate T. 48 % e-106 
decarboxylase ten con ensis 206/426 
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Figure A. 2.14 
JLA520 (SH1000 hla:: lacZhla+aht6 (brnQ)) 
Identity = 93 % (194/208) 
Tn551 
0 
Query: 1 TATAAAGTTAATTTTCAGCCAACCTAACTTACTAATAACACTGAAAATCGACAATATAAA 60 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIII111111111111111111111111111111 
SbjCt: 1453753 TATAAAGTTAATTTTCAGCCAACCTAACTTACTAATAACACTGAAAATCGACAATATAAA 1453812 
Query: 61 TNCNATNATAACNGGAATTTGTTGNGAAATGCGTTTTGNCGGNNTGAATTTGGCAATTAA 120 
11 II 11111 11111111111 1111111111111 III II11111111111111 
Sbjct: 1453813 TACGATAATAACTGGAATTTGTTGTGAAATGCGTTTTGTCGGTATGAATTTGGCAATTAA 1453872 
Query: 121 AATTAATNATNCAACNGTTNTTGNTACTGGGTATACAATGCTTAATACCGGAATTGACAT 180 
1111111 II 1111 III III IIII11111111111111111111111111111111 
Sbjct: 1453873 AATTAATAATACAACAGTTATTGCTACTGGGTATACAATGCTTAATACCGGAATTGACAT 1453932 
Query: 181 TGNGATAACAGCATTTAAACCTTGGTTA 208 
II 1111111IIIIIIIIIIIIIIIIII 
Sbjct: 1453933 TGAGATAACAGCATTTAAACCTTGGTTA 1453960 
The transposon insertion was in SA1443. BLASTP hits against the protein sequence of 
SA1443 are shown in the table below. 
Accession no. Protein Organism Identity Expect 
AAC38146.1 Branched-chain amino acid S. aureus 84 % e-150 
carrier protein BrnQ RN450 (361/429) 
NP_764645.1 Branched-chain amino acid S. epidermidis 74 % e-155 
carrier protein BrnQ (333/447) 
NP_246812.1 BrnQ P. multocida 47 % 3e-90 
(209/436) 
G97940 Branched-chain amino acid S. pneumoniae 38 % le-64 
transport system II carrier (168/437) 
protein Brn 
C69596 Branched-chain amino acid B. subtilis 39 % 5e-62 
transporter Brag 172/440 
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Figure A. 2.15a 
JLA524 (SH1000 hla:: lacZhla+ahtl0 (yjbH)) 
Identity = 99 % (202/203) 
TnSSl 
0 
Query: 1 ATCTGGATATTTAAGTTTTTCAATTTTTTGTTGAATGGCTAACTTCTTTAANTCTTTGTT 60 
1111111111111111111111IIIIIIIIII111111111111111IIII IIIIIIII 
Sbjct: 1015395 ATCTGGATATTTAAGTTTTTCAATTTTTTGTTGAATGGCTAACTTCTTTAACTCTTTGTT 1015454 
Query: 61 TAAAAGTTTTTCTGGCCATTCATAAATAGTAAGTAATTCTTCCATCGTTACAAGTTGTTG 120 
IIIItIIIIIIIIIIIII11111IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
SbjCt: 1015455 TAAAAGTTTTTCTGGCCATTCATAAATAGTAAGTAATTCTTCCATCGTTACAAGTTGTTG 1015514 
Query: 121 TTGCTGTATATAAGTTTCTAATTTAGGAGGAAGATTCTTTTCGATAGGTTTACCCATCAA 180 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII11111 
SbjCt: 1015515 TTGCTGTATATAAGTTTCTAATTTAGGAGGAAGATTCTTTTCGATAGGTTTACCCATCAA 1015574 
Query: 181 TTCATTAATTATATAAGTATAGA 203 
III 1111111111111 IIIII11 
Sbjct: 1015575 TTCATTAATTATATAAGTATAGA 1015597 
Tn917 was found to have inserted into the same base in JLA525 (SH1000 hla:: lacZ hla+ 
ahtl l (yjbH)) as in JLA524 (SH1000 hla:: lacZ hla+ahtl0 (yjbH)). 
The transposon insertion was in SA1006. BLASTP hits against the protein sequence of 
SA1006 are shown in the table below. 
Accession no. Protein Organism Identity Expect 
H69843 Hypothetical protein YjbH B. subtilis 31 % 7e-28 
(81/261) 
AB1553 B. subtilis YjbH protein L. innocua 29 % 4e-27 
homolog 1in0963 (75/253) 
AD 1195 B. subtilis YjbH protein L. mono- 28 % 2e-26 
homolog 1mo0964 cytogenes (73/253) 
EGD-e 
NP_655103.1 Hypothetical protein B. anthraces 26 % 5e-23 
76/288 
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Figure A. 2.15b 
JLA526 (SH1000 hla:: lacZ hld ahtl2 (yjbH)) 
Identity = 99 % (207/210) 
Query: 210 ACAGTCACAAATCATTGATTCTGTAATAATATCTCTTTTAGGTATGATTTCATTTTGCAT 151 
I111111111111111111IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII1111 
SbjCt: 1015788 ACAGTCACAAATCATTGATTCTGTAATAATATCTCTTTTAGGTATGATTTCATTTTGCAT 1015847 
Query: 150 TAAATGTATAAATCGTTCN-CACGTACACGACCTTGTAACTCAGCTGCTTTATAAGCTAG 92 
IIIIIIIIIIIIIIIIII IIIIIIIIIIIIIIIIIIIII11111111111IIIIIIII 
Sbjct: 1015848 TAAATGTATAAATCGTTCGACACGTACACGACCTTGTAACTCAGCTGCTTTATAAGCTAG 1015907 
Query: 91 GNCGATGTTATCAAAGTTGGATGTACTTTGAGCTTGGCATTTCGTTAANACTTTTAACGA 32 
I IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII11111111 11111111111 
Sbjct: 1015908 GGCGATGTTATCAAAGTTGGATGTACTTTGAGCTTGGCATTTCGTTAATACTTTTAACGA 1015967 
TnSS1 
0 
Query: 31 AGGATTTAATATATGTCTGATACGTATATAT 1 
IIIIIIIIIIIIIIIII1111111IIIIIII 
Sbjct: 1015968 AGGATTTAATATATGTCTGATACGTATATAT 1015998 
Tn917 was found to have inserted into the same base in JLA527 (SH1000 hla:: lacZ hla+ 
ahtl3 (yjbH)) as in JLA526 (SH1000 hla:: lacZ hla+ aht12 (yjbH)). The gene 
inactivated, SA1006, is the same as that inactivated in JLA524 (SH1000 hla:: lacZ hla+ 
aht10 (yjbH)). 
The transposon insertion was in SA1006. BLASTP hits against the protein sequence of 
SA1006 are shown in Figure A. 2.15a. 
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Figure A. 2.16 
JLA528 (SH1000 hla:: IacZ hla+ aht14 (agrB)) 
Identity = 98 % (222/225) 
Query: 225 GAAATAACTTAGATCATATTCAATTTTTGCAAGTACGATTAGGGATGCAGGTCTTAGCTA 166 
I111111III11IIIIIIIIIIIIIII1111111111IIIIi111111111111I11111 
Sbjct: 2083190 GAAATAACTTAGATCATATTCAATTTTTGCAAGTACGATTAGGGATGCAGGTCTTAGCTA 2083249 
Query: 165 AAAATATAGGTAAATTAATTGTTATGTATACTATTGCCTATATTTTAAACATTTTTCTGT 106 
IIII1111111111III11111111111111III11111111I111111I1111111111 
Sbjct: 2083250 AAAATATAGGTAAATTAATTGTTATGTATACTATTGCCTATATTTTAAACATTTTTCTGT 2083309 
Query: 105 TTACGTTAATTACGAATTTAACATTTTATTTAATAAGAAGACATGNACATGGTGCACATN 46 
11111IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 1111111111111 
Sbjct: 2083310 TTACGTTAATTACGAATTTAACATTTTATTTAATAAGAAGACATGCACATGGTGCACATG 2083369 
Tn551 
0 
Query: 45 CACCTTCNTCTTTTTGGTGTTATGTAGAAAGTATTATACTATTTA 1 
IIIIIII IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
SbjCt: 2083370 CACCTTCTTCTTTTTGGTGTTATGTAGAAAGTATTATACTATTTA 2083414 
Tn917 was found to have inserted into the same base in JLA529 (SH1000 hla:: lacZ hla+ 
ahtl5 (agrB)), JLA530 (SH1000 hla:: lacZ hla+ ahtl6 (agrB)) and JLA531 (SH1000 
hla:: lacZ hla+ahtl7 (agrB)) as in JLA528 (SH1000 hla:: lacZ hla+ahtl4 (agrB)). 
The transposon insertion was in SA2023. BLASTP hits against the protein sequence of 
SA2023 are shown in the table below. 
Accession no. Protein Organism Identity Expect 
P21545 Accessory gene regulator S. aureus 99 % le-77 
protein AgrB 8325-4 (188/189) 
1 AF173933 Accessory gene regulator S. lugdunensis 50 % 4e-45 
_ protein AgrB (101/202) 
CAA89193.1 Accessory gene regulator S. epidermidis 52 % 3e-39 
prote AgrB (99/188) 
AF346718_1 Accessory gene regulator S. caprae 43 % 3e-15 
protein AgrB 47/109 
NP_346723.1 Accessory gene regulator C. 27 % 3e-08 
protein B acetobutylicum 47/171 
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Figure A. 2.17 
JLA532 (SH1000 hla:: lacZhla+ahtl8 (saeR)) 
Identity = 97 % (212/218) 
Tn551 
0 
Query: 1 AATAAGTGTTAATTCATCAAACGACAGTTGTTCAACTGGTTGATNATGNNATTTCTTCAT 60 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII III IIIIIIIIII 
SbjCt: 789059 AATAAGTGTTAATTCATCAAACGACAGTTGTTCAACTGGTTGATGATGGTATTTCTTCAT 789118 
Query: 61 CCTTGNAAGTAAATTATTAATACGTAAAACGAGTTCCCTTGGACTAAATGGTTTTTTGAC 120 
fill IIIIII111111111111111111111111111111111111111111111111 
Sbjct: 789119 TCTTGTAAGTAAATTATTAATACGTAAAACGAGTTCCCTTGGACTAAATGGTTTTTTGAC 789178 
Query: 121 ATAGTCATCTGCACCTAAAGTTAAGGCGTAAATGGTATCATGTTCTTGNGTTTTGGCAGT 180 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII IIIIIIIIIII 
SbjCt: 789179 ATAGTCATCTGCACCTAAAGTTAAGGCGTAAATGGTATCATGTTCTTGTGTTTTGGCAGT 789238 
Query: 181 TAAATAGATAAAGGGGATATCTAATTTTTGCCTTTTCA 218 
IIIIIIIIIIIIIt11111111111III1111111111 
SbjCt: 789239 TAAATAGATAAAGGGGATATCTAATTTTTGCCTTTTCA 789276 
The transposon insertion was in SA0766. BLASTP hits against the protein sequence of 
SA0766 are shown in the table below. 
Accession no. Protein Organism Identity Expect 
373916.1 NP Response regulator SaeR S. aureus 100 % e-119 
_ (228/228) 
AE014209_12 DNA-binding response S. agalactiae 46 % 3e-49 
regulator 2603V/R (104/224) 
344631.1 NP DNA-binding response S. pneumoniae 46 % 5e-49 
_ regulator (105/227) 
AF430807_10 VanRE E. faecalis 39% 2e-41 
(91/230) 
NP_655198.1 REC, cheY-homologous B. anthraces 41 % 6e-41 
receiver domain A2012 (92/223 
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Figure A. 2.18 
JLA542 (SH1000 hla:: lacZ hla+ hin 10 (lysC)) 
Identity = 98 % (222/226) 
Query: 226 GAACAATTAATTGTCGTTGTAAGTGCTATGGGTAACACAACAGATCAATTAATGACGAAT 167 
IIIIIIIIIIIIIIIII11111111111111111111IIIIIIIIIIIIIIIIII11111 
SbjCt: 1440703 GAACAATTAATTGTCGTTGTAAGTGCTATGGGTAACACAACAGATCAATTAATGACGAAT 1440762 
Query: 166 GTATCAACCTTGACTAAAGCACCAAAACAACAAGAACTGGCATTATTATTGACAACCGGA 107 
IIIIIIIII11111111II11111IIIIIIIIIIIIII1111111IIIIIII11111111 
SbjCt: 1440763 GTATCAACCTTGACTAAAGCACCAAAACAACAAGAACTGGCATTATTATTGACAACCGGA 1440822 
Query: 106 GAGCAACAAACTGTATCTTATTTATCAATGGTATTAAATGATATCGGNATGAATGCCANN 47 
IIIIIIIIIIIIIIIIIIII111111111111IIIIIIIIIIIIIII II1I111111 
SbjCt: 1440823 GAGCAACAAACTGTATCTTATTTATCAATGGTATTAAATGATATCGGTATGAATGCCAAA 1440882 
Tn551 
Query: 46 GCAATGACTGGCTATCAAGCGGGTATTAAAACCATTGGCNATCATT 1 
11111111111111111IIIIIIl111111111111111 111111 
Sbjct: 1440883 GCAATGACTGGCTATCAAGCGGGTATTAAAACCATTGGCCATCATT 1440928 
The transposon insertion was in SA1428. BLASTP hits against the protein sequence of 
SA1428 are shown in the table below. 
Accession no. Protein Organism Identity Expect 
AF306669_1 Aspartokinase II LysC S. aureus 99 % 0.0 
8325-4 (400/401) 
NP_229318.1 Aspartokinase II LysC T. maritima 40 % 3e-81 
(159/397) 
NP_464760.1 Aspartokinase II alpha L. 41 % le-73 
subunit mono to enes (167/398) 
NP_419660.1 Aspartokinase C. crescentus 38 % le-69 
CB15 159/416 
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Figure A. 2.19 
JLA549 (SH1000 hla:: lacZ hla+ htn17 (hypl)) 
Identity = 100 % (214/214) 
Query: 214 CTAAGTAATAACGTTGATAAAATAATGCAAAATAATCCACCAATAATGCCGGCAATAATA 273 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIºIIIIIIIIIIIIIIIIIIIIIIIIIII 
Sbjct: 1466872 CTAAGTAATAACGTTGATAAAATAATGCAAAATAATCCACCAATAATGCCGGCAATAATA 1466931 
Query: 274 TCTGTTGGATAATGTACACCTAGATATACACGTGATATGGAAATCAATAAAATCATAGCT 333 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
Sbjct: 1466932 TCTGTTGGATAATGTACACCTAGATATACACGTGATATGGAAATCAATAAAATCATAGCT 1466991 
Query: 334 GCACATAACCCTATAAGAATACCTTTTGAATTACCTTGATTTAATCGATTTAATAGATAG 393 
III III III 111111111111111111111111111111111111111111I11111111 
Sbjct: 1466992 GCACATAACCCTATAAGAATACCTTTTGAATTACCTTGATTTAATCGATTTAATAGATAG 1467051 
Query: 394 ATACCACTTCCAAAATATGCAGTTGATCCCATAGCATGACCGCTAGGAAAACTAAATCCT 453 
I1111111111111111111111IIIIIi11111IIIIIIII111111111111111111 
Sbjct: 1467052 ATACCACTTCCAAAATATGCAGTTGATCCCATAGCATGACCGCTAGGAAAACTAAATCCT 1467111 
BLASTX hits against the DNA sequence flanking the transposon insertion are shown in 
the table below. 
Accession no. Protein Organism Identity Expect 
371940.1 NP Hypothetical protein S. aureus Mu50 100 % 5e-30 
_ (57/57) 
NP_374530.1 Hypothetical protein S. aureus N315 100 % 5e-30 
57/57 
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Figure A. 2.20 
JLA550 (SH1000 hla:: IacZ hla+ hin 18 (saeS)) 
Identity = 93 % (210/225) 
Tn551 
"; 7, -7 
Query: 1 CGTTAGCAANTTGCTTAGTTTTTATATTAAACTGCTTAATTTTTTGTATAAGNGGATTAA 60 
IIIIIIIII IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 1111111 
SbjCt: 788549 CGTTAGCAAATTGCTTAGTTTTTATATTAAACTGCTTAATTTTTTGTATAAGTGGATTAA 788608 
Query: 61 TANAANNNCTNCATATTAATAAGGTTAAACAGCTTGNAATTATTGNCGTTAAGGTCAAAG 120 
II II II IIIIIIIIIIIIIIIIIIIIIIIII 11111111 IIIIIIIIIIIIII 
SbjCt: 788609 TAAAAATACTACATATTAATAAGGTTAAACAGCTTGTAATTATTGTCGTTAAGGTCAAAG 788668 
Query: 121 TTAGTNGCATATGGGCCGTTAAACCACATTAAAANATNTGCAATTGNTAAAATAGTTGAA 180 
11111 1111111 IIIIIIillllllllllil II IIIIIIII IIIIIIII11111 
Sbjct: 788669 TTAGTGTCATATGG-CCGTTAAACCACATTAAAATATATGCAATTGCTAAAATAGTTGAA 788727 
Query: 181 GTTAATAGTATACTCGATACGACGCCAATAATGATTTGACTTCTA 225 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII1111 
Sbjct: 788728 GTTAATAGTATACTCGATACGACGCCAATAATGATTTGACTTCTA 788772 
Tn917 was found to have inserted into the same base in JLA551 (SH 1000 hla:: lacZ hla+ 
htn19 (saes)) as in JLA550 (SH1000 hla:: lacZ hla+ htnl8 (saes)). 
The transposon insertion was in SA0765. BLASTP hits against the protein sequence of 
SA0765 are shown in the table below. 
Accession no. Protein Organism Identity Expect 
AF129010_2 Histidine protein kinase SaeS S. aureus 89 % e-147 
Newman (316/353) 
NP344632.1 Sensor histidine kinase S. pneumoniae 33 % 9e-42 
(117/347) 
NP_687428.1 Sensor histidine kinase S. agalactiae 33 % 2e-39 
2603V/R (115/348) 
NP_624089.1 Sensory transduction T. 29 % le-30 
histidine kinases ten con ensis 97/331 
A27650 Phosphate response regulator B. subtilis 30 % 2e-25 
histidine kinase PhoR 72/239 
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Figure A. 2.21 
htn2l (SH1000 hla:: lacZ hla+ htn21 (listG)) 
Identity = 99 % (217/219) 
TnSS! 
ý 
Query: 1 TGTAATAAATATTTGATCCAAATGTTGCATCACCTGTCGNTATCTCAACAATATATCCAG 60 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 11111111111111111111 
SbjCt: 1434114 TGTAATAAATATTTGATCCAAATGTTGCATCACCTGTCGCTATCTCAACAATATATCCAG 1434173 
Query: 61 TCATTGNTTGAATCGAACTTGTTAAACTTAATGAAGCTGTTGGCGAACTACCTGCCGCTA 120 
111111 11111111111111111111111111111111111111111111111111111 
SbjCt: 1434174 TCATTGTTTGAATCGAACTTGTTAAACTTAATGAAGCTGTTGGCGAACTACCTGCCGCTA 1434233 
Query: 121 ATGATACAATCATCGTTTCTCCAATTGCTCTTGAAATCGCGAGAACGATTGAAGCTACAA 180 
IIIIIIIIIIIIIII1111111IIIIIIIIIIIII1111111IIIIIIIIIIIIIIIIII 
Sbjct: 1434234 ATGATACAATCATCGTTTCTCCAATTGCTCTTGAAATCGCGAGAACGATTGAAGCTACAA 1434293 
Query: 181 TACCTGATGTTGCTGCGGGAAGTACGACTTTAGTTGCTA 219 
II1111111111111111111111111111111111111 
Sbjct: 1434294 TACCTGATGTTGCTGCGGGAAGTACGACTTTAGTTGCTA 1434332 
The transposon insertion was in SA1423. BLASTP hits against the protein sequence of 
SA1423 are shown in the table below. 
Accession no. Protein Organism Identity Expect 
NP_279517.1 Phosphate ABC transporter Halobacterium 50 % 1 e-53 
permease PstC sp. NRC-1 (127/253) 
BAC00817.1 Phosphate transport system R. sphaeroides 46 % 2e-49 
permease ABC transporter (120/257) 
protein 
NP 070186.1 Phosphate ABC transporter, A. fulgidus 47 % 6e-49 
_ permease protein PstC (119/251) 
BAC09717.1 Permease protein of T. elongatus 42 % 2e-47 
hos hate ABC transporter BP-1 (113/264) 
NP_540905.1 Phosphate transport system B. melitensis 44 % 5e46 
permease protein PstC 116/260 
116/260 
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